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ADOLESCENT TUBERCULOSIS: THE MISSING MIDDLE
Dodd P.J.1, Kranzer K.2
1School of Health and Related Research, University of Sheffield,
Sheffield;
2Clinical Research Dept., London School of Hygiene and Tropical
Medicine, London, UK
Adolescence is characterised by a dramatic increase in the risk of devel-
oping tuberculosis, a fact that has been appreciated since the early 20th
century. The majority of the world’s adolescents live in low and middle-
income countries where tuberculosis remains common. It is increasingly
apparent that adolescents lie at the heart of the global tuberculosis
epidemic, but they have not yet been addressed as a distinct population
in tuberculosis policy or within tuberculosis treatment services.
We will review the epidemiology of Mycobacterum tuberculosis (M.tb)
infection among 10-24 year olds globally and in high tuberculosis burden
countries. We will discuss the management of M.tb infection and disease,
including HIV co-infection and multidrug resistant tuberculosis. In addi-
tion we will highlight special considerations regarding the tuberculosis
continuum of care during adolescents.
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DISRUPTING POWER DIFFERENTIALS: LEARNINGS FROM THE
YOUTH RESEARCHERS ACADEMY
Mavodza C.V.1,2, Dziva Chikwari C.1,2, Tembo M.1,2, McHugh G.1,2,
Dauya E.2, Grundy C.1, Dringus S.1,2, Kranzer K.1,2, Ferrand R.A.1,2
1London School of Hygiene and Tropical Medicine, London, UK;
2Biomedical Research and Training Institute, Harare, Zimbabwe
Young people are often seen as subordinate to, and/or in the position
where they are only ’learning from’ adults. When thinking about how
the full spectrum of youths’ needs are considered in health care delivery,
then engaging young people as partners in implementation, research
and learning is necessary. As a way of addressing this necessity, we
conducted a Youth Researchers Academy (YRA) to train and involve youth
researchers in health research/projects. Moreover, funders and imple-
menters of research and health projects that focus on youths are keen
to see, know and understand the value (if any) of meaningfully engaging
young people in research and projects about their own health.
We will describe and explore youth engagement activities- the Youth
Researchers Academy, and Youth Advisory Groups that we work with.
We will discuss power shifts, benefits, challenges and opportunities of
meaningfully involving young people in research and projects. In addition,
we will highlight the nuances and value add (reciprocity, bi-directional
exchange of ideas) considerations for youth to youth and/or youth for
youth engagement in research projects.
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PAIRING CHILDREN WITH HEALTH SERVICES: A NEW ROLE FOR
SCHOOL HEALTH SERVICES IN THE 21ST CENTURY
Baltag V.
Dept. of Maternal, Newborn, Child and Adolescent Health, World
Health Organization, Geneva, Switzerland
Introduction: Globally, over 90% of children in the primary school age,
and over 80% of children in the lower secondary school age are enrolled
in school where they spend 1/3 of their time. This makes schools a
unique setting for preventive interventions, and school years an impor-
tant period to establish healthy behaviours that will contribute to a
lifetime of health promotion. This is probably why school health ser-
vices constitute a common way of organizing services in educational
institutions.
Aim: To understand better how school health services are organized, and
what are the priority services and interventions, a global overview of
school health services will be presented describing characteristics such
as target group, providers, staffing level, services, settings, evidence-base
and organizational challenges.
Methods: The literature in 6 databases as well as other sources were
reviewed systematically. New global initiatives calling for a renewed
attention to school health will be highlighted.
Results: School health services exist in some form in at least 102 coun-
tries and territories, and in the majority of cases they are part of routine
service provision. Usually services are provided within school premises (97
countries), by dedicated school health personnel (59 countries). Services
are provided in 16 areas; the top 5 interventions include vaccinations,
sexual and reproductive health education, vision screening, nutrition
screening, and nutrition health education. Routine screening practices
exist in at least 65 countries, and at least 47 have systems for routine
health reviews that include but are not limited to screenings. Good
practices in conducting screenings are rarely reported. Implementation
challenges include luck of adequate budget allocation, staff shortage and
lack of professional development and training, inadequate coordination
among multiple service providers, as well as insufficient evidence of
effectiveness to enable advocacy.
Conclusion: School health services and regular medical check-ups are
common in both LMIC and high- and upper middle- income countries. To
strengthen their role in improving the health of school-age children, the
evidence base needs to be strengthened, and priority health and devel-
opment issues and the content of school health services better aligned.
Recent global initiatives and investment cases provide new opportunities
for school health.
References:
1. Baltag V and Moran D. (2018). Are Routine Health Examinations
Fulfilling their Promise for Prevention? Health Behavior & Policy Review,
2018; 5(6):3-22. DOI: https://doi.org/10.14485/HBPR.5.6.1. https://www.i
ngentaconnect.com/contentone/psp/hbpr/2018/00000005/00000006/a
rt00001;jsessionid=135oho7f8rt0q.x-ic-live-03#
2. Baltag V, Pachyna A, & Hall J. (2015). Global Overview of School
health Services: Data from 102 Countries. Health Behavior & Pol-
icy Review 2[4], 268-283. http://ingentaconnect.com/content/psp/
hbpr/2015/00000002/00000004/art00004
3. Baltag V. & Saewyc E. (2017). Pairing Children with Health Services:
The Changing Role of School Health Services in the Twenty-first Centu-
ryIn: Cherry, A, V. Baltag, and M. Dillon, editors. International handbook
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CHEMICAL WATER QUALITY IN INPATIENT THERAPEUTIC
FEEDING CENTRES: POTENTIAL RISKS TO PAEDIATRIC SEVERE
ACUTE MALNUTRITION PATIENTS AND PROPOSED MANAGE-
MENT STRATEGIES
Ali S.I.1, Turnbull J.1,2, Arnold M.1, Holt F.1,3, Narang T.1, Falade
S.1, Van Der Kam S.4, Fesselet J.F.4, Orbinski J.1
1Dahdaleh Institute for Global Health Research, York University,
Toronto, Canada;
2Dept. of Pediatrics, McGill University, Montreal, Canada;
3The Hospital for Sick Children, Toronto, Canada,
4Public Health Dept., Médecins Sans Frontières, Amsterdam, The
Netherlands
Introduction: Paediatric patients with severe acute malnutrition (SAM)
in intensive therapeutic feeding centres (ITFCs) are highly sensitive to
electrolyte and mineral inputs they receive during treatment. Thus, the
composition of therapeutic feeding (e.g., F75, F100) and other products
(e.g., ReSoMal) used in ITFCs are carefully calibrated with respect to
electrolyte and mineral content. These products, however, are usually
reconstituted using locally available water, which can have widely varying
electrolyte and mineral concentrations, referred to as its chemical
water quality (CWQ). Concerns that elevated levels of electrolytes and
minerals could adversely affect the treatment and recovery of paediatric
SAM patients in ITFCs have existed since 2007 following experiences
in Somalia, and were reignited in 2017 following an unusual mortality
cluster among paediatric SAM patients in an ITFC in Ethiopia.
Aim: At present, we have no guidance on allowable CWQ in ITFC water
supplies. We carried out a knowledge synthesis study in order to propose
provisional CWQ guidelines for ITFCs.
Methods: We adopted the standard water quality risk assessment
approach from public health for the unique context of paediatric SAM
patients in ITFCs. We identified CWQ parameters of concern based
on their metabolic and physiological roles, developed an exposure
assessment tool to determine patient intakes under various clinical
scenarios, carried out a systematic literature review to gather available
data on upper intake limits for this sub-population, and convened a
panel of medical, nutritional, and water experts to integrate findings
and generate provisional recommendations.
Results: We identified a shortlist of CWQ parameters of greatest concern
for this sub-population that included sodium, magnesium, sulphate,
nitrate/nitrite, total dissolved solids, and osmolarity. Provisional CWQ
guidelines for ITFC water supplies are proposed based on best-available
data on upper intake limits for paediatric SAM patients.
Conclusion: Chemical water quality is an under-considered contributor
to patient outcomes in ITFCs despite the importance of electrolyte and
mineral intakes for paediatric SAM patients. The guidance generated by
this project will improve how CWQ issues are managed in emergency
feeding programs and contribute toward improving quality of patient
care in ITFCs.
005
METRONIDAZOLE-SENSITIVE ORGANISMS IN CHILDREN WITH
SAM: AN EVALUATION OF THE INDICATION FOR EMPIRIC
METRONIDAZOLE TREATMENT
Zangenberg M.1,2, Abdissa A.3, Johansen Ø.H.4,5, Tesfaw G.3,
Girma T.6, Friis H.7, Kurtzhals J.A.L.1,2
1Centre for Medical Parasitology, Dept. of Immunology and Micro-
biology, University of Copenhagen, Denmark;
2Dept. of Clinical Microbiology, Copenhagen University Hospital
(Rigshospitalet), Copenhagen, Denmark;
3Dept. of Medical Laboratory Sciences and Pathology, Jimma Uni-
versity, Ethiopia;
4Dept. of Clinical Science, University of Bergen, Bergen, Norway;
5Dept. of Microbiology, Vestfold Hospital Trust, Tønsberg, Norway;
6Dept. of Pediatrics and Child Health, Faculty of Medical Sciences,
Jimma University, Ethiopia;
7Dept. of Nutrition, Exercise and Sports, University of Copenhagen,
Denmark
Introduction: Children with severe acute malnutrition (SAM) are at
increased risk of death due to severe infections. All are given empiric
antibiotic treatment; hospitalized cases with parenteral penicillin and
gentamicin and outpatients with oral amoxicillin. Experts have suggested
adding empiric metronidazole to cover for anaerobic bloodstream
infections and diarrhoea caused by Giardia duodenalis or Clostridioides
difficile. However, there is limited information on the prevalence and
clinical impact of these infections.
Aim: The aim of this study was to assess the prevalence of metronidazole-
sensitive organisms and their association with severity of disease in
children with SAM.
Methods: Children from 0.5 to 15 years with SAM were enrolled in three
sites in Ethiopia. Anaerobic and aerobic blood cultures were obtained,
positive samples sub-cultured, isolates frozen at -80◦C and shipped to
Denmark followed by identification with MALDI-TOF. In addition, stool
samples were collected, frozen and tested for C. difficile (toxin B gene),
G. duodenalis and Entamoeba histolytica using PCR. Clinical outcome
data were collected by study staff during admission and from medical
records.
Results: A total of 334 children were enrolled, a stool sample was
obtained from 218 (65%), aerobic blood culture from 273 (82%), and
anaerobic blood culture from 153 (46%). Four percent of the children
had bacteraemia, but none with strict anaerobic bacteria. G. duodenalis
was detected in 57%, toxigenic C. difficile in 6%; no E. histolytica
were detected. The children with G. duodenalis weighed less and
more often had bilateral oedema. Detection of C. difficile in stool was
associated with increased mortality (OR 43.34, 95%CI 3.89; 482.93).
However, detection of Giardia and C. difficile was not associated with
diarrhoea.
Conclusion: Our results do not provide support for a strategy of
empirically treating with metronidazole to cover for anaerobic blood
stream infection. The high prevalence of G. duodenalis and C. difficile
suggests that trials evaluating the effect of empiric metronidazole should
include an examination of stool samples to assess the effect on these
organisms.
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COMMUNITY HEALTH WORKER LED ART DELIVERY (CLAD)
IMPROVED SCHEDULED ANTIRETROVIRAL DRUG REFILL AMONG
MEN WHO HAVE SEX WITH MEN (MSM) IN AN IDENTIFIED HIV
CLINIC, LAGOS STATE, NIGERIA
Ibiloye O.1, Osindero O.2, Oyekanmi F.2, Emerenini F.1, Omole
T.1, Omoniyi D.2, Obioha E.2, Plang J.1, Akande P.1
1APIN Public Health Initiatives, Clinical Services, Abuja;
2APIN Public Health Initiatives, Lagos, Nigeria
Introduction: Men who have sex with men are underserved and have
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key populations (KP)-friendly community-based approaches have been
proposed, which may be more accessible than facility-based HIV care.
Aim: Community Health Worker Led Antiretroviral (ART) Delivery (CLAD)
model was implemented in a community setting to promote drug refill
among MSM originally accessing care in a regular HIV clinic, Lagos,
Nigeria.
Methods: We implemented CLAD model in a HIV clinic from July to
December, 2018. This CLAD model involved devolvement of HIV posi-
tive MSM on ART to KP friendly community-based organization for their
monthly drug refill. In the community, lay healthcare workers refilled
antiretroviral for MSM and in addition, offered counselling, symptom
check and condoms during drug refill visit.
Ninety-three (93) MSM were initiated on ART in the clinic prior to the
intervention in July 2018. 24 (25%) of these patients were active in care
(picked up drugs within the last 3 months) and 69 (75%) were inactive.
Thirty-six (36) patients made up of 24 active patients and 12 patients
traced back to care from the inactive group were enrolled into the CLAD
model and monitored for 6 months during the intervention period. We
assessed adherence to scheduled drug refill appointment pre and post-
intervention. A paired T-test was performed to determine the difference
between the frequency of scheduled drug refill before and after CLAD
model intervention.
Results: The mean age of MSM recruited into the CLAD model was 25
years ± 4.4 SD. There was a significant difference in the mean number
of months of drug refill by MSM between the 6 month period prior to the
commencement of the CLAD model (M = 1.4 ± 0.7 SD) and after (M = 4.7
± SD = 1.2); t (35) = 13.3, p < 0.001.
Conclusion: The CLAD model was found to be effective in improving drug
refill appointment among KP attending a regular HIV clinic. We strongly
recommend specialized client-centred approach to improve drug refill
among MSM.
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HIV/AIDS-RELATED KNOWLEDGE AND STIGMA AMONG VIL-
LAGE HEALTH WORKERS IN RURAL LESOTHO, SOUTHERN
AFRICA: ANALYSIS OF DATA FROM GET ON RESEARCH PROJECT
Lejone I.T.1, Lefu K.1, Kopo M.1, Kao M.1, Muhairwe J.1, Glass
R.T.2,3, Labhardt D.N.2,3,4, Amstutz A.2,3,4
1SolidarMed, Swiss Organization for Health in Africa, Lesotho;
2Swiss Tropical and Public Health Institute;
3University of Basel, Basel;
4University Hospital Basel, Basel, Switzerland
Introduction: Lesotho has an adult HIV prevalence of 25.6% with the
majority of the population living in rural areas where distances to health
care facilities are often long. A lay health worker cadre, called village
health workers (VHW), has been introduced in 1978 with more than
4000 VHWs currently operating in the country. In 2017 UNAIDS launched
the 2 million African community health workers initiative to end AIDS and
ensure sustainable health for all in Africa. Data about VHWs knowledge
and stigma regarding HIV/AIDS are limited.
Aim: This study aimed to assess the level and determinants of HIV/AIDS-
related knowledge and stigma among VHWs in Lesotho, as a basis
of giving VHWs more responsibilities in the care of people living with
HIV.
Methods: The study is a cross-sectional survey involving 469 VHWs
from rural villages in two districts of Lesotho. The survey is part of the
cluster-randomized GET ON (GETting tOwards Ninety, NCT03598686)
research project. HIV/AIDS-related knowledge (10 items, 1 point
each, the higher the better knowledge) and stigma (8 items, 1 point
each, the higher the more stigma) were assessed using a validated
questionnaire (Bowen et al. BMC Public Health (2016) 16:70). We
conducted multivariable linear regression analyses to explore VHW char-
acteristics potentially associated with HIV/AIDS-related knowledge or
stigma.
Results: Median age of participating VHWs was 51 years (interquartile
range 42-60) with 92% being females. Overall, participants obtained
high scores on the HIV/AIDS-related knowledge scale (mean of 9.18
(standard deviation [SD] 1.24)) and low scores on the HIV/AIDS-related
stigma scale with a mean of 0.97 (SD 1.54). A higher HIV/AIDS-related
knowledge score was associated with lower HIV/AIDS-related stigma
scores (P<0.001). In multivariable regression older age was associated
with lower scores in HIV/AIDS-related knowledge (P<0.001) and higher
score on HIV/AIDS-related stigma (P<0.05).
Conclusion: VHWs in northern Lesotho showed good knowledge about
HIV/AIDS and low HIV/AIDS-related stigma. Younger VHWs and those
with better knowledge showed less stigma towards people living with
HIV. These findings encourage further involving VHWs in HIV programs
and to potentially extend their competencies towards patient ART
delivery.








Age in years, median (IQR) 50 (42-59) 52 (42-61) 51 (42-60)
Female Gender, n (%) 144 (92) 286 (91) 429 (92)
HIV/AIDS-related
knowledge, mean (SD)
9.30 (1.10)a 9.12 (1.29)b 9.18 (1.24)
HIV/AIDS-related stigma,
mean (SD)
0.93 (1.48)c 0.99 (1.57)d 0.97 (1.54)





Table 2. Factors associated with HIV/AIDS-related knowledge
Multiple linear regression (R2 =0.07,
F=10.86, P<0.0001)
β coefficient P value 95% CI
Variable lower upper
Age (per year) –0.029 <0.001 –0.039 –0.018
Female (vs Male) 0.189 0.369 –0.223 0.600
MKG (vs BB) –0.137 0.264 –0.377 0.104
Complete-case regression analysis (N = 434); 35 missing data for
HIV/AIDS-related knowledge
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Table 3. Factors associated with HIV/AIDS-related stigma
Multiple linear regression (R2 =0.21,
F=27.57, P<0.0001)
β coefficient P value 95% CI
Variable lower upper
Age (per year) 0.017 0.007 0.005 0.029
Female (vs Male) 0.287 0.243 –0.195 0.769
MKG (vs BB) 0.017 0.905 –0.265 0.299
HIV/AIDS-related
knowledge (per point)
–0.528 <0.001 –0.644 –0.411
Complete-case regression analysis (N = 427); 30 missing data for
HIV/AIDS-related knowledge, 7 missing data for HIV/AIDS-related
stigma, 5 missing data both for HIV/AIDS-related knowledge and
HIV/AIDS-related stigma
Abbreviations: BB (Butha-Buthe), MKG (Mokhotlong), CI (Confidence
Interval)
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A NEW RAPID ACTING ANTI-WOLBACHIA DRUG FOR ONCHOCER-
CIASIS AND LYMPHATIC FILARIASIS
Hong W.D.1,2, Johnston K.L.2, Berry N.G.1, Gusovsky F.3, Heming-
way J.2, Turner J.D.2, Taylor M.J.2, Ward S.A.2, O’Neill P.M.1
1Dept. of Chemistry, University of Liverpool, Liverpool, UK;
2Liverpool School of Tropical Medicine, Liverpool, UK;
3Eisai AiM Institute, Eisai Inc., Andover, USA
Introduction: Onchocerciasis and lymphatic filariasis are two neglected
tropical diseases (NTDs) that together affect ∼157 million people and
inflict severe disability. Both diseases are caused by parasitic filarial
nematodes with elimination efforts constrained by lack of a safe drug
that can kill the adult filaria (macrofilaricide). Previous proof-of-concept
human trials have demonstrated that depleting >90% of the essential
nematode endosymbiont bacterium, Wolbachia, using doxycycline, can
lead to permanent sterilisation of adult female parasites and a safe
macrofilaricidal outcome. However, protracted treatment regimens and
contraindications restrict the widespread implementation of doxycycline
as the cure of these two NTDs.
Aim: To find a new anti-Wolbachia macrofilaricidal drug that can fulfil the
profile of a short (ideally ≤7 days) oral treatment for onchocerciasis and
lymphatic filariasis.
Methods: Starting from a phenotypic screen using a Wolbachia infected
insect cell line, a selected hit series, thienopyrimidine was developed
through a multi-parameter medicinal chemistry optimisation to improve
the potency and drug metabolism/pharmacokinetic (DMPK). Leads iden-
tified through the optimisation campaign were evaluated extensively for
efficacy, pharmacokinetics and safety to select a candidate molecule for
onward development.
Results: After synthesising and testing of over 300 analogues in this
series, we obtained compounds that had better potency than the ‘gold-
standard’ anti-Wolbachia macrofilaricide doxycycline. Within all these
analogues, AWZ1066S stands out as the best compound with the balance
between efficacy, DMPK and safety. AWZ1066S shows superior efficacy
to existing anti-Wolbachia therapies in validated preclinical models of
infection and has DMPK characteristics that are compatible with a short
therapeutic regimen of seven days or less. In addition to the ability to
elicit efficacy after seven days of treatment, AWZ1066 also has a faster
kill rate compared to other known antibiotics tested against Wolbachia in
vitro which suggested a novel mode of action for AWZ1066S.
Conclusion: The programme has delivered the first novel synthetic can-
didate molecule, AWZ1066S. This candidate meets all Target Candidate
Profile criteria for an anti-Wolbachia macrofilaricidal drug and has entered
formal preclinical evaluation. AWZ1066S has the potential to significantly
impact current global onchocerciasis and lymphatic filariasis elimination
programmes and to reduce elimination time frames from decades to
years.
References:
1. Hong W. D. et al. AWZ1066S, a highly specific anti-Wolbachia drug
candidate for a short-course treatment of filariasis Proc. Natl. Acad. Sci.
U.S.A. 116 (4) 1414-1419;
2. Johnston K. L. et al. Identification and prioritization of novel anti-
Wolbachia chemotypes from screening a 10,000-compound diversity
library, Sci. Adv. 3 (9), eaao1551.
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THE HIDDEN HAND OF ASYMPTOMATIC INFECTION HINDERS
CONTROL OF NEGLECTED TROPICAL DISEASES
Rock K.S.1, Chapman L.A.C.2, Dobson A.3, Adams E.R.4,
Hollingsworth T.D.5
1Zeeman Institute, University of Warwick, Coventry, UK;
2Global Health and Development, London School of Hygiene and
Tropical Medicine, London, UK;
3Ecology and Evolutionary Biology, Princeton University, Princeton,
USA;
4Tropical Disease Biology, Liverpool School of Tropical Medicine,
Liverpool; 5Big Data Institute, University of Oxford, Oxford, UK
Introduction: Neglected tropical diseases are responsible for a large
burden of chronic morbidity and mortality in low-income populations. A
significant component of their impact stems from the high proportion
of asymptomatically infected individuals who may transmit infection
without developing symptoms that qualify them for treatment. Although
large-scale international control efforts have reduced the burden of
NTDs, their transmission persists and interventions rarely target the
asymptomatic pool of individuals.
Aim: To estimate the contribution of asymptomatically infected individ-
uals relative to symptomatic cases to the transmission of three major
vector-borne NTDs – visceral leishmaniasis (VL), the Gambian form of
human African trypanosomiasis (HAT), and Chagas disease – and assess
the likely success of current and alternative control interventions, such as
active screening, vector control and treating asymptomatic individuals.
Methods: A generic mathematical framework for analysing the trans-
mission dynamics of vector-borne NTDs was developed and used to
estimate the relative contribution of asymptomatic individuals for each
disease based on data on their relative prevalence and infectiousness
from the literature.
Results: Based on available data, asymptomatics contribute to a large
proportion of transmissions for HAT and Chagas disease, but transmission
of VL appears to be driven mainly by symptomatic individuals, though the
relative asymptomatic contribution increases as VL incidence decreases.
HAT appears to be the easiest of the three diseases to control using
currently available screening and vector control interventions, which
are predicted to be sufficient to interrupt transmission within 10-15
years. Treatment of asymptomatics in combination with vector control
would greatly reduce Chagas transmission and potentially interrupt
transmission, though over a much longer timescale (decades). Current
VL case detection and vector control appear to be insufficient to stop
transmission of VL.
Conclusion: Our results highlight that asymptomatics can act as a
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additional interventions targeted at these groups could lead to consid-
erable progress in the control and elimination of these and other vector-
borne NTDs.
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ARE WE THERE YET? ASSESSING WHO IS BEING LEFT BEHIND
AND WHY IN PREVENTIVE CHEMOTHERAPY TREATMENT FOR
NEGLECTED TROPICAL DISEASES
Simpson S.J.1, Muleta M.D.2, Negussu N.3, Zeleke Z.K.4, Adekeye
O.5, Shu’aibu J.6, Isiyaku S.7, Dean L.8, Koller T.S.9, Mbabazi
P.S.10
1EquiACT, Lyon, France;
2Independent consultant, Addis Adaba, Ethiopia;
3Disease Prevention and Control Directorate, Federal Ministry of
Health;
4WHO Country Office, Addis Adaba, Ethiopia;
5Dept. of Psychiatry, Ahmadu Bello University Teaching Hospital,
Zaria, Kaduna State, Nigeria/Sightsavers Nigeria Country Office;
6Sightsavers Nigeria Country Office/Dept. of Family Medicine, Bing-
ham University College of Medicine, Jos, Nigeria;
7Sightsavers, Kaduna State, Nigeria;
8Liverpool School of Tropical Medicine, Liverpool, UK;
9Gender Equity and Rights, WHO;
10(NTD/PCT) Neglected Tropical Diseases, World Health Organiza-
tion WHO, Geneva, Switzerland
Introduction: Preventive chemotherapy (PC) treatment for prevention
and elimination of neglected tropical diseases (NTDs) is delivered as a
targeted intervention. NTDs have been identified as the “litmus test” for
universal health coverage. However, equity of coverage is affected by a
range of social and structural factors meaning that some groups in the
population are potentially being left behind.
Aim: To present findings about guidance designed to support NTD
programme managers and partners to monitor and analyse differences
in PC coverage between subpopulations within a country.
Methods: The guidance “Towards universal coverage for preventive
chemotherapy for Neglected Tropical Diseases” encourages use of
existing data and evidence, including analysis of the existing sex- and
age-disaggregated data routinely collected at the community level as
part of PC interventions. It also draws on additional quantitative data such
as Demographic Household Surveys and encourages use of any existing
qualitative studies. The analysis framework is designed to identify barriers
and facilitators towards effective coverage by assessing the dimensions
of availability, accessibility, acceptability, and quality of treatment.
Results: There are limited existing country studies that (a) make use
of sex- and age-disaggregated data linked with social or structural
factors and or (b) include a gender and or equity analysis. Pilots of
the guidance are underway in Oromia and Amhara States, Ethiopia and
Kwara State, Nigeria. Qualitative information is critical for understanding
which groups in the population may not be reached (e.g. nomadic
populations, marginalized groups, people with a disability, those who
work or attend school outside of their communities) and why. Monitoring
and evaluation have largely focused on quantitative data about PC and
only more recently has use of disaggregated data been prioritised.
Feedback on the guidance suggests that some aspects, e.g. gender
and equity analysis, may pose a challenge to uptake without additional
capacity-building and resources. This is being explored as part of the
piloting process.
Conclusion: This presentation will discuss progress to date, focusing on
how the guidance can be used to strengthen monitoring of not only
‘who’ is being left behind in PC but also ‘why’ to improve prevention and
elimination of NTDs.
011
REGIONAL NETWORKS FOR RESEARCH CAPACITY AND WHY
THESE ARE NEEDED TO BE PREPARED FOR DISEASE OUTBREAKS
Jamieson N.1, Netongo P.M.2, Dias A.G.3, Ogunfowokan G.4,
Baker B.1, Horby P.5, Wilder-Smith A.6, Lang T.1
1The Global Health Network, University of Oxford, Oxford, UK;
2Biotechnology Centre, University of Yaounde I, Yaounde, Cameroon;
3Capanema, Para, Brazil;
4National Hospital, Abuja, Nigeria;
5ERGO, University of Oxford, Oxford, UK;
6Public Health and Clinical Medicine, Umea University, Umea, Swe-
den
Introduction: During the Ebola and Zika outbreaks research findings were
needed in rapid response in order to determine how to best treat the
disease and prevent their spread. This was acutely evident during the Zika
outbreak where even less was known about this disease than Ebola. Here
data was needed immediately on areas such as transmission, disease
pathology and all types of studies where needed, from social science to
vector biology through to observational clinical research. However, this
outbreak occurred in regions where there was little research capacity.
This grave situation showed why local research capacity and experience
is important.
Aim: To build research capacity development networks that through skill
and experience sharing could enable locally-led research that would be
addressing everyday health challenges. Thereby creating lasting capacity
that could respond to outbreaks.
Methods: Two networks were created, one in Africa and one in Latin
America, which bring together experienced research organisations and
connecting them through locally led research capacity activities to raise
research awareness, skills and experience. These networks would be
coordinated locally and have a vibrant presence online that would serve
to connect the members and deliver ongoing access to tools, resources,
training and each other.
Results: The REDe and ALERRT networks are vibrant communities of prac-
tice for knowledge sharing and research capacity development. Thou-
sands of researchers are accessing online training, hundreds have reg-
istered onto the Professional Development Scheme. Over 15 workshops
have delivered research skills training and networking opportunities to
over 2,000 frontline health workers such as nurses, community health
workers, laboratory staff and pharmacists. Regional activities are raising
participant retention in studies, raising research standard and improving
community engagement.
Conclusion: It is possible to deliver research capacity to areas where
currently there was little research experience. However, this has to be
done in a sustainable way with a long-term view. Therefore having the
focus on gaining evidence to tackle the everyday health burdens is a
viable approach to create lasting capacity that can then be taken up and
used to deliver a locally-led research response in the event of an outbreak.
012
HEALTH WORKFORCE DEVELOPMENT IN EMERGENCY PRE-
PAREDNESS FOR VIRAL HAEMORRHAGIC FEVERS
Okware S.1, Okware B.2, Walimbwa S.1, Omuut W.1, Nanyondo
J.1, Nabukenya I.1, Walwema R.1, van de Sande M.3
1GHS Program, Infectious Diseases Institute;
2Case Western Reserve, Makerere University Collaboration, Kam-
pala, Uganda;
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Introduction: Emergency preparedness is the ability of the governments
or organisations to anticipate, respond to and recover from public health
emergencies. Human resources for health (HRH) is vital in sustaining
emergency preparedness efforts in Viral Haemorrhagic fever (VHF)
outbreak-prone regions. [1] Substantial resources have been directed
towards HRH in emergency preparedness.
Aim: We sought to evaluate the Uganda health workforce development
for emergency preparedness for VHF.
Methods: We extracted data from Uganda National guideline for
preparedness and response and clinical case reports from two actual
outbreaks, National Task Force (NTF) Minutes, accountability fora, national
level contingency plans for VHF. The data were analysed with an
adopted human resource for health framework and pillars of Ebola
Viral Disease control (coordination, case management, surveillance,
laboratory, logistics and community engagement). Data was analysed
in the broad categories of policy, leadership, partnerships, education,
financing and HRH management systems. [3,4]
Results: Uganda has policies supporting recruitment of health workers
and workforce capacity development. Oversight is provided by the NTF-
a multisectoral, multidisciplinary management platform; mirrored at
district level. Funding for capacity development is primarily through
partner support. The development of training materials is centralised
at national level ensuring harmony of training materials and criteria for
participant selection. However, strategy of implementation varied among
implementors from didactic to simulation exercise based. Participant
selection was limited to public health facilities, village health teams and
community leaders. Trainee database was limited to dataset maintained
at central level, but custody of the database changed with each outbreak.
Capacity building efforts are only activated during outbreaks and cover
all supporting pillars of VHF control.
Conclusion: Leadership from the NTF in provision of both technical and
political direction remains key in health workforce development. Efforts
have been placed to build competencies in the health work force however,
little has been done in planning on how to maintain these gains outside of
outbreaks. [1] This may be enhanced by improving on the human resource
management system and identification of local dedicated funding to
develop clear strategies to ensure supply of fit-for-purpose public and
private health sector health workers to meet demand.[2,3]
References:
1. World Health Organization. International Health Rgulations (2005).
Third Edit. Vol. 2005. World Health Organization. 2005
2. World Health Organization, Management Sciences for Health. Tools for
planning and developing human resources for health for HIV/AIDS and
other services. Geneva. 2006
3. World Health Organization. A Strategic Framework for Emegency Pre-
paredness. 2017.
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ASSESSING THE IMPACT OF A NEW EMERGENCY TRIAGE
SYSTEM ON HEAD INJURY MORTALITY: TIKUR ANBESSA
SPECIALIZED HOSPITAL EMERGENCY DEPARTMENT, ADDIS
ABABA, ETHIOPIA
Fantaye H.1, Lomencho A.2, De Vos P.4, Azazh A.3
1National Blood Bank Service Agency, FMOH;
2Internal Medicine and Public Health, AMC, Addis Ababa, Ethiopia;
3Institute of Global Health and Development Queen Margaret
University, Edinburgh, UK;
4Emergency Medicine Dept., Addis Ababa University, Addis Ababa,
Ethiopia
Introduction: One of the improvements in Ethiopia’s emergency medical
system was the introduction of a five level Emergency Triage System
(ETS) in January 2015 that was piloted in selected Addis Ababa hospitals.
Aim: This study aims to assess the effect of this intervention on the head
injury mortality in Tikur Anbessa Specialized Hospital (TASH) Emergency
Department (ED).
Methods: Data were retrospectively collected from all medical records of
head injury patients seen in Adult TASH- ED over two 6 months’ periods,
before and after the new Emergency Triage System implementation:
01/04/2014 – 30/09/2014 versus 01/04/2016 – 30/09/2016. An inclusion
criterion was age above 13 for whom records could be retrieved. Exclusion
criterion was ‘patient declared dead on arrival’. Mortality and patterns of
head injury were compared pre and post intervention. Chi square was
used for the analysis using STATA 14.
Results: A total of 522 Head injury patients were analysed in the ED
in both the pre- 258 and post-264 intervention study periods. Among
head injury admission in the ED in both study periods, the highest
number of patients were Road Traffic Accident /RTA/ victims, males and
young age (<30). Mortality rate among head injury patients decreased
from a pre-intervention 44(17.05%) to post-intervention 27(10.2 %)
(OR=0.55, 95% CI (0.32, 0.95), p=0.02).The median age of death were
45 years in pre- and 40 years in post-intervention period with ages
ranging from 13 to 85 and 13 to 96 years respectively. The proportion
of deaths from moderate head injury decreased significantly from 14.0
% in pre-intervention to 6.3 % in post-intervention period respectively
(p<0.001).
Conclusion: In Conclusion Emergency Triage System at TASH-ED has
decreased mortality caused by head injury. This could increase life-years
saved and productivity in a cost effective and easily achievable way in
resource poor settings.
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FINDING THE MISSING CHILDREN WITH HIV: INDEX-LINKED
TESTING IN CLINICS AND COMMUNITIES
Dziva Chikwari C.1,2, Bandason T.2, Simms V.1, Dringus S.1,
Sibanda E.3, Chikodzore R.4, Mutseta M.5, Page-Mtongwiza S.6,
Weiss H.A.1, Ferrand R.A1,2
1London School of Hygiene and Tropical Medicine, London, UK;
2Biomedical Research and Training Institute, Harare, Zimbabwe;
3Health Services Dept., Bulawayo City Council, Bulawayo,
Zimbabwe;
4Ministry of Health and Child Care;
5Population Services International, Harare, Zimbabwe;
6Organization for Public Health Interventions and Development,
Harare, Zimbabwe
Background: HIV prevalence is much lower in children than in other age
groups but the proportion undiagnosed is significantly higher. Innovative
and targeted strategies are required to improve uptake and yield of HIV
testing among children.
Aim: To evaluate the effectiveness of index-linked HIV testing for children
aged 2-18 years living in the household of an HIV-infected individual in
Zimbabwe.
Methods: Individuals attending for HIV care at 3 urban and 3 rural clinics
in Zimbabwe who had children (2-18 years) of unknown HIV status living
in their households were offered 3 options for their children to access HIV
testing:
1) Clinic-based testing
2) Home-based testing by community health workers
3) Testing performed by caregivers using an oral mucosal test (caregiver
testing)
Demographic data was collected from consenting caregivers who were
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Results: We recruited 2813 people living with HIV (median age 38, IQR
32-46 years) who had 3431 children eligible for testing (median age 9,
IQR 6-13 years). Testing was accepted for 2757 (80.4%) eligible children.
Overall, 74.7% selected clinic-based testing, 19.2% opted for community-
based testing and 6.1% for caregiver testing, with no difference in trend
by setting. Among the 2757 children for whom testing was accepted,
1977 (71.7%) completed testing. Those who selected community-based
testing were more likely to complete testing than those who selected
clinic-based testing (OR=1.69 95%CI:1.3-2.2, p<0.001) or caregiver test-
ing (OR=2.38 95%CI:1.0-2.3, p=0.04). Overall HIV prevalence was 1.4%,
however, prevalence among 12-18-year olds was 2.5% and 81% of those
diagnosed were >7 years. HIV yield was 0.8%. Previously undiagnosed
HIV was strongly associated with older age (OR=3.54, 95%CI:1.1-11.1,
p=0.03) comparing 13-18 years to 2-5year olds and with single or double
orphanhood (OR=3.10, 95%CI:1.4-6.9, p=0.005). All 28 HIV positive chil-
dren were linked to care within 2 weeks.
Conclusion: Index-linked testing is a feasible HIV testing strategy for chil-
dren in Zimbabwe. Clinic-based testing had the highest uptake; however,
children were more likely to be tested in community settings. Older chil-
dren and orphans are at increased risk of undiagnosed HIV. Strengthening
of testing strategies to target this age group are required.
Note: Only preliminary data is presented here. If accepted final data will
be presented.
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SIMPLE INDIRECT MEASURES OF ADIPOSITY ARE DISCRIMI-
NATORY OF ELEVATED BLOOD PRESSURE: A CROSS SECTIONAL
ANALYSIS AMONG ADOLESCENTS IN A RESOURCE-POOR SET-
TING IN NORTHEAST NIGERIA
Wariri O.1, Jalo I.2, Bode-Thomas F.3
1MRC Unit The Gambia at The London School of Hygiene and
Tropical Medicine, Banjul, The Gambia;
2Dept. of Paediatrics, Federal Teaching Hospital Gombe (FTHG),
Gombe, Nigeria;
3Dept. of Paediatrics, Jos University Teaching Hospital (JUTH), Jos,
Nigeria
Introduction: Sub-Saharan Africa accounts for a significant proportion of
the number of undernourished children globally. However, the number
of overweight and obese children in the continent increased steeply over
the past three decades with associated increase in adiposity-related
cardiovascular diseases. In resource-constrained health systems which
grapples with treats from infectious diseases, there is limited availability
of trained paediatric workforce and adoption of simple, non-invasive
measures needed to monitor adiposity-related health risk.
Aim: We aimed to determine the discriminative ability of the Body
Mass index (BMI), Waist Circumference (WC), and Waist-to-Height Ratio
(WHtR) adiposity measures for elevated blood pressure (prehypertension
and hypertension combined) among adolescents in Gombe, northeast
Nigeria.
Methods: This cross-sectional study used a multi-stage sampling
technique and involved 367 secondary school adolescents (10-18 years)
in Gombe Local Government Area, Gombe State, northeast Nigeria
from January to September 2015. We examined and compared the
associations and discriminative ability of the BMI, WC and the WHtR
for elevated blood pressure using multiple logistic regression and receiver
operating characteristics (ROC) curves. Area under the curves (AUC), odds
ratio (OR) and 95% confidence intervals (CI) are reported.
Results: All three measures of adiposity were strongly and positively
associated with elevated blood pressure. The BMI obesity showed the
strongest association with elevated blood pressure with odds that was
double the odds of WC and triple that of WHtR [adjusted OR for BMI 15.3,
95% CI (4.8-27.9)]. The discriminative ability of adiposity measures for
elevated blood pressure using AUC was comparable (0.786 for BMI, vs
0.780 for WC, vs 0.761 for WHtR).
Conclusion: We provide evidence, here on the BMI, WC and WHtR to
support the use of simple indirect measures of adiposity in evaluating
adiposity-related risk including prehypertension and hypertension among
Nigerian adolescents.
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THE UK’S CURRENT AND FUTURE SUITABILITY FOR AEDES
ALBOPICTUS
Metelmann S.1,2, Caminade C.1,2, Hernandez-Colina A.1, Sher-
lock K.1, Blagrove M.S.C.1,2, Jones A.E.1, Medlock J.M.2,3, Baylis
M.1,2, Morse A.P.1,2
1University of Liverpool, Liverpool;
2NIHR Health Protection Research Unit for Emerging and Zoonotic
Infections, Liverpool;
3Public Health England, UK
The Asian tiger mosquito Aedes albopictus is extending its northern range
in Europe. In 2016 and 2017, its eggs and larvae have been found in the
UK for the first time. As this mosquito is an important vector species, able
to transmit various pathogens of animals and humans there is a major
interest in whether this originally sub-tropical mosquito could become
established in the temperate climate of the UK.
In order to analyse the UK’s suitability for Ae. albopictus, we built a
dynamical model for the mosquito’s life cycle that takes into account
its dependencies on temperature, precipitation, and human population
density. To parametrise the model for European Ae. albopictus, we com-
pared the development of a mosquito strain from Italy with a strain from
the tropics in the laboratory. Monitoring larvae, pupae, and blood feeding
behaviour at low temperatures did not show a suspected cold adaptation
for the Italian strain though. In consequence, the whole data range
derived from tropical strains could be used for parameter estimations.
Finally, we used current and future climate data sets to analyse the
chances for a long-term establishment in the UK. For the moment, we
find only a low suitability in the UK, except for some warmer and densely
populated regions such as Greater London and parts of the south coast
of England. Still, mosquito surveillance will be necessary for most of
England, as we can show how the suitability will increase in the next 50
years.
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IMPACT OF CLIMATE CHANGE ON VECTOR-BORNE DISEASES,
RECENT FINDINGS
Caminade C.1,2, Baylis M.1,2, Blagrove M.1,2, Metelmann S.2,3,
Morse A.P.M.2,3, Medlock J.2,4
1Dept. of Epidemiology and Population Health, Institute of Infec-
tion and Global Health, University of Liverpool, Liverpool;
2NIHR Health Protection Research Unit in Emerging and Zoonotic
Infections, Liverpool;
3Dept. of Geography and Planning, University of Liverpool, Liver-
pool;
4Medical Entomology Group, Emergency Response Dept., Public
Health England, Porton Down, Salisbury, UK
Introduction: Zika, dengue, chikungunya, yellow fever, malaria, Lyme
disease, bluetongue, Shmallenberg are vector-borne diseases with large
impacts on societies. These diseases are transmitted by exothermic
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extremely sensitive to external environmental conditions. Rainfall is an
important factor as it provides breeding sites for larvae. Temperature
impacts a broad range of factors such as vector development, its survival,
vector biting rates and the time required for the pathogen to develop
inside the arthropod vector. Given anthropogenic climate change, the
distribution and severity of vector-borne diseases might be severely
modified in future.
Aim: This presentation will discuss climate change impact studies on
animal and human vector-borne diseases, conducted primarily within the
NIHR Health Protection Research Unit in Emerging and Zoonotic Infection.
Methods: Epidemiological mathematical models of various complexities
(SEIR compartmental models, climate envelopes, Basic Reproduction
number e.g. R0, vectorial capacity models. . .) can be dynamically coupled
with climate and population data to model historical VBD risk. Following
validation with observed disease data, these models can then be
driven by an ensembles of climate model scenarios, driven by different
greenhouse gases emission scenarios to estimate future trends, and their
related uncertainties, in VBD risk emergence or disappearance.
Results: Our work anticipated the northward spread of Aedes albopictus,
the Asian tiger mosquito, in Europe and into southern UK. Recent findings
further suggest that most of England might become suitable for this
species by the 2070s, based on the extreme RCP8.5 emission scenario. A
study using the Ross-MacDonald Ro model framework, showed that the
climatic conditions related to the 2015 El Niño climate event favoured the
Zika outbreak that had a devastating impact on Latin America that year.
Our modelling work also confirmed the impact of the 2006 heatwave
on the emergence of bluetongue, a midge-borne disease affecting
ruminants, into northern Europe.
Conclusion: There is a wealth of evidence that climate variability and
climate change has already impacted the distribution and severity of
VBDs in temperate, highland, peri-arctic and arctic regions. Predictive risk
models are valuable as they can inform vaccine deployment and disease
control strategies in advance.
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CLIMATE INFORMATION FOR PUBLIC HEALTH ACTION IN
ETHIOPIA
Thomson M.C.1,2, Woyessa A.3, Mason S.J.1, Dinku T.1
1International Research Institute for Climate and Society, Earth
Institute, Columbia University, New York, USA;
2Mailman School of Public Health, Columbia University, New York,
USA;
3Ethiopian Public Health Institute, Addis Ababa, Ethiopia
Introduction: Urgent action to combat climate change and minimize
its impacts (Goal 13) is integral to the successful implementation of
the Sustainable Development Goals. As a result, the Ethiopian govern-
ment has developed a Climate Resilient Green Economic plan to achieve
middle-income status by 2025 in a climate-resilient green economy. In
this context, the health sector must adapt to a changing climate and
minimize its contribution to greenhouse gas production.
Aim: To ensure effective adaptation of the health sector in Ethiopia health
policy-makers and practitioners are increasingly seeking to understand
the climate, its primary drivers, its spatial and temporal structure, how it is
measured, where, when and how it can be predicted. Of primary interest
is how climate information can be used in policy and practice to improve
current health outcomes while increasing the adaptive capacity of the
public health sector to longer-term climate change.
Methods: Joint capacity building and co-production processes involving
both health and climate communities have been undertaken that sup-
ports routine incorporation of climate information into epidemiological
surveillance systems, early warning and risk assessment including hydro-
meteorological disasters, infectious disease emergencies and nutrition
crises. The approach requires health experts to work alongside climate
colleagues to produce new analyses of health-related risks while consid-
ering local context, the spatial and temporal structure of climate-related
risk and the opportunities for interventions.
Results: Since 2011 the National Meteorological Agency of Ethiopia has
implemented the Enhancing National Climate Services (ENACTS) initiative
which is improving the availability, access and use of climate infor-
mation for national decision-making, including health. ENACTS is now
being implemented in 10 African countries supported by two regional cli-
mate centres (https://iri.columbia.edu/resources/enacts/). To ensure that
health workers have the requisite knowledge and capacity to understand
and use climate information to improve health decision-making ready
access to authoritative resources, tailored to the specific needs of the
health sector have been produced.
Conclusion: To enable climate-informed decision-making in the health
sector new and innovative mechanisms for simultaneously strengthening
climate services and uptake of climate information by health users is
needed.
019
THE RE-EMERGENT BRUGIA SPECIES IN SRI LANKA IDENTIFIED
AS A NOVEL STRAIN OF B. MALAYI WITH A CLOSE NUCLEOTIDE
HOMOLOGY TO B. PAHANGI
Mallawarachchi C.H.1, Chandrasena N.T.G.A.N.2, Premaratna
R.3, Gunawardane N.Y.I.S.4, Mallawarachchi S.M.N.S.M.1, de
Silva N.R.2
1Postgraduate Institute of Medicine, University of Colombo,
Colombo;
2Dept. of Parasitology, Faculty of Medicine, University of Kelaniya,
Kelaniya, Sri Lanka;
3Dept. of Medicine, Faculty of Medicine, University of Kelaniya,
Kelaniya, Sri Lanka;
4Molecular Medicine Unit, Faculty of Medicine, University of
Kelaniya, Kelaniya, Sri Lanka
Introduction: Brugian filariasis has re-emerged in Sri Lanka, after a
quiescent period of four decades. The re-emergent strain is a subperiodic
strain of probable zoonotic origin. Cats and dogs are known to harbor
sub-periodic Brugia species filariae. Ascertaining the species identity of
the re-emergent Brugia filarial parasites required molecular analysis,
since microscopy alone was inadequate.
Aim: Molecular speciation of the re-emergent Brugia species microfilariae
in humans and those circulating among dogs and cats in the vicinity of
human infections.
Methodology: A community-based night blood survey was carried out in
selected areas of the Gampaha district for brugian filariasis using thick
blood smears (TBS) to detect patent infections. Cats and dogs within
the residential areas of human cases were surveyed for microfilariae
using TBS. Brugia microfilariae positive samples (human and animal)
were analysed by Polymerase Chain Reaction (PCR) and DNA sequencing.
Microfilariae in 1ml of anticoagulated human blood were concentrated
by Nuclepore® membrane filtration and genomic DNA was extracted
from filter membranes. A representative sample of Brugia microfilariae
positive animal blood spotted on filter paper was selected and DNA was
extracted using ReliaPrepTM Blood DNA Miniprep System (modified). PCR
was performed with pan-filarial primers specific for internal transcribed
spacer region 2 (ITS2) of the ribosomal DNA. PCR products were analyzed
by gel-electrophoresis on 2% agarose with positive and negative controls
(B. malayi and distilled water respectively).
Results: PCR analysis of human (n=8), canine (n=53) and feline (n=24)
samples elicited bands in the region of 615bp, which confirmed B. malayi
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canine and feline B. malayi microfilariae revealed a higher sequence
homology with B. pahangi than B. malayi but phylogenetically, the
sequences were closer to B. malayi than B. pahangi.
Conclusion: The re-emergent Brugia species is a strain of B. malayi that
has closer nucleotide homology to B. pahangi than B. malayi, indicating
the possibility of a novel or hybrid B. malayi / B. pahangi strain. The
high prevalence of this novel strain of B. malayi among cats and dogs
implicates them as reservoir hosts.
020
A ONE-HEALTH PERSPECTIVE FOR SCHISTOSOMIASIS CONTROL
IN AFRICA?
Webster B.L., Rollinson D.
Dept. of Life Sciences, Natural History Museum, London, UK;
London Centre for Neglected Tropical Disease Research (LCNTDR)
Schistosomes are parasitic trematodes that cause Schistosomiasis, the
most important water-borne Neglected Tropical Disease burdening and
inflicting unnecessary suffering on many poor rural communities. Schis-
tosomiasis is also a major disease of animals affecting large numbers of
domestic livestock worldwide. Compared to Africa, Asian schistosomiasis
is highly zoonotic, complicating control. Uniquely among trematodes
schistosomes are dioecious. The sexually dimorphic adult worms form
pairs providing opportunity for inter species mating. Inter-species cross-
ing experiments have demonstrated that hybridisation readily occurs
between closely related species resulting in hybrid vigour, expanded
snail host ranges, increased fecundity/vectoral capacity and heightened
animal heterosis / pathology.
In nature pre- and post-zygotic reproductive isolating barriers, such as
host specificity, anatomical site of infection, distribution, mating pref-
erences, competition and incompatibility are thought to prevent prolific
inter-species admixture. However, reports of suspected natural hybridisa-
tion date back to the 1940’s with possible implications for disease pathol-
ogy, host switching/range, drug efficacy and transmission dynamics.
Recent advances in our ability to capture, preserve and genetically anal-
yse schistosome larvae (eggs, miracidia, cercariae) have allowed us to
identify natural inter species hybridisation between many schistosome
species. Hybridisation may enable the genetic exchange of biomedi-
cally important traits between species. Moreover hybridisation between
species that are reproductively isolated by their human and animals
hosts, suggests a level of undetected zoonotic/zooanthroponotic trans-
mission, complicating disease control.
Here we will bring together molecular data that shows the extent and
dynamics of hybridisation between multiple schistosome species across
Africa. We will particularly focus on the hybridisation between human and
animal schistosome species possibly facilitated by or facilitating zoonotic
transmission. We will show how more advanced genomic data is provid-
ing further insights into the genomic consequences of these hybridisation
events and helping to distinguish active and ancient hybridisation. We
will discuss how this is allowing us to assess the true impact that this
hybridisation may be having on human and animal health and present
future studies that will help determine if African schistosomiasis control
needs to incorporate a one health perspective.
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PAST HUMAN-ANIMAL INTERACTIONS AND THE EVOLUTION OF
ZOONOSES IN ETHIOPIA: A CONTRIBUTION FROM ARCHAEOL-
OGY AND ANCIENT GENETICS
Lebrasseur O.1,2, Woldekiros H.3, Belay S.2,4, Girdland-Flink L.5,
Hanotte O.2,6, Mor S.2,7, Dobney K.1
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2International Livestock Research Institute, Addis Ababa, Ethiopia;
3Dept. of Anthropology, Washington University, St Louis, USA;
4Dept. of Microbial, Cellular and Molecular Biology, Addis Ababa
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5School of Natural Sciences and Psychology, Liverpool John Moores
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6School of Life Sciences, University of Nottingham, Nottingham,
UK; 7Institute of Infection and Global Health, University of Liver-
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Introduction: Since their introduction in Ethiopia, domesticated animals
have adapted to the country’s diverse, yet harsh, environment and its
endemic diseases, leading them to display a unique genetic pool of
resilient traits. However, crossbreeding with European stock and a lack of
identification, characterisation and conservation of the indigenous gene
pool is leading to the erosion and loss of that resilience.
Aim: Through genetic analysis of zooarchaeological remains, our research
brings a temporal dimension to animal health and production in Ethiopia.
We intend to begin mapping the evolution of authentic indigenous traits
linked to environmental adaptation and disease resistance by charac-
terising past genetic diversity of local cattle and goat populations. We
also aim to recover ancient genomes of pathogens in order to trace their
evolution and spread through time and in relation to specific lifestyles and
environments.
Material and Methods: Once the DNA preservation is assessed, bone and
teeth samples will be tested for pathogen DNA content. Well-preserved
specimens will undergo high coverage sequencing for targeted Single
Nucleotide Polymorphism analysis and whole genome recovery.
Expected Outcomes: Provided high quality genetic material is recovered,
our findings will inform on emergence, selection pressures and loss of
genes involved in adaptation and disease resistance among populations
through time. It will also enrich our understanding of the biomolecular
mechanisms of zoonoses, ultimately contributing key data for the devel-
opment of countermeasures.
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ADDING PROACTIVE AND REACTIVE CASE DETECTION INTO
THE INTEGRATED COMMUNITY CASE MANAGEMENT SYSTEM
(ICCM+) TO OPTIMISE DIAGNOSIS AND TREATMENT OF
MALARIA IN A HIGH TRANSMISSION SETTING OF CAMEROON
Epie Bekolo C.E.1, D’Arcy Williams T.2
1University of Dschang, Dschang, Cameroon
Objective: Integrated community case management (iCCM) of childhood
illness is a powerful intervention to reduce mortality. Yet, less than 20%
of children with fever in sub-Saharan Africa have access to malaria
testing. We conducted an action research to explore how iCCM+ based on
incorporating proactive and reactive case detection of malaria into iCCM
could help accelerate coverage.
Design: A community-led cross-sectional survey to measure the propor-
tion of Plasmodium infection detected under iCCM+ compared with iCCM
alone.
Setting: Four primary schools, 4 health facilities and 13 neighbourhoods
of the rural community of Bare-Bakem in Cameroon.
Participants: Children and adults with fever between April and June 2018.
Intervention: A modified iCCM programme (iCCM+) comprised of a proac-
tive screening of febrile children under five years old for malaria using
rapid diagnostic testing to identify index cases and a reactive screen-
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Primary and secondary outcome measures: The proportion of index and
secondary malaria cases detected by iCCM+ compared with iCCM alone.
Results: We screened a total of 501 febrile patients of whom Plasmodium
infection was confirmed in 425 (84.8%) cases including 176 (83.4%) index
cases and 249 (85.9%) secondary cases. Of these cases, 102 (24.0%)
were index cases identified in the community during routine iCCM activity
and 36 (8.5%) cases detected passively in health facilities; 38 (8.9%) were
index cases identified proactively in schools; and 249 (58.6%) were addi-
tional cases detected in the homes of index cases by RACD – computing
to a total of 287 (67.5%) additional cases found by iCCM+ showing the
added value of iCCM+ over iCCM alone. The likelihood of finding additional
cases increased with increasing family size [adjusted odd ratio (aOR) =
1.2, 95% CI: 1.1 – 1.3] and with increasing age ((aOR) = 1.7, 95% CI:
1.5 – 1.9).
Conclusion: Most symptomatic cases of malaria remain undetected in
the community despite the introduction of community case manage-
ment of malaria but most of these undiagnosed cases can be mopped-up
by iCCM+. This approach should be targeted to schools, older children and
large households.
023
SILENT CIRCULATION OF ZIKA VIRUS IN THE STATE OF
SERGIPE, NORTHEAST OF BRAZIL
La Corte R.1,2, Jesus M.C.S.2, Batista M.V.A. 2,3, Chagas R.D.O.4,
Storti-de-Melo L.M.2,3
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Introduction: The state of Sergipe showed the second highest prevalence
(227.2 cases per 100,000 live births) of microcephaly associated with Zika
virus (ZIKV) in the 2015 epidemic year in Brazil, although no cases of
ZIKV infection were reported in Sergipe that year. This situation reveals
problems in differential diagnosis and reporting of arboviruses faced by
the State.
Aim: To investigate ZIKV infection in mosquitoes from cities located along
one of the highways linking Sergipe to the State of Bahia.
Methods: Mosquitoes were collected using battery-powered aspirator
in neighborhoods of high mosquito infestation in the counties of São
Cristóvão, Laranjeiras, Itabaiana e Simão Dias. After collection, they were
transferred to cups and brought alive to the laboratory, where they were
frozen and quickly screened for species and sex. Females were sectioned
at the waist and the heads and thorax were inserted into microtubes
and macerated. Viral RNA was extracted using PureLink® Viral RNA / DNA
Mini Kit and then a reaction was performed for the complementary DNA
(cDNA) using the High-Capacity cDNA Reverse Transcription Kit (Thermo
Fisher Scientific). The diagnosis for arboviruses was performed by PCR with
Flavivirus-specific primers. Positive samples were submitted to PCR with
the use of primers specific for ZIKV.
Results: From February to October 2018, 423 households were sampled,
and 3,451 mosquitoes were collected, of which 184 were Ae. aegypti
females. The highest density of females (female / house) was detected in
Itabaiana (0.68), followed by Simão Dias (0.43), Laranjeiras (0.35) and São
Cristóvão (0,24). Flavivirus infection was detected in 35 females, of which
10 were positive for ZIKV, all them from Itabaiana, showing an infection
rate of 5.4% (10/75) for that city.
Conclusion: Our results showed that although three of the counties were
negative, ZIKV is circulating in the state and may be causing asymp-
tomatic or mild infections. In 2018 only 8 cases of Zika were reported
across the state, which is inconsistent with the mosquito infection rate
we found and alert to the need for surveillance of neurological diseases,
care for the pregnant woman and intensification of vector control and
infrastructure improvement.
024
FIEBRE (FEBRILE ILLNESS EVALUATION IN A BROAD RANGE OF
ENDEMICITIES): A MULTI-SITE PROSPECTIVE OBSERVATIONAL
STUDY OF CAUSES OF FEVER IN SUB-SAHARAN AFRICA AND
SOUTHEAST ASIA
Hopkins H.1, Bassat Q.2, Chandler C.I.R.3, Crump J.A.4, Feasey
N.A.5, Ferrand R.A.1,6, Lalloo D.G.5, Mayxay M.7, Newton P.N.7,8,
Mabey D.C.W.1
1Faculty of Infectious and Tropical Diseases, London School of
Hygiene and Tropical Medicine, London, UK;
2ISGlobal, Hospital Clínic, Universitat de Barcelona, Spain; Centro
de Investigação em Saúde de Manhiça (CISM), Maputo, Mozam-
bique; ICREA; Pediatrics Dept., Hospital Sant Joan de Déu (Univer-
sity of Barcelona), Barcelona, Spain;
3Dept. of Global Health and Development, London School of
Hygiene and Tropical Medicine, London, UK;
4Centre for International Health, University of Otago, Dunedin,
New Zealand;
5Dept. of Clinical Sciences, Liverpool School of Tropical Medicine,
Liverpool, UK; Malawi-Liverpool-Wellcome Trust Clinical Research
Programme, Blantyre, Malawi;
6Biomedical Research and Training Institute, Harare, Zimbabwe;
7Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
(LOMWRU), Mahosot Hospital, Vientiane, Laos;
8Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
(LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane,
Laos; Centre for Tropical Medicine and Global Health, Nuffield
Department of Medicine, University of Oxford, Oxford, England,
UK
Introduction: Fever is a common reason for health care seeking and hos-
pital admission in sub-Saharan Africa and Asia, but little is known about
its aetiology in many parts of the world. Many febrile illnesses present
with non-specific symptoms and signs, presenting a case management
challenge. Currently there is sparse evidence on which to base empirical
treatment guidelines, burden of disease estimates, or control measures
and resource allocation.
Aim: FIEBRE is a multi-site investigation, using consensus clinical, labora-
tory, and social science protocols, designed to identify infections that are
treatable and/or preventable; to document antimicrobial susceptibility
in micro-organisms that are isolated; to evaluate biomarkers that may
distinguish bacterial from other causes of fever and/or prognosticate; and
to inform new fever case management algorithms.
Methods: FIEBRE enrols febrile in- and outpatients aged ≥2 months pre-
senting for care in Laos, PDR, Malawi, Mozambique, and Zimbabwe. Study
staff take a targeted illness and exposure history; perform a physical
examination; and collect pharyngeal swabs and venous blood samples
from all participants, and urine samples where indicated. Bacterial culture
and antimicrobial susceptibility testing are performed on site. Point-of-
care tests are performed for malaria, and in subpopulations for HIV,
cryptococcal antigen, and urinary lipoarabinomannan. At Day 28, clinical
outcome is noted and patients provide a further blood sample for serol-
ogy. Serology and other laboratory tests for arboviruses, Leishmania spp.,
Leptospira spp., rickettsiae, and respiratory viruses will be performed at
reference laboratories. Community controls, matched to a proportion of
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infections in the study areas; and are surveyed to obtain representative
data about treatment seeking and medicines use, and to estimate the
incidence of common infections. In two sites, interviews and observations
are used to understand antimicrobial use patterns among patients and
prescribers.
Results: Recruitment lasting >12 months is on-going at each site to
capture seasonal variation, targeting enrolment of 2,400 patients and
>600 controls per site. Preliminary data will be presented on study
populations and diagnostic results.
Conclusion: The FIEBRE study will provide harmonized data from repre-
sentative sites to inform fever case management guidelines, and strate-
gies to improve antimicrobial use.
025
THE GUT MICROBIOTA AND IMMUNE STATE OF WILD RODENTS
- CHALLENGES AND OPPORTUNITIES
Viney M.
Dept. of Evolution, Ecology and Behaviour, Institute of Integrative
Biology, University of Liverpool, Liverpool, UK
The vertebrate gut microbiota is a large, diverse assemblage of bacteria
that can have profound effects on host individuals – for example, it
is critical for the development of gut immune function and stimulates
mucosal immune responses. While the microbiome is central to the
healthy life of humans and other animals, we don’t fully understand what
comprises a normal healthy microbiome nor what shapes and controls its
composition.
Most of what we know about the gut microbiome comes from studies of
laboratory animals, mainly mice. Laboratory animal models are valuable
when they capture relevant traits of another species (e.g. humans), or
of the same species in a different environment (e.g. the wild). But, the
microbiome of laboratory mice differs substantially among laboratories
and suppliers, and is markedly less diverse than that of wild mice. There is
evidence that the microbiome can have major impacts on immune func-
tion and resilience to infection. Therefore, arguably, laboratory mouse
microbiomes and immune systems are artificial constructs and so do not
represent the normal, healthy mouse microbiome.
Microbiomes, immune systems, and interactions between them, need to
be studied in more natural systems, for three reasons: (i) to provide data
that are more representative of free-ranging animals, rather than basing
our understanding on phenomena specific to certain laboratory mouse
strains, obtained from certain suppliers, studied in certain laboratories; (ii)
laboratory-based systems show what patterns and processes can occur,
but we need to know what patterns and processes actually do occur,
and (iii) because we need to understand which aspects of microbiome
biology and immunobiology are modelled well in laboratory animals, and
which are not, thereby validating where laboratory models are – and are
not – useful. Studying the gut microbiome of wild mice is complemen-
tary to laboratory-based microbiome studies, recognising that despite
the advantages of wild animal systems, laboratory-based systems have
advantages too.
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Introduction: Senegal in partnership with Enabel, the Belgian develop-
ment agency, implemented a project between 2012 and 2017, concern-
ing health insurance at large scale for the rural informal sector. An exten-
sive modelling exercise was conducted in order to match the intervention
in the field with the latest findings in health insurance organisation and
dynamics and in community-based health insurance in particular.
Aim: Modelling is an important part of all intervention research in order to
conceptualise and to share with all stakeholders the vision and strategic
options of the intervention. Models are constructed for different aspects
of the object of intervention. The purpose of the intervention was to
confirm (or adapt) the model and to make the model a living and evolving
idea. This presentation wants to make clear the potential of the use of
models in complex interventions and that they are even indispensable
for success.
Methods: Descriptive study on the evolution of the models and how the
vision evolved over time, justified by the progressive insights at each
moment in the process, as an illustration of paving the pathway in
complex human systems.
Results: Initial, rather general models and views evolved towards more
robust -argued- and detailed models, that in their principles can be
transferred to or applied in other settings.
Conclusion: Models are evolving mental maps to enable interventions in
complex environments. Compared to the initial model, in the more final
versions of the model, new dimensions were added such as patient’s
rights and the actuarial function and the anchorage of the operational
unit evolved from district towards departmental level. Community par-
ticipation needed complete revision.
Reference:
1. Paul Bossyns, Fabienne Ladrière and Valéry Ridde: Une assurance
maladie à grande échelle pour le secteur informel en Afrique sub-
saharienne. Six ans d’expérience au Sénégal rural. Studies in Health
Services Organisation & Policy, 34, 2018
027
HEALTH INSURANCE AND HEALTH CARE ORGANISATION IN
RURAL SENEGAL
Ndèye Bineta M.1, Sow K.2
1Director health insurance unit, Koungheul;
2Anthropology Dept., University Cheikh Anta Diop, Dakar, Senegal
Introduction: Very few interventions in the area of health insurance
actually address structures, procedures and problems from both the
supply and demand side. This is astonishing because one can state
that the ‘Supply’ is a condition of success for the ‘Demand’ side, but
the contrary is true as well.
Aim: In order for a health insurance to be effective, many technical
aspects need to be fulfilled and favorable conditions assured. They form
the basis for replicability and sustainability. If certain marginal conditions
are not met, health insurance cannot be properly implemented, even if
the initiative is technically sound. Both the supply and demand side are
tackled in a complementary way.
Methods: The political economy of the process is presented, aside the
material and organisational conditions that determine the success of
health insurance schemes for the informal sector. Political motivation,
resource mobilisation and effective subsidies from the government,
transparent (financial) management of the health facilities and regu-
lation of the fee-paying system are some of the conditions that are
analysed in this presentation.
Results: The results from the implementation of the organisation of a
large scale health insurance for the rural informal sector in 2 regions
of Senegal covering the demand and the supply side are presented:
utilisation rates, penetration rate, portability, financial viability, degree of
protection, the health care package.
Conclusion: The implementation pathway and monitoring of the process
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simultaneously for at least 7 different, semi-autonomous factors in order
to really understand the dynamics of the insurance scheme and to be
able to compare different schemes in terms of efficiency, effectiveness
and coverage. On the other hand, a large-scale health insurance cannot
succeed if the necessary systemic conditions are not fulfilled.
028
AN INITIATIVE FOR SOCIAL PROTECTION IN HEALTH, AND
BEYOND: THE EQUITY FUND IN MAURITANIA
Van Belle E.
Memisa (medical NGO), Brussels, Belgium
Introduction: A project in Mauritania of the Belgian Medical NGO Memisa
in consortium with a local NGO APSDN has nearly 15 years’ experience
with a social assistance arrangement for health but which covers also
other aspects, such as school fees. Being indigent has a repercussion on
all events in life. Health is only part of it, and for instance the right to
education is another aspect that should be addressed simultaneously in
order to help people to get out of the poverty trap. Locally, this particular
social assistance arrangement has been labelled ‘equity fund’. The Sene-
galese experience addresses the question of equity and protection of the
poorest only marginally.
Aim: To create a model of how social assistance could function and under
which conditions, in an African (and Mauritanian) context.
Methods: Descriptive intervention study and monitoring of change over
time.
Results: Although Senegalese authorities made a lot of (financial) efforts
through the payment of health insurance premiums for indigent families
(family allocation scheme), its effectiveness is probably low: no other
accompanying measures are taken and the selection of the benefitting
families is not very clear either. There is no individualized approach. In
Mauritania, an equity fund was developed for the purpose of assuring
access to quality health care for the poorest, but soon started addressing
other social determinants of health. It is locally managed by a small
professional team and involves the local community to a maximum.
The identification of indigent people is done by a multi-stakeholder
committee and the follow up is personalized based on home visits and
reintegration measures.
Conclusion: Poverty is sometimes structural (e.g. handicapped people
for instance) and therefore chronic, but sometimes it can very well be
temporary and some financial support can then pull families out of the
‘poverty trap’. Such dynamics can only be managed at a local level, while
in many countries, national social assistance funds are run from central
level, mainly because no peripheral structures exist. Health Insurance
Units at district level can alter this situation and can become an opportu-
nity to actually liaise with social assistance funds at the operational level.
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Introduction: Traditionally health committees with representatives of the
population are supposed to deal with complaints from users. In practice
one observes many obstacles, not the least the low level of training
of those representatives and the ‘asymmetric information’ regarding
technical health issues. The social power equilibrium between informal
representatives of the population compared with nurses and doctors is
very much pending towards the latter.
Enabel worked with local communities and local authorities in order to
create a platform of patients’ rights in Benin since 2012. Such platforms
have more power than health committees because they are created
independent from the health facilities and anchored at the level of the
local authorities.
Aim: To organize users of health services to improve their autonomy
towards their health and defend their rights. This implies access to
quality information about health & health services, transparency from
the supply side and participating in the quality control of health
services.
Methods: An action-research approach was used with as initial
hypothesis “By putting in place an independent platform of informed
users of health services (‘PUSS’) engaging in a dialogue with the health
providers, the quality of health care will improve.
Results: In 5 health districts health user-platforms were created. They
influenced the relations between health providers and users by i) a more
constructive atmosphere based on dialogue, with overall increase of user-
satisfaction by 20% over 2,5 years, ii) the creation of a dialogue platform
(related to RBF) between the users (PUSS), local authorities and health
providers to discuss quality of services and to analyze complaints. About
500 complaints were registered over a period of 2,5 years of which 81%
were treated in a satisfactory way.
Conclusion: The empowerment of the users of health services is an
important component of any functional health assurance.
030
PROGRESS IN THE CONTROL OF MALARIA IN GUINEA: ANAL-
YSIS OF HEALTH FACILITY DATA FROM THE USAID GUINEA
STOPPALU PROJECT, 2014–2018
Bisanzio D.1, Fofana A.2, Regan E.3, Preston A.4, Guilavogui T.5,
Baldé M.A.2, Taton J.L.2, Condo P.6, Reithinger R.1
1RTI International, Washington D.C., USA;
2RTI International, Conakry, Guinea;
3RTI International, RTP, NC, USA;
4RTI International, Fort Collins, CO, USA;
5National Directorate of Disease Control, Ministry of Health,
Conakry, Guinea;
6President’s Malaria Initiative, US Agency for International Devel-
opment, Conakry, Guinea
Introduction: Guinea has made tremendous progress in its fight against
malaria. Most of this progress is due to Guinea’s leadership and commit-
ment to scale-up key malaria interventions, backed by substantial exter-
nal financial support such as the Global Fund to Fight AIDS, Tuberculosis
and Malaria and the President’s Malaria Initiative (PMI). PMI’s main plat-
form from 2013 onwards has been the USAID Guinea StopPalu project,
which has been operational in 19 of the country’s 38 districts. The project
supported Guinea’s National Malaria Control Program in the distribution
of long-lasting insecticidal nets, training of health care workers in malaria
case management, strengthening community engagement at different
levels, and the integration of malaria services between the public and
private sector.
Aim: Evaluate spatio-temporal decline of malaria burden in Guinea from
2014 to 2018.
Methods: We analyzed temporal and spatial changes in the malaria rest
positivity rate to assess changes in the malaria burden in the project’s 19
districts from 2014–2017. Analyses were performed on routine monthly
data from 141 public and private facilities and stored in a District Health
Information System 2 (DHIS2) project database. Generalized additive
mixed models were used to describe the temporal trend of the test
positivity rate. Spatial analyses were applied to identify malarial fever hot-
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maps to estimate the spatial pattern of malarial fever fraction from 2014–
2017.
Results: Trend analyses highlighted that the test positivity rate had a
strong seasonality and was significantly reduced by 34.5% from 79.1%
in 2014 to 52.3% in 2017. This reduction mostly affected children under
5 years of age but was also evident in other age groups. The analyses also
showed that the test positivity rate had a marked spatial heterogeneity,
with a rapid decrease in malaria fevers shown in northern Guinea. These
findings corroborate prevalence data on children under 5 years of age
from the country’s 2016 Demographic and Health Survey.
Conclusion: Developed maps could be used by Guinea’s national program
to target interventions to those areas with continued high malaria trans-
mission.
031
OLOROFIM, AN INVESTIGATIONAL OROTOMIDE ANTIFUNGAL
AGENT WITH IN VITRO ACTIVITY AGAINST MADURELLA
MYCETOMATIS
Lim W.1, Eadie K.1, Konings M.1, Fahal A.H.2, Birch M.3, Rijnders
B.1, Verbon A.1, Van de Sande W.W.J.1
1Medical Microbiology and Infectious Diseases, ErasmusMC, Rot-
terdam, The Netherlands;
2Mycetoma Research Centre, Khartoum, Sudan;
3F2G Ltd, Manchester, UK
Introduction: Madurella mycetomatis is the main causative agent of
eumycetoma, a chronic granulomatous infection of the subcutaneous
tissue. Currently, the only antifungal agents with activity against M.
mycetomatis are agents acting on ergosterol in the fungal cell membrane.
Itraconazole is currently the drug of choice, but the duration of treatment
is long and therapeutic failure is common. Therefore there is an urgent
need to identify more potent antifungal agents with activity against
M.mycetomatis. One of the novel classes of antifungal agents are the
orotomides and olorofim is the first representative of this class. It inhibits
fungal pyrimidine biosynthesis and it is currently being clinically evaluated
in a global Phase II trial for invasive fungal infections in patients lacking
treatment options.
Aim: To determine if olorofim also has in vitro activity against M.
mycetomatis.
Methods: The in vitro activity of olorofim and itraconazole against 40
clinical isolates of M. mycetomatis was determined using our CLSI-based
in vitro susceptibility testing with XTT endpoint reading.
Results: It was demonstrated that olorofim was highly active against
all M. mycetomatis isolates. An MIC range of <0.004 – 0.125 μg/ml
was found. This range was comparable to the MIC range obtained for
itraconazole. To determine if olorofim would be superior to itraconoazole
treatment, in vivo efficacy testing is needed.
Conclusion: This study for the first time demonstrated that M. mycetoma-
tis can also be inhibited with antifungal agents with a different mode of
action. Olorofim showed potent in vitro activity against M. mycetomatis
isolates.
032
FIELD PERFORMANCE OF THE HIGHLY-SENSITIVITY RAPID
DIAGNOSTIC TEST IN A SETTING OF HIGHLY SEASONAL
MALARIA TRANSMISSION
Mwesigwa J.1,2, Slater H.3,4, Bradley J.5, Kandeh B.6, Saidy B.1,
Ceesay F.1, Whitiker C.3, Bouseman T.7, Van Geertruyden J.P.2,
Drakeley C.8, Achan J.1, D’Alessandro U.1
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3MRC Centre for Global Disease Analysis, Dept. of Infectious Dis-
ease Epidemiology, Imperial College London, London, UK;
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5London School of Hygiene and Tropical Medicine, London, UK;
6National Malaria Control Program, Banjul, The Gambia;
6Radboud University Nijmegen, The Netherlands;
7Dept. of Microbiology, London School of Hygiene and Tropical
Medicine, London, UK
Introduction: The Gambia has succeeded in reducing the burden of
malaria. The human reservoir of infection could further decrease if
malaria-infected individuals were identified by highly sensitive field-
based diagnostic tools and then treated.
Aim: The objective of the study was to determine the performance of the
highly sensitive Alere rapid diagnostic test (HS-RDT) was assessed and
modelled for mass screening and treatment (MSAT) strategy.
Methods: A cross-sectional survey was done at the peak of the 2017
malaria transmission season in 47 Gambian villages. From each village,
100 residents were randomly selected for a finger prick blood sample
to detect P. falciparum infections using HS-RDT and varATS qPCR.
Results by HS-RDT were compared against varATS qPCR across varying
transmission intensities, age groups, febrile and asymptomatic subjects.
A deterministic model was used to predict HS-RDT performance for the
MSAT strategy.
Results: Of the 4,060 participants screened; the median age (SD) was
13 years (6,31). Malaria prevalence by HS-RDT was 14.6% (592/4060,
95% CI:13.78-16.01). Compared to varAST qPCR, HS-RDT’s sensitivity
and specificity was 38.43% (191/497 95% 34.1-42.9) and 88.5%
(2922/3301; 95%: 87.4-89.6), respectively. HS-RDT’s sensitivity varied
by malaria prevalence, and highest (50.89% (43.31-58.48%) in villages
with prevalence 20-50%. In low transmission areas, three rounds of
MSAT with the HS-RDT at 85% coverage would result in 80% reduction
of malaria prevalence from 5% to 1% and reductions were maintained
for 400 days. In moderate transmission areas, two MSAT rounds at 80%
coverage or three rounds at 65% coverage resulted 60% reductions in
malaria prevalence from 15% to 6%.
Conclusion: The performance of the HS-RDT varied, with sensitivity
increasing with increasing P.falciparum prevalence and performing
better where transmission was most intense. Multiple MSAT rounds
implemented in low transmission to moderate areas using the HS-RDT
for two or three years may be used as an additional strategy to achieve
elimination.
033
HIGH-INTERMEDIATE ENDEMIC PREVALENCE OF HEPATITIS B
VIRUS AMONGST FEBRILE PATIENTS IN BANGLADESH, INCLUD-
ING EVIDENCE OF OCCULT INFECTION
Chowdhury F.R.1,2,3, McNaughton, A.L.2, Amin M.R.4, Barai L.5,
de Cesare M.6, Bowden R.6, Klenerman P.2,7, Das B.C.8, Dunachie
S.J.2,3, Matthews P.C.2,7
1Dept. of Internal Medicine, Bangabandhu Sheikh Mujib Medical
University, Dhaka, Bangladesh;
2Nuffield Dept. of Medicine, University of Oxford, Medawar Building
for Pathogen Research, Oxford, UK;
3Mahidol-Oxford Tropical Medicine Research Unit, Bangkok,
Thailand;
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5Dept. of Microbiology, BIRDEM General Hospital, Dhaka,
Bangladesh;
6Wellcome Centre for Human Genetics, Oxford, UK;
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Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford,
UK;
8Food for the Hungry and Medical Team International, Cox’s Bazar,
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Introduction: Bangladesh has recently been identified as one of the ten
countries worldwide with the highest burden of viral hepatitis infection.
Data on circulating genotypes remain limited, but both recombinant
strains and occult infection have been previously reported in the region.
Aim: To assess the prevalence of HBV and occult HBV infection among
febrile patients admitted to two medical facilities in Dhaka, including the
Dhaka Medical College Hospital.
Methods: Any adult patients of ≥18 years with a history of fever >38◦C
for >48 hours admitted to the study sites between June-October 2017
were eligible to be enrolled. Blood samples were collected from patients
and screened for HBV infection and previous HBV exposure, using HBsAg
and total anti-HBc respectively. All anti-HBc-positive patients were
screened for HBV DNA to identify occult HBV infection. HBV DNA positive
patients with viral loads ≥3.0 log10 IU/ml underwent a target-enrichment
approach for HBV whole genome sequencing (WGS) on an Illumina Mi-
Seq platform in Oxford.
Results: A total of 201 patients were recruited into the study. Exposure
to HBV was common in the cohort, with 74/201 (37%) anti-HBc positive.
HBsAg was present in 14/201 (7%). Additionally, 3/201 (1.5%) of the
cohort were anti-HBc-positive, HBsAg-negative and HBV DNA-positive,
indicating occult infection. Viral loads in patients with occult infection
were 1.1, 2.6 and 5.3log10 IU/ml.
WGS for HBV was performed on four patients, including one patient
with occult infection. A median of 60,997 HBV reads per sample and
median coverage of 869 reads/site was obtained after de-duplication.
Genotypes A (n=1), C (n=1) and D (n=2) were observed, with the occult
infection being a genotype C isolate. None of the sequences identified
were recombinants.
Conclusion: Our findings indicate a high-intermediate endemic preva-
lence of HBV in this setting. Occult HBV infection is present in the region,
accounting for 3/17 (18%) of HBV infections. This is of relevance to in
clinicians assessing their patients and is also important in informing
approaches to screening blood products for transfusion. A diverse range
of HBV genotypes are present in Bangladesh, and the detection of a
genotype A strain supports studies suggesting that this genotype is
increasingly common in Bangladesh.
034
DISK DIFFUSION AND E-TESTING TO DETERMINE THE IN VITRO
SUSCEPTIBILITY OF M. MYCETOMATIS TOWARDS COMMONLY
USED ANTIFUNGAL AGENTS
Nyuykonge B.1, Eadie K.1, Fahal A.H.2, Mouton J.W.1, Van de
Sande W.W.J.1
1Erasmus MC, Dept. of Medical Microbiology and Infectious Dis-
ease, Rotterdam, The Netherlands;
2Mycetoma Research Center, Khartoum, Sudan
For many fungal infections, in vitro susceptibility testing is used to predict
if an isolate is resistant or susceptible towards the antifungal agent
used to treat the fungal infection. For Madurella mycetomatis, the main
causative agent of mycetoma, in vitro susceptibility is currently not per-
formed on a routine basis. This is because the currently used in vitro sus-
ceptibility testing method is labour intensive and expensive because the
viability dye XTT is needed for endpoint visualisation. For bacterial agents,
disk diffusion and E-testing methodologies are available and also for
certain fungal species this is performed. Here we demonstrate that using
a hyphal suspension, disc diffusion and E-testing can be used to deter-
mine the minimal inhibitory concentration of itraconazole, posaconazole,
voriconazole and amphotericin B for Madurella mycetomatis. MICs found
with the E-test were comparable to those obtained with our CLSI-based
microtiter dilution in vitro susceptibility assay.
035
SCHOOL BASED CLINICAL TRIALS IN LOW RESOURCE SETTINGS
AND FACTORS ASSOCIATED WITH LOW INTERVENTION COVER-
AGE: LESSONS LEARNED FROM THE START-IPT TRIAL
Khozoee B.1, Rehman A.M.1, Maiteki-Sebuguzi C.2, Gonahasa
S.2, Kamya M.R.3, Staedke S.G.1
1London School of Hygiene & Tropical Medicine (LSHTM), London,
UK;
2Infectious Diseases Research Collaboration;
3School of Medicine, Makerere University College of Health Sci-
ences, Kampala, Uganda
Introduction: Intermittent preventive treatment (IPT) of malaria is
recommended for specific vulnerable groups, and may also benefit
school-aged children, who serve as an infectious reservoir of malaria
parasites. START-IPT (School-based Treatment with ACTs to Reduce
Transmission of malaria) was a cluster-randomised trial that investigated
the community-level impact of IPT of primary schoolchildren with
dihydroartemisinin-piperaquine (DP) in Jinja, Uganda. Students enrolled
from intervention schools received monthly IPT with DP for up to 6
rounds of treatment. IPT with DP was found to have a positive impact
on community-level malaria parasite prevalence (19.0% intervention vs
23.1% control, adjusted risk ratio 0.85, 95% CI 0.73–1.00, p=0.05), but
intervention coverage was low (43.3%), which may have blunted the
effect of IPT.
Aim: To better understand reasons for poor intervention coverage in the
START-IPT study, a secondary analysis was conducted to evaluate the
factors associated with intervention enrolment and treatment.
Methods: Data on students registered in the 42 intervention schools were
analysed. Descriptive analysis was performed to explore characteristics of
students screened, enrolled and treated, stratified by variables of interest.
Logistic regression was used to perform univariate and multivariate
analysis, adopting a causal modelling framework to investigate the
association between student characteristics and treatment coverage.
Results: Of the 23,280 registered students, 7,997 (34.4%) were excluded
because the parent/guardian could not be found, and 15,283 (65.6%)
were screened. Of these, 5,204 (34.1%) were excluded, primarily because
of inability to locate the student (31.4%) and menarche in females
(25.9%). Overall, 10,079 (43.3%) students received at least one dose of
DP; 3995 (39.6%) received > 3 rounds of IPT with DP. In an adjusted
analysis, larger school size, school location, older age, male gender,
lower bednet use, and history of fever at enrolment were all significantly
associated with receiving < 3 rounds of DP.
Conclusion: Low parental engagement, exclusion of females at menar-
che, and poor school attendance contributed to low enrolment in this
school-based trial in a low-resource setting. Characteristics of schools and
students at risk for low treatment coverage were identified, which could
be targeted through community sensitisation and parental education in
future research studies and programmes.
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Introduction: Microscopy remains the gold standard for malaria
diagnosis but its reliability depends heavily on the proficiency of human
operators. Automated malaria microscopy could provide an alternative
to standardize malaria parasite detection, speciation and quantification,
thus aiding to the harmonization of microscopy performed in the context
of drug, vaccine or diagnostic trials and research activities.
Aim: To evaluate the performance of the EASYSCAN GO automated
malaria microscopy device, applying an artificial intelligence (AI) imaging
software, using expert microscopy as a reference standard.
Methods: Febrile patients were recruited at SMRU clinics (Mae Sot,
Thailand) and Hanura, Indonesia between November 2016 and July
2017. Giemsa-stained blood films were prepared and read by both expert
microscopists and the automated microscope. The performance of device
was evaluated for parasite detection, species identification and parasite
density estimation.
Results: Of 793 patients enrolled in the study, 170 tested positive by
expert microscopy (30 Plasmodium falciparum, 130 Plasmodium vivax
and 10 mixed infections). Diagnostic sensitivity and specificity of the
device were 89.4%(95%CI = 83.8%-93.6%) and 97.1%(95%CI = 95.4%-
98.3%). Sensitivity was correlated to the parasite density, ranging from
7.7% in samples with low parasite density (1-50 p/μL) to 100% in samples
with densities higher than 2000 p/μL. Sensitivity and specificity of the
device were not significantly different when compared with nested PCR.
Parasite species were correctly identified in 128 out of 152 samples
(84.21%), yielding Cohen’s kappa value of 0.64 (95%CI = 0.50-0.76). A
total of 46 out of 152 (30.26%) of the parasite density estimates from the
device were within ± 25% of the reference results. Interclass correlation
coefficient (ICC) for parasite density estimates was 0.65 (95%CI = 0.56-
0.73) indicating good agreement between the parasite density estimates.
Conclusion: These results represent unprecedented accuracy in field
conditions for computer-based malaria parasite detection, identification
and quantification on Giemsa-stained blood films. The current version
of the device and software corresponded to WHO Competence Level 3
overall and Level 2 for diagnostic sensitivity & specificity. A multicentre
trial is being conducted to test an updated AI version of the device in
more diverse field and clinical trial settings.
037
LIVER HEALTH IN HIV MONOINFECTED AND HIV/HBV COIN-
FECTED INDIVIDUALS IN GHANA
Villa G.1, Phillips R.2,3, Smith C.4, Owusu D.2, Abdullahi A.1,
Sayeed L.5, Austin H.1, Chadwick D.5, Bhagani S.6, Geretti A.M.1
1Institute of Infection & Global Health, University of Liverpool,
Liverpool, UK;
2Kwame Nkrumah University of Science & Technology;
3Dept. of Medicine, Komfo Anokye Teaching Hospital, Kumasi,
Ghana;
4Institute for Global Health, University College London, London;
5Centre for Clinical Infection, James Cook University Hospital, Mid-
dlesbrough;
6Royal Free Hospital NHS Foundation Trust, London, UK
Introduction: The scale-up of ART in Africa has dramatically decreased
HIV-related morbidity and mortality. Long-term impact of ART on liver
health among HIV mono-infected and HIV/HBV co-infected subjects has
been poorly investigated.
Aim: To assess liver status in HBsAg-positive and negative individuals on
long-term ART in Kumasi, Ghana.
Methods: Consecutive patients who were established on ART and
accessed routine HIV outpatient care over a 2-week period in February
2018 were screened for viral hepatitis co-infection (HBV, HCV, HDV)
and assessed for liver fibrosis and steatosis by measures of transient
elastography and controlled attenuated parameter (Fibroscan, Ecosens,
France). Additional variables included demographics, anthropometric
measures, behavioural factors and biochemistry data. Chi-squared test,
Fisher’s exact test and Mann Whitney’s test were used as appropriate to
compare participants’ characteristics according to HBsAg status.
Results: The study population comprised 330 individuals: 91/330 (27.6%)
were males, median age was 48 years (IQR 42-53) and 90/330 (27.3%)
had positive HBsAg. Alcohol was consumed regularly by 6/330 (1.8%)
subjects. Median time on ART was 8.9 years (IQR 5.7-11.3); 288/330
(87.3%) subjects were on a NNRTI, 35/330 (10.6%) on a PI and 7/330
(2.1%) not on ART. Median CD4 count was 620 cells/mm3 (IQR 359-
830). HIV-1 RNA was <40 copies/mL in 163/330 (49.4%) individuals; HBV
DNA was >2000 IU/mL in 7/330 (2.1%) and between 40-2000 IU/mL in
9/330 (2.7%). HCV RNA was detected in 1/330 (0.3%) subject; 4/330 had
positive anti-HDV antibodies. Fibrosis grade ≥F2 was found in 50/330
(15.2%) individuals; steatosis grade ≥S1 in 69/330 (20.9%). HBsAg-
positive individuals presented higher prevalence of fibrosis than negative
subjects (F2 23.3% vs 5.4%; F3 8.9% vs 1.3%; F4 4.4% vs 0.4%; p<0.01).
Median plasmatic concentration of platelets, cholesterol and triglycerides
were lower in HBsAg-positive individuals (238 vs 209 x109/L, p<0.01; 4.8
vs 4.4, p=0.01; 1.3 vs 1.1 mmol/L, p<0.01, respectively); conversely, AST
and ALT concentrations were higher (27 vs 30 mmol/L, p<0.01; and 17 vs
21 mmol/L, p<0.01, respectively). No differences were observed on renal
function, prevalence of metabolic syndrome or steatosis grade.
Conclusion: Liver fibrosis is more prevalent in HBV/HIV co-infected
subjects, whereas no difference was observed in hepatic steatosis.
038
USING COUNTRY-SPECIFIC MODELLING OF MALARIA INTER-
VENTIONS FOR NATIONAL STRATEGIC PLANNING
Runge M.1,2, Mohamed A.3, Mandike R.3, Molteni F.1,2,3, Snow
R.5,6, Thawer S.1,2, Lengeler C.1,2, Smith T.1,2, Pothin E.1,2,6
1Epidemiology and Public Health, Swiss Tropical and Public Health
Institute;
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3National Malaria Control Program, Dodoma, Tanzania;
4Centre for Tropical Medicine and Global Health, Nuffield Dept. of
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5Population Health Unit, Kenya Medical Research Institute-
Wellcome Trust Research Programme, Nairobi, Kenya;
6Clinton Health Access Initiative, Boston, USA
Introduction: Malaria modelling has proven useful for comparing impact
and costs of interventions and strategies at global level. However there
has been little application of dynamic models by national programs
to predict program impacts at the geographical resolution used for
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Aim: A process was developed to provide analytical support to the
National Malaria Control Program (NMCP) of Tanzania for the mid-term
review and updating of the National Malaria Strategic Plan (NSP). This
entailed use of the ‘OpenMalaria’ model of malaria dynamics to predict
the impact of different geographical stratifications of intervention mixes
at district level.
Methods: Workshops involving modellers, program managers (the
NMCP), epidemiologists, and local experts agreed on the assumptions
and data to use for model calibration and the strategies and scenarios
to be simulated. Available data at district level included malaria indicator
surveys, school parasitaemia surveys, entomological surveillance data,
and vector control distribution. The district-specific outcomes of interest
were chosen to be 2020 prevalence and the numbers of cases averted
between 2017 and 2020. The predictions were evaluated against the
national target (national prevalence less than one per cent by 2020) and
used to suggest alternative intervention strategies.
Results: Shared understanding across of the relevance of the modelling
required considerable engagement from the different groups of stake-
holders. The key determinants of success were continual interaction
and iterative revisions of the analyses following up feedbacks from
the stakeholders. The modelling presented simulations of impact of
strategies of interest and results showed that given the available data
and the current plan, the objective of prevalence lower than 1% was
not achievable by 2020. These conclusions led to an update of the NSP
strategies and a revision of its objectives.
Conclusion: Research and policy planning are two worlds that do not
interact as often as desirable. This project has helped to bridge this gap
by providing a platform where policy makers and scientists can agree on
what to put in the planning of the simulations. Beyond the immediate
results, the process in itself has been useful to inform policy with evidence.
039
IPAMU – A MADAGASCAR-GERMANY PARTNERSHIP PROJECT
AIMING TO INVESTIGATE HEALTH CARE WORKER INFECTIONS
DURING THE 2017 PNEUMONIC PLAGUE OUTBREAK
Kratz T.1, Andrianasolo R.2, Meurs L.3,4, Markus I.4, Kolie D.5,
Rajerison M.6, Rakoto Andrianarivelo M.7, Malvy D.8, Grunow
R.9, Razafimbia V.10
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Pathogens, Robert Koch Institute, Berlin, Germany;
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3European Centre of Disease Control and Prevention, Solna,
Sweden;
4Dept. of Infectious Disease Epidemiology, Robert Koch Institute,
Berlin, Germany;
5Faculté des Sciences et Techniques en Santé, Université Gamal
Abdel Nasser de Conakry, Guinea;
6Unité de Peste, Institut Pasteur de Madagascar;
7Centre d’Infectiologie Charles Mérieux, Antananarivo, Madagas-
car;
8Université de Bordeaux, Faculté de Médecine, Bordeaux, France;
9Centre for Biological Threats and Special Pathogens, Robert Koch
Institute, Germany;
10Direction de la Veille Sanitaire et Surveillance Epidemiologique,
Ministère de la Santé Publique, Antananarivo, Madagascar
Introduction: A pneumonic plague (PP) outbreak occurred in Madagascar
from August to November 2017. According to World Health Organization
reporting, it lead to 2417 cases including 209 deaths, the majority of
cases (77%) were clinically identified as PP and 81 Health care workers
(HCWs) had symptoms compatible with plague. So far only anecdotal
reports describe possible transmission and burden of PP within HCW.
HCW PP infections can have a great impact as regular medical care is
affected due to absent HCW and patients fear of contracting PP within a
hospital setting.
Aim: In order to better understand HCW infections with PP, the Malagasy-
German IPAMU partnership project was founded. The overall objective is
to obtain the serological status, characteristics and knowledge, attitude
and practices (KAP) of cases (HCW who had symptoms compatible with
PP during the epidemic according to the Malagasy surveillance authority,
DVSSE), compared with KAP of HCW who are non-cases.
Methods: This study was structured in three parts: serology, KAP survey
and in-depth qualitative interviews. Serology of cases was obtained (June
2018) and data collection realized (September 2018). Quantitative data
collection was guided by structured interviews using a KAP questionnaire.
The KAP survey was conducted in two major cities; Antananarivo (four
hospitals) and Toamasina (two hospitals and a mobile clinic). All available
cases that underwent serology were included. HCW who were non-cases
from the same departments were randomly selected and added to the
KAP survey as a comparative group. Non-structured qualitative interviews
were performed with cases and key informants (e.g. head of department).
Using information from the KAP, we compared risk behavior, e.g. usage
of personal protective equipment of cases and non-cases.
Results: Out of 81 HCW who had symptoms compatible with plague
according to WHO, 36 cases were located in the two cities and recruited
for serology. One participant (3%) was anti-Yersinia pestis – IgG positive.
Sixteen symptomatic HCWs could be included in the KAP survey, as well as
53 non-symptomatic HCWs. Data analysis is ongoing. Upcoming results
will be presented.
Conclusion: Transmission and infection patterns of PP among HCW
remain a complex and understudied concern.
040
BYPASSING OF HEALTHCARE FACILITIES AMONG NATIONAL
HEALTH INSURANCE SCHEME (NHIS) ENROLLEES IN IBADAN,
SOUTH-WEST NIGERIA
Oladimeji A.1, Adeniji F.2, Adewole D.2
1Health Strategy and Delivery Foundation, Minna;
2Dept. of Health Policy and Management, University of Ibadan,
Ibadan, Nigeria
Introduction: Choosing a healthcare provider is an important decision
that individuals and families make. Bypassing occurs when patients
knowingly visit a health facility other than the one nearest to him/her.
Bypassing can contribute to higher costs of access and poor outcomes.
Among National Health Insurance (NHIS) enrollees who do not have to
pay for healthcare services and whose choice of healthcare facilities is
often made in the healthy state, the factors that determine the facility
chosen are not well known.
Aim: This study assessed the choice of healthcare provider and perceived
quality of care among NHIS enrollees within Ibadan, South-west Nigeria.
Methods: The study was a descriptive cross-sectional survey conducted
among NHIS enrolees registered and accessing health care services in
outpatient departments of 5 randomly selected NHIS-accredited health
facilities in Ibadan. A total of 311 NHIS enrollees were consecutively
recruited for the study and a semistructured, pre-tested, interviewer-
administered questionnaire was used for data collection. Descriptive and
inferential statistics were used to present results at 5% significance level.
Distance travelled by patients from their residence to the facilities was
estimated using Google maps.
Results: Mean age of respondents was 37.1±16.1 years. About half
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(28.9%) of respondents were being treated for malaria and related febrile
illnesses while 43% reported needing care for eye, heart, orthopedic
and general surgical care. Overall, bypassing rate was 55.3%. About
41% chose their present hospitals on physician referral while 42% made
the choice themselves. Respondents who by-passed travelled 27±34.1
more minutes to the farther hospital. The private hospitals providing
secondary care [Alaafia hospital (77.8%), Toun Memorial (73.9%), The
Vine medical centre (66.7%) and Victory Medical center (72.7%)] had
greater proportion of respondents who perceived their hospital had good
quality than the government-owned tertiary hospital University College
Hospital (32.8%). There was positive association between poor perception
of the quality of healthcare and by-passing (X2 = 11.90, p< 0.001).
Conclusion: Evidence in this study show that by-passing occurs among
NHIS enrollees in Ibadan, Southwest Nigeria and it is associated with
patients’ perception of quality.
041
EFFECTS OF PERFORMANCE-BASED FINANCING ON HEALTH
SYSTEMS OUTCOMES: CONCLUSIVE EVIDENCE OR UNDUE
HYPE? A SYSTEMATIC REVIEW
Brugnara L.1 Marx M.1,2
1Heidelberg Institute of Global Health, University of Heidelberg,
Heidelberg;
2evaplan at the University Hospital Heidelberg, Heidelberg, Ger-
many
Introduction: The WHO ´s Health Systems Framework comprises four
major Outcomes: 1) improved health (level and equity), 2) responsive-
ness, 3) social and financial risk protection, and 4) efficiency improve-
ment. Performance-based financing (PBF), or pay-for-performance, are
mechanisms to disburse funds according to pre-established criteria of
service delivery or performance targets. It has been applied in different
low- and middle-income countries as a strategy to improve quality of
health services and to strengthen health systems in order to achieve
better outcomes.
Aim: To investigate the effect of performance-based financing on health
system outcomes in low- and middle-income countries.
Methods: We carried out a systematic literature review on PBF in primary
health care in low- and middle-income countries and its effects on
health systems outcomes. We searched in four scientific databases
(Pubmed, Web of Science, SciELO and Google Scholar) considering more
than 30 MeSH/key terms like performance-based financing, reimburse-
ment incentive, or outcome assessment. We selected peer-reviewed
publications that investigated health status (clinical/laboratorial) and
equity (including equity in health services access), responsiveness, risk
protection (including out-of-pocket/catastrophic expenditures), and
efficiency (cost-effectiveness or resource use improvement).
Results: We identified 286 documents. We excluded 136 based on
their title, 119 based on abstract, and three which we couldn’t access
the full text. Out of the 28 remaining publications, we could identify
only ten referring to at least one of the health system outcomes. Two
papers investigated health status improvement (no effect/slight effect),
four equity between economic groups (one described positive effect,
one no effect, two reverse effect), five responsiveness (four papers
showed improved patient satisfaction, one no effect), two financial risk
protection (one positive effect, one inconclusive), and one efficiency
(inconclusive).
Conclusion: Most papers describing the effects of PBF focus on service
performance (direct outputs), probably because in practice, such
administrative data is easier to generate and easier to apply for
performance pay. Yet, if PBF is to be used as a method for health
systems strengthening, the effect on health systems outcomes should
be considered. We claim that to better understand the effects of PBF
more research at the health system and outcome level is needed.
042
WHAT CAN BEHAVIOURAL CHANGE ANALYSIS BRING TO THE
COMPREHENSIVE UNDERSTANDING OF PERFORMANCE-BASED
FINANCING SUSTAINABILITY? EXPLORATION THROUGH THE
APPLICATION OF THE I-CHANGE MODEL ON THE CASE OF BENIN
Bodson O.1, Paul E.1,2
1Faculty of Social Sciences, University of Liege, Liege;
2School of Public Health School, Université Libre de Bruxelles, Brus-
sels, Belgium
Introduction: Performance-based financing (PBF) is promoted as a way
to improve health workers’ performance. However, despite a growing
interest in the issue of motivation and the use of several motivational
theories to appraise it, little is still known about PBF internal mechanisms
leading to behavioural change, even less on their sustainability. The
recent termination of donor-funded PBF programmes in Benin represents
a unique opportunity to analyse which motivational mechanisms are
sustained when incentives cease.
Aim: This study aims to refine the understanding of PBF by using the
I-change model1 and to explore how PBF affects health workers behav-
ioural change in Benin during implementation and after termination.
Methods: Our study rests on a qualitative design. We conducted semi-
structured interviews with healthcare providers and managers from
health centres (N=6) and hospitals (N=2) in two health districts supported
by different donors), first during PBF implementation in 2017 and
secondly, with some of the stakeholders previously interviewed (N=40), 6
and 9 months after the programmes stopped. Interviews were analysed
thematically.
Results: PBF produced positive effects on some health workers’
behaviours, like interpersonal communication and reporting, that are
sustained after PBF termination. During implementation, the prospect
of extra gain contributed to the motivation of health workers to adopt
these behaviours, however that effect was reduced due to low level and
perceived unfair distribution of financial incentives, and reversed with
their cessation. Beyond financial incentives, other mechanisms also play
an important role in health workers behaviours adoption, which persisted
after PBF termination, notably awareness of inner duty, social pressure,
and demonstration of the usefulness of some practices. However, some
systemic constraints, design and implementation issues, and the absence
of an exit strategy reduced their motivational effect.
Conclusion: Our behavioural change analysis using the I-change
model helps refine the understanding of PBF and sheds light on its
effects on health workers’ behaviours that go beyond the effects of
financial incentives, but can be reduced by systemic constraints, design,
implementation and exit strategy issues.
Reference:
1. De Vries H., Dijkstra M., Kuhlman P. Self-efficacy: the third factor besides
attitude and subjective norm as a predictor of behavioral intentions.
Health Education Research 1988; 3; 273–282.
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A CROSS-SECTIONAL MIXED-METHODS STUDY OF SEXUAL AND
REPRODUCTIVE HEALTH NEEDS, KNOWLEDGE AND ACCESS TO
SERVICES AMONG REFUGEE ADOLESCENT GIRLS IN THE NAKI-
VALE REFUGEE SETTLEMENT, UGANDA
Ivanova O.1, Rai M.1, Mlahagwa W.2, Tumuhairwe J.2, Bakuli A.1,
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Introduction: Humanitarian crises and migration make girls and women
more vulnerable to poor sexual and reproductive health (SRH) outcomes.
Nevertheless, there is still a dearth of information on SRH outcomes and
access to SRH services among refugee girls and young women in Africa.
Aim: We aimed at assessing SRH needs, experiences and knowledge of
refugee girls in the Nakivale settlement, Uganda.
Methods: A cross-sectional survey among 260 adolescent girls 13-19
years old was conducted between March and May 2018. Concurrently,
in-depth interviews and focus group discussions were conducted among
a subset of adolescents. For both methods, information was collected
regarding SRH knowledge, experiences and access to services and com-
modities. The questionnaire was entered directly on the tablets using the
Magpi® app. Descriptive statistical analysis was performed. Qualitative
data was transcribed and analysed using thematic content analysis.
Results: A total of 260 participants were interviewed, with a median
age of 15.9 years. The majority of girls were born in DR Congo and
Burundi. Of the 93% of girls who had experienced menstruation, 43%
had ever missed school due to menstruation. Regarding SRH knowledge,
a total of 11.7% were not aware of how HIV is prevented, 15.7% did not
know any STI and 13.8% were not familiar with any method to prevent
pregnancy. A total of 30 girls from 260 were sexually active, of which
11 had experienced forced sexual intercourse. The latter occurred during
conflict, in transit or within the camp. A total of 27 of 260 participants had
undergone female genital mutilation (FGM). The most preferred sources
for SRH information was parents or guardians, although participants
expressed that they were afraid or shy to discuss other sexuality topics
apart from menstruation with parents. A total of 30% of the female
adolescents had ever visited a SRH service centre, mostly to test for HIV
and to seek medical aid for menstrual problems.
Conclusion: Adolescent refugee girls lack adequate SRH information,
experience poor SRH outcomes including school absence due to men-
struation, sexual violence and FGM. Comprehensive SRH services including
sexuality education, barrier-free access to SRH services and parental
involvement are recommended.
044
INCREASING TRENDS IN ADOLESCENT CHILDBEARING AMONG
WOMEN IN ALL EDUCATIONAL GROUPS IN ZAMBIA, BUT OVER-
ALL DECLINE
Kampata L.1,2,3, Sandøy I.1,3
1Center for International Health, University of Bergen, Bergen,
Norway;
2School of Public Health, University of Zambia, Lusaka, Zambia;
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Introduction: Early age at childbirth poses risks to the health, social and
economical wellbeing of women and their children. Studies have shown
that higher educational attainment leads to higher age at first birth. In
Zambia, access to education for women has increased since the 1990s,
and this is expected to have affected trends in early childbearing.
Aim: To examine trends in childbearing before age 18 across education
attainment levels among Zambian women aged 18-24 from 1992 to
2014.
Methods: We analysed data on age at first birth from the 1992, 1996,
2001/2, 2007 and 2013/14 Zambia Demographic and Health Surveys. The
analyses were restricted to women aged 18-24 years (n=13,818). Mixed
effects logistic regression was used to assess the trends.
Results: Overall, there was a significant negative trend in the proportion
giving birth early from 33.8% in 1992 to 30.6% in 2013 (p<0.001).
However, the odds of giving birth before age 18 tended to increase
across all educational attainment levels. The proportion increased among
women with middle educational attainment from 31.1 to 39% (OR=1.42,
95% CI, 1.17-1.72) and among those with high educational attainment
from 5.9 to 15.9% (OR=3.04, 95% CI, 1.70-5.43). The difference in early
childbirths between the low and high educational attainment groups was
greater in 1992 (40.4 to 5.9%, OR=0.09, 95% CI, 0.05-0.17) than in 2013
(44.9 to 15.9%, OR=0.23, 95% CI, 0.19-0.29), and it was greater among
urban (OR1992=0.05, 95% CI, 0.02-0.14; OR2013=0.13, 95% CI, 0.09-0.20)
than rural women (OR1992=0.16, 95% CI, 0.07-0.34; OR2013=0.32, 95% CI,
0.24-0.42).
Conclusion: The odds of giving birth before age 18 increased at all edu-
cational levels since 1992 despite the overall slowly declining trend. The
increased odds among higher educated women probably reflects that
this group grew in size (from 10% to 44% of the sample) and was more
heterogeneous in 2013, comprising a higher proportion of sexually active
women, compared to the highly selected group of educated women
in 1992. This may indicate that education in itself is not adequate in
reducing adolescent childbearing and that other factors probably also
must be tackled in order to reduce early childbearing.
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ASSESSING THE IMPACT OF CLIMATE CHANGE ON SLEEPING
SICKNESS IN ZIMBABWE USING A GEOSPATIAL MODEL OF
TSETSE POPULATION DYNAMICS
Longbottom J.1,2, Lord J.1, Torr S.1
1Dept. of Vector Biology, Liverpool School of Tropical Medicine,
Liverpool;
2Centre for Health Informatics, Computing and Statistics, Lan-
caster University, Lancaster, UK
Introduction: Climate change influences the entomological and
epidemiological components of vector-borne diseases. For Rhodesian
human African trypanosomiasis (rHAT), recent increases in temperature
have resulted in a decline in tsetse fly abundance at one field
site in Northern Zimbabwe1. Researchers demonstrated this using a
mechanistic model of tsetse population dynamics, incorporating the
effects of temperature on tsetse mortality and development rates1.
Aim: We aimed to produce a geospatial model of tsetse population
dynamics to explore the effect of climate change on the abundance of
the rHAT vector Glossina pallidipes throughout other sites within Northern
Zimbabwe.
Methods: We compared remotely sensed MODIS temperature data to
local weather station data previously used to fit the mechanistic model
to longitudinal G. pallidipes abundance1. We then used the MODIS data
to estimate mortality and development rates in the existing ordinary
differential equation (ODE) model, running simulations for each 1 km × 1
km cell in Northern Zimbabwe, from 2000 to 2016. The projection of this
model throughout Northern Zimbabwe produced estimates of changes
in tsetse abundance for locations currently lacking longitudinal data.
Results: Our model predicts decreasing abundance of tsetse within
several low elevation areas in relation to increasing temperature trends
during 2000-2016. Conversely, we show that several high elevation
areas, previously considered too cold to sustain tsetse, are now suitable
climates, with viable population predictions.
Conclusions: The model produced here details, to the best of our
knowledge, the first temperature-driven spatial projection of tsetse
population dynamics within Zimbabwe. Both rHAT occurrence and tsetse
abundance show decreasing trends across much of the Zambezi valley,
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Future work including empirical studies to validate model predictions is
planned.
References:
1. Lord JS, Hargrove JW, Torr SJ, Vale GA (2018) Climate change and
African trypanosomiasis vector populations in Zimbabwe’s Zambezi Val-
ley: A mathematical modelling study. PLOS Medicine 15(10): e1002675
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MALARIA: BAD AIR - IS CLIMATE A RELIABLE PREDICTOR
FOR MALARIA CASE DISTRIBUTIONS IN THE DOMINICAN
REPUBLIC?
Tapia L.1,2, Arredondo-Abreu C.2, Ruiz-Matuk C.B.2, Paulino-
Ramirez R.1,2
1Institute for Tropical Medicine & Global Health, Universidad
Iberoamericana;
2Research Dept., Universidad Iberoamericana, Santo Domingo,
Dominican Republic
Introduction: Malaria, caused by the Plasmodium spp parasite, has
established endemicity in the Dominican Republic. Malaria cases reports
follow a seasonality pattern throughout the tropical regions. With the
United Nations’ goal to eradicate Malaria, understanding it’s infectious
dynamics has taken a front stage in the fight against this disease.
Aim: The aim of this study is to describe the relationship between
climatologic factors and Malaria cases in Santo Domingo.
Methods: Weekly malaria reports from January 2013 to December
2017 were extracted from the Ministry of Health database. Meanwhile,
Maximum, Minimum and Mean Temperature, Rainfall and Relative
Humidity were obtained from to the National Meteorological Office.
Correlation of individual factors was calculated using 1 week, 4 weeks,
and 24 weeks lag time to establish a relationship between disease
and climate. Regressions for these lags were conducted to explain the
combined variance explained by the climatologic factors.
Results: At 1-week lag time, rain correlates with Malaria cases (tau =
0.10, p < 0.05). At a 4-week lag time, a negative correlation (tau= - 0.09,
p < 0.05) exists between Humidity and Malaria cases reported. At 24
weeks lag, correlations between malaria cases and Mean Temperature
(tau= -.10, p <0.05), Minimum Temperature (tau= - 0.11, p < 0.05) and
maximum temperature (tau= - 0.10, p < 0.05) were found. Regression
models carried out with each lag were not significant.
Conclusion: Climatologic factors correlate with reported Malaria cases
but fail to function as a predictive model for future disease. Strongest
correlation occurs at a 24 week lag between malaria cases and tem-
perature measures. Temperature proves to be a determining condition
for Anopheles mosquito metabolic demand. Behavior factors related
to malaria prevention is recommended to have a more comprehensive
model.
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HUMAN RELEVANT TICKS AND TICK-BORNE PATHOGENS FROM
MIGRATORY BIRDS IN SOUTHERN AND CENTRAL EUROPE
Battisti E.1, Urach K.2, Cardinale M.3, Felsberger G.4, Ferroglio
E.1, Fusani L.2, Hodžić A.5, Hufnagl P.4, Duscher G.G.5
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5Institute of Parasitology, University of Veterinary Medicine,
Vienna, Austria
Introduction: Every year in spring time migratory birds carry larvae
and nymphs of foreign tick species e.g. Hyalomma spp., along their
way through Europe. During the bird ´s journey the ticks drop off and
in case of suitable prevailing weather conditions, those ticks are able
to develop further to adult ticks and quest for new hosts in the new
habitat. So happened in October last year in the north of Austria, where
an adult male Hyalomma marginatum was found on a Haflinger horse.
Additionally this tick was harbouring Rickettsia aeschlimannii, clearly
pointing out the risk of importation of “exotic” diseases such as Crimean-
Congo Hemorrhagic Fever virus (CCHFv), which can be transmitted by
especially this tick species.
Aim: Therefor we investigated mirgratory birds on their spring travel
towards northern Europe for the abundance of ticks and tick-borne
pathogens and to give a risk assessment for the transfer of pathogens
via migratory birds.
Methods: In 2016 and 2017 on the bird ringing station on the Island
Ponza ticks were removed from mirgratory birds and those ticks were
further analysed for the occurrence of zoonotic pathogens by the use of
PCR.
Results: From 728 captured birds, 104 birds showed tick infestation
and 231 ticks were derived from these. The vast majority of ticks were
Hyalomma spp. Out of these 20.1 % were tested positive for “spotted-
fever-group” Rickettsia comprising Rickettsia aeschlimannii, Rickettsia
africae and Rickettsia raoultii. None of the ticks were found positive for
CCHFv.
Conclusion: Migratory birds represent a constant possibility for exotic tick
species to be introduced to northern areas. With these tick species new
zoonotic pathogens such as R. aeschlimannii come along and there is a
potential for CCHFv to be introduced as well. The public should be trained
to notice “new and exotic” tick species.
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Introduction: National Parks in East and Southern Africa are hotspots
for human and animal trypanosomiasis, caused by trypanosomes
transmitted by tsetse flies. Our work in farming areas on the edge of the
Serengeti National Park (SNP) in Tanzania suggests that unexpectedly
low numbers of tsetse1 may be due to widespread treatment of cattle
with pyrethroids by livestock keepers.
Aim: To estimate the proportion of cattle treated with insecticide by
livestock owners around the SNP and the amounts applied. Also, to
develop a simple and cost-effective method for quantifying insec-
ticide concentration on cattle hair to aid monitoring of large-scale
interventions.
Methods: Hair samples were collected from 44 cattle herds located
within 5 km of the SNP and surrounding game reserves, and a short
questionnaire on insecticide use was administered. The concentration of
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spectrometry (GC-MS). Hair was also collected from experimental cattle
treated with known concentrations of alphacypermethrin at 1-14 days
post-treatment, bioassayed by exposing tsetse to the hair, and the
insecticide concentration assessed using GC-MS and high-performance
liquid chromatography (HPLC). Sub-samples from the farming area
and experimental herd were also analysed using a modified simple
colorimetric method (Insecticide Quantification Kit, IQK) suitable for
quantifying cyano-pyrethroids2.
Results: In the questionnaire, 67% of livestock owners reported using
insecticide in the previous month to control tick- and tsetse-borne
diseases in livestock. Chemical analyses of hair showed that pyrethroids
were present in ∼20% of herds. Bioassays showed that tsetse exposed to
hair treated 1-4 days post treatment were killed but mortality declined
to 2% by day 14; HPLC and GC-MS of the hair showed a similar decline
in concentration of alphacypermethrin. The IQK was able to provide a
semi-quantitative measure of pyrethroids present in cattle hair.
Conclusion: High levels of pyrethroid use in herds is a likely important
cause of the low numbers of tsetse in areas bordering the SNP, providing
an example of a One Health solution to the risk of sleeping sickness. The
IQK shows potential as a simple and cost-effective method for assessing
use of pyrethroids by livestock keepers.
References:
1. Lord et al. J Appl Ecol. 2018;1-11
2. Russell et al. Malar. J. 2014; 13:178
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Introduction: Crimean-Congo haemorrhagic fever virus (CCHFV) is a tick-
borne zoonotic orthonairovirus which can cause fatal haemorrhagic dis-
ease in human patients and has a reservoir in domestic livestock species.
The virus has a wide geographic range and is known to circulate in
areas where no human cases have previously been reported. The virus
has recently emerged in human populations in Uganda, leading to a
number of fatalities, but the presence of CCHFV elsewhere in East Africa
remains poorly understood. Northern Tanzania has been identified as an
area of risk for human exposure but currently almost nothing is known
about virus circulation in the country. Elsewhere, patterns of exposure
in livestock have been shown to provide important insights into CCHFV
exposure risk in humans so further investigation into animal reservoirs is
required to better understand the potential threat to human health.
Aim: This study aims to investigate the seroprevalence, spatial distri-
bution and risk factors associated with CCHFV exposure in Tanzanian
livestock species.
Methods: Serum samples from approximately 8000 cattle, sheep and
goats were collected as part of a cross-sectional survey in Arusha and
Manyara regions, Tanzania during 2016. Samples were tested for CCHFV
seropositivity using in-house and commercial N-protein based indirect
and double-antigen sandwich ELISAs.
Results: Initial investigations indicate that approximately 40% cattle,
30% goats and 25% sheep were seropositive for CCHFV. Further testing
and risk factor analysis is ongoing.
Conclusion: This is the first study to investigate CCHFV exposure in Tan-
zanian livestock. Initial results demonstrate that the virus is circulating in
northern Tanzania and may present a hazard to human health. This One
Health investigation, into the spatial patterns and risk factors associated
with livestock exposure, is an important first step in characterising the
potential threat CCHFV poses to human health in Tanzania.
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J.1, Damian P.1, Naranjo V.1, Jaramillo K., Villavisencio F.2,
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Introduction: Antimicrobial resistance (AMR) is a worldwide concern
and must be addressed with a One Health approach. The prevalence
of indicator ESBL Escherichia coli and Salmonella, and its resistant
characteristics in poultry production and humans are unknown in
Ecuador.
Aim: To establish the prevalence and genetic determinants of AMR in ESBL
E. coli and Salmonella isolated from poultry farms, chicken carcasses and
humans in Ecuador.
Methods: We isolated ESBL E. coli (TBX agar + cefotaxime 3mg/l) and
Salmonella (ISO 6579) from 13/11/2017 to 25/9/2018 in Quito city
(Ecuador). Bacterial isolation was conducted in samples from 133 poultry
flocks, 335 chicken carcasses at retail and 302 human gastroenteritis
cases. AMR to 6 families of antibiotics was assessed by VITEK® system
for ESBL E. coli and Kirby Bauer method for Salmonella. Serotypes of
Salmonella isolates were obtained by PCR. Genes determining AMR to
cephalosporins and colistin were tested by PCR and DNA sequencing.
Results: ESBL E. coli was present in 93.2% (n=124/133), 77.9 %
(n=261/335) and 50.6% (n= 153/302) of farms, carcasses and humans
respectively. Salmonella was present in 41.4% (n=55/133), 55.5%
(n=186/335), and 1.9% (n=7/302) of farms, carcasses and humans
respectively. Serotypes of Salmonella isolates (n=248) were Infantis
(241), Tiphymurium (3), Enteritidis (2) and Dublin (1). One isolate could
not be serotyped. Antimicrobial resistance rates >90% were found for β-
lactams, quinolones and fosfomycin; resistance to nitrofurantoin was
registered in 8% of isolates. Lower AMR rates (<5%) were found for
amikacin and carbapenemes. 98% of ESBL E. coli and ESBL Salmonella
presented multi-drug resistant phenotypes. Genes of the blaCTX-M group
were found in 85% of ESBL isolates. The most frequent variant was
blaCTX-M-55 followed by blaCTX-M-65, blaCTX-M-3, blaCTX-M-2, blaCTX-M-123,
blaCTX-M-15 and blaCTX-M-8. On the other hand, 1,5% of isolates presented
the blaCMY-2 variant. ESBL E. coli with the presence of mcr-1 gene were
found in 18 isolates.
Conclusion: This research brings insights to the epidemiology of AMR
foodborne bacteria. Specifically, the poultry sector appears to be a
hotspot for antimicrobial resistance in Ecuador, but further research in
other livestock is needed to have a broader epidemiological view.
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IDENTIFYING THE ROLE OF THE DIFFERENT RESERVOIR HOSTS
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Introduction: Schistosomiasis is a neglected tropical disease caused
by Schistosoma parasitic worms, which inflicts a significant burden on
human and animal populations, particularly across sub-Saharan Africa.
Anthropogenic land-use changes affect the distribution and availability
of suitable definitive and intermediate hosts, increasing opportunities
for hybridization between human and animal schistosomes with subse-
quent zoonotic transmission. This can have a substantial impact on the
dynamics and distribution of schistosomiasis, with further challenges and
constraints for effective control.
Aim: Our aim was to elucidate the role of different definitive hosts as
reservoirs of zoonotic Schistosoma single species and hybrids in a region
of northern Senegal subject to important anthropogenic change.
Methods: Extensive and systematic parasite sampling from human, live-
stock, and rodent definitive hosts, combined with snail intermediate
hosts, were performed over three years across key transmission sites
in northern Senegal. Multi-locus molecular analyses of all Schistosoma
isolates, followed by Maximum Likelihood (ML) and Bayesian Inference
(BI), were used to infer phylogenetic and transmission dynamics between
the circulating zoonotic Schistosoma species/hybrids and their hosts.
Results: Molecular analyses confirmed the presence of widespread viable
hybridization within and between Schistosoma species of humans and
animals. Phylogenetic analyses indicated shared transmission of zoonotic
Schistosoma species and hybrids between humans and animals (both
wild and domestic), providing unique insights into the role of different
host species in maintaining transmission.
Conclusion: Our study emphasizes the need for a One Health multi-host
framework for schistosomiasis control in both people and animals living
in high zoonotic transmission zones of sub-Saharan Africa.
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Introduction: Schistosomiasis affects over 240 million people, predomi-
nantly in sub-Saharan Africa. Schistosomiasis in Africa was thought to be
a largely human disease. Recent research identifies zoonotic transmission
in sub-Saharan Africa as more significant than previously assumed,
potentially reducing the efficacy and cost-effectiveness of preventative
chemotherapy (PC) control programmes.
Methods: A review of economic evaluations of human and animal schis-
tosomiasis control programmes was conducted, focusing on, economic
interactions between human and animal disease. Systematic searches of
eleven databases were carried out using structured methodology. Focus
groups (n = 30) were carried out with farmers in four areas of Senegal
(Barkadji, Richard Toll, Dakar and Koungheul). In-depth interviews (n
= 32) were conducted with veterinarians, human health workers and
policy makers to ascertain knowledge, attitudes and practices in relation
to schistosomiasis. The rationale and availability of data for conducting
a One Health economic evaluation to inform policy on schistosomiasis
control in Africa we assessed.
Results: 53 studies were identified: 13 reported costs per child treated
with PZQ or screened for schistosome infection; 39 reported cost-
effectiveness or cost-benefit of schistosome control. Eleven studies
in China considered zoonotic disease control, of which one reported
costs reflecting a One Health perspective, but no studies on zoonotic
control were reported from Africa. Farmers in endemic regions considered
schistosomiasis to be in the top three severe livestock diseases. Human
and animal formulae medications were used for animal treatment and
participants felt a One-Health approach was needed in some regions.
Conclusions: A lack of data on the impact of livestock schistosomiasis was
highlighted. A framework for a one-health cost–effectiveness evaluation
was developed. In high knowledge regions, participants indicated that
livestock treatment could benefit both animals and people. Further work
is imperative to evaluate costs, disease impact and control options of
schistosomiasis on animal health and production.
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Introduction: T. gondii is a zoonotic parasite of worldwide distribution.
Seroprevalences of 70%-90% have been reported among the human
population of Yucatan. Recent studies suggested that the pork produced
in this area could have important public health implications but studies
in pigs are limited in this locality. The parasite presents geographical
patterns of strain variation with contrasting high levels of diversity across
South America and restricted variation across North America, but little is
known about the diversity of strains originated in Yucatan which lies in
the transitional area between the two continents.
Aim: The aims of the present work were to investigate the prevalence of
T. gondii in domestics pigs of Yucatan and genotyping of strains among
pigs and sympatric animal species.
Methods: T. gondii prevalence and genotypes were investigated through
a cross-sectional survey of commercial pig farms, together with post-
mortem sampling at abattoirs. Nested-PCR amplification of the major
surface antigen (SAG1) and the modified agglutination test (MAT) were
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was used for genotyping of strains. The viability of the parasite was further
investigated in tissue samples by mouse bioassay.
Results: The overall prevalence among 632 pigs was 1.4% (95%CI, 0.6%-
2.7%) with the MAT (cut-off ≥ 1:25) and 19.8% (95%CI, 16.7%–23%) by
PCR on blood. A total of 46 pig tongues were collected from 2 abattoirs
of which 34.8% (95%CI, 21.4%–50.3%) were positive by PCR. Mouse
bioassay was attempted in 40 of these tongues and 7.5% (95%CI, 1.5%–
20.4%) were positive. Genotyping results revealed a high diversity among
Yucatan strains with evidence of recombination and novel alleles. T. gondii
strains from Yucatan possessed a mixture of genotypes found in both
North and South America with a lack of a clear predominant genotype.
Conclusion: Prevalence and bioassay results indicate that pork could be a
potential T. gondii infection risk to humans. Genetic population structure
of the parasite in Yucatan resembles to other regions of Central America
with significant levels of allelic variation and recombination which consti-
tutes a reservoir for new strains.
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Introduction: Short-term missions providing patients in low-income
countries with (specialized) reconstructive surgery are often criticized
because evidence of their value is lacking.
Aim: This study aims to assess the effectiveness of short-term recon-
structive surgical missions in low- and middle-income countries.
Methods: A systematic review was conducted according to PRISMA
guidelines. We searched five medical databases from inception up to 2
July 2018. Original studies of short-term reconstructive surgical missions
were included, which reported data on patient safety measurements,
health gains of individual patients and sustainability. Data were combined
to generate overall outcomes, including overall complication rates.
PROSPERO registration: CRD42018099285.
Results: Of 1662 identified studies, 41 met full inclusion criteria, which
included 48,546 patients. The overall study quality according to Oxford
CEBM and GRADE was low. Ten studies reported a minimum of six months
follow-up, showing a follow-up rate of 56.0% and a complication rate of
22.3%. Twelve studies that did not report on duration or follow-up rate,
reported a complication rate of 1.2%. Fifteen out of 20 studies (75%) that
reported on follow-up, also reported on sustainable characteristics.
Conclusion: Evidence on the patient outcomes of reconstructive surgical
missions is scarce and of limited quality. Higher complication rates were
reported in studies which explicitly mentioned the duration and rate of
follow-up. Studies with a low follow-up quality might be underreporting
complication rates and overestimating the positive impact of missions.
This review indicates that missions should develop towards sustainable
partnerships. These partnerships should provide quality aftercare,
perform outcome research and build the surgical capacity of local
healthcare systems. In line with this conclusion the author is currently
conducting one such study on post-burn contractures in rural Tanzania.
The study is conducted in a low-income country hospital with a long-
standing sustainable partnership with high-income countries, which
enables local capacity building. The study aims to provide quality clinical
research outcome with a long-term follow-up.
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Introduction: Recent efforts in malaria control in mainland Tanzania has
led to progressive changes in the epidemiological profile of malaria with
prevalence in children aged 6-59 months declining from 18.1% in 2008
to 7.3% in 2017. As heterogeneity in malaria transmission increases, a
sub-regional stratification becomes crucial for optimised implementation
of interventions. However to this aspect, malaria global strategy only
provide generic guidance to countries.
Aim: Developing an approach for country specific stratification at
district level according to malaria burden for identification of suitable
intervention packages per strata.
Methods: The annual parasite incidence, test positivity rate, confirmed
malaria incidence and malaria positivity in pregnant women obtained
from routine District Health Information System (DHIS2), and parasite
positivity rate in school children (PfPR5to16) obtained from the two latest
biennial district representative School Malaria Parasitological Surveys
(SMPS) were used as malaria burden indicators. The PfPR5to16 was taken
as reference for the other indicators to determine appropriate thresholds.
The maximum value of the past three years was used to allocate each
district to one of four risk strata determined based on the identified
thresholds. After stratification, modelling was used to predict the impact
of intervention packages per strata.
Results: The identified thresholds defined four epidemiological strata:
very low (<1% PfPR5to16), low (1-<5% PfPR5to16), moderate (5-<30%
PfPR5to16) and high (>30% PfPR5to16). Out of 184 districts, 28 districts
were in the very low strata (12% of the population), 34 in the low strata
(28% of population), 49 in the moderate strata (23% of population) and
73 in the high strata (37% of population). Geographically, most of the
districts in the low strata were situated in the central corridor running
from north-east to south-west parts of the country, whilst the areas in
the moderate to high strata were seen in the north-west and south-east
regions.
Conclusion: A stratification approach based on routinely collected
malaria burden estimates was developed. The resulting stratification
allowed for setting effective targeted interventions towards malaria
burden reduction or elimination according to the transmission intensity
in mainland Tanzania.
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Introduction: Tertian malaria has been long assumed to relapse. Yet,
also other malaria parasites seem capable of evoking reappearing
parasitaemia months to years after the primary infection. Recently,
doubts about the currently accepted relapse theory of Plasmodium ovale
(Po) spp. were raised by the scientific community as hypnozoites could
so far not be demonstrated in the human host. Also, molecular methods
have barely been used to support relapse reports.
Aim: The aim of this study was to describe Po spp. reappearance and
relapse using molecular methods.
Methods: Baseline Po spp. mono or mixed infections were included and
treated with artemether-lumefantrine. Participants were followed up
biweekly for up to one year. In case of microscopic positivity, blood
was drawn for further analyses. Blood samples were analysed by ultra-
sensitive Pan-Plasmodium RT-PCR and Plasmodium species-specific
nested singleplex quantitative real-time PCR. In case of reappearance
of the same ovale species, 18S, potra, and porbp2 genes were partially
sequenced and isolates were compared. Criteria for relapse were
sameness of isolates in at least two genes, documented treatment of the
preceding malaria episode, adequate D7 lumefantrine concentration and
at least one negative PCR result between the two concerning episodes.
Results: 26 participants were eligible for analyses. The male/female ratio
was 1, mean age was 8.2 years (range 2-81). At baseline, 17 participants
had a real-time qPCR diagnosed P. ovale curtisi (Poc) infection, 13 were
positive for P. ovale wallikeri (Pow). Twenty-four Poc reappearances and
four Pow reappearances were detected in twelve participants, all before
week 33. Ten reappearances fulfilled the criteria for Poc relapse. No Pow
relapse could be discovered.
Conclusion: This is the first prospective analysis postulating ovale relapse
in a patient cohort based on molecular methods. Genotyping shows
homologous reappearance of the same Poc parasites following initial
blood stage clearance which is in line with the current relapse theory.
The results further prove that Poc and Pow circulate as sympatric species
in Gabon. Interestingly, Poc was more prevalent than in this cohort than
Pow. All observed relapses were caused by Poc, the absence of Pow
relapses remains to be explained.
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Introduction: There have been several attempts at mapping malaria
prevalence, particularly in areas where there is the highest burden of
the disease, in Sub Saharan Africa. Unfortunately, there is the least
availability of information in these areas. Most of these maps aim to
bridge these gaps by estimating the prevalence, where this information
is not available, based on mathematical models, utilising geographic
information of the various locations. Some of these maps include the
Malaria Atlas Project (MAPs) and Mapping Malaria Risk in Africa (MARA)
in West Africa. We propose a new way of mapping Malaria transmission
globally, particularly in areas where there is some information of malaria
transmission.
Aim: To map malaria transmission intensity in Wamakko, Nigeria and
propose a method for mapping malaria intensity globally.
Methods: We use Geographic Information Systems to make these maps.
Using a base map of Nigeria, we geo-locate the sites of previous malaria
surveys, particularly the Nigerian Malaria Indicator Survey of 2010. The
prevalence in each of the sites is transformed to the estimated prevalence
among children 2 to 10 years of age, as exists in the MAP database and
extend the prevalence in each case to 10km of the index site, based on
the average flight distance of the predominant vector in this region. It is
also extended a further 5Km, based on the maximum flight distance of
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Results: The map shows a representation of the prevalence of malaria
across the sites, using the same colours and identifiers as the MAPs
representations. This is compared with the corresponding timepoint
of MAP representation. It shows significant differences from MAPs.
However this is more accurate than MAPs, where data is available,
but it doesn’t cover the entire landscape, leaving areas of limited
information.
Conclusion: Using GIS, data on malaria transmission intensity can be
extended beyond the actual sites of conduct of malariometric surveys,
with a greater accuracy than mathematical models and can be the gold
standard for mapping disease-transmission-intensity. The challenge lies
in ensuring that these surveys are conducted uniformly and with universal
spread.
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Introduction: The coverage of Prevention of Mother to Child Transmission
(PMTCT) of HIV with anti-retroviral therapy (ART)reached 87% in 2015
in Zambia. However, risk of vertical transmission remains high (6%).
Although the transition to Option B+ has brought a paradigm shift in the
implementation of PMTCT, poor male involvement in PMTCT services has
been identified as one of the factors contributing to reduced effectiveness
of the programme.
Aim: To determine the extent and the role of male involvement in the
PMTCT programme during the Option B+ roll out of PMTCT in Ndola
district, Zambia and its impact on the uptake of PMTCT services.
Methods: We conducted a retrospective analysis of routine clinical data
in the PMTCT programme in Ndola district from Jan 2015 to Dec 2017
using descriptive statistics and time trends to describe the levels of male
involvement; that is any male partner accompanying and participating
with the women in PMTCT/antenatal (ANC) clinics in Ndola. We conducted
univariate and multivariate logistic regression to examine the association
with uptake of PMTCT services.
Results: Among the 48,702 HIV+ and HIV- women who used ANC ser-
vices in which PMTCT is integrated, 6,288 (14.3%) reported male involve-
ment. Male involvement among HIV+ women increased significantly
over time from 10.4% in 2015 to 20.6% in 2017. Male involvement
among HIV+ women was found to be significantly associated with 3
or more ANC visits (aOR= 1.6, p-value 0.048), earlier gestational age at
first ANC visit (first trimester aOR 2.4, p<0.008 compared to second/third
trimester), and infant’s ARV prophylaxis (aOR=8.0, p<0.01). PCR HIV pos-
itivity among infants aged 6 weeks was1%, no association with male
involvement.
Conclusion: The extent of male involvement in PMTCT services in Ndola
increased but remains suboptimal. HIV+ women with involvement of
male partners were twice as likely to initiate ANC in the first trimester
and were 8 times more likely to provide ART prophylaxis to their infants.
Restructuring of PMTCT programmes during Option B+ era must be a
priority. Enabling and encouraging male partners’ involvement is a key
factor for improving uptake, timeliness and effectiveness of services to
HIV+ women and their infants.
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INTIMATE PARTNER VIOLENCE AND MATERNAL DEPRES-
SION DURING PREGNANCY: A COMMUNITY BASED CROSS-
SECTIONAL STUDY IN ETHIOPIA
Belay S.1, Astatkie A.1, Emmelin M.2, Hinderaker S.G.3
1School of Public Health, College of Medicine and Health Sciences,
Hawassa University, Hawassa, Ethiopia;
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Introduction: Intimate partner violence (IPV) is regarded as an important
public health and human rights issue characterized by physical, sexual or
emotional abuse. Globally more than one in three women report having
experienced physical or sexual violence by their intimate partner. We
found no studies from Ethiopia using standard tools in assessing both
IPV and depression among pregnant women.
Aim: To measure the prevalence of IPV and depression during pregnancy
and assess the association between IPV and depression and other
determinants.
Methods: A community based cross-sectional study was conducted
as part of a prospective cohort study which enrolled 589 pregnant
women living in Wondo-Genet district. Exposure to IPV was assessed
using a structured questionnaire of the WHO multi-country study of
violence against women and maternal depression, was measured
by the Edinburgh Postnatal Depression Scale (EPDS) at the time of
enrollment. Data was collected by five female nurses, double entered and
validated using Epi-data and analyzed using SPSS. Descriptive statistics
was computed and multivariable logistic regression was carried out
to estimate the risk and adjust for confounders, keeping in the model
variables with associations p<0.25.
Results: A total of 589 women out of 606 were interviewed, making a
response rate of 97%. The mean age of the participants was 25 years,
ranging from 16 to 45 years. The overall prevalence of IPV was 21%
(95%CI, 18.1-24.7). The prevalence of emotional, physical and sexual
violence was 14.6%, 9.2% and 9.5% respectively. After adjusting for
potential confounders, increased risk of IPV remained among rural
participants (AOR=2.09; 95%CI=1.06-4.09), parental exposure to IPV
(AOR=14.00; 95%CI=6.43-30.48), pregnancy not desired (AOR=9.64;
95%CI=3.44-27.03), alcohol use by husband (AOR=17.08; 95%CI=3.83-
76.19) and low social support (AOR=13.93; 95%CI=6.98-27.77). The
prevalence of antenatal depressive symptom (with EPDS score above 13)
was 6.8% (95% CI 6.2-11.3). Exposure to IPV (AOR=17.60; 95%CI=6.18-
50.10) and alcohol use by husband (AOR=3.31; 95%CI=1.33-8.24) were
predictors of depression.
Conclusion: One in five pregnant women experienced domestic violence,
confirming that pregnancy does not protect from IPV; and it was strongly
associated with depression. Screening for IPV and depression at antenatal
visits with referral to relevant care and service is recommended.
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EXPLORING THE GENDER-SPECIFIC IMPACT OF EDUCATIONAL
FILM ON MATERNAL AND CHILD HEALTH KNOWLEDGE AND
BEHAVIOUR: A QUALITATIVE STUDY IN SERENJE DISTRICT,
ZAMBIA
Mweemba O.1, Smith H.2, Coombe H.3
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Introduction: Men’s involvement in antenatal, childbirth and postnatal
care is important for the health of mothers and new-borns. Yet many men
do not consider they have a role to play, and evidence suggests they are
discouraged by socio-cultural attitudes and lack of knowledge. Medical
Aid Films creates educational films for communities and health workers in
low resource settings. In Serenje district, Zambia, MAF and the Ministry of
Health run a rural health outreach project, screening maternal and child
health (MCH) films for women that also attracted male audiences.
Aim: We conducted a qualitative study to understand gender-specific
responses to film content and the suitability of film for MCH education.
Specific objectives explore effects on knowledge and behaviour and draw
out recommendations for improved content and delivery.
Methods: We conducted in-depth interviews with women and male
partners (n=8), six focus group discussions with men and women in
catchment areas and key informant interviews with health workers (n= 3)
in three purposefully selected health outposts with high numbers of film
screenings. The research approach and thematic analysis were informed
by communication-behaviour theory, which specifies inputs that may
influence the extent of change after exposure to different communication
media.
Results: Women and men reported increased knowledge and awareness
of key MCH topics, the need to seek skilled care during pregnancy and
birth and the importance of male involvement in supporting the care
of women and children. Health workers also perceived that more men
were accompanying women to antenatal, outpatient and under 5 clinics
and that traditional care-seeking and treatment practices had changed.
Whilst men perceive male involvement in tangible and patriarchal ways,
in contrast women expressed a desire for more and different types of
male support.
Conclusions: Results show the potential of educational film to improve
community knowledge and awareness and encourage healthy practices
and care-seeking, including male involvement. Further exploration of the
needs, values and preferences of men and women and the integration
and delivery of screenings is required to ensure that widespread imple-
mentation maximises participation of men and women in MCH but does
not undermine women’s rights, autonomy or safety.
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FISTULA BURDEN IN ETHIOPIA IN 2005 AND 2016 USING
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Introduction: Vaginal fistula is a devastating maternal complication
characterized by an abnormal opening between the bladder and/or
rectum and vagina, which results in continuous leakage of urine or stool.
Although it is one of the major public health problems of Ethiopia, its
magnitude and distribution nationally is not well studied.
Aim: We aimed at estimating the number of cases, district-level
geographical disparities and change over time of self-reported symptoms
of vaginal fistula in Ethiopia.
Methods: We used data from 2005 and 2016 Ethiopia Demographic
Health Surveys, which included self-reported signs of vaginal fistula for
14,070 and 15,683 women of childbearing age (15-49 years) respectively.
We fitted mixed-effect linear models with site-level prevalence of lifetime
and untreated vaginal fistula on a suite of potential risk factors. We
included a random effect to account for unexplained variability between
regions. Fitted models were then used over gridded maps of the selected
covariates to produce continuous maps of predicted prevalence with
corresponding 95% confidence intervals.
Results: The estimated number of women of reproductive age with
lifetime vaginal fistula and untreated cases in 2016 were 72,533 (95%
CI 38,235–124,103) and 31,961 (95% CI 11,596–70,309) respectively.
These figures show reduction with regard to 2005 estimates: 98,098
(95% CI 49,819–170,737) life time fistula and 59,114 (95% CI 26,580–
118,158) untreated cases. In 2016, district level lifetime and point
(untreated) prevalence ranged from 2.3 to 6.7 and from 0.6 to 3.9
per 1,000 women of childbearing age respectively. By 2016 there was
a 19 times difference between predicted point prevalence of vaginal
fistula rates when comparing districts with the highest point prevalence
vaginal fistula rates against those with the lowest point prevalence rates.
Nonetheless, the number of districts having more than 200 untreated
cases declined drastically from 54 in 2005 to 6 in 2016.
Conclusions: Ethiopia has made substantial progress in reducing the
prevalence of vaginal fistula over the last 10 years. Novel evidence from
our study can be used to understand and identify granular disparities
for local level tracking, planning, spatial targeting of resources and
implementation of interventions against vaginal fistula.
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OUTBREAK OF AN UNKNOWN PARALYTIC DISEASE IN NORTH-
ERN MOZAMBIQUE – DISCOVERING THE EPIDEMIOLOGY OF
KONZO
Cliff J.
Community Health Dept., Faculty of Medicine, Eduardo Mondlane
University, Maputo, Mozambique
In August 1981, Hans Rosling was working as a district medical officer
in northern Mozambique when he received the news of an outbreak
of paralysis at a remote mission station, 100 km away. He went there
immediately and found that the patients had a uniform history of sudden
onset of spastic paraparesis. The number of cases was rapidly increasing,
and reports began to come in from a wide area covering hundreds of
kilometres, with a population of around half a million people. A classic
epidemiological investigation followed, with Hans organizing community
leaders to carry out active case finding. After six weeks, 1102 cases
had been identified. The epidemic had begun in May, peaked in August
and lasted until October. Children over two years of age and women of
reproductive age predominated. The nearby coastal region and urban
centres were spared. The area was suffering from a severe drought. The
cause of the disease was not known, and laboratory results from patients
showed no infectious agent. Suspicion fell on a toxin, but the grass pea,
known to cause spastic paraparesis, was not consumed in this area. Hans
turned to anthropology, staying with rural families and taking detailed
histories of food consumption. He found that people were dependent on
a diet of newly harvested bitter cassava, the only crop to have survived
the drought. Bitter varieties of cassava contain high concentrations of
cyanogenic glucosides that need to be removed by processing. People
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for serum thiocyanate and found extremely high concentrations (mean
298 μmol/l). We hypothesized that the cause was cyanide intoxication
from a monotonous diet of bitter cassava. The epidemiology fitted – the
peak of the epidemic coincided with the cassava harvest, children over
two and women of reproductive age were more dependent on cassava
and on the coast, people had access to fish. Although we had not found
the disease in our textbooks a thorough grey literature search subse-
quently revealed that an identical disease, konzo, had been described by
Trolli in the then Belgian Congo in 1938.
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A SECOND OUTBREAK OF KONZO IN TANZANIA – DEFINING THE
CLINICAL PICTURE OF KONZO
Howlett W.P.
Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania
Introduction: Outbreaks of paraplegia are known historically to occur in
the tropics and have been documented from the early part of the last
century. Their aetiology has been mostly attributed to nutritional causes
varying from lathyrism caused by consumption of large quantities of chic
pea (lathyrus sativus) to B vitamin deficiency and more recently cassava
consumption.
Aim: The aim of this presentation is to report the neurological findings
from an outbreak of paraplegia occurring in a drought affected cassava
growing rural area of northern Tanzania in 1985.
Methods: A detailed neurological examination was carried out on 39
affected persons.
Results: The clinical findings was similar in all cases: characterised by
an abrupt onset of initial difficulty in walking progressing to paraparesis
over 2-3 days. Typically a previous heathy child or young adult developed
heaviness in the legs or inability to stand either during or after long
walk or present on waking. Less than one third complained of transient
lumbar pain, numbness in legs, difficulty speaking and difficulty seeing
typically clearing in the first days or week. On examination, the physical
findings were characterized by a symmetrical spastic paraparesis with
hyperreflexia in the legs 100%, ankle clonus 90% and extensor plantar
response 85%. Power was reduced in the legs in 82% varying from severe
54% to mild 23%. Arms were involved in 56% typically with isolated
hyperreflexia or mild weakness except in 2 most severely affected cases
with severe weakness. Optic pallor was noted in 6 cases 15% 5 (83%)
of whom had had a previous episode of paraplegia. A selection of the
affected patients were re-examined at 1, 2, 10 months and 3 years after
the first examination and the neurological findings remained unaltered
with the same degree of spastic paraparesis and a characteristic scissors
gait.
Conclusion: The clinical findings were those of a unique form of epidemic
spastic paraparesis, which resulted in almost identical upper motor find-
ings in affected patients but differing only in degree.
References:
1. Howlett WP, Brubaker GR, Mlingi N, Rosling H. Konzo an epidemic upper
motor neurone disease studied in Tanzania. Brain 1990 ;113 :223-35.
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MOLECULAR ANTHROPOLOGY – WHAT WE CAN LEARN FROM
HANS ROSLING’S INTERDISCIPLINARY WAY OF CONDUCTING
RESEARCH IN AFRICA
Tylleskär T.
Centre for International Health, University of Bergen, Bergen,
Norway
Hans Rosling had a bright research career in the 1980s and 1990s before
his career as ‘edutainer’ and stand-up statistician from Karolinska Insti-
tute and the Gapminder foundation. It started during his time a district
medical officer in Nacala in northern Mozambique in 1981 when he was
confronted with this outbreak of konzo. This was the starting point for
a series of field studies in several African countries. His research was
characterized by an extreme interdisciplinary approach, which he called
molecular anthropology. In the first outbreak in Mozambique, he noticed
that the field staff he sent out in the rural villages where there was
drought and famine came back with cassava for their own consumption
– every day. In the then strictly socialist society, this required a lot of
tact, sensitivity, patience and anthropologic methods to reveal the truth
about how cassava was handled because of the stigma attached to it.
No one had heard of cyanide or cyanogen compounds causing paralysis,
so biochemical methods had to be developed and then brought out in
the field for confirmatory use. The larger research community could not
understand why people we so “stupid” to grow toxic food crops but
Hans was convinced that poor people were not stupid, there was a good
reason for why they did what they did. Again, this required tact, sensitiv-
ity, patience and anthropologic methods to understand the agricultural
aspects of growing cassava. Hans was able to show that the mostly
female cassava farmers had good food security reasons for growing bitter
cassava containing high concentrations of cyanogen compounds, which
requires processing before consumption. Today, some of his methodology
would be called ‘mixed-methods’ but it rarely stretches so far as from
anthropology via medicine and chemistry to agricultural research. In
addition, Hans supervised a dozen PhD-candidates in clinical medicine,
clinical chemistry, nutrition and agronomy.
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SUMMARY OF PRESENT-DAY KNOWLEDGE OF KONZO AND CAS-
SAVA TOXICITY
Tylleskär T.
Centre for International Health, University of Bergen, Bergen,
Norway
Introduction: Cassava toxicity is still a problem in many areas of Africa.
Updated prevention methods may be needed.
Aim: In this presentation, recent studies of cassava, cassava toxicity, and
clinical aspects of konzo and prevention efforts will be summarised.
Methods: Literature review.
Results: Studies in agronomy, food processing, clinical studies and pre-
vention efforts show that 1) there are good reasons to grow bitter
cassava, the idea of ‘choosing sweet cassava instead’ is not valid; 2) konzo
may be affecting more than just the upper motor neurons; 3) cassava
toxicity may also be associated to ataxic neuropathy in Nigeria; 4) proper
processing of cassava is primordial in prevention.
Conclusion: Cassava toxicity is closely linked to extreme poverty, ecolog-
ical degradation and extremely tough socio-economic conditions. In the
worst-off societies, prevention must focus on cassava processing that is
not too taxing on the available work force.
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Introduction: High prevalence and mortality from Cryptosporidiosis
among children in sub-Saharan Africa has been shown in recent years,
however transmission dynamics and reservoirs are yet to be investigated.
Aim: This multicentre study traces back Cryptosporidium positive children
to their close human and animal contacts in order to identify transmission
networks and reservoirs.
Methods: Stool samples from children below 5 years with diarrhoea
were collected at hospitals in Gabon, Ghana, Madagascar and Tanzania.
Cryptosporidium positive and negative initial children were followed to
the community, where stool samples from all household members,
neighbouring children and animal contacts were obtained. Samples were
screened for Cryptosporidium spp. by PCR-RFLP analysis of the small
subunit rRNA gene and sequence analysis of the 60 kDa glycoprotein
gene for C. hominis and C. parvum. Contact networks were identified and
rate ratios (RR) calculated.
Results: Among 1,363 initial children 44 (20%), 47 (11%), 25 (11%) and
68 (14%) were diagnosed with Cryptosporidium spp. in Gabon, Ghana,
Madagascar and Tanzania, respectively. The following species were diag-
nosed: 144 (79%) C. hominis, 26 (14%) C. parvum, 10 (5%) C. meleagridis,
2 (1%) C. felis and 1 (1%) C. xiaoi/bovis. Across the countries the proportion
of infections ranged from 8% to 20% in household members, from 20% to
36% in neighbouring children and from 11% to 15% in animals. Among
108 contact networks gp60 subtyping established 37 clusters, which
contained 49% and 54% of Cryptosporidium positive household members
and neighbours, respectively, but only 18% of Cryptosporidium positive
animals. In comparison to Cryptosporidium negative initial children,
positive initial children had an increased risk of having positive household
members (RR = 2.5; 95%-Confidence Interval (CI): 1.5–5.2) or positive
neighbouring children (RR = 2.7; 95%-CI: 1.6–4.8), but no risk of having
positive animals (RR = 1.3; 95%-CI: 0.8–2.1) in their contact network.
Conclusion: Cryptosporidiosis in rural sub-Saharan Africa is characterized
by clusters among human contacts, to which zoonotic transmission,
despite close human-livestock contacts, seems to contribute only
marginally. Shared sanitation facilities or water sources may be
responsible for anthroponotic neighbourhood transmission. Public health
programmes need to focus hygiene and sanitation practices.
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Introduction: Brucellosis is an economically important bacterial disease
of livestock and a neglected zoonosis. The disease is endemic in Punjab,
the Indian State with the highest milk production per capita Infected
cows cannot be culled and vaccine coverage and availability is low.
Information is needed to support the implementation of sustainable
control programmes for the disease in this setting.
Aim: To develop and fit a disease transmission model to cross-sectional
serosurvey data on brucellosis in dairy farms in Punjab and to simulate
the impact of different vaccination strategies.
Methods: A cross-sectional serosurvey was conducted in 425 dairy farms
to estimate the seroprevalence of brucellosis in rural Ludhiana district,
Punjab using a multi-stage sampling strategy. In addition to sampling
livestock, all persons present involved with livestock husbandry were
offered brucellosis screening. Accompanying data were collected on
herd structure and farm management. A stochastic, demographically-
structured within- and between-herd brucellosis transmission model
was developed and fitted to the seroprevalence data using Approximate
Bayesian Computation methods to estimate the effective contact rate
(‘transmission’ parameter) among animals. The fitted model was used
to simulate the impact of vaccination campaigns at village level.
Result: Individual livestock seroprevalence was 15.1% (95% CI: 13.5
to 16.8) and farm-level seroprevalence was 32.9% (28.6% to 37.6%).
Seroprevalence in 595 occupationally-exposed individuals was estimated
to be 9.7% (95% CI: 7.4% to 12.3%). Persons assisting with calving and
abortion and those in contact with seropositive cattle had increased
odds of being seropositive. The model indicated that vaccination of
calves only, which is more acceptable to farmers, could significantly
reduce seroprevalence to less than 2% within 30years without the need
to achieve perfect coverage.
Conclusion: Brucellosis is highly endemic in Punjab and occupationally-
mediated zoonotic transmission to humans is common. Vaccination
could significantly reduce the incidence of the disease in livestock and
thus also the risk of human exposure. A new proposed control programme
is being planned by Indian authorities, which aims to eliminate the
disease in selected villages within 5 years. However, given the productive
age of cattle in Punjab, this model indicates that a commitment for
sustained vaccination beyond this period is needed.
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Introduction: Cryptosporidiosis and giardiasis are highly prevalent in
Ethiopia and are major causes of diarrhoea in young children. Cryp-
tosporidium, in particular, is well known to be associated with paediatric
mortality in sub-Saharan Africa. Although we have progress on diagnosis
of these infections in sub-Saharan Africa, our knowledge on sources and
transmission routes remains poor due to lack of targeted studies, and
the contribution of zoonotic infection to the burden of human disease is
also poorly documented. Lack of awareness, sharing the same house with
animals, unsafe water supplies, inadequate sanitation, and poor hygiene
are all factors that may increase transmission, but the relative importance
of these factors remains unknown.
Aim: In this study, we used a One Health approach to investigate the
contribution of domestic animal infections and contaminated water and
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Methods: A cross-sectional study design was used to collect samples
from 209 calves, 269 lambs, 258 goat kids, 221 children and adults, 55
vegetables and 37 water samples that were analysed for occurrence of
Cryptosporidium oocysts and Giardia cysts, with subsequent genotyping
of positive samples. Questionnaires were also used to collect information
on possible risk factors for infection from 221 animal owners and 41 non-
animal owners.
Results: Laboratory analysis has started but not yet finalized. We would
like to present preliminary data on the occurrence of infection with these
two parasites among domestic animals and their owners, and also people
who do not own animals, in this region.
Conclusion: Although diagnosis and treatment remain important touch-
stones in intestinal parasitic infections, prevention is equally important.
A One Health approach can be used to provide indicators of the most
important sources and routes of infection.
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SOMIASIS AND EFFICACY OF PRAZIQUANTEL TREATMENT IN
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Introduction: Urogenital schistosomiasis (UGS), an important disease
caused by the blood fluke Schistosoma haematobium, is endemic along
the shoreline of Lake Malawi. Male genital schistosomiasis (MGS), an
under-reported manifestation of UGS, is defined by the presence of schis-
tosome eggs within seminal fluids, genitalia and associated pathologies1.
In a cohort study among fishermen along southern lakeshores of Malawi’s
Mangochi District, the baseline prevalence of UGS was 17.1% (eggs in
urine) while for MGS (eggs in semen) was 10.7%. There is need to assess
whether recommended praziquantel treatment for UGS also clears eggs
in semen and averts MGS pathologies observable by ultrasonography.
Aim: To investigate the morbidity associated with MGS as observed by
ultrasonography, and the efficacy of praziquantel treatment in clearing
egg-patent infection in semen.
Methods: Participants (fishermen) recruited in the cohort MGS study and
treated with praziquantel at baseline, were invited to follow-up studies
after 1-, 3-, 6- and 12-months. Mid-morning urine and semen were
examined for parasitological diagnosis of schistosome ova. Transabdom-
inal and scrotal ultrasonography were conducted on the participants to
investigate for genital pathologies. Praziquantel treatment at 40 mg / kg
was offered to all the participants.
Results: At 1-month follow-up study, prevalence of UGS reduced to
11.1%, with mean egg count of 13.5 per 10 ml whilst that of MGS was 0%
(no eggs seen in semen). At 3-months follow-up, UGS prevalence rose to
11.7%, with higher mean egg count of 15.6 per 10 ml and MGS prevalence
was 8.9%, mean of 3.6 eggs per ml. Follow-up at 6-months, revealed UGS
prevalence was reduced further to 4.3%, mean egg count of 0.4 per 10
ml and MGS was 4.8% and mean of 0.9 eggs per ml. MGS pathologies
was detected in 20% of the participants, which were seen to reduce on
follow-up studies.
Conclusion: MGS is prevalent among fishermen along Lake Malawi, known
to be endemic for UGS, and is associated with pathologies observed by
ultrasonography. The current treatment of choice, praziquantel, can clear
the infection which raises the need for wider availability and accessibility
to diagnostics and treatment for all people in endemic areas, together
with other complementary control interventions.
Reference:
1. Kayuni, S., Lampiao, F., Makaula, P., Juziwelo, L., Lacourse, E.J.,
Reinhard-Rupp, J., Leutscher, P.D.C. and Stothard, J.R. ‘A systematic
review with epidemiological update of Male Genital Schistosomiasis
(MGS): A call for integrated case management across the health
system in sub-Saharan Africa’, Parasite Epidemiology and Control, 2019;
4; doi: 10.1016/j.parepi.2018.e00077
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Kulkarni M.3, Mwalimu C.D.4, Rowland M.5, Protopopoff N.5
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Insecticide Treated Nets (ITNs) are the primary method of malaria con-
trol in Sub-Sahara Africa. New types of mosquito nets, that combine
a pyrethroid and either a second insecticide or a synergist, have been
developed to respond to the expanding threat of insecticide resistance
in malaria vectors. The Pan African Malaria Vector control research Con-
sortium (PAMVERC), a research partnership between LSHTM, NIMR and
KCMUCO, is supporting the development and evaluation of several of
these new vector control products from laboratory assessment to large
scale community trials. Recently we completed a cluster randomized
controlled trial (RCT) comparing an ITN combining a pyrethroid and the
synergist piperonyl butoxide (PBO) to a standard pyrethroid Long Lasting
Insecticidal Net (LLIN), in an area of insecticide resistance in Tanzania,
The study showed a reduction in malaria prevalence of 44%, 33% and
17% after one, two and three years of use in the intervention compared
to the control arm. This finding led to a policy recommendation by
WHO and the deployment of PBO-ITN in areas with pyrethroid resis-
tance in Sub-Sahara African countries. Following WHO requirements on
generating epidemiological evidence for novel vector control product
class, we are conducting a new RCT to evaluate the efficacy of two
dual ITNs combining pyrethroid with a second adulticide chlorfenapyr or
with a hormone growth regulator; pyriproxyfen, conferring sterility to the
mosquitoes.
071
CRITICAL DECISION MAKING AND FIGHTING INSECTICIDE
RESISTANCE IN MALARIA PREVENTION
Sherratt P.
Against Malaria Foundation, UK
Global malaria rates are no longer falling. Strong evidence has been
building over the last 15 years of increasing resistance to the three
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This presentation looks at the decision making process behind the first
use of next generation nets at scale, and draws conclusions for research
and net programmes going forwards.
I will examine how the various pieces – views from leading academics,
research publications, WHO guidance, net manufacturing and net pur-
chase decisions - can be brought together to make innovative and opti-
mal decisions. I will focus on the largest ever trial of nets, which began in
2017 and continues to date. This involves 6 million ‘’PBO” next generation
nets currently being deployed in Uganda alongside 6 million standard
nets. The key research outcome is a randomised control trial, led by the
Liverpool School of Tropical Medicine and funded by AMF. I will cover why
AMF decided to fund research at this scale for the first time and what we
are doing with the results.
This will lead me to cover the principal ways in which the academic
community can directly and quickly influence malaria interventions. 4
organisations (Global Fund, PMI, AMF and UNICEF) purchase and deploy
91% of all bed nets provided in development. I will outline how AMF
considers choice of net, how we look at options for monitoring net
effectiveness and how the views and published research from academics
can and should influence these decisions.
There is also a free market dynamic at play. Bed net manufacturers need
to be incentivized to develop new products, but high prices exacerbate
the overall large gaps in funding for malaria programmes. I will discuss
how we weigh this balance and the importance of breaking the deadlock
which can arise, and did arise in the context of PBO nets.
Finally I will discuss specific plans for the future, how we are planning
and executing large net programmes in the light of insecticide resistance,
including mass campaigns in countries such as DRC which present unique
challenges for successful malaria outcomes.
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INDOOR RESIDUAL SPRAYING FOR MALARIA CONTROL: PAST,
PRESENT AND . . .. DOES IT HAVE A FUTURE?
Invest J., Lucas J.
Sumitomo Chemical Company
The invention and deployment of long lasting bed nets (LLINs) on a
massive scale in the last 15 years has resulted in dramatic falls in malaria
across Africa and the rest of the world (Bhatt et. al. 2015). A predominant
reliance on this tool containing a single class of chemistry has however
resulted in widespread pyrethroid resistance. There is mounting evidence
that nets have lost biological efficacy especially in Africa, leading to
concerns that bed nets are now starting to lose their effectiveness and
malaria rates could rise and challenge the WHO malaria elimination
goals.
Pyrethroid +PBO LLINs have recently been shown to be more effective
than pyrethroid only nets in reducing malaria transmission in areas of
high resistance, and so offer some hope for the future. As a solution
however, as these PBO containing nets still rely on pyrethroids, they are
seen more as a temporary solution while LLINS treated with novel modes
of action chemistry are developed. Olyset Plus® containing permethrin
and PBO is the first ‘PBO‘ LLIN to show epidemiological impact in reducing
malaria compared to a standard permethrin only net in an area of
pyrethroid resistance in Muleba, Tanzania.
Due to the complexity in the way bed nets function, providing both
personal protection and a community effect, it is recognised that epi-
demiological data will be needed to support such products, with the result
that it will take many years before LLINs treated with alternative modes
of action chemistry to come to market.
However Indoor Residual Spray (IRS) products effectively kill mosquitoes
but have to some extent fallen from favour in malaria control pro-
grammes and been replaced by LLINs. However there are already high
levels of resistance reported in many malaria endemic countries to IRS
products containing DDT, pyrethroids and carbamates with worrying
signs that resistance is now growing to more recently introduced
organophosphate product (WHO, 2015). New chemistry with different
modes of action are desperately needed to allow rotation in IRS and help
preserve insecticide susceptibility.
Thankfully SumiShield® 50WG, which is based on the neonicitinoid insec-
ticide clothianidin has recently been reviewed under the new WHO Pre-
qualification system, and has obtained a PQ listing. This is the first new
mode of action IRS product for almost 40 years!
While we wait for new mode of action bed nets to come to market
new IRS tools like SumiShield will become essential in areas where there
is evidence that LLINs are failing as there are currently no other tools
available that provide such good control. IRS also has the benefit over
LLINs that the treatment requires no user compliance as nets do, and
works during early evening and morning when people may not be under
their LLIN but relaxing in their homes.
Sumitomo is one of several manufacturers working with the IVCC
NGenIRS program that seeks to bring products like SumiShield into the
market at scale and in a cost effective manner. This allows IRS to play a
critical role in insecticide resistance management and the journey on the
road to malaria elimination and ultimate eradication.
References:
1. Bhatt et al Nature (2015), 526 p207-211
2. WHO 2015: http://gamapserver.who.int/gho/interactive_charts/mala
ria/insecticide_resistance/atlas.html
3. www.thelancet.com published online April 11, 2018 http://dx.doi.o
rg/10.1016/S0140-6736(18)30427-6
4. SumiShield and Olyset Plus are trademarks of Sumitomo Chemical
Company Ltd.
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CONTRASTING HEALTH POLICY AND SYSTEMS RESEARCH
(HPSR) IN DIFFERENT LOW AND MIDDLE INCOME COUNTRY
CONTEXTS AND DISCUSSION ON PRIORITIES FOR FUTURE
GLOBAL HPSR
Bou-Orm I.R.1, Yang J.2, Merritt R.K.3, Omigbodun A.4, Whitty
C.5
1Institute for Global Health and Development, Queen Margaret
University, Edinburgh, UK;
2The School of Public Health, Fudan University, Key Laboratory of
Public Health Safety, Ministry of Education, China;
3Centre for Health Services Studies, University of Kent, UK;
4Obstetrics and Gynaecology, University College Hospital, Ibadan,
Nigeria;
5Dept. of Health and Social Care, London, UK
Introduction: The National Institute for Health Research (NIHR) Global
Health Research (GHR) Programme, funded by the UK Government aid
budget as Official Development Assistance (ODA), supports high quality
research primarily and directly relevant to people in low-middle income
countries (LMICs). Through developing equitable partnerships between
researchers in LMICs and the UK, NIHR is supporting research and capacity
to improve the lives of the poorest and most vulnerable people through
major initiatives including and a new health policy and systems research
programme (www.nihr.ac.uk/globalhealth).
Aim: To compare the approaches, findings and challenges of undertaking
health policy and systems research (HPSR) across different contexts
within LMICs, with a panel discussion on future priorities for global HPSR
and funding models to strengthen health systems in LMICs.
Methods: NIHR GHR Units and Groups work in health policy and
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of fragility in Sierra Leone and Lebanon, to improving health in informal
settlements in Africa, to exploring the evidence for policy pathways to
immunisation in China. Panel members from these partnerships will
present on their research and contextual challenges, with discussion
to contrast and share learning. During 2018/19 NIHR, in partnership
with Health Systems Research UK and Health Systems Global, has
consulted to identify priorities for further research in global HPSR.
Findings will be presented, and a discussion will focus on the priorities
identified and partnership models to address this area in a global
context.
Results:
• Panel members and the audience will share learning on context relevant
approaches to improve health services, integrate systems and apply
policy research to inform health service delivery in different contexts.
• A discussion on priorities emerging for health policy and systems
research in LMICs and how best to address them.
Conclusion: There are shared and distinct challenges faced when work-
ing in different settings: informal settings, fragile states, low resourced
compared to middle-income countries. Equitable partnerships between
UK researchers and LMICs, and active early engagement of policy makers
and communities in defining priorities and working collaboratively are
key. Consultation findings to define priorities for global HPSR to inform
NIHR funding will be presented.
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DEATHS OF MOTHERS, NEWBORNS AND CHILDREN IN KAMPALA
CITY, UGANDA: CONTEXT, DRIVERS AND POTENTIAL MITIGA-
TION STRATEGIES WITHIN A PUBLIC-PRIVATE MIXED HEALTH
CARE SYSTEM
Waiswa P.1,2, Mugerwa Y.3, Kananura R.M.1, Wanduru P.1, Kwe-
siga D.1, Birabwa C.1, Tetui M.1, Daniel O.4, Balaba D.3
1Makerere University School of Public Health, Kampala, Uganda;
2Dept. of Global Health, Karolinska Institute, Solna, Sweden;
3Population Services International Uganda, Kampala, Uganda;
4Kampala City Council Authority, Kampala, Uganda
Introduction: Rural-urban migration to Kampala has resulted in a grow-
ing urban-poor population (1.5 million in 2018) without a corresponding
improvement in health care infrastructure and quality. Poverty, illiteracy
and a health system that is rural-centric and not responsive has led
to a loss of the urban survival advantage. In Kampala, health care is
dominated by private, unregulated and unaffordable providers, with few
overcrowded public health facilities unable to provide good quality care.
Little is known about health care among the urban poor or organisational
models to serve the most vulnerable.
Aim: As part of formative research to inform the design of an intervention
to develop a health care delivery model for socio-economically vulnerable
mothers and babies (The Kampala MaNe project), we explored the status,
context and actors in Kampala slums.
Methods: We triangulated descriptive analyses from three data sources.
Firstly, we analysed maternal health services utilization in Kampala
district in the representative 2016 Uganda Demographic and Health
Survey (UDHS). We also analysed the District Health Information System
data for Kampala facilities, with a focus on facility births and birth
outcomes. We analyzed PSI data to determine general characteristics
of the urban poor.
Results: While 98% of women attended antenatal care at least once, only
67% had 4+ visits, mainly due to initiation late in pregnancy. 94% gave
birth in a health facility, 64% of these at private facilities. The maternal
mortality rate in Kampala was 100/100,000 live births and perinatal
mortality was high at 34/1000 live births, with the worst outcomes
among the poorest. Women living in slums were young, with 91% aged
<30 years. Women had limited knowledge on birth preparedness. 90%
preferred to give birth at public facilities due to affordability.
Conclusion: Maternal and perinatal outcomes in Kampala remain
suboptimal despite proximity to health facilities and high utilization. The
MaNe project will include demand generation through social behaviour
change communication, improving private and public health facility
(mixed health system) networking, accessibility and responsiveness for
the poor, and emergency transportation. The model could be scaled up
in similar large cities elsewhere.
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MAPPING THE SERVICE DELIVERY LANDSCAPE FOR BREAST-
FEEDING: A CASE STUDY IN MANILA, PHILIPPINES
Camiling-Alfonso R.1, Escober A.E.2, Calibo A.2, Capili D.I.3
1Alliance for Improving Health Outcomes, Manila;
2Dept. of Health, Family Health Office, Manila;
3Kalusugan ng Mag-Ina, Manila, Philippines
Introduction: Breastmilk is the ideal source of nutrition for newborns
and young infants. While >90% of Filipino women initiate breastfeeding,
only half of infants are exclusively breastfed by one month of age.
Improving breastfeeding continuation requires a three-pronged approach
of promotion, protection and support. Most efforts focus on promotion,
and practical help to women and their families is neglected. Promotional
activities increase women’s intention to breastfeed, and the consequent
lack of support from the public health system is being recognised. The
issue is exacerbated in large cities where community-based support
activities are more challenging to organise and sustain.
Aim: The aim of this scoping exercise is to identify gaps and opportunities
in provision of breastfeeding support in metropolitan Manila (23 million
inhabitants), and to facilitate enabling dialogues to allow for coherent
systems strengthening action from a broad range of stakeholders.
Methods: We reviewed key national and local policy documents related
to service delivery of breastfeeding promotion and support. We mapped
and characterized providers through interviews with relevant actors (e.g.
program managers, technical experts, leading advocates, mother sup-
port group leaders). Last, we conducted a mapping of support networks
with key leaders and consultation with key informants.
Results: Various components of essential breastfeeding support have
not been articulated in policy and service delivery documents, result-
ing in variable quality, availability and cost of care. We identified gaps
between policies and service delivery; e.g. community health workers
have a formal role in breastfeeding support, but no practical instructions
are provided. No systematic referral network exists in Manila. The gap
in provision of breastfeeding support has been addressed mainly by
breastfeeding women themselves, through voluntary groups facilitated
by social media (i.e. Facebook groups), augmenting public services to the
extent that health workers are learning from them. However, issues with
misinformation occur and challenges around the control of the dominant
narrative are anticipated in the future.
Conclusion: We present a case study of Manila which can be replicated in
other urban settings to assess whether breastfeeding support is appro-
priate. Evidence generated through such landscape exercise can inform
future urban policy and practice dialogues to recommend solutions that
are context-adapted.
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DEVELOPING HIGH-RESOLUTION AIR QUALITY AND ENVIRON-
MENTAL NOISE ESTIMATES IN SUB-SAHARAN AFRICAN CITIES:
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Clark S.1, Alli S.2, Arku R.2 on behalf of the Pathways Measure-
ment and Monitoring working group
1Epidemiology and Biostatistics., Imperial College London, London,
UK;
2School of Public Health and Health Sciences, University of
Massachusetts-Amherst, Amherst, USA
Introduction: As a result of rapid and largely unregulated growth in
sub-Saharan African (SSA) cities, air and noise pollution are increasingly
becoming a public health problem. There has been increasing local and
global attention to pollution in African cities, and how to best reduce
the current health harming levels, particularly in Accra, Ghana. However,
long-term high-quality monitoring of pollution and its sources are lacking,
which is a major barrier to strategic policy making.
Aim: We designed and piloted a transferable and scalable measurement
campaign that in combination with state-of-the-art modelling will char-
acterize air quality, noise pollution, and its sources, in high-resolution in
the Greater Accra Metropolitan area.
Methods: We will capture the temporal and spatial variation in pollution
and its sources through a combination of fixed (n=10 sites, 1 year of mon-
itoring) and rotating monitoring sites (n=130 sites, 7-days of monitoring)
that were piloted in April 2019 and will continue for 1 year. We will capture
noise levels, audio, PM2.5 air pollution, weather conditions, and time-lapse
imagery, with affordable and rugged equipment that can deliver high-
quality data. We will analyse noise levels and ambient PM2.5 for spatial
and temporal trends. We will further apply machine learning methods
to the imagery and the audio to extract objects in the images that are
potential sources of pollution and classify different types of urban sounds
from the audio (e.g., biotic, road-traffic sounds) that may be health harm-
ing/ promoting beyond absolute decibel levels. Finally, spatiotemporal
and physics-based dispersion models will be parametrized for the local
context and used to generate the first ever high-resolution pollution
surface maps in an SSA city.
Results: From the month-long pilot conducted in April 2019 (n=182 site-
days of monitoring), average weekly PM2.5 concentrations (range: 16-33.5
μg/m3) and noise levels (range: 55-71 A-weighted decibels) exceeded
international and national air quality and noise guidelines at the majority
of monitoring locations.
Conclusion: The pilot proved that the measurement campaign can deliver
high-quality and data rich measurements that can provide useful infor-
mation for policy makers and practitioners in Accra and other SSA cities
to design evidence-based policies for reducing pollution and improving
health.
077
DIAGNOSIS OF GENITO-RECTAL SCHISTOSOMIASIS IN A
FEMALE TRAVELLER 8 YEARS AFTER EXPOSURE
Van Den Broucke S., Bottieau E.
Dept. of Clinical Sciences, Institute of Tropical Medicine, Antwerp,
Belgium
Introduction: Genital Schistosomiasis has a high disease burden in
endemic countries. In travellers however, it is rarely described.
Aim: We describe a case of delayed diagnosis of genital and rectal
schistosomiasis and give an overview of the literature of documented
genital schistosomiasis in female travellers and migrants.
Methods: Search in PubMed and Google Scholar using search terms
‘Genital’, ‘Schistosoma’, ‘Schistosomiasis’, ‘Bilharzia’, ‘Traveller’, ‘Female’,
‘After Travel’.
Results: A 28-year-old women had menorrhagia, dysmenorrhea,
dyspareunia, hypogastric pain, fatigue and difficulties to conceive.
Intermittent haematochezia was reported. The complaints started 8
years ago after a holiday where she accidently fell in the Niger River in
Mali and the following days an ‘abdominal eczema’ was seen. During
these 8 years the patients consulted several gynaecologists and had
extensive investigations without diagnostic yield. On a cervical biopsy we
found calcified Schistosoma eggs surrounded by granulomas. Cervical,
vaginal and rectal skin snips showed calcified S. haematobium eggs in
granulomata. 44 Cases of female genital schistosomiasis in travellers and
migrants are described in the literature presenting with a wide range of
gynaecological complaints.
Conclusion: Female genital schistosomiasis is a rare diagnosis in travellers
but might be underdiagnosed in women with chronic gynaecological
symptoms. Delay in diagnosis of this treatable disease can lead to
important morbidity and unnecessary investigations.
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MULTI-MORBIDITY IN GHANAIAN MIGRANTS IN EUROPE AND
RESIDENTS IN GHANA: THE RODAM STUDY
Marza Florensa A.M.1, Boateng D.1, Agyemang C.2, Levitt K.3,
Klipstein-Grobusch K.1,4 on behalf of the RODAM consortium
1Julius Global Health, Julius Centre for Health Sciences and Primary
Care, University Medical Center Utrecht, Utrecht;
2Dept. of Public Health, Amsterdam Public Health Research Insti-
tute, Amsterdam University Medical Center, University of Amster-
dam, Amsterdam, The Netherlands;
3Diabetic Medicine and Endocrinology, Groote Schuur Hospital,
University of Cape Town, Cape Town;
4Division of Epidemiology & Biostatistics, School of Public Health,
University of the Witwatersrand, Witwatersrand, South Africa
Introduction: Multi-morbidity (MM), or the presence of multiple chronic
diseases, is an increasingly relevant public health problem due to
the growing burden of non-communicable diseases (NCDs). This is
particularly important in low- and middle-income countries (LMICs)
undergoing a health transition with considerable socioeconomic and
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migrate from LMICs to high-income countries. In this context, the RODAM
Study investigates NCDs in Ghana and among Ghanaian migrants in
Europe.
Aim: To investigate the distribution and patterns of MM in Ghanaian
migrants in Europe and residents in Ghana, and to elucidate the influence
of site of residence on multi-morbidity.
Methods: 5695 individuals aged 25-70 years from Ghanaian origin living
in Amsterdam, London, Berlin and urban and rural Ghana were included.
Eight conditions were studied: hypertension, obesity, diabetes mellitus,
hypercholesterolemia, cardiovascular disease, chronic kidney disease,
rheumatic disorders and depression. Participants were categorized
according to the number of diseases they presented: 0-1, 2-3, and
4 or more. Patterns of MM were determined from the most frequent
combinations of diseases, and the effect of geographical site on MM was
assessed with ordered logistic regression.
Results: The most prevalent condition was hypertension in Europe
(prevalence ranged from 49.4% to 57.0%) and rheumatic disorders in
Ghana (31.6% to 40.1%). MM affected 39.2% of men and 47.8% of
women, and the overall MM prevalence was highest in urban Ghana
and lowest in rural Ghana. The prevalence and composition of disease
patterns differed by site and sex. With rural Ghana as reference, the odds
of MM was higher for men in Europe and urban Ghana (OR, 95%CI):
Amsterdam (2.1, 1.5-2.9); Berlin (2.1, 1.5-3.0), London (2.1, 1.4-3.1),
urban Ghana (2.6, 1.9-3.7); and women in urban Ghana (1.7, 1.4-2.1).
Conclusion: The prevalence of diseases and disease patterns differed
between Ghanaians residing in Europe and Ghana and also between
those living in urban and rural Ghana. MM was most prevalent in
urban Ghana and least in rural Ghana, and more common in women
than men. In light of this, it is recommended that healthcare brings
attention to multi-morbidity, particularly in contexts of migration and
urbanization.
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MODELLING THE IMPACT OF PYRETHROID RESISTANCE ON THE
MASS COMMUNITY EFFECT OF LONG-LASTING INSECTICIDE
TREATED NETS
Unwin H.J.T., Sherrard Smith E., Churcher T.S., Ghani A.C.
MRC Centre for Global Infectious Disease Analysis, Dept. of Infec-
tious Disease Epidemiology, Faculty of Medicine, Imperial College,
London, UK
Introduction: Long-lasting insecticidal bed nets (LLIN) provide personal
protection against malaria by reducing exposure to infectious bites,
and community protection by reducing the local mosquito population
and hence onward transmission of the parasite. Standard LLIN contain
a pyrethroid insecticide, but resistance to this chemistry, which is
widespread in mosquitoes, may diminish the community impact of LLIN.
The relative effect of personal (direct) versus mass community (indirect)
protection at different levels of pyrethroid resistance could influence
decisions on LLIN product choice.
Aim: To quantify the direct versus indirect effects of existing LLIN, and
how these change as pyrethroid insecticide resistance in mosquito
populations increases.
Methods: A mathematical model of Plasmodium falciparum transmission
is used to estimate the reduction in all-age clinical incidence that can be
attributed to personal or community protection with LLIN. The LLIN inter-
vention model is parameterised using data from a systematic review of
hut studies which measure the killing and repellence effects of LLIN. LLIN
efficacy wanes as pyrethroid resistance in local mosquitoes, measured
using mosquito survival in discriminatory dose bioassays, increases1.
We demonstrate how direct versus indirect effects vary with increasing
net usage and increasing pyrethroid resistance.
Results: LLIN users are consistently predicted to have lower levels of
malaria prevalence and incidence irrespective of the level of pyrethroid
resistance. In the absence of resistance, in areas of high transmission
(pre-intervention EIR of 100), we estimate 42% of the reduction in clinical
incidence to be attributed to mass community effect when 50% of the
community use LLINs. At 80% LLIN usage, this decreases to 18% because
a much larger proportion of the population sleep under LLIN and so are
directly protected. However, when simulating pyrethroid resistance at
80%, only 34% of the reduction in clinical incidence is attributed to
community effects for 50% LLIN usage, and this drops to 14% if LLIN
usage is at 80%.
Conclusion: Pyrethroid resistance may diminish the mass community
effect gained from LLIN interventions, with the scale of this lost protection
associated with the proportion of population using LLINs.
Reference:
1. Churcher T.S., Lissenden N., Griffin J.T., Worrall E., Ranson H. The
impact of pyrethroid resistance on the efficacy and effectiveness of
bednets for malaria control in Africa. eLife 2016; 5; e16090. DOI:
10.7554/eLife.16090.001
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THE EFFECTS OF INSECTICIDAL BED NETS ON INSECTICIDE
RESISTANT MOSQUITO HOST SEEKING AND BLOOD FEEDING
BEHAVIOUR
Guy A.1, Foster G.1, Matope A.1, Parker J.1, Voloshin V.2, Ranson
H.1, Towers D.2, McCall P.J.1
1Dept. of Vector Biology, Liverpool School of Tropical Medicine,
Liverpool;
2School of Engineering, University of Warwick, Coventry, UK
Long lasting insecticidal nets (LLINs) are essential for malaria control in
Africa, but their future is threatened by resistance to pyrethroid insecti-
cides, the primary insecticide class used. A deeper understanding of how
LLINs affect mosquitoes, particularly via sub lethal impacts on behaviour
or longevity post-exposure is fundamental to design innovative nets.
Using a range of video techniques in free-flight assays, we are investi-
gating the impact on insecticide resistant An. gambiae s.l., of a range of
current and next generation bed nets on host seeking, blood feeding and
a range of impacts. During the test, bloodfeeding through the bednet
was permitted or prevented, and detailed behavioural events ranging
from pre-contact repellency/ contact-irritancy to duration of bloodfeed-
ing were recorded for analysis.
With standard ‘first generation’ pyrethroid LLINs all four mosquito strains,
responded rapidly, landing and bloodfeeding through nets with no clear
evidence that pyrethroid treatments repel when a human host is present.
Responses of resistant and susceptible strains were remarkably similar at
the same net types. Exposure to pyrethroid did not affect mortality rates
of resistant mosquitoes immediately after exposure, nor did it impact on
longevity rates.
Results will be presented from current research investigating responses
at bednets treated with piperonyl butoxide (PBO) and new chemistries
such as chlorfenapyr, in comparison with first-generation pyrethroid-
only nets. The value of these studies on mosquito behaviour in the
domestic environment is measured by its contribution to the vector
biology knowledge base and to the search for novel vector control tools.
Importantly, this quantitative characterisation of the impacts of next-
generation LLINs provides invaluable data for the development of reliable
entomological endpoints to permit the likely impact of novel LLINs on
transmission and incidence of malaria. Thus, accelerating the likelihood
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RELATIONSHIPS BETWEEN ABUNDANCE OF EARLY INSTAR
LARVAE IN AQUATIC HABITATS AND OVIPOSITION IN THE
MALARIA VECTOR ANOPHELES ARABIENSIS USING GENOTYPIC
RECONSTRUCTION OF SIBLING GROUPS
Odero J.O.1,2, Fillinger U.1, Rippon E.J.2, Masiga D.K.1, Weetman
D.2
1Human Health Theme, International Centre of Insect Physiology
and Ecology, Nairobi, Kenya,
2Vector Biology Dept., Liverpool School of Tropical Medicine, Liver-
pool, UK
Background: Strategies for controlling malaria vectors outdoors are gain-
ing importance as we reach the limitations of the primary indoor inter-
ventions. One such strategy is to target oviposition site-seeking female
or her offspring as all mosquitoes require aquatic habitats for immature
development irrespective of their biting or resting preferences. Oviposition
site selection by gravid females is frequently studied by counting early
instar larvae in habitats. This approach is however only valid if the number
of larvae correlates with the number of females laying eggs. We tested
this hypothesis against the alternative, that a higher abundance of larvae
results from improved survival of a similar or fewer number of families.
Methods: In a controlled experiment, 18 artificial ponds were left uncov-
ered for 4 days to allow oviposition by wild mosquitoes, then covered with
netting for a further 6 days to prevent further egg-laying. Early instar
larvae were sampled daily from day 5. Additionally, natural Anopheles
habitats of two different types were identified, and larvae sampled. The
larvae were PCR-identified to species and most samples of the predom-
inant species, An. arabiensis, genotyped using microsatellites. We used
BAPS and COLONY softwares for sibling group reconstructions.
Results: In the ponds, the number of families predicted larval abundance
(BAPS R2=0.318, p=0.01; COLONY R2=0.476, p= 0.001). BAPS estimated
that 57%, 95% CI (39-75) of females had deposited larvae in multi-
ple ponds, whilst COLONY estimated 45%, 95% CI (30-56). In natural
habitats, the mean family size predicted the larval abundance using
BAPS (R2=0.829, p=0.017) but not in COLONY (R2=0.218, p=0.68). BAPS
estimated 73%, 95% CI (59, 87) of the females to have deposited larvae
in multiple natural habitats and COLONY, 60%, 95% CI (53, 67).
Conclusion: Our study shows that, whether in closely-located artificial
habitats or natural breeding sites, higher early instar larval densities
result from more females laying eggs in these sites. These results provide
empirical support for the approach of using early instar larvae abundance
as a proxy indicator for oviposition site preference. Furthermore, the
sharing of habitats by multiple females and the high skip-oviposition
rate in An. arabiensis suggest that larviciding by auto-dissemination of
insecticide may be successful.
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THE PLACE OF THE “PHARMACY” AND “DRUG SELLERS” IN LOW-
AND MIDDLE-INCOME COUNTRIES: A SCOPING REVIEW
Oleffe A., Mahieu C.
School of Public Health, Université Libre de Bruxelles, Brussels,
Belgium
Introduction: Faced with numerous barriers reducing access to formal
health systems, many people in low- and middle-income countries
(LMICs) turn themselves to “pharmacies” and other drug sellers. After
having been neglected for a long time in health system policies, these
stakeholders are progressively taken into account. This slow recognition
is sustained by two main interconnected elements: an inability of public
health systems to take charge efficiently of endemic and emerging
non-communicable diseases; and the increasing importance of self-
medication as first therapeutic resort of a large portion of people
across the world, both in urban and rural settings. Thus “pharmacies”
seem to have become unavoidable in the health-seeking behaviours of
populations in LMICs, and now play an essential role in the health system.
Aim: This study aims to identify existing knowledge and clarify key
concepts related to the “pharmacy” and its connected professional
groups, so as to better understand their place and role in the broader
context of changing health systems.
Methods: We use the scoping review method which has been structured
around a three-step search strategy. The inclusion criteria were
developed on the basis of the PCC model: Public – Concept – Context.
Different types of sources have been searched (primary, secondary and
others which includes grey literature). Among the primary sources, the
following databases have been selected for the review: Medline (via
PubMed), Sociological Abstracts, Psychinfo (via Proquest) and Scopus.
Results: After applying our extraction framework, the results will be
presented in a search and selection decision flowchart, following the
PRISMA mode. Results will be presented around following themes:
professional groups’ categories, articulation to health systems, role in
care delivery, relations to other healthcare professionals.
Conclusion: By establishing a cartography of existing knowledge and
key concepts underlying the topic, this scoping review aims to better
understand the state of the art on the place of the “pharmacy” in a
changing health system in LMICs. This will allow to clearly identify the
areas that need to be further investigated by public health researchers
in order to nurture the reflections around the reorganisation of care
provision in those settings.
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SOCIAL, CULTURAL AND ECONOMIC FACTORS INFLUENCING
BED NET USE IN THE PREVENTION OF MALARIA IN PREGNANCY
IN GHANA
Aberese-Ako M.1, Magnussen P.2, Ampofo G.3, Tagbor H.3
1Institute of Health Research, University of Health and Allied Sci-
ences, Ho, Ghana;
2Dept. of Veterinary Disease Biology, University of Copenhagen,
Copenhagen, Denmark;
3School of Medicine, University of Health and Allied Sciences, Ho,
Ghana
Introduction: Improving maternal health remains a priority to the
Ghanaian government. Consequently it has implemented the WHO
recommendation of distributing free insecticide treated bed nets to
pregnant women - one of the most effective strategies to combat malaria
in pregnancy. However negative outcomes of malaria in pregnancy such
as low birth weight and miscarriages still recur. Yet the socio-cultural and
economic dynamics that influence bed net use is not well understood.
Aim: This ethnographic study sought to describe and understand
community and health care dynamics in utilization of bed nets among
pregnant women in two Ghanaian regions.
Methods: In depth interviews were conducted among pregnant women,
health workers and opinion leaders. Observations were conducted in
thirteen communities and eight health facilities. Ethical clearance was
obtained and the study was conducted according to the principles of the
Declaration of Helsinki and good clinical Practice. Nvivo 11 was used
to support data coding. Data were triangulated and analyzed using
grounded theory approach.
Results: Findings suggest personal, social, cultural, interpersonal and
health system factors influenced use and non-use of nets. Women with
a history of net use prior to becoming pregnant remained consistent









ent_1/S1/5569919 by guest on 24 M
arch 2020
Oral Presentations
not. Fear of sleeping under a bed net, experiencing irritating effects of
chemicals used to treat nets and preference for traditional methods, to
wade off mosquitoes at night, reduced net use. Pregnant women whose
husbands and other family members used bed nets were influenced
positively to use them. Sharing a room with a husband who did not
support use of bed net denied pregnant women the right to use them.
Poverty resulting in sharing of a room with others, staying out late for
business purposes and to converse, exposed some pregnant women to
mosquito bites. Receiving ample education from health providers and
encouragement from public officials improved bed net use.
Conclusion: Bed net use is influenced by the socio-cultural and economic
context of pregnant women. Thus giving out nets at facility level should
be backed by mass community education to promote community
acceptance and use of nets.
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EFFECT OF UPTAKE OF INTERMITTENT PREVENTIVE TREAT-
MENT IN PREGNANCY (IPTP) ON BIRTHWEIGHT OF BABIES IN
A RURAL GHANAIAN SETTING
Awini E.1, Gyapong M.2, Darkwa E.1, Odonkor G.1, Williams J.1
1Dodowa Health Research Centre, Accra;
2University of Health and Allied Sciences, Ho, Ghana
Introduction: Low birthweight (LBW) is a major cause of neonatal and
infant mortality. A major cause of LBW is malarial infection during preg-
nancy. Knowing the effect of IPTp doses of pregnant mothers on LBW in
rural settings will contribute to informed decision.
Aim: To determine the effect of IPTp intake on birthweight of babies born
between 2012-2016 in a rural Ghanaian setting.
Method: Data on pregnancy, child birth, demographic and socioeconomic
status of 11,744 mothers who delivered from 2012-2016 were extracted
from the Dodowa Health and Demographic Surveillance System (HDSS)
database. Information on their 12,929 babies was also extracted. The
HDSS is a dynamic cohort that monitors events of individuals in the
system. Effect of IPTp on birthweight was estimated adjusting for con-
founders such as maternal age, sex of baby, socioeconomic, marital
status and number of previous livebirths. Logistic regression analysis was
employed using STATA.
Results: About 12,929 livebirths by 11,744 mothers were recorded from
2012-2016. Mothers of 88.8% (11,485) of children received at least one
dose of IPTp during pregnancy, but 48.7% received 3+ doses. The overall
proportion of LBW was 7.0%. About 6.7% of children whose mothers
received IPTp had LBW compared to 10.3% of those whose mothers never
received IPTp. In the unadjusted analysis, the odds of LBW for children of
mothers who received up to two and 3+ doses of IPTp were 71% (OR:
0.71, 95%CI: 0.54-0.95) and 55% (OR: 0.55, 95%CI: 0.42-0.73) of those
whose mothers did not receive IPTp. The effect of IPTp on LBW decreased
slightly after adjusting for other exposures. The odds of LBW were 73%
(OR: 0.73, 95%CI: 0.55-0.97) and 59% (OR: 0.59, 95%CI: 0.45-o.79) of
those who did not receive IPTp. Other variables such as maternal age,
sex of baby, previous livebirths and socioeconomic status were associated
with birthweight. Mothers aged below 20 years and those above 35 years
were more likely to have LBW compared to mothers aged between 20
and 34 years.
Conclusion: Intake of IPTp during pregnancy was consistently associated
with decrease LBW, thus IPTp intake is crucial to reducing LBW in malaria
endemic countries.
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RISK FACTORS FOR GESTATIONAL DIABETES AND COMPARI-
SON OF ASSOCIATED PREGNANCY OUTCOMES BY DIAGNOSTIC
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1Dept. of Family and Community Health, School of Public Health,
University of Health and Allied Health Sciences, Ho, Ghana;
2Institute of Global Health, Medical Faculty and University Hospital,
Heidelberg University, Heidelberg, Germany;
3Dept. of Nutritional Science, School of Allied Health Sciences,
University for Development Studies, Tamale, Ghana
Introduction: Gestational diabetes mellitus (GDM) has risen considerably
in Africa. Studies have extensively investigated the risk factors but
reported prevalence is often based on one diagnostic test and cut-off
whilst pregnancy outcomes have been scarcely explored.
Aim: We assessed the prevalence of GDM using diverse cut-offs, identified
maternal risk factors and compared the associated adverse pregnancy
outcomes by diagnostic criteria.
Methods: This study was an unmatched case-control nested in a
prospective cohort involving 807 women recruited consecutively from
five antenatal clinics serving rural, semi-urban and urban communities
in Ghana. Dietary and obstetric risks were assessed retrospectively while
physiologic measurements were repeated throughout pregnancy. Non-
diabetic, singleton pregnant women (n=490) were tested between 20-34
weeks using fasting venous plasma glucose (FVPG) and single-step 75-
g 2-hour oral glucose tolerance test (OGTT). Diagnosis was based on
2-h OGTT ≥8.5 mmol/l and FVPG ≥5.6 mmol/l. At delivery, pregnancy
outcomes of 403 women were traced. Adjusted odds ratio (OR) for GDM
was estimated by unconditional logistic regression and Mantel-Haenszel
statistic and the relative risk (RR) for adverse pregnancy outcomes
estimated by multiple logistic regression.
Results: Prevalence per 2-h OGTT was 9.0% and FVPG was 10.8%;
14.9% had at least one abnormal value while 3.9% had both abnormal
values. GDM was higher in primary (27.2%) facilities compared to
secondary (13.6%) and tertiary facilities (6.3%) (p=0.009). Independent
risk factors included excess intake of high glycemic index foods (aOR;
2.91 confidence interval [CI];1.05-8.06), obesity (aOR;2.13 CI;1.12-
4.03), arm circumference >30cm (aOR;2.96 CI;1.31-10.58), previous
cesarean delivery (aOR;4.01 CI;1.08-14.76), antenatal care in primary
facilities (aOR;4.951 CI;1.87-3.76) and low partner education (aOR; 3.36
CI;1.27-8.89). GDM by OGTT was associated with large-for-gestational-
age (aRR;5.56 CI;1.39-12.77) whilst GDM by FVPG was associated with
neonatal resuscitation (aRR; 5.72 CI;1.37-23.85). No significant adverse
maternal outcome was identified.
Conclusion: The higher GDM prevalence in primary facilities suggests
social disparities in access to healthcare. Despite the diverse risks,
pregnancy outcomes were not convincing. While weight control
and dietary counselling are crucial, primary facilities need ameni-
ties for testing. Further studies would clarify the etiologic path-
ways of OGTT and FPG and the valid diagnostic cut-offs for African
populations.
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OBSERVATIONAL STUDY OF VISCERAL LEISHMANIASIS IN
PREGNANCY IN SOUTH SUDAN: MATERNAL AND PREGNANCY
OUTCOMES
Pekelharing J.E.1, Gatluak F.2, Harrison T.1, Maldonado F.3,
Ritmeijer K.1
1Médecins Sans Frontières, Amsterdam, The Netherlands;
2Médecins Sans Frontières, Lankien, South Sudan;
3Royal Tropical Institute, Amsterdam, The Netherlands
Introduction: South Sudan is one of the most endemic countries for
visceral leishmaniasis (VL), and is frequently hit by large epidemics,
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the immune system during pregnancy, pregnant women are considered
particularly vulnerable for developing complications of VL disease and
opportunistic infections. Small cohort studies in the literature indicate
high mortality rates in pregnant women with VL. There is limited
evidence available about clinical aspects and treatment outcomes of
VL in pregnancy.
Aim: We aimed to describe characteristics, treatment outcomes and
pregnancy outcomes for patients with VL in pregnancy, using data from
a VL cohort.
Methods: A retrospective analysis was conducted of routine programme
data from a MSF health facility in Lankien, Jonglei State, South
Sudan, for the period 2015-2018. Patients with VL in pregnancy and
a comparison group, a random selection of female non-pregnant
VL patients in reproductive age, were identified from the database.
Medical records of these patients were reviewed for medically relevant
information.
Results: Data were obtained for 113 women with VL in pregnancy and
223 patients in the comparison group. Patients with VL in pregnancy
presented with more severe anaemia and higher need for blood
transfusions (OR 9.3; 95%CI 2.5-34.2), and antibiotics were prescribed
more often (OR 6.0; 95%CI 3.4-10.6) compared to the comparison group.
Adverse pregnancy outcomes (including miscarriage and premature
delivery) were reported in 28% of cases. Postpartum haemorrhage was
common. Patients with VL in pregnancy required more often extension of
treatment to achieve cure (OR 10.0; 95%CI 4.8-20.9). Nevertheless, cure
rates were high (96.5%) and mortality was low (1.8%) in this cohort of
patients with VL in pregnancy.
Conclusion: This is the largest cohort in the literature of outcomes
associated with VL in pregnancy. Our data suggest that good survival
rates for women with VL in pregnancy are possible in resource-limited
settings, despite the high incidence of complications. Limitations of
the work include the lack of follow-up data for pregnancy or neonatal
outcomes after discharge from treatment for VL.
087
LESSONS LEARNED FROM THE IMPLEMENTATION OF A DIGITAL
HEALTH INFORMATION SYSTEM IN A RESOURCE-CONSTRAINED
URBAN ENVIRONMENT




Introduction: Urban health context in the Democratic Republic of
the Congo (DRC) is highly fragmented and suffers from technological
constraints. Nonetheless, with carefully planned steps, it is possible to
implement a flexible and resilient digital health information system.
This digitalization presents multiple benefits: data is collected once,
with improved quality, and aggregate data can be produced for the
mandatory national health information system. Furthermore, additional
local analysis can be made to ensure better healthcare and better facility
management.
Aim: The aim is to improve the process of introducing electronic medical
records in hospitals located in DRC.
Methods: Based on experiences collected in Kinshasa, several hypotheses
on how to improve the implementation of a digital health system
(CERHIS) in a hospital were formulated. They were then tested in another
hospital in Goma, DRC.
Results: Results are of two types: (1) technical and (2) medical. (1)
We confirmed the hypothesis that both external and internal technical
supports are necessary. Logistic difficulties have caused delays and
complications in the deployment of the system. We examine their nature
and propose solutions. (2) We studied the degree to which implementing
a new system would allow the modification of procedures and practices
in the health structure. The experience shows that even though the
hospital management team is involved, it is difficult to create new
health procedures leveraging digital technologies. However, the proce-
dures already in place are easily integrated into the digital system. The
health workers were trained to use the system to perform their routine
duties. This approach was more efficient than the former one where all
the users had to learn how to use the entire system. The importance
of giving a global view of the system for its proper use is however
acknowledged.
Conclusion: Some hypotheses have been confirmed or reformulated.
Before any generalization, it is necessary to test the results obtained
in other settings. However, these results can be used as preliminary
guidelines for the implementation of a digital health system in a
hospital.
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MAKING DATA SHARING EASY, FEASIBLE AND ACCESSIBLE
Olesen O.F.1, Hajduk G.K.2, Jamieson N.E.2, Baker B.L.2, Pandya
L.J.1, Habarugira J.M.V.1, Lang T.2
1European & Developing Countries Clinical Trials Partnership
(EDCTP), The Hague, The Netherlands;
2Centre for Tropical Medicine & Global Health, University of Oxford,
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Introduction: The sharing of clinical trial data is increasingly required
by research publishers, regulatory agencies, ethics committees, and
funding bodies. Despite these requirements, there are currently no
clear standards, best practices or guidelines on how, where and when
researchers should share their data.
Aim: Funders such as the European & Developing Countries Clinical Trials
Partnership (EDCTP) aim to provide their grantees, and the wider global
health scientific research community, with clear guidance and a range of
tools and resources to aid the data sharing process.
Methods: In an effort to support and facilitate data sharing, EDCTP is
collaborating with The Global Health Network to develop a cross-cutting
knowledge hub for data sharing. This hub will help researchers find
the optimal repository for their clinical trials data, and to collect and
organise their data in an appropriate format that is ready for sharing.
We carried out a gap analysis to assess researchers’ needs, as well as
the resources and training opportunities available to them. Our approach
was three-fold: (1) we used specialist web browsing software to carry out
a comprehensive audit of online training courses, learning materials and
educational videos related to data sharing in health; (2) we conducted a
workshop on data sharing and obtained feedback from the attendees
regarding their training needs in the area; (3) we investigated the
availability and characteristics of existing repositories in order to develop
a tool that will guide researchers to the repositories most appropriate for
their datasets.
Results: We have created an online platform, The Knowledge Hub
(EDCTPKnowledgeHub.tghn.org), that will provide free and accessible
resources, guidance and training on data sharing for clinical trials,
plus access to a virtual research community. This includes resources
relevant to all stages of data sharing, from data processing and
management, through preparation of metadata and documenta-
tion, to guidance on choosing an appropriate repository for data
deposition.
Conclusion: The aim of this Hub is to become a core resource for
researchers that can guide and support the data sharing process. Ongoing
feedback from the research community will be essential to refine and













UNCOVERING THE HIDDEN: SURVEILLANCE OF THE EMER-
GENCE OF ANTHELMINTIC RESISTANCE IN HUMAN POPULA-
TION WITH SOIL-TRANSMITTED HELMINTHS IN SOUTHERN
MOZAMBIQUE
Grau-Pujol B.1,2,3, Martinez-Valladares M.4, Gandasegui J.1,4,
Cano J.5, Cossa A.2, Sacoor C.2, Muñoz J.1,2
1Barcelona Institute for Global Health, ISGlobal, Universitat de
Barcelona, Spain;
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3Fundación Mundo Sano, Buenos Aires, Argentina;
4Dept. of Animal Health, Instituto de Ganadería de Montaña (CSIC-
Universidad de León), León, Spain;
5Faculty of Infectious and Tropical Diseases, London School of
Hygiene and Tropical Medicine, London, UK
Introduction: Over one billion people worldwide are infected with
soil-transmitted helminths (STH). STH infections (Ascaris lumbricoides,
Trichuris trichiura, hookworm and Strongyloides stercoralis) can
contribute to anaemia, malnutrition, and delayed cognitive develop-
ment among others. Currently, the cornerstone for controlling STH is
mass drug administration (MDA) programs with benzimidazole drugs,
albendazole or mebendazole. However, some studies start to suspect
of benzimidazole-resistance, already observed in veterinary medicine in
high rates.
Aim: The aim of this study was to design and implement a pilot
surveillance platform to characterize treatment response and genotypic
albendazole-resistance in Manhiça district, Mozambique.
Methods: We conducted a cross-sectional study with 800 participants
older than 5 years of age in Manhiça district. A grid sampling method-
ology was used to obtain infection spatial representativeness in the
district. Two stool samples were collected from each participant on two
consecutive days. For participants with positive STH infection, a third
stool sample was collected twenty-one days after treatment. Samples
were analysed by Telemann concentration and Kato-Katz thick smear
techniques. Genotypic albendazole-resistance is being evaluated by
pyrosequencing to detect single nucleotide polymorphisms (SNP) related
with anthelmintic resistance in the β-tubulin gene. The Kulldorff’s scan
statistic method was employed for identification of clustering of STH
infection and albendazole-resistance. Bayesian Kriging was used to
estimate general spatial trends in infection.
Results: A proportion of 21% of participants were infected with at least
one STH, and 20% of participants older than 15 years were infected
with hookworm. We detected a high rate cluster of STH infection in
Calanga region, a sandy and watery area. The lowest cure rate and
egg reduction rate were for T. trichiura (47.3% and 50.2%, respectively).
The correlation of β-tubulin SNPs with treatment response will be
presented.
Conclusion: We observed high rates of STH treatment failure, particularly
for T. trichiura. The correlation of treatment failure and β-tubulin SNPs
will be conferred. Periodical surveillance and better understanding of
benzimidazole-resistance mechanisms are needed to predict treatment
response and to monitor anthelmintic resistance appearance progres-
sion. This could contribute on STH infection control and interruption of its
transmission.
References:
1. Augusto, G., et al., Geographic distribution and prevalence of schistoso-
miasis and soil-transmitted helminths among schoolchildren in Mozam-
bique. Am J Trop Med Hyg, 2009. 81(5): p. 799-803.
2. Diawara, A., et al., Association between response to albendazole
treatment and beta-tubulin genotype frequencies in soil-transmitted
helminths. PLoS Negl Trop Dis, 2013. 7(5): p. e2247.
3. Vercruysse, J., et al., Is anthelmintic resistance a concern for the control
of human soil-transmitted helminths? Int J Parasitol Drugs Drug Resist,
2011. 1(1): p. 14-27.
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A MAJOR HURDLE IN THE ELIMINATION OF UROGENITAL
SCHISTOSOMIASIS REVEALED: IDENTIFYING COMMUNITIES
AND HEALTH WORKERS’ PERCEPTIONS AND EXPERIENCES OF
FEMALE GENITAL SCHISTOSOMIASIS IN GHANA
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Theobald S.5 , Gyapong M.6
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5Dept. of International Public Health, COUNTDOWN Consortium,
Liverpool School of Tropical Medicine, Liverpool, UK;
6Institute for Health Research, University of Health and Allied
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Introduction: Female Genital Schistosomiasis (FGS) is a serious chronic
gynecological condition that affects about 56 million African wom-
en/girls. There is little known at the community level about how
people interpret symptoms of FGS and how health workers respond to
symptoms. In Ghana the national schistosomiasis control program’s
response has prioritized mass drug administration of praziquantel to in-
school children and FGS has been largely overlooked.
Aims: We aimed to understand community and health worker’s
perceptions and experiences of FGS in a schistosomiasis endemic district
of Ghana.
Methods: We used qualitative methods to explore experiences and
practices relating to FGS with community members and health workers
in schistosomiasis affected communities. This included 12 focus group
discussions, 34 in-depth interviews and 6 vignettes with health workers,
community members, teachers and school children. We purposively
selected fifteen riverside communities in Shai-Osudoku district where
urogenital schistosomiasis prevalence was between 54.8% and 60.0%.
The analysis was guided by the framework approach.
Results: For both health workers and community members there was
little understanding of schistosomiasis as a disease that could affect girls,
or could cause general gynecological problems. When adolescent girls
had reported blood in their urine and gynecological symptoms at primary
health care clinics they had been misdiagnosed with an STI. During these
interactions’ girls reported being chastised by health workers for being
sexual promiscuous.
Conclusion: It is imperative for the national control programme to better
engage on FGS and implement interventions to meet girls’/women’s
needs. There is need to integrate FGS into sexual and reproductive health
services with health worker training and support community awareness
for appropriate management of FGS. More broadly, harmonizing the
portfolio of all actions on FGS is essential in at-risk areas if we are to
aspire to leave no women or girls behind.
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CHALLENGES IN ACHIEVING ELIMINATION OF LYMPHATIC
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Introduction: Lymphatic filariasis (LF) was endemic in all 14 health
districts (HDs) and mass drug administration (MDA) with ivermectin and
albendazole started in 2008. Since 2009 annual epidemiologic coverage
of ≥65% has been reported in 12 HDs. In 2013, a pre-transmission
assessment survey (pre-TAS) using microfilaremia (mf) was conducted
and 8HDs passed (mf prevalence <1%) and 4HDs (Bombali, Koinadugu,
Kailahun and Kenema) with high baseline mf prevalence (6.9%, 5.7%,
2.6% and 0.6% respectively) failed. In 2017 these 8HDs also passed the
TAS using Filariasis Test Strips (FTS) and stopped MDA. The 4 HDs repeated
the pre-TAS in 2017 and the results presented.
Methods: One sentinel and one spot check site per HD (with 2 spot check
sites in Bombali) were selected and 300-350 persons aged ≥5 years/site
were tested. All positive results were confirmed by a second FTS test and
a follow-up mf study was later conducted for positives only.
Results: A total of 3,394 persons were tested and 296 were FTS positive,
Bombali: 17.2%, Koinadugu: 13.3%, Kailahun: 4.5% and Kenema: 1.8%.
236 positives were traced and retested for Wucheria bancrofti mf using
midnight and 232 for Mansonella perstans mf using midday blood sam-
ples: 9 and 13 positives respectively.
Conclusion: These 4 HDs again failed the pre-TAS (antigen prevalence
>2%). All share borders with Guinea and/or Liberia with difficult ter-
rain and limited communications. The Guinean districts bordering the
north had even higher baseline prevalence: 11%. Cross-border migration
is common for farming, trading and is also observed for campaigns
(not just LF-MDA). Guinea and Liberia only started LF-MDA in 2014 and
2016 respectively. Bombali and Koinadugu also have traditional healers
attracting lymphedema patients which seem to have created secretive
non-compliant foci. Sub-district-level data is essential to identify and
resolve these challenges. Unreliable denominators and hence coverage
appear to be no more significant in the HDs that are failing versus those
that have already passed the pre-TAS. In this remote region people rely
heavily on cattle rearing which may provide a natural reservoir for W.
bancrofti. At least three more rounds of MDA will be conducted before
a repeat pre-TAS is conducted.
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CRYPTOSPORIDIUM DIARRHOEA IN ADULT PATIENTS AT QUEEN
ELIZABETH CENTRAL HOSPITAL, BLANTYRE, MALAWI
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Introduction: Diarrhoeal diseases are a major global cause of mor-
bidity and mortality, with a significant burden in Sub-Saharan Africa.
Diarrhoea accounts for >300 adult admissions/year at Queen Eliza-
beth Central Hospital (QECH), the majority of whom have HIV infec-
tion. The prevalence of cryptosporidium infection in this population is
unknown.
Aim: The aim of this single-centre prospective pilot study was to deter-
mine the prevalence of infection with cryptosporidium and other enteric
pathogens amongst adults admitted to QECH with a primary diagnosis of
diarrhoea (≥3 loose stool/24hr).
Methods: Adults admitted to QECH with a primary diagnosis of diarrhoea
were prospectively recruited July-September 2016. Demographics, clin-
ical parameters, and HIV status were recorded. Stool specimens were
obtained and analysed by multiplex-PCR to detect cryptosporidium and
up to 42 other bacterial, viral, protozoan or helminthic pathogens.
Results: 100 patients (M=53) were recruited during the study period, of
whom 80% were HIV seropositive. Median age was 35.5 years (IQR 29-
43) with a median 7 days (IQR 4-21) duration of symptoms. From 99
stool specimens suitable for analysis by multiplex-PCR, 182 pathogens
were detected (64% bacteria, 22% protozoa, 14% virus). Cryptosporid-
ium was detected in 16/99 samples (14/16; 87.5% HIV positive). Co-
infection with more than one organism was common (n=62), ranging
from 2 (n=17) to 13 pathogens (n=1) detected. 13/16 cryptosporid-
ium positive patients had at least one other organism detected by PCR
(92% HIV positive), most frequently E. coli spp. (21.5%) and Shigella
(8%). The frequency of co-infection and number of pathogens detected
were not correlated with World Health Organisation (WHO) HIV disease
stage.
Conclusion: This study highlights that Cryptosporidium infection remains
an important factor in HIV seropositive patients admitted to QECH due
to diarrhoea. Co-infection with more than one organism is common
and leads to uncertainty in attributing pathogen causation with clinical
disease. Future work aims to describe the frequency of asymptomatic
carriage of enteric organisms. Furthermore, this study provides baseline
epidemiological data for a planned randomised trial of a repurposed
therapeutic (Clofazimine) in cryptosporidiosis.
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ANTIBIOTIC RESISTANCE PATTERN OF URINARY TRACT
INFECTIONS IN A FACILITY IN ETHIOPIA: EXPERIENCE OF A
CLINICIAN
Lomencho A.
AMC, Addis Ababa, MEPI Junior Scholars, University of Gondar,
Gondar, Ethiopia
Introduction: Urinary tract infection is a common outpatient medical
problem. A knowledge of the common causative agents and their resis-
tance pattern is important to come up with local recommendations. At
present there is lack of national data to support this and facility based
studies are a good starting point.
Aim: To see the etiologic pattern and antimicrobial resistance profile of
Urinary tract infections seen in a facility in Ethiopia.
Methods: This was a retrospective observational study of all urine cultures
done for UTI over a 7 months period (January-July, 2018).
Results: There were a total of 75 urine cultures done over six months
period out of whch 65% was for female patients. The age range was from
18 to 90 with a mean age of 45. 85% of the urine cultures were done for
outpatient cases. Common comorbidities seen among the participants
included diabetes (4%) and HIV (2%). Among the cultures done, 60%
were done for a consideration of recurrent UTI. 42% (32) of the culture
results showed growth. E. coli accounted for 68.7% of the positive cultures
while Enterococcus fecalis accounted for 10%. The rest were klebsiella
pneumoniae (9%) S. Saprophyticus (4%), citrobacter (3%) and other
organisms.
Conclusion: E.Coli accounted for a majority of urinary tract infections
seen at our facility. The resistance pattern noted for E.Coli could be an
indirect indication of widespread use of antibiotics including amoxicillin,
ceftriaxone and Ciprofloxacin. The antibiotic resistance pattern noted
in this study needs to be further investigated to come up with local
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Background: Autodissemination of pyriproxyfen (PPF), i.e. co-opting adult
female mosquitoes to transfer the insect growth regulator, pyriproxyfen
(PPF) to their aquatic habitats has been demonstrated against Aedes
and Anopheles mosquitoes. This approach, could potentially enable high
coverage of aquatic mosquito habitats, including those hard to locate
or reach via conventional larviciding. This study demonstrated impacts
of autodissemination in crashing a stable and self-sustaining popula-
tion of the malaria vector, An. arabiensis under semi-field conditions in
Tanzania.
Methodology: Self-propagating populations of An. arabiensis were estab-
lished inside large semi-field cages. Larvae fed on naturally occurring
food in 20 aquatic habitats in two study chambers (9.6 × 9.6 m each),
while emerging adults fed on tethered cattle. The mosquito population
was monitored using emergence traps and human landing catches, each
time returning captured adults into the chambers. Once the population
was stable (after 23 filial generations), PPF dissemination devices (i.e. four
clay pots each treated with 0.2- 0.3 g PPF) were introduced into one of
the chambers (treatment) and their impact monitored in parallel with
untreated chamber (control).
Results: Daily adult emergence was similar between control and treat-
ment chambers, with average (±S.E) of 14.22 ± 0.70 and 12.62 ±
0.74 mosquitoes/trap respectively before treatment. Three months post-
treatment, mean number of adult An. arabiensis emerging from the habi-
tats was 5.22 ± 0.42 in control and 0.14 ± 0.04 in treatment chambers.
This was equivalent to >97% suppression in treatment chamber with-
out re-treatment of the clay pots. Similarly, the number of mosquitoes
attempting to bite volunteers inside the treatment chamber decreased
to zero, six months post-exposure (i.e. 100% suppression). In contrast,
biting rates in control rose to 53.75 ± 3.07 per volunteer over the same
period.
Conclusion: These findings demonstrate effective suppression of stable
populations of malaria vectors using a small number of simple autodis-
semination devices, from which adult mosquitoes propagated pyriprox-
yfen to contaminate aquatic habitats in the system. This is the first proof
that autodissemination can amplify treatment coverage and deplete
vector populations. Field trials are necessary to validate these results,
and assess impact of autodissemination as a complementary malaria
intervention.
095
HIGH LEVELS OF COPY NUMBER VARIATION IN METABOLIC
INSECTICIDE RESISTANCE GENES IN MALARIA MOSQUITOES
Lucas E.R.1, Miles A.2,3, Harding N.J.2, Lawniczak M.K.N.3, Weet-
man D.1, Kwiatkowski D.P.2,3, Donnelly M.J.D.1,3, the Ag1000G
consortium
1Dept. of Vector Biology, Liverpool School of Tropical Medicine,
Liverpool;
2Big Data Institute, Li Ka Shing Centre for Health Information and
Discovery, Oxford;
3Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, UK
The rise and spread of insecticide resistance in mosquitoes represents a
worrying trend that threatens the progress made in controlling malaria.
Duplication or amplification through copy number variation is a key mech-
anism by which expression of a gene can be increased, yet relatively little
is known about the importance of copy number variation in the observed
rise in insecticide resistance. Using the 1142 genomes of Anopheles
gambiae and An. coluzzii from the Phase 2 release of the Anopheles
gambiae 1000 Genomes project, we scanned the whole genome for copy
number variants and found that gene duplications were enriched for
metabolic gene families, which are commonly associated with insecticide
resistance. Focusing on four gene regions with known associations to
metabolic insecticide resistance (GSTU4-GSTE3, CYP9K1, CYP6M2-CYP6Z1
and CYP6AA1-CYP6P2), we produced detailed characterisations of all
local duplications. All of these regions contained duplications, with the
GSTU/GSTE, CYP9K1 and CYP6AA/CYP6P region showing multiple inde-
pendent duplications of varying size, distribution and frequency. Several
duplications show evidence of being under selection, indicating a likely
role in insecticide resistance, and recent collections indicate that these
duplications are increasing in frequency.
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MEASURING THE INTERACTION OF MOSQUITOES WITH BIO-
CIDE PRODUCTS USING 3D INFRARED VIDEO TRACKING
Fatou M.1,2, Fry S.N.3, Müller P.1,2
1Dept. of Epidemiology and Public Health Dept., Swiss Tropical and
Public Health Institute, Basel;
2University of Basel, Basel;
3SciTrackS GmbH, Bertschikon, Switzerland
Introduction: Biocide products, such as topical repellents or insecticide-
treated nets, are important tools for mosquito bite prevention and vector
control. The efficacy of biocide products is measured in bioassays that
typically record endpoints, such time to first bite, mortality rates or blood-
feeding inhibition. These endpoints, however, provide no information as
to how the mosquitoes interact with the repellent or the insecticide-
treated net. A better understanding of how mosquitoes behave to these
products would lead the way to improved formulations, modes of delivery
or designs of more realistic biological assays. One promising approach
to study how mosquitoes interact with biocide products is to record
their flight trajectories in 3D. Recent advances in hardware and software
provide the means to achieve this goal.
Aim: The objective of our work is to quantify the behaviour of host-seeking
mosquitoes when they interact with topical repellents or insecticide-
treated nets.
Methods: We measured the behaviour of host-seeking mosquitoes com-
bining standard bioassays with Trackit 3D fly, which allows the 3D flight
trajectories of several mosquitoes to be measured in real time using two
arbitrarily positioned high resolution cameras. We have then compared
the mosquito flight trajectories in the presence and absence of biocide
products.
Results: Making use of Trackit 3D’s customization and automated cal-
ibration features, we equipped various bioassay set-ups, including the
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us to acquire 3D flight trajectories at 90 measurements per second in real
time. The real time functionality allowed us to monitor the measurement
and store the position data without the need to store large amounts
of video data, and process these offline. Filming under near-infra-red
lighting conditions allowed us to measure the natural behaviour of the
night active mosquitoes under naturalistic lighting conditions.
Conclusion: We are able to measure the 3D flight trajectories of several
mosquitoes in real time in the vicinity of topical repellents and insecticide-
treated nets using an efficient approach. We will present our latest results
on how mosquitoes interact with biocide products, and we will discuss the
pros and cons of our set-up with other systems currently available.
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LYMNAEID SNAIL VECTOR CONTROL WITHIN ONE-HEALTH OR
ECO-HEALTH INITIATIVES AGAINST HUMAN FASCIOLIASIS
Bargues M.D., Mas-Coma S.
Dept. Parasitologia, Fac. Farmacia, Univ. Valencia, Valencia, Spain
Introduction: Human fascioliasis is a vector-borne zoonotic trematodia-
sis transmitted by freshwater Lymnaeidae snails. This disease is caused
by two liver flukes: Fasciola hepatica transmitted by Galba/Fossaria species
in mild temperature areas and altitude zones throughout, and F. gigantica
by Radix species in warm lowlands of wide parts of Africa and Asia, where
fasciolid intermediate hybrid forms appear where lymnaeids of the two
aforementioned groups locally overlap.
Aim: Ecology, behaviour and colonization capacity of lymnaeids are those
of typical r-strategist organisms with a high multiplication rate, thus
defining crucial aspects of the transmission patterns and epidemiological
scenarios of the disease in humans and livestock reservoirs. They are
therefore a key element to be considered within One-Health or Eco-Health
initiatives against human fascioliasis.
Methods: A highly singular feature of lymnaeid snail vectors is their
marked amphibious behaviour. This appears related to their high depen-
dence on environmental factors and climate variables, and explain why
these vectors and fascioliasis are so much influenced by climate and
global changes, mainly anthropogenic environmental modifications such
as artificial irrigation developments, domestic ruminant movements and
livestok export/import. Methods to assess these characteristics should be
applied according to different seasons, different environment types, and
different livestock management traditions.
Results: The complexity of the control activities to undertake differ from
endemic areas where only one lymnaeid vector species is present up to
areas where more than one species of different ecological characteristics
are involved. Within Galba/Fossaria there are species showing different
capacities for disease transmission to humans, with G. truncatula as the
most efficient. Similarly occurs within Radix group, with R. viridis as main
vector for human infection.
Conclusion: Scenarios appear to be so different depending on regions
and areas, that extrapolation of control measures becomes difficult. The
One-Health initiative at present running in the Northern Bolivian Altiplano
human hyperendemic area, where only one lymnaeid species is involved,
is expected to be the first step in this way.
Funding: Projects Nos. 2017/ACDE/001583, AECID, Ministry of Foreign
Affairs and Cooperation; PI16/00520, AES, ISCIII-MINECO; RD16/0027/
0023, RICET, RETICS, Ministry of Health and Consumption, Madrid, Spain;
and 2016/099, PROMETEO Program, Generalitat Valenciana, Valencia,
Spain.
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DISTRICT HEALTH MANAGEMENT AND ITS ASSOCIATION WITH
DISTRICT PERFORMANCE: A STUDY OF SIX DISTRICTS IN THE
EASTERN REGION OF GHANA
Heerdegen A.C.S.1,2, Aikins M.3, Amon S.3, Agyemang S.3, Gerold
J.1,2, Prytherch H.1,2, Wyss K.1,2
1Swiss Centre for International Health, Swiss Tropical and Public
Health Institute;
2University of Basel, Basel, Switzerland;
3School of Public Health, College of Health Sciences, University of
Ghana, Accra, Ghana
Introduction: Evidence suggests weak management and leadership
(M&L) capacities being a major obstacle for responsive health service
delivery, especially in low and middle-income countries. The district
health system in Ghana, as in other countries, plays a pivotal role in the
delivery of basic health services. District health managers are responsible
for converting inputs and resources such as finance, staff, supplies,
equipment and infrastructure into effective services that are responsive
to population needs. Some districts perform better than others in terms
of health outcomes and meeting service delivery targets. This may, in
part, be associated with M&L competencies at district level as well as the
availability of management support systems.
Aim: To examine district health managers’ M&L competencies, as well as
contextual characteristics, in high, average and poor performing districts.
Methods: The study took place as part of the EC-funded PERFORM2Scale
project that is scaling-up a piloted district level management strength-
ening intervention. Sixty-nine health managers’ in six districts completed
a self-administered questionnaire in the Eastern Region of Ghana.
Participants provided socio-demographic information; information on
their previous management experience and training; and assessed
their general and health-system related M&L competencies, work
environment and the extent of functional support systems. The districts
were grouped into high performing (n=2), average-performing (n=2) and
low-performing (n=2) according to the Ghana Health Service League of
District Performance that rank district performance.
Results: There were no major differences in socio-demographic charac-
teristics and previous management experience between the different
performing districts groups, yet exposure to management training
differed with more exposure in poor performing districts. Nevertheless,
District Health Managers’ in high performing districts rated their overall
M&L competencies significantly better than those is lower performing
districts. Furthermore, study participants in the high performing
districts reported a higher extent of functional support systems and
significantly better communication within their teams, job satisfaction
and organizational commitment.
Conclusion: The findings underline the importance of management
development at district level. Efforts focusing on building managerial
competence should also give emphasis to developing better support
systems, collaboration and teamwork among district health managers.
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PERCEPTIONS OF CARE AND TREATMENT OF PEOPLE LIVING
WITH HIV/AIDS IN BIHAR: A QUALITATIVE STUDY FROM INDIA
Nair M.1, Kumar P.2, Pandey S.2, Harshana A.1, Kazmi S.1,
Moreto-Planas L.3, Agarwal N.2, Singh C.M.2, Ranjan A.2,
Burza S.1
1Medecins Sans Frontieres, New Delhi;
2Comunity and Family Medicine Dept., All India Institute of Medical
Sciences, Patna, India;
3Medecins Sans Frontieres, Barcelona, Spain
Introduction: Patients with advanced HIV face significant difficulties
in accessing treatment in Bihar, India. However, routine stigma and
discrimination is often implicit and anecdotally reported rather than
formally documented. This study aimed to explore perceptions of care
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districts of Bihar and uncover perceptions of PLHA among healthcare
providers and community members.
Methods: Two districts of Bihar were purposively selected for the study,
namely the capital Patna and another peripheral district located within
100 km of Patna. We conducted semi-structured, in-depth interviews
with PLHA, healthcare personnel, as well as community members
accessing care at health facilities across the two districts to triangulate
findings. Audio-recordings were transcribed and translated into English
and entered into NVIVO for in-depth coding and analysis. Researchers
engaged in a grounded theory analysis and followed open, axial and
selective coding processes to develop a core theory.
Results: 71 participants were interviewed, including 35 HIV positive
patients, 10 community members, and 26 healthcare providers. HIV
was conceptualized as a “dirty” or “immoral” illness even in healthcare
settings: the majority of doctors engaged in mandatory testing of all
patients rather than following universal precautions, and several refused
to treat HIV positive patients. Intentional and non-consensual disclosure
of HIV positive status by healthcare personnel was commonly reported
by patients and doctors alike, with anticipated stigma limiting public
disclosure of illness among patients. Among healthcare personnel, a
pervasive fear of contracting HIV and poor knowledge of transmission
were major drivers of stigmatizing behaviors such as refusing to touch
or treat. Stigma played a crucial role in hampering access to care,
particularly outside Patna and within private healthcare.
Conclusion: The Government of India’s current approach to stigma
reduction in health care is mostly punitive in nature, and assumes high
level of provider awareness. We argue that there is a pressing need to
implement universal precautions across all health facilities in the state,
and implement evidence-based stigma reduction interventions. Given
the gaps in knowledge however, impact will be dependent on educating
healthcare providers on modes of transmission.
Ethics Statement: This study was approved by the MSF Ethical Review
Board and the Ethics Committee of the All India Institute of Medical
Sciences, Bihar, India.
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QUALITY IMPROVEMENT IN THE KENYAN COMMUNITY HEALTH
SYSTEM: A MECHANISM TO DRIVE LOCAL INNOVATIONS TO
OVERCOME LOCAL CHALLENGES
Otiso L.1, Kumar M.B.2, Wingfield T.2, Doyle V.2,3, Okoth L.1,
Muturi N.1, Karuga R.1, Kimani M.1, Ogwang E.1, Regeru R.N.1,
Taegtmeyer M.2
1LVCT Health, Nairobi, Kenya;
2Dept. of International Public Health, Liverpool School of Tropical
Medicine, Liverpool;
3Capacity Development International, Liverpool, UK
Introduction: Community health worker (CHW) programs have been
scaled up globally to response to primary health care challenges.
Concerns about data quality, quality of care and limited effectiveness
of CHWs in improving health outcomes have remained. Quality Improve-
ment (QI) is a systematic approach to identify and improve on gaps in the
delivery of health services. QI has been used in health facilities to address
quality gaps through local data collection, analysis and use for problem
solving. Few studies have applied or assessed QI approaches in CHW
programs.
Aim: We tested the feasibility of implementing QI approaches in
community health programs in Kenya as a means of solving local health
problems.
Methods: We implemented a QI program in purposively-selected
community health units (CHUs) in Kenya between October 2016 and
December 2018. We established 27 QI teams made up of CHWs, their
supervisors, and staff from the primary health care link facility. We
carried out a three phased training in QI methods interspersed with
periods of implementation and team coaching over nine months. We
hosted ‘learning events’ where we used a wide range of active methods
and competitive awards to exchange ideas and stimulate and promote
innovation.
Results: We highlight two community-initiated and -led innovations to
showcase the ways that teams designed solutions within their available
resources founded on robust root cause analyses:
1. CHWs extended growth monitoring from facilities to informal day-care
centres to reach more children under 5 years in Nairobi contributing to
increased diagnosis of moderate acute malnutrition at community level
from 1.2% to 44% cases.
2. Improving antenatal care through mother-to-mother support groups
– Kitui
3. CHWs developed waiting cards for antenatal care to allow women
who come early to be seen first in Nairobi. The average waiting time was
reduced by 25 minutes per mother.
Conclusion: We demonstrate the value of guided, structured QI in
community-led approaches, resulting in innovation and implementation
of ‘what works’ in users’ micro-context. Recognising that implementation
challenges persist, here we highlight how QI capacity can lead to
creativity of community teams to design and drive meaningful change in
their priority health issues.
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A PRAGMATIC NCD PROJECT IN RURAL KENYA
Van Den Broucke S.1,2, Nzomukunda Y.2, Scholtes C.2, Prasai M.2,
Kizito W.3, Muthinji E.4, Njiru R.4, Ellman T.5




5MSF-OCB SAMU, Capetown, South-Africa
Introduction: Early 2017, Médecins Sans Frontière, Belgium (MSF-OCB)
was invited by Ministry of Health (MoH) to start an integrated NCD-project
dealing with hypertension, diabetes, asthma and epilepsy in Embu, a rural
county in Kenya. After an initial assessment of the current NCD program
strengths and challenges, 5-year goals where set.
Project Aims: To develop a model of care for NCDs that is easy to scale-up
and duplicable by Ministry of Health (MoH). To develop specific advocacy
messages on NCD’s supported by outcome results through operational
research.
Assessment: In the county reference hospital, 46% of hospitalizations in
internal medicine are NCD related. NCD management is chaotic and lacks
uniformity compared to HIV and TB care. National NCD guidelines are
sometimes conflicting, not always adapted to the local context and on
rare occasions utterly detrimental. Quality laboratory monitoring for NCDs
is rarely available. Patients referred to higher level cannot be transferred
back to PHC level. Supply of NCDs treatments is unreliable at all levels
and 90% NCD drugs come from non-WHO pre-qualified manufacturers.
National Health Insurance (NHI) is beneficial for NCD patients and 1/3
patients are insured but regular drug stock-outs undermine the NHI and
cause patients double costs (still need to buy drugs in private pharma-
cies).
Proposal: An integrated mentoring and coaching project was launched
focussing on capacity building in primary health care (PHC) with a referral
and back-referral policy between central and peripheral health structures.
Simple, pragmatic, locally adapted and innovative project guidelines were
created, with SOPs adapted to PHC level. Point-of-Care HbA1c, cholesterol
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CHWs will create disease awareness in the community to stimulate
health-care seeking behaviour for patients most at risk. Operational
research to document outcomes of the model of care and on the fea-
sibility of the innovative guidelines is planned. First cohort outcomes are
expected mid-2019.
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POST-UNIVERSITY SPECIALTY TRAINING (PUST) OF FAMILY
DOCTORS IN TAJIKISTAN
Bohle L.F.1,2, Kasymova Z.3, Davlyatova D.3, Ross G.3, Yarbaeva
S.3, Galeazzi R.1,2, Wyss K.1,2, Prytherch H.1,2
1Swiss Centre for International Health (SCIH), Swiss Tropical and
Public Health Institute (Swiss TPH);
2University of Basel, Basel, Switzerland;
3Swiss Agency for Development and Cooperation’s Medical Educa-
tion Reform Project, Dushanbe, Tajikistan
Introduction: Medical education reform is a priority of the National Health
Strategy 2010-2020 of the Government of Tajikistan. Swiss support has
facilitated the establishment of a 2-year Post-University Specialization
Training (PUST) for Family Doctors. The PUST has a stronger focus on
clinical skills and on-site tutored practical learning than the conventional
1-year work experience period designated as ‘Internatura’ which also
continues to be offered to graduates from medical university.
Aim: The clinical skills, attitudes, behaviour and theoretical knowledge
of Family Doctors graduating from the 2-year programme were com-
pared to Family Doctors completing the conventional 1-year internship
(‘Internatura’), as well as to those of newly graduated medical students
entering the PUST programme.
Methods: An Objective Structured Clinical Examination (OSCE) and a
60-item Multiple Choice Questionnaire focusing on 20 tracer diseases
were conducted. Three sub-samples participated: i) graduated medical
students newly entering the PUST (“Ordinators-1st Year” N=20/20); doc-
tors newly completing the 1-year ‘Internatura’ (“Interns” N= 6/8); and
Family doctors newly graduated from the 2-year PUST (“Ordinators-FDs”
(N=26/24). Results were tested for significance.
Results: In the OSCE the Ordinators-FD performed best, achieving on
average (60%, equal to 84 out of 139 possible points), followed by
the Ordinators-1st Year, with the Interns in fact performing poorest of
all. The differences between the performance of the Ordinators-FD and
both other groups were significant (F=8.64, P=0.01). For the MCQs the
difference was less marked, with Ordinators-FD answering 44% correctly;
Ordinators-1st Year” 42%, and Interns 38%.
Conclusion: The PUST programme is a successful and impactful pro-
gramme for improving the clinical skills, attitudes and behaviour of Family
Doctors in Tajikistan. However, there is still room to continuously and sys-
tematically further strengthen the theoretical and practical knowledge,
skills and competencies of medical graduates entering family medicine,
as well as their tutors. To further improve the knowledge and skills the
programme should be enlarged to a total of three years to bring it
closer to international standards. A strengthening of the programme and
expansion would consequently result in an increase in the provision of
health services of highest quality with a positive impact on reducing the
morbidity and mortality of the Tajik population.
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PROMOTING GLOBAL RECOMMENDATIONS TO PREVENT MATER-
NAL MORTALITY AND MORBIDITY IN LOCALLY UNACCEPTABLE
CIRCUMSTANCES - SAFE MOTHERHOOD PRIORITIES (1987-
2017)
Solnes Miltenburg A., Kvernflaten B.
Dept. of Community Medicine and Global Health, Institute of
Health and Society, University of Oslo, Oslo, Norway
Introduction: Worldwide too many women are unnecessarily dying in
childbirth. However, thirty years of global attention for maternal mor-
tality, sparked by the Safe Motherhood Initiative in 1987, has resulted
in significant progress. Also in low resource settings, more women have
access to essential services and seek care during pregnancy and birth.
Nevertheless, by 2015, it has become clear that increased access to
care, did not result in the expected reduction of mortality in every coun-
try, particularly in low resource settings. The crucial gap in the qual-
ity of care revealed a lack of focus on the implementation of global
recommendations of interventions to prevent maternal mortality and
morbidity.
Aim: We aim to illustrate how the recurrent local promotion of global
standard models as a way to improve maternal health, have resulted in
sometimes damaging consequences for women and health providers on
the ground.
Methods: We performed a desktop review of Safe Motherhood priorities
in the past thirty years, and rely on several years of fieldwork and research
on maternal health in low-resource settings.
Results: Throughout the past 30 years, global focus has remained on
interventions argued to be effective to achieve reduction of maternal
mortality. Consequently, these have been framed in an increasingly med-
icalized service model, disseminated through a universal, ‘one-size-fits-
all’ approach, while local contexts are divers and dynamic. Examples from
several countries in sub-Saharan Africa, illustrate how the global standard
models and related interventions (e.g. focussed antenatal care, birth
with a skilled attendant, emergency obstetric care) over time have been
negotiated, shaped and transformed influenced by the socio-economic
and political context.
Conclusion: The Sustainable Development Goals era, the 4th Safe Moth-
erhood decade, provides a new opportunity, to move beyond numerical
indicators of progress on maternal mortality reduction, and to promote
maternal well-being and dignity, prioritizing the values and needs of
women and their families, in the contexts in which they live and seek care.
In order to achieve this however, efforts should be made to assist policy
makers and health providers to adapt global recommendations, fitting
to their, often unacceptable, country realities, rather than to universal
dreams and aspirations.
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JUDICIAL AND HEALTH RESPONSES TO CHILD SEXUAL ABUSE
IN WESTERN KENYA: A CASE STUDY OF ADOLESCENT SUR-
VIVORS OF SEXUAL ABUSE
Wangamati C., Sundby J., Nyangor M., Prince R.
1Dept. of Community Medicine and Global Health, Institute of
Health and Society, University of Oslo, Oslo, Norway;
2Plan International
Introduction: Child sexual abuse (CSA) is a global, social and health
challenge. Extant literature in Kenya indicates an increasing number of
minors seeking health and legal services for sexual abuse. However, little
is known about the experiences of CSA survivors when they seek health
and legal services.
Aim: The aim of this study was to gain contextual insight in the experi-
ences of CSA survivors in Kenya, and their access to justice.
Methods: We conducted in-depth interviews with 10 girls who had experi-
enced sexual abuse and held informal conversations with their guardians
and service providers, reviewed medical and court records, and observed
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Results: We report on experiences of two girls seeking justice through
the Kenyan justice system as they are representative of the ten cases.
We found that these minors’ rights to justice were violated. They were
subjected to long delays at the law courts before their cases could be
heard. Sexual and reproductive health services offered to the minors were
of poor quality. Moreover, guidelines on screening CSA and mandatory
reporting were non-existent in health facilities.
Conclusion: There is need for the criminal justice system in Kenya to
prioritize sexually violated minors in courts. Health providers should be
trained and given guidelines on how to screen for CSA and cater to the
needs of CSA survivors.
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EFFECTS OF REFRESHER TRAINING ON THE USE OF MANUAL
VACCUM ASPIRATION IN THE TREATMENT OF INCOMPLETE
ABORTIONS: A QUASI-EXPERIMENTAL STUDY IN MALAWI
Odland M.L.1,2
1Dept. of Public Health and Nursing, Norwegian University of Sci-
ence and Technology, Trondheim, Norway;
2Institute of Applied Health Sciences, University of Birmingham,
Edgbaston, Birmingham, UK
Introduction: The maternal mortality ratio is decreasing globally,
although it remains high in Malawi. Unsafe abortion is a major cause
and treatment of complications after abortion is a big burden on the
health system. Even though manual vacuum aspiration (MVA) is the
recommended surgical treatment of incomplete abortions in the first
trimester, many hospitals in Malawi continue to use sharp curettage.
It is known to have more complications and is more expensive in the
long run.
Aim: The purpose of this study was to determine the effectiveness of
a structured MVA training programme in the treatment of incomplete
abortions in Malawi.
Methods: A quasi-experimental before-and-after study design was
employed in an MVA training programme for health personnel at three
hospitals in Southern Malawi. A total of 53 health personnel at the
Queen Elizabeth Central Hospital and the district hospitals of Chikwawa
and Chiradzulu (intervention hospitals) were trained in the use of MVA.
Kamuzu Central Hospital in Lilongwe and the Thyolo District Hospital
served as control institutions. Medical files for all women treated for an
incomplete abortion at the study hospitals were reviewed before and
after the intervention. Information on demographic and obstetric data
and the type of treatment was collected.
Results: There was a significant increase in the use of MVA from 7.8%
(95% CI 5.8 to 10.3) to 29.1% (95% CI 25.9 to 32.5) 1 year after the
intervention. In comparison, we found a mere 3% increase in the control
hospitals.
Conclusions: By providing a refresher training programme to health
personnel who treat women with incomplete abortions, it was possible
to increase the use of MVA as recommended in the Malawi national
guidelines.
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INVESTING SCARCE RESOURCES WISELY – SYSTEMATICALLY
ANALYSING RESEARCH FUNDING TO IMPROVE DECISION-
MAKING IN HEALTH RESEARCH AND REDUCE FUTURE BURDENS
OF DISEASE
Head M.G., Brown R.J., Batchelor J.
University of Southampton, UK
The aim of health research is to provide new tools, knowledge and
approaches that can be applied to the healthcare sector and reduce the
burden of disease. However, investors in global health research makes
decisions on funding without a clear widespread picture of the overall
cross-funder research landscape and the impact and benefits of these
decisions.
The Research Investments in Global Health (ResIn) study (http://researchi
nvestments.org/) is a long-running project that analyses funding trends in
health research. We have previously mapped and described investments
in UK-funded global health research, and compared to the burden of
disease to gain insight into level of funding compared with level of
disease. In 2018 we published a report (Sizing Up Pneumonia Research)
describing the worldwide underspend on pneumonia R&D, and also a
Lancet Global Health paper quantifying the sites of malaria research
hubs across sub-Saharan Africa (e.g. Kenya, Tanzania) along with the
geographical gaps in dissemination of funds (e.g. Chad, Central African
Republic).
Now, ResIn is producing an extensive, fully-categorised, global dataset
that incorporates 80,000 separate infectious disease research invest-
ments, totally an estimated $100 billion, from 46 countries over the time
period 2000-2017. Findings from this large analysis will cover type of
science of the awards, disease in focus, geography of research, and be
available in 2019 and be presented at ECTMIH.
Our results have, and will continue to, inform high-level global health
policymakers e.g. we are cited in policy documents from the World Health
Organisation and UK government, as well as funders, professional bodies
and societies, and in-country stakeholders of low- and middle-income
countries. We provided original data and expert comment to the 2018
World Bank ’Money and Microbes’ report, which described how data on
funding, research capacity, level of skills and evidence gaps are vital
information to accurately describe if decreases in health burden are to
be maximised. Our Methods and findings can underpin and support the
moves from global health stakeholders to improve the quality of this
evidence base.
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SOCIOECONOMIC INEQUALITIES IN ARBOVIRAL DISEASES IN
LATIN AMERICA: ESTIMATING AND DECOMPOSING THE INDEX
OF INEQUALITY FOR DENGUE, ZIKA AND CHIKUNGUNYA IN
COLOMBIA AND BRAZIL
Carabali M.1, Harper S.1, Lima-Neto A.2,3, Caprara A.4, Restrepo
B.N.5, Kaufman J.S.1
1Dept. of Epidemiology, Biostatistics and Occupational Health,
McGill University, Montreal, Canada;
2Fortaleza Health Secretariat (SMS-Fortaleza);
3University of Fortaleza (UNIFOR;
4University State of Ceara (UECE), Fortaleza-CE, Brazil;
5Instituto de Medicina Tropical- Universidad CES, Medellin,
Colombia
Introduction: Dengue, chikungunya, and zika are arboviruses transmitted
to humans by Aedes sp. mosquitoes. These endemic diseases in Latin
America have similar symptomatology, no specific curative treatments,
and no effective vaccines. Overall notified cases, dengue deaths and
severe forms of zika and chikungunya are more common among people in
low socioeconomic position, but no formal assessment of the inequality
has been done yet.
Aim: To estimate the socioeconomic inequality of dengue, chikungunya
and zika at the neighborhood level in Brazil and Colombia.
Methods: We used data on all notified cases from 2008 to 2017 in
Medellin, Colombia and Fortaleza in Brazil, to estimate the magnitude
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poral analysis to estimate neighborhood-level monthly incidence rates
and used income data to estimate the relative concentration index
of inequality (RCI). To identify the main contributors to inequality, we
decomposed the RCI and described its time trend. A priori covariates
included in the RCI decomposition were age, sex, occupation, educa-
tion, as well as neighborhood-level climate, entomological, and social
variables. We fitted overall and disease-specific Poisson models, using
random effects for time and spaces and semiparametric functions for cli-
matic variables using Integrated Nested Laplace Approximation Methods
(r-INLA).
Results: In Fortaleza there were 274,089 reported arboviral diseases
(dengue=195,483; chikungunya=77,024; and zika=1582 cases). The over-
all RCI was -0.07 (95% CI= -0.08, -0.06) indicating a concentration of
arboviruses among the poor, even after adjusting for the spatiotemporal
trend, with a 7% reduction on the incidence rates per every $100 USD
increase in the median income per neighborhood. The overall RCI using
a fully adjusted model was -0.02 and the main contributor to inequal-
ity was waste management (21.6%). The lowest RCI (-0.11) was from
2010 while the highest were 2012 (-0.015), 2015 (-0.027), and 2017
(-0.014).
Conclusion: Our quantitative assessment of data from the last 10 years
in two endemic Latin American cities highlights the contribution of social
determinants to inequality in arboviral diseases. Results indicate the
concentration of arboviruses among the poor, however, such concen-
tration is more marked during interepidemic years and decreases during
outbreaks.
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Introduction: Rabies is preventable through prompt administration of
post-exposure prophylaxis (PEP) to exposed persons, but PEP access is
limited in many rabies-endemic countries.
Aim: We investigated how access to PEP can be improved to better
prevent human rabies.
Methods: Using data from different settings in Tanzania, including
contact tracing (2,367 probable rabies exposures identified) and large-
scale mobile phone-based surveillance (24,999 patient records), we
estimated the incidence of rabies exposures and bite-injuries, and
examined health seeking and health outcomes in relation to PEP access.
We used surveys and qualitative interviews with stakeholders within the
health system to further characterise PEP supply and triangulate these
findings.
Results: Incidence of bite-injury patients was related to dog population
sizes, with higher incidence in districts with lower human-dog ratios
and urban centres. A substantial percentage (25%) of probable rabies
exposures did not seek care due to costs and limited appreciation of risk.
Upon seeking care a further 15% of probable rabies exposed persons
did not obtain PEP due to shortages, cost barriers or misadvise. Of
those that initiated PEP, 46% did not complete the course. If no PEP
was administered, the risk of developing rabies following a probable
rabies exposure was high (0.165), with bites to the head carrying most
risk. Decentralized and free PEP increased the probability that patients
received PEP and reduced delays in initiating PEP. No major difficulties
were encountered by health workers whilst switching to dose-sparing ID
administration of PEP. Health infrastructure also includes sufficient cold
chain capacity to support improved PEP provision. However, high costs
to governments and patients currently limit the supply chain and PEP
access. The cost barrier was exacerbated by decentralization of budgets,
with priority given to purchase of cheaper medicines for other conditions.
Reactive procurement resulted in limited and unresponsive PEP supply,
increasing costs and risks to bite victims.
Conclusion: PEP access could be improved and rabies deaths reduced
through ring-fenced procurement, switching to dose-sparing ID regimens
and free provision of PEP.
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Introduction: Achieving the London Declaration goal of a 90% reduction
in neglected tropical diseases (NTDs) by 2030 requires innovative and
cost-effective control strategies.
Aim: This proof-of-principle study examined the effectiveness of inte-
grating control programs for two NTDs: soil-transmitted helminths (STH)
in humans and dog rabies. Treatment integration required combining
mass drug administration (MDA) for STH and mass dog rabies vaccination
(MDRV).
Methods: The study was carried out in remote villages in the Ngorongoro
District, Tanzania, where there is an existing national primary school-
based deworming program. The first objective was to investigate the
effectiveness, cost and time savings, and community perceptions of
integrated delivery. The second objective was to quantify the impact
of the study’s MDA strategy on reaching primary school-aged children
(whether or not enrolled in school) and other community members. To
implement, we randomly selected villages for delivery of MDA and MDRV
(Arm A), MDA only (Arm B), or MDRV only (Arm C).
Results: Cost per delivered dose was lower under integrated strategy by
$0.12 (33%) and $0.82 (16%) for deworming and rabies, respectively.
The percentage of households in Arms A and B that participated in the
deworming event was 82% and 86%, respectively (χ2 = 0.2, p = 0.66).
The percentage of households in Arms A and C that participated in the
rabies vaccination event was 80% and 88%, respectively (χ2 = 2, p =
0.16). It took 33% less time for a single person and a dog to attend the
integrated delivery than two separate events. Strong community support
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Conclusion: This proof-of-principle study demonstrated integrated deliv-
ery platforms for health interventions are popular, cost and time saving.
Further, integrating human and animal health interventions is feasible,
locally acceptable and does not appear to result in a reduction of the
proportion of people reached for deworming or constrain the ability to
achieve a 70% target for dog rabies vaccination. Thus, indicating the
utility of integrated One Health delivery platforms and suggesting a role in
the global campaign to reduce NTDs, especially in remote communities.
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Introduction: Rabies is an important and under-reported infectious dis-
ease of the central nervous system which is endemic in many Sub-
Saharan African countries. Bites from infected dogs are the main cause
of human infections. The disease can be prevented if post-exposure-
prophylaxis (PEP) is administered immediately post bite. However, many
dog bite victims do not receive PEP.
Aim: The aim of this study was to examine the reasons why dog bite
victims do not report to health services to obtain PEP in Blantyre, Malawi.
Methods: Between February and June 2018, people presenting to the
Regional Veterinary Laboratory (RVL) in Blantyre, Malawi after exposure
to a dog bite or scratch were randomly selected to participate in a
questionnaire survey combining quantitative and qualitative data on the
exposure and its management. Contact tracing of nearby households
was also carried out to identify other people exposed to dog bites or
scratches in the area in the preceding 3 months. A multivariable logistic
regression model was developed to assess factors associated with RVL
attendance.
Results: A primary cohort of 102 dog exposures reported to the RVL were
investigated. Contact tracing of these exposures led to a subsequent 2410
household interviews which identified a secondary cohort of 97 further
dog bite exposures. Of the secondary cohort, 72.2% of exposures had not
been reported to the RVL. 46.4% did not present to either RVL or any other
clinic for assessment after their exposure. Only 4.6% had washed their
wound for the period of time recommended by WHO following exposure,
and 16.3% had received PEP vaccine. Factors associated with attendance
at the RVL included bite from a stray dog, more severe bite, and higher
household income.
Conclusions: Passive surveillance of potentially rabid dog bites will signif-
icantly underestimate incidence of dog exposures. Barriers to rabies PEP
vaccine uptake include knowledge, financial barriers and public percep-
tion that health services will be unable to supply vaccine.
111
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EASES AFFECTING CATTLE BY COMMUNAL FARMERS IN ZIM-
BABWE
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Introduction: Tick-borne diseases (TBDs) account for losses exceeding
millions of United States Dollars (USD) annually in most African countries.
In Zimbabwe, TBDs are responsible for at least 60% of cattle mortalities
annually. The resource poor communal farmers are most affected since
they own the majority of the cattle. There is need to investigate how
these communal farmers are managing and controlling ticks and TBDs
in their areas. This will help in coming up with enhanced strategies to
reduce the losses encountered by farmers.
Aim: The aim of this study was to investigate how communal farmers
were managing and controlling ticks and TBDs by assessing level of
knowledge and perception on ticks and TBDs, knowledge, frequency and
type of acaricide used and access to veterinary services.
Methods: A nationwide survey was conducted in 33 / 55 farming
districts of the country. Six hundred farmers were personally interviewed
using a semi-structured questionnaire in order to answer the study’s
objectives. The data was analysed using descriptive statistics for the
dependant variables under investigation as well as cross tabulations
to check for relationships between demographic and dependant
variables.
Results: The results showed a deep awareness of ticks and TBDs with
70% of the sampled farmers being able to mention tick-borne diseases
and relate to their clinical signs. This was however influenced (p<0.05)
by gender, participation in farmer training courses and age. The most
common TBDs affecting cattle nationally were heartwater, anaplasmosis,
babesiosis and theilerosis in that order. The acaricide amitraz was
the most frequently used (68%) followed by organophosphates (25%)
and synthetic pyrethroids (7%). It was observed that most farmers
(79%) were participating in government co-ordinated communal dipping
programmes and there was a strong reliance (85%) on veterinary
personnel for assistance.
Conclusion: Ticks and TBDs continue to be a problem for resource poor
communal farmers. The high level of knowledge by farmers on TBDs will
ensure a cheap form of data collection in the absence of resources to
carry out traditional epidemiological studies. With the high frequency of
use of amitraz as an acaricide there might be need to investigate issues
to do with resistance.
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Introduction: Avian influenza virus is endemic in Bangladesh and
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Aim: This study aims to assess (1) the socio-economic factors shaping
Bangladeshi poultry value chains and (2) the consequences for the
transmission of avian influenza viruses (AIVs) to poultry and humans.
Methods: An inter-disciplinary approach was adopted, combining
ethnography, epidemiology, virology and mathematical modelling.
Overall, about 2500 poultry production stakeholders were interviewed
to explore the value chains supplying Dhaka and Chittagong. This
informed the design of cross-sectional and longitudinal virological and
serological surveys of farmed and marketed poultry, as well as in-contact
humans.
Results: Demand and availability of poultry greatly varied according
to breeds and species. While this resulted in different poultry origin
and market destination patterns, value chains intertwined in markets,
promoting the mixing of poultry of all breeds, species and geographical
origins, as well as of their viruses. Although infection of market
workers by AIVs was rare, market air and environment were highly
contaminated. AIV bird-level prevalence in marketed poultry was more
than 10-times as high as in farms supplying those markets, and co-
infection with multiple strains was common. Model Results suggested
that this viral amplification from farms to markets resulted from
transmission events mainly occurring during transportation, rather than
at markets. Moreover, the value chains’ topologies likely resulted in
various viral strain mixing patterns depending on poultry types and
market locations, with consequences for the design of surveillance and
control programmes. These model outputs are currently being validated
through phylodynamic analyses and field experiments. We also identified
actors with key roles – such as credit providers – whose choices and
transaction decisions shaped poultry trade, influencing AIV infection
patterns.
Conclusion: Trading practices created conditions for the co-circulation of
multiple AIV strains at high prevalence levels in the Bangladeshi poultry
trading system, increasing the risk of viral reassortment. To mitigate
this risk, it is essential to alter value chain structures by influencing
transaction dynamics through economic incentives and promoting
access to economic capital and information.
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Introduction: One Health is particularly relevant to the Horn of Africa
where people livelihoods are highly dependent on livestock and their
shared environment. In this context, zoonoses may have a dramatic
impact on both human and animal health, but also on the ability of
livestock owners to sustain themselves.
Aim: This scoping review aimed at characterizing and evaluating the
nature of zoonotic disease research in the Horn of Africa (Djibouti, Eritrea,
Ethiopia, Kenya, Somalia, Sudan, South Sudan and Uganda). Specifically,
this review addressed the following questions: what specific zoonotic
diseases have been prioritized for research in each country, what domains
are reported (human, animal, environment), and what methods were
applied?
Methods: We used a combination of keywords to search online
databases for peer-reviewed papers and theses. Screening and data
extraction (disease, country, domain and method) was performed using
DistillerSR.
Results: A total of 9222 papers were retrieved through database
searches. After duplicate removal, 3871 relevant studies were assessed
for inclusion, resulting in more than 2000 relevant studies. Ethiopia had
the largest number of papers followed by Kenya, Uganda and Sudan.
Most frequently studied zoonoses were brucellosis and echinococcosis.
A large majority of studies used epidemiology Methods (descriptive or
cross-sectional) and focused on one domain only (animal or human).
Conclusion: Recommendations arising from this scoping review include:
(1) reducing study duplication through better communication and col-
laboration; (2) aligning research with country priorities; (3) encouraging
One Health approaches and reporting following COHERE guidelines;
(4) adopting research Methods that support evidence-based zoonoses
management.
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Introduction: Buruli ulcer (BU) endemicity is long-established in Nigeria;
however the substantial increase of reported new cases in the last years,
suggests that dimensions of BU endemicity might not be fully understood
yet. BU epidemiology exhibits small, yet highly clustered incidence
and transmission from contaminated environments to humans. Thus,
identification of climatic, epidemiological and socio-environmental
factors predictive of BU endemicity is of key importance.
Aim: To analyze the association of the 164 BU cases, reported between
2012 and 2015, in 4 Nigerian States with major climatic, socio-
environmental and epidemiological factors at the level of the respective
Local Government Areas (LGAs).
Methods: All BU cases were geocoded. Cumulative number of new cases
per 100,000 at LGA level (CNNCs), served as our outcome variable. Data on
relevant climatic, socio-environmental and epidemiological parameters,
serving as independent variables, were obtained from remote Earth
Observation data, OpenStreetMap, online mapping tools, literature review
and geocoding of field data. Geospatial illustrations of reported BU
and Spearman rank correlation between outcome and independent
variables was performed. Linear regression analysis for assessing the
most accurate predictive model for BU CNNCs was used.
Results: Proximity of BU cases towards different types of waterbodies
was evident in the geospatial illustration. BU CNNCs correlated directly
with topological wetness index and inversely with median land slope,
average annual rainfall, as well as to distance to ponds, lakes and all
kinds of waterbodies (composite variable comprising ponds, lakes, rice
fields and rivers). Regarding prediction quality, the best performing model
included two independent variables, i.e. distance to rivers and to all kinds
of waterbodies, yielding a Root Mean Square Deviance of 3.85.
Conclusion: In line with prior evidence, we found an association
of BU CNNCs with proximity to waterbodies and level landscapes.
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best prediction quality for the presence of BU. In the face of the
required systematic active case finding, geospatial analysis could serve
as a prioritization tool in planning efficient BU-interventions at the
subnational level. Future studies, encompassing regions with wider
climatic, sociodemographic and epidemiological diversity and higher
number of BU cases are urgently needed.
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Introduction: Dairy cattle movement is an important risk factor for the
spread of bovine tuberculosis (BTB), particularly in endemic countries with
poor or no restrictions on animal movements or trade. Understanding the
frequency and patterns of dairy cattle movement is essential for predict-
ing the risk of spread of BTB between farms and potentially important for
targeting controls.
Aim: The study aimed to investigate the network structure of dairy cattle
movement and its influence on the transmission and prevalence of BTB in
three emerging dairy areas of Ethiopia, namely in the cities of Hawassa,
Gondar, and Mekelle.
Methods: A questionnaire survey was conducted in 278 farms to collect
data on the pattern of dairy cattle movements during the last five years
(2014-2018). Visualization of the network structure and analysis of the
relationship between network characteristics and BTB prevalence in these
dairy farms was performed using social network analysis.
Results: The cattle movement network displayed both scale free and
small world properties implying local clustering with fewer farms being
highly connected, at higher risk of infection and with the potential to
act as super spreaders of BTB if being infected. Farms having a history
of cattle movements onto the herds were more likely to be affected
by BTB (OR: 2.2) compared to farms not having such history. Euclidean
distance between farms and the batch size of animals moved on were
positively correlated with prevalence of BTB. Conversely, farms having
outgoing cattle showed a decrease on the likelihood of BTB infection
(OR=0.57) compared to farms which maintained their cattle. Targeted
removal of farms in the network based on the eigenvector centrality
measures showed a faster rate of change on the size of the giant con-
nected component and largest community size compared to a random
removal of farms implying that targeted intervention could be one control
option.
Conclusion: This study describes the patterns of cattle movement in
Ethiopia contributing to disease transmission between herds and could
help to identify critical points along the path to impose control measures.
It finally provides a starting point to build and estimate dynamic trans-
mission models for BTB, and other infectious diseases.
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Introduction: Diarrhoea lasting less than 7 days is defined as acute
(AD), 7-13 days as prolonged (ProD), and 14 days or longer as persistent
(PD). Causes and risk factors of AD are well-described, but we lack good
data on factors associated with ProD and PD (ProPD) in children. Acute
malnutrition is assumed to be one of the main contributors to extended
duration of a diarrhoea episode.
Aim: We aimed to assess the prevalence of, and variables associated with
ProPD in a hospital and health centre in Ethiopia with special focus on
associations with acute malnutrition.
Methods: We conducted a case-control study where cases were chil-
dren aged under 5 years with diarrhoea and controls were frequency-
matched weekly by age and district of residency. Controls for infants were
recruited from vaccination rooms serving areas where the cases lived,
those 12-59 months of age by house visits using a procedure based on
random points in the catchment area of the respective study site. Data
were collected on enrolment and on follow up 14 days after onset of
diarrhoea and was later analysed in an unconditional mixed regression
model.
Results: We enrolled 1084 cases and 933 controls. 921 (85%) of the
cases had AD, 124 (12%) had ProD and 34 (3%) had PD. Of the 370
cases with follow-up data 78 (21%) had ProPD. Twenty-eight per cent
of the cases with ProPD had acute malnutrition. Children with diar-
rhoea were more often moderately or severely wasted on enrolment
or were born prematurely, when compared with controls. Children with
ProPD were more often moderately or severely wasted or stunted, and
more often reported having received zinc when compared with children
with AD. A higher proportion of children with AD reported vomiting or
had fever.
Conclusion: ProPD is common and not confined to children with acute
malnutrition. ProPD was however associated with moderate or severe
wasting and with having received zinc treatment. Other factors such
as vomiting and fever differed between AD and ProPD; one of several
possible explanations for this could be that these diarrhoeal syndromes
have different aetiologies.
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EPIDEMIOLOGICAL AND CLINICAL PROFILE OF IMMUNOSUP-
PRESSED PATIENTS WITH IMPORTED STRONGYLOIDIASIS: A
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Introduction: Strongyloides stercoralis infection is asymptomatic most
of the times. However, in immunosuppressed population severe clinical
presentations may occur: S. stercoralis hyperinfection syndrome and
disseminated strongyloidiasis, with high mortality rate.
Aim: The aim of this study was to describe the clinical and epidemiological
profile of immunosuppressed patients with imported strongyloidiasis
in a non-endemic setting, the yield of the different microbiological
diagnostic techniques, and to compare these Results with a group of
non-immunosuppressed patients.
Methods: This is a case-control substudy from a larger observational
retrospective study that included all patients with strongyloidiasis
registered in the +REDIVI Spanish Collaborative Network from January
2009 to February 2017. REDIVI is a Spanish collaborative network of 23
Tropical Medicine Units, with a national database to record all cases of
immigrants and travellers visited. The following information was retrieved
from the REDIVI database: demographic information (age, sex, country
of origin), patient classification (immigrant, VFR, traveller), presence of
immunosuppressant conditions, travel-related information (country,
duration), main symptoms, and diagnosis. Extra information of these
patients was requested to the participant centres: eosinophil cell count,
microbiological techniques performed, treatment, and follow-up.
Results: During the study period, 1245 patients with imported strongy-
loidiasis were registered in the +REDIVI database. From these, 80 (6.4%)
patients had some kind of immunosuppression: 56 (70%) patients
with HIV infection, 19 (23.7%) patients receiving immunosuppressive
therapies, and 5 (6.3%) patients with solid organ transplantation.
The vast majority were immigrants (97.5%), 3 (3.8%) patients had a
hyperinfection syndrome, and 34 (52.3%) patients had eosinophilia.
The percentages of positive Results of the formalin-ether technique, the
fecal culture and serology were 12.3%, 21.1% and 95.4% respectively.
When comparing the main characteristics between immunosuppressed
and non-immunosuppressed patients, immunosuppressed patients had
higher proportion of severe clinical manifestations (3.8% vs 0%, p=0.036)
and lower proportion of eosinophilia (52.3% vs 78.5%, p<0.001). No
differences were found regarding yield of microbiological techniques and
treatment response.
Conclusions: These results stress the importance of strongyloidiasis
screening among immunosuppressed patients coming from endemic
areas, and serological tests have an acceptable sensitivity to be used as
a screening tool among this population.
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Introduction: Mass drug administration (MDA) of praziquantel is one
of the main control measures against human schistosomiasis. Although
pregnant women, infants and children under the age of 5 in high endemic
areas should be considered for MDA, they are usually not treated without
diagnosis. Diagnostic tools identifying infections at primary health care
centre (PHCC) level could therefore help to integrate this vulnerable
group into control programmes. freeBILy (Fast and reliable easy-to-use-
diagnostics for eliminating Bilharzia in young children and mothers)
is an international multi-centre consortium focused on improving
schistosomiasis diagnostics.
Aim: In Madagascar, the study aims to determine the effectiveness
of a Test-Based-Schistosomiasis-Treatment (TBST) strategy for pregnant
women and their infants and children up until the age of 2.
Methods: A two-armed (intervention and control) cluster randomised
controlled phase III trial including 5200 women and their offspring
assesses the impact of TBST on child growth and maternal haemoglobin
in areas of medium to high endemicity of S. mansoni. The participants
will be tested with the Point of Care-Circulating Cathodic Antigen
(POC-CCA) assay, a urine-based non-invasive rapid diagnostic test for
schistosomiasis. In the intervention arm, a POC-CCA-TBST strategy will
be offered to women during pregnancy, 9 months after delivery and for
their infants at 9 months of age. In the control arm patient care will follow
national schistosomiasis management guidelines rather than POC-CCA-
TBST. All participants will be offered the POC-CCA-TBST at 24 months after
delivery. This trial will be integrated into the routine maternal and child
primary health care programmes at 40 different PHCC in Madagascar’s
highlands.
Results: freeBILy in Madagascar is in the implementation phase.
Thus far, all sites have been selected and set up for the study. Fifty
local staff including nurses, midwives, data managers and laboratory
technicians have been trained in Good Clinical Practice and the
study protocol. The recruitment phase will end in the last quarter of
2019.
Conclusion: This trial assesses a strategy to integrate pregnant women
and their children under the age of 2 into schistosomiasis control
programmes. It also represents an opportunity in Madagascar for local
capacity-building in clinical trials and large-scale intervention research.
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AFTER AN INTENSIFIED TREATMENT PROTOCOL WITH PRAZI-
QUANTEL
Mueller A.1, Fuss A.2, Mazigo H.D.3
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of Tropical Medicine;
2Medical Mission Institute, Wuerzburg, Germany;
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Introduction: Annual rounds of praziquantel treatment for populations
at risk are the mainstay of schistosomiasis control programs. In many
endemic settings this has been successful but in areas of intense trans-
mission more frequent interventions could ensure a greater impact on
infection levels.
Aim: The main objective of this study was to investigate the effectiveness
of intensified praziquantel treatment.
Methods: The study was carried out on Ijinga Island near the southern
shoreline of Lake Victoria, located in Magu district, north-western Tanza-
nia. An intensified treatment protocol of the entire population was carried
out as follows: The first three treatments with praziquantel were admin-
istered at intervals of five to six weeks, the fourth and fifth treatment
rounds half and one year after the first treatment, respectively. A sentinel
group of 223 school-aged children (SAC) was examined 6 weeks after
each treatment round by Kato-Katz and POC-CCA test.
Results: Before treatment, the prevalence of infection was 84% for SAC
determined by Kato-Katz and 98% determined by POC-CCA test. The
follow-up prevalences decreased after the first 3 rounds of treatment to
12.6% (POC-CCA) / 3.6% (KK). After the 4th round of treatment an increase
in the prevalence to 53.4% (POC-CCA) / 28.7% (KK) was found. After the
5th round of treatment a decrease to 31.8% (POC-CCA) / 19.3% (KK) had
to be noted. The intensity of infection was medium before treatment
giving a mean egg count of 248 epg (of positives). After five rounds of
treatment the intensity of infection was reduced to 44 epg.
Conclusion: The baseline data showed that the area had a major problem
of schistosomiasis. A significant reduction in the prevalence of S. mansoni
Figure 1. Prevalence of S. mansoni infections of the sentinel group
infection was achieved after 3 rounds of chemotherapy in short intervals.
But extending the intervals of re-treatment to 3 and 6 months lead
to a significant increase in the prevalence again although the intensity
remained low. These data demonstrate, that even an intensified prazi-
quantel treatment regimen alone will not allow to interrupt transmission
of schistosomiasis in a high transmission setting. Additional interventions
focussing on WASH and a change in the defecation practices need to be
implemented.
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SEROPREVALENCE STUDY OF ANTI-EBOLAVIRUS (EBOV)
IMMUNOGLOBULIN G (IGG) AT THE INDEX SITE OF 2013-
2016 WEST AFRICAN EBOV OUTBREAK: INSIGHT INTO EARLY
TRANSMISSION AND CASE FATALITY RATE
Timothy J.1, Hall Y.2, Akoi-Boré J.3, Diallo B.4, Tipton T.2, Bower
H.1, Glynn J.1, Carroll M.2
1London School of Hygiene & Tropical Medicine;
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Introduction: Despite extensive diagnostic, molecular and phylogenetic
research into the transmission of EBOV during the 2013-2016 West
African outbreak, no quantitative study or diagnostic Methods have been
employed at the suspected index location; Meliandou village in Guécké-
dou prefecture, Guinea. Previous studies in this area, conducted during
the outbreak, were necessarily limited and did not include serological
investigation.
Aim: To understand the full details immediately following the spill over
event that initiated the 2013-2016 EBOV outbreak. To identify risk factors
for transmission and assess the true case fatality rate of the early phase
of the outbreak.
Methods: Over 200 participants of the village of Meliandou agreed to
provide oral fluid samples that were subsequently assessed for EBOV
using a highly specific glycoprotein (GP) IgG ELISA. All participants were
extensively interviewed regarding health status and contact with poten-
tially infected villagers during the early phase of the outbreak.
Results: Analysis revealed 8 seropositive survivors and 2 other suspected
deaths of EVD, including two which were sub-symptomatic. True case
fatality rate was 55.6% (95% CI 30.8-78.5) compared to 100% as pre-
viously reported.
Conclusion: This thorough retrospective epidemiological study performed
concomitantly among the resident adult population greatly expands our
understanding of the initiating events including transmission dynamics,
probable transmission chains, lower case fatality rates and the presence
of both mild and asymptomatic cases.
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TEST AND TREAT CAMPAIGN: ADULT INDIVIDUALS AS A
SOURCE OF SCHISTOSOMA MANSONI INFECTION IN
FISHING COMMUNITIES OF ILEMELA AND NYAMAGANA
MUNICIPALITIES- NORTH-WESTERN TANZANIA
Bakuba E.1, Kaatano G.1, Kreibich S.2, Parisi S.2, Müller M.3,4,
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Introduction: Tanzania has the second highest prevalence of schis-
tosomiasis in sub-Saharan Africa. The national prevalence is esti-
mated at 52.5%. Currently, control programmes in Tanzania against
schistosomiasis target only school children using the Mass Drug
Administration (MDA) approach with praziquantel. Leaving the adult
population out of control programmes neglects their human right for
treatment and leaves them as a potential source of infection and further
transmission.
Aim: We report the prevalence of Schistosoma mansoni among adult
individuals participating in test and treat campaigns in North-Western
Tanzania.
Methods: In November 2017 and January 2019, test and treat campaigns
for Schistosoma mansoni infection were conducted among fishing
communities in Ilemela and Nyamagana municipality on the southern
shoreline of Lake Victoria. The campaigns included individuals aged ≥15
years. Participant’s age, sex and history of participating in MDA were
recorded using a questionnaire. A single urine sample was collected from
each participant and screened for S. mansoni infection using a point-
of-care Circulating Cathodic Antigen (CCA) test. All infected participants
were treated with praziquantel (40mg/Kgbwt).
Results: A total of 2,137 and 2,070 individuals participated in the
campaigns in 2017 and 2019 respectively. The overall prevalence of S.
mansoni based on the CCA urine test was 81.7% (95%CI: 79.9-83.2) and
70.9% (95%CI: 68.9-72.8) for the year 2017 and 2019 respectively. In
both years, male individuals had a higher prevalence of S. mansoni than
female individuals. Similarly, the youngest age group (15-25 years) had
the highest prevalence compared to older age groups.
Conclusion: The findings demonstrate that Schistosoma mansoni infec-
tion is highly prevalent among adult individuals living in the study areas.
Taking into account the availability of effective treatment, it is ethically
unacceptable to leave this population without appropriate treatment.
In addition an untreated population acts as a reservoir of infection,
potential source of environmental contamination and finally a cause of
re-infections to treated school children. Thus, there is a need to consider
alternative treatment strategies that include the adult population. This
will reduce their risk to develop severe complications associated with
schistosomiasis and furthermore reduce the risk of perpetuation of
transmission.
Reference:
1. Mazigo HD, Nuwaha F, Kinung’hi SM, Morona D, Pinot de Moira
A, Wilson S, Heukelbach J, Dunne DW: Epidemiology and control
of human schistosomiasis in Tanzania. Parasites and Vectors, 2012;
5: 274.
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Introduction: Diagnostic uncertainty about the aetiology of febrile dis-
eases in tropical settings often leads to overconsumption of antibiotics.
In acute fever, the inflammatory biomarker C-reactive protein (CRP) has
proven to reduce antibiotic use by helping to exclude bacterial disease in
low risk patients. The usefulness of biomarkers has not been studied in
the approach to persistent fever in the tropics.
Aim: To describe the diagnostic accuracy of CRP and PCT to identify
bacterial disease in patients with persistent fever in the tropics, with
special attention to severe bacterial illnesses.
Methods: CRP and PCT levels were determined in stored serum samples
of a prospective observational study on the causes of persistent fever
(defined as fever of one week or longer), conducted in Cambodia, Nepal,
Sudan and the Democratic Republic of Congo. Receiving Operating Char-
acteristics (ROC) curves were generated and sensitivity and specificity
were calculated for identifying any bacterial cause of persistent fever,
as well as a predefined group of severe bacterial infections for which
antibiotic treatment cannot be delayed.
Results: Among 1838 febrile patients, serum concentrations were deter-
mined in 1777 (96.7%) and 1711 (93.1%) samples for CRP and PCT
respectively. The Area Under the ROC curve (AUROC) for detecting all
and severe bacterial infections was 0.574 and 0.734 for CRP and 0.545
and 0.679 for PCT, respectively. The sensitivity of CRP at a threshold of
10mg/L (normal value) was 66.9% and 88% for all and for severe bacterial
infections, with a specificity of 42.4% and 42.7% respectively. For PCT at
a threshold of 0.1μg/L, sensitivity was 55.4% and 74.9% for all and for
severe bacterial infections, while the specificity was 52.0% and 52.6%
respectively.
Conclusion: In patients with persistent fever, the diagnostic accuracy
of CRP and PCT for identifying bacterial disease in general was low,
suggesting a lower clinical utility than in acute fever. The sensitivity was
higher in the predefined category of severe bacterial illnesses, which
could help withholding (unnecessary) immediate antibiotic treatment
when biomarker values are normal. However, randomised controlled
studies are required to assess whether reduction in antibiotic use is safe
in this group of patients.
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Introduction: Gambiense HAT (g-HAT) used to be a major public health
problem in Sub-Saharan Africa but massive control efforts resulted in a
significant decline of cases and elimination is deemed feasible by 2020.
Case management remains the main g-HAT control strategy. Currently
case detection is mainly done by dedicated teams and specialized health
centers but integration of these activities in the general health system is
needed to ensure the sustainability of elimination.
Aim: To estimate the costs and identify challenges regarding the
implementation of an integrated approach of g-HAT case detection and
treatment.
Methods: An integrated case finding system was introduced in two health
zones in the DRC. Initially 3 fixed health structures were able to perform
serological screening and parasitological confirmation. In 2016, 33 health
facilities were trained and equipped to perform g-HAT screening with
Rapid Diagnostic Tests (RDTs). Additionally, the laboratory skills of 8 larger
health centres were reinforced to increase the parasitological confirma-
tion capacity. Further a referral system was introduced. Epidemiological
and costing data was collected from a healthcare provider perspective to
estimate the average cost per person screened and treated. To examine
the robustness of the Results, sensitivity analyses were conducted on
key parameters of the baseline scenario (epidemiological data and cost
drivers).
Results: In 2018, 61,491 people visited the health structures out of
which 62% was tested for malaria. All patients testing negative and/or
presenting clinical HAT symptoms were screened for g-HAT. In total
7,668 people were tested with an RDT which led to the identification
of 100 g-HAT suspects and 3 g-HAT cases. The estimated annual cost
of the implementation of this system was 105,000$ or 14$ per person
screened for g-HAT. 87% of this cost was financed through the national
sleeping sickness program and the remaining part by the health centres
and patients.
Conclusion: These results will contribute to rational decision making
in g-HAT control and elimination programs. Furthermore, main costs
drivers are identified which can support context-based adaptions of the
approach to realize cost reductions if possible. Additionally, potential
challenges for the integration process in the health care system are
highlighted.
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Introduction: With the development and the use of tiny targets,
implementation of tsetse control in complement to the “screen and
treat” strategy has significantly impacted gambiense Human African
Trypanosomiasis (g-HAT) incidence in Guinea, Chad, Côte d’Ivoire and
Uganda. This combination of Methods, in addition to saving lives and
reducing/eliminating transmission, is easily accepted by populations that
are not anymore disturbed by tsetse bites and that are more protected
against g-HAT.
Aim: However, with the reduction of the tsetse densities together
with decrease in disease incidence, and decrease in funding when the
number of cases has gone down, the question of sustainability of vector
control operations emerges. Tsetse eradication can be contemplated in
potentially isolated areas (e.g. like the Mandoul in Chad), but in many HAT
foci tsetse populations are not isolated, e.g. in areas like the mangrove
in Guinea. In these areas, the question becomes: until when should the
vector control be maintained, and by who? If it has to be stopped, what
are the conditions to be fulfilled in before stopping?
Results: We propose here an algorithm aiming at helping decision on
tsetse control in g-HAT foci according to the incidence of HAT cases in
the focus, which consists in: 1) maintaining vector control as long as
new cases are still found, 2) decreasing vector control when number of
new cases reaches zero, but keeping a capacity of reaction to be able
to implement vector control in the vicinity of new cases, should they be
found (« reactive vector control »), and 3) stopping vector control when
no cases have been found during 5 consecutive years with similar medical
effort. Parallel to these decisions, other tools (xenomonitoring in tsetse,
monitoring in animals and tsetse densities surveillance) should be used
to help for early response if necessary, using prediction models.
Conclusion: Such an approach is useful and will give some common
guidelines for decision making, depending on the context, provided
stakeholders have the same understanding on the description/definition
of the different situations.
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Introduction: Control of gambiense-Human African Trypanosomiasis
(gHAT) has been largely based on the screening and treatment of cases.
Vector control was considered too expensive and logistically demanding
for widespread use. The development of small (25x50 cm) insecticide
impregnated targets (‘Tiny Targets’) has offered a cost-effective method
of vector control that can be combined with medical interventions.
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subspecies of Glossina fuscipes, the most important vector of gHAT,
in three different countries (Chad, DRC, Uganda) with varying agro-
ecological and epidemiological settings.
Methods: Vector control was carried out in different habitats: riparian
vegetation in the West Nile focus of Uganda, swamp in the Mandoul
focus (Chad) and degraded rainforest in Yasa Bonga Health Zone (DRC).
Monitoring of the impact of Tiny Targets on tsetse was assessed using
networks of monitoring traps (176 traps in DRC and 44 in Chad, both
deployed quarterly; 96 traps deployed weekly in Uganda). Personnel
from local communities deployed targets, largely on foot in Uganda
(6,000km2) and Chad (840 km2), and from dugout canoes in DRC
(3,000 km2). Targets were deployed biannually in Uganda (36,000
targets/year) and DRC (12,000 targets/year) and annually in Chad (2,700
targets/year). Planning, management and supervision of the operations
were conducted by local entomologists with limited external support.
Results: In all settings, >90% reduction in the tsetse populations
was achieved within three months of targets being deployed and the
reduction was sustained thereafter. Higher levels of control (>99%)
were achieved in more isolated foci (e.g., Mandoul). Targets were
deployed more rapidly when local teams were recruited and paid for
the deployment but greater acceptance of the intervention by local
communities was achieved by community-based approaches. The
economic cost of controlling tsetse in these settings was ∼$100/km2,
with lower costs being achieved in areas where tsetse were more spatially
restricted.
Conclusion: Tiny Targets offer an important means of accelerating
progress towards the elimination of gHAT. The effectiveness, low cost and
limited external support required for Tiny Targets make this technology
suitable for large-scale operations. Local communities are important
partners in the successfully use of control operations.
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Introduction: Access to quality-assured medicines is crucial for universal
health coverage, but the World Health Organization (WHO) estimates
that 10% of medicines in low and middle-income countries (LMICs)
are substandard/falsified. The WHO Pre-Qualification (PQ) Programme
guides purchasers toward quality-assured medicines in selected ther-
apeutic areas, but majority of essential medicines remain out of its
scope.
Aim: We conducted a qualitative exploratory assessment of unmet needs
of medical humanitarian/development organizations linked to Belgian
consortia, that purchase medicines for programs in LMICs.
Methods: Respondents were sampled among representatives of all the
22 organizations, members of two well-established platforms, i.e. Be-
cause Health and QUAMED. Data were collected via semi-structured inter-
views in September-October 2018. Interviews were manually coded and
allowed to identify priority unmet needs, as well as patterns emerging by
categories of respondents.
Results: 17 participants from 15 organizations were able to participate
and interviewed. The reported challenges to purchasing quality-assured
medicines were grouped into three interrelated categories: Availability
(i.e. shortages; poor stock management; regulatory or administrative
barriers); Quality Assurance (i.e. lack, or single sources, of pre-qualified
sources; lack of interest of pre-qualified manufacturers in small pur-
chasers; poor institutional awareness); and Price.
It appeared that the WHO PQ approach (based on pre-qualification of the
couple product-manufacturer) is relevant for big purchasers, including
major medical-humanitarian organizations, but is less fit to address
needs of small and medium-sized organizations, and of programmes
operating at primary health care or hospital level. These stakeholders
purchase a panoply of essential medicines and would benefit from “pre-
qualification” of distributors and procurement agencies.
It was also suggested that the scope of WHO PQ should be expanded,
e.g. to include antibiotics; medicines for noncommunicable diseases
(NCDs); and some products for tuberculosis, sexual reproductive health
and neglected tropical diseases.
Conclusions: Only organizations with strong institutional awareness and
significant investments in QA systems seem able to use the WHO PQ list
adequately and consistently. However, most organizations in our sample
would benefit from the WHO PQ expansion to new areas, in particular
antibiotics and medicines for NCDs; and from public, reliable information
on distributors/wholesalers that supply pre-qualified products at fair and
transparent pricing policy.
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Introduction: Hypertension (HTN) control is a major obstacle among
sub-Saharan African populations partly due to poor self-management.
Aim: We explore and compare how one’s social and physical context
shapes their illness representations regarding HTN and the coping
strategies they develop and adapt to mitigate challenges in self-
management.
Methods: A cross sectional multisite qualitative study using semi-
structured interviews among 55 Ghanaians with HTN living in The
Netherlands and urban and rural Ghana. A thematic approach was used
in data analysis.
Results: Family HTN history, personal experiences with HTN and
outcomes of using biomedical and traditional treatments shaped
participants illness representations and coping strategies. Migrants and
urban non-migrants modified medication schedules and integrated
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effects of taking antihypertensive medication. Rural non-migrants
used traditional remedies and medicines to mitigate antihypertensive
medication side effects and/or to cure HTN.
Conclusion: Contextual factors within person’s social and physical
environments shape their illness representations and coping strategies
for HTN though interactive phrases. How patients understand the
permanence of HTN, the risk implications of having HTN are for them
and their use of alternative remedies in order to identify those for whom
personalized educational and motivational efforts might improve anti-
hypertensive medication acceptance and long-term adherence. Health
professionals should also harness the relationships within peoples’ social
and physical environments, encourage implementation of family wide
behavioural changes and involve family relatives in HTN treatment to
enhance patients’ self-management of HTN.
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Background: Per United Nations 2030 Sustainable Development Goal
aspirations, Indonesia has since 2014 been implementing a Universal
Health Coverage (UHC) scheme that covers family planning (FP) services.
No prior studies examine the impact of health insurance on contraceptive
use in low- and middle-income countries. This study sought to assess
progress in providing insured women with access to free FP services and
the correlates thereof.
Method: We analyse the experiences of 3,707 married women who used
modern contraception at the time of the Indonesian 2015 Performance
Monitoring and Accountability 2020 survey and had received FP services
in the 12 months prior to the survey. We assessed type of payment
(insurance vs. out-of-pocket) for FP services in relation to health insurance
coverage, contraceptive method, type of health facility, and respondent
background characteristics. Logistic regression was used to assess net
effects of the factors considered.
Results: Although 51% of study subjects were covered by some form of
health insurance, the member of BPJS and JAMKESMAS/DA were 19.2%
and 21.4% of them received free FP services. While insured women
were 2.5 times likely to have received free services than non-insured
women, only about 20% of insured women avoided out-of-pocket pay-
ments. Receipt of free services was far more likely with public sector
service providers and when long-acting contraceptive Methods were
chosen. Other factors influencing receipt of free services included par-
ity, level of informed choice, and residence (urban vs. rural; inner vs.
outer islands).
Conclusions: The findings are indicative of the issues that many countries
will have to address in trying to reach SDG goals with regard to UHC
and reproductive health, especially countries with sizeable private sector
participation in providing family planning services and countries with
decentralized systems of government. If service delivery is dominated by
the private sector and financed largely by out-of-pocket payments, then
moving to free services under UHC will be challenging for FP programme.
Future research on how countries are choosing to address these issues
and the relative success of alternative approaches will be important. This
topic is virtually certain to be one of high interest in the post-FP2020
agenda.
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BEYOND 2020 WITH NEGLECTED TROPICAL DISEASES: LEAV-
ING NO ONE BEHIND IN THE JOURNEY TO 2030
on behalf of and with Uniting to Combat NTDs Equity Working
Group: Simpson S.J.1,2, Ducker C.3, Dean L.4
1EquiACT, Lyon, France;
2University of NSW, Australia;
3Uniting to Combat NTDs, Haywards Heath, West Sussex;
4Liverpool School of Tropical Medicine, Liverpool, UK
Efforts to combat neglected tropical diseases (NTDs) reached a turning
point in 2007, when the World Health Organization (WHO) convened
the first meeting of global partners. That meeting produced a shared
commitment to support WHO strategies and goals by working together
in an innovative, flexible and cost-effective way leading to the WHO 2020
Roadmap on NTDs in 2012. The Roadmap in turn inspired the London
Declaration which calls on all endemic countries and the international
community to join in a commitment to provide the resources necessary
across sectors to lift over one billion people from the heavy burden that
NTDs continue to place on their lives. In January 2016, the 17 Sustainable
Development Goals (SDGs) reaffirmed the commitment to the control and
elimination of NTDs in relation to goals (1,3 and 6). In July 2016, a Uniting
to Combat NTDs: Women and Girls in Focus meeting was held in London
and from this a working group on Gender and Equity was established
to ensure more attention to gender analysis in research, policy and
programming. The group which is formed of members from researchers,
donors and implementers, strives to strengthen collaboration and
learning about how to strengthen equity and inclusiveness in NTD policy
and programmes.
By 2030, with the SDGs that universally apply to all, countries are
expected to have mobilized efforts to end all forms of poverty, fight
inequalities and tackle climate change, while ensuring that no one is
left behind. As part of efforts to ensure no one is left behind in the
prevention and treatment of NTDs, a range of activities are taking place
to support countries in monitoring and assessing who is being left behind
and why. Using these data, we will have to creatively address gaps to
achieve our goals in 2030.
This interactive session seeks to bring together implementers, donors,
researchers and activists to review experiences on the relationship of
GER to the implementation of NTD programs, the data required, and
how utilizing a GER lens can contribute to more effective coverage and
accessing harder to reach and vulnerable groups, both in preventive
chemotherapy (PC) and innovative and intensified disease management
(IDM) NTDs. We are keen however to learn from participants with
experience in strengthening equity and inclusiveness in delivery of
interventions and programmes for other conditions such as malaria
or AMR.
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ELEARNING SOLUTION FOR CAPACITY STRENGTHENING OF
HEALTH PROFESSIONALS: THE EXPERIENCE OF GUINEA
Delvaux T.1, Delamou A.1,2, Millimouno M.2, Kourouma K.2, Kolié
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1Institute of Tropical Medicine, Antwerp, Belgium;
2Centre National de Formation et Recherche en Santé Rurale de
Maferinyah, Forécariah, Guinea
Introduction: There is a need for capacity strengthening of health pro-
fessionals in public health and sexual and reproductive health and rights
(SRHR) in Guinea.
Objective: To describe and discuss an innovative training program in
Guinea.
Methods: Two online courses namely on Primary Health care (eSSP) and
Management of SRHR services (eSSR) were developed in French by the
Research Centre in Rural Health (CNFRS) Maferinyah in Guinea with the
support of the Institute of Tropical Medicine (ITM), Antwerp in 2017.
Moodle Platform was used to deliver, manage the two courses and
generate course statistics.
Results: eSSP and eSSR courses included 7 and 8 modules, running over
a total of 10 and 11 weeks, respectively. Six cohorts of an average of
25 participants from all regions in Guinea were trained in 2018. Lessons
learnt through the first cohort were used to refine both courses. Results
from the six cohorts showed that of the 135 participants enrolled in the
eSSP course, 22% (n = 30) were from other countries other than Guinea
and women accounted for 21% (n = 29). Regarding the professional back-
ground, 75% were medical doctors, 7% nurses, 7% graduated medical
students. The number of participants having completed the eSSP course
was 92, of which 63 (68%) validated it and received a certificate. Of the
147 participants enrolled in the eSSR course, 21% (n = 31) were from
countries outside Guinea and women made up 33% (n = 49). In terms of
professional background, the majority were physicians (71%), 5% were
nurses, 7% (n = 10) were midwives and 7% were medical graduates. The
number of participants who completed the eSSR course was 100, of which
93 (93%) validated and got a certificate.
Conclusion: This innovative training program targeting health profession-
als showed that it is feasible to deliver online courses even in far to reach
settings in Guinea. Involving women in elearning courses remains one of
the challenges.
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BREAKING TRANSMISSION FOR SCHISTOSOMA MANSONI:
DETERMINING POST-TREATMENT SURVEILLANCE CRITERIA
FOR DETECTING ELIMINATION
Toor J.1,2, Truscott J.E.1,2,3, Werkman M.1,2,3, Turner H.C.4,5,
Phillips A.E.1,2, King C.H.6, Medley G.F.7, Anderson R.M.1,2,3
1London Centre for Neglected Tropical Disease Research, Dept.
of Infectious Disease Epidemiology, St Mary’s Campus, Imperial
College London;
2MRC Centre for Global Infectious Disease Analysis, Dept. of Infec-
tious Disease Epidemiology, School of Public Health, Faculty of
Medicine, St Mary’s Campus, Imperial College London;
3The DeWorm3 Project, The Natural History Museum of London,
London, UK;
4Oxford University Clinical Research Unit, Wellcome Trust Major
Overseas Programme, Ho Chi Minh City, Vietnam;
5Centre for Tropical Medicine and Global Health, Nuffield Dept. of
Medicine, University of Oxford, Oxford, UK;
6Center for Global Health and Diseases and Dept. of Mathematics,
Case Western Reserve University, Cleveland, USA;
7Centre for Mathematical Modelling of Infectious Disease, London
School of Hygiene and Tropical Medicine, London, UK
Introduction: The World Health Organization has set elimination
(breaking transmission) as the end goal for schistosomiasis. However,
there is currently a lack of guidance on what programmes should do
once very low prevalence levels have been reached to determine whether
elimination or recrudescence of the disease will occur after stopping
treatment.
Aim: To determine the surveillance criteria for detecting whether
elimination or recrudescence of Schistosoma mansoni will occur after
stopping treatment.
Methods: We use a stochastic individual-based model of Schistosoma
mansoni transmission and treatment impact to determine a prevalence
threshold which can be used to determine whether elimination
or recrudescence will occur. We use Kato-Katz as the diagnostic
technique. We calculate positive predictive values (PPV) to determine
reliable certainty measures for detecting elimination. We show when
post-treatment surveillance should be carried out and how many
individuals should be sampled.
Results: We find that a prevalence threshold of 1% by Kato-Katz is
optimal for detecting elimination at two years (or later) after the last
round of treatment using a sample size of 200 individuals across the
entire community (where the community size is 500-1000 individuals).
Conclusion: A prevalence threshold of 0.5% is sufficient for surveillance
6 months after the last round of treatment. However, as such a low
prevalence can be difficult to measure in the field, we recommend using
1% 2 years after the last round of treatment (with a sample size of 200
individuals). For treatment programmes where elimination is highly likely,
higher prevalence thresholds can be used but require waiting longer for
post-treatment surveillance.
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IMPACT OF POPULATION MOVEMENT BETWEEN VILLAGES
ON THE LIKELIHOOD OF BREAKING TRANSMISSION OF SOIL-
TRANSMITTED HELMINTHS
Vegvari C.1,2, Truscott J.1,2, Kura K.1,2, Hardwick R.1,2, Anderson
R.M.1,2
1London Centre for Neglected Tropical Disease Research (LCNTDR);
2Dept. of Infectious Disease Epidemiology, Imperial College Lon-
don, UK
Soil-transmitted helminth (STH) infections affect predominantly socio-
economically disadvantaged populations in sub-Saharan Africa, East Asia
and the Americas and are commonly treated by preventive chemother-
apy. Once cleared individuals can become re-infected. In recent years,
there has been increasing interest in whether it is feasible to break trans-
mission of STHs by mass drug administration (MDA). Detailed mapping
data from the TUMIKIA study and DeWorm3 trial suggest a high level
of heterogeneity in infection prevalence and intensity within implemen-
tation units. Treatment coverage and individual compliance are also
expected to vary in most endemic regions. Spatial heterogeneity in dis-
ease prevalence in combination with human population movement have
been recognised as important drivers for ongoing transmission in malaria,
dengue and neglected-tropical diseases, for example, trachoma and
human African trypanosomiasis. Given the heterogeneity in the distribu-
tion of STH infections, human movement patterns are likely to play a role
in the transmission of STHs between different spatial units. The impact
of infected individuals moving between locations on disease prevalence
is likely to become more important as local populations move towards
STH elimination. Here we examine how human population movement
affects the outcome of MDA programmes, using a stochastic individual-
based metapopulation model. We show that the risk of re-introduction
of infection depends on the age group of moving individuals and STH
species. If a village is infection-free, an annual movement rate of 2-
3% from an infected source village imposes a risk of re-introduction of
STH of 75% or higher. Planning for STH elimination programmes should
account for human mobility patterns. We recommend that individuals
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ventive chemotherapy for STHs. This can most easily be implemented
if migration is seasonal and overlaps with treatment rounds, e.g. sea-
sonal migrant labour. In areas where there is substantial cross-border
movement, STH programmes should be co-ordinated among countries.
Transmission hotspots in or near treatment clusters should be eliminated,
for example, by implementing appropriate WASH measures and targeting
treatment to individuals living in hotspots.
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HISTORICAL PERSPECTIVE ON HUMAN AFRICAN TRYPANOSO-
MIASIS (HAT) IN THE DEMOCRATIC REPUBLIC OF THE CONGO
Miaka E.M.1, Boelaert M.2, Mpanya A.1
1PNLTHA, Kinshasa, DRC;
2Dept. of Public Health, ITM, Antwerp, Belgium
Introduction: The Democratic Republic of Congo (DRC) is currently the
epicentre of HAT and reports more than 85% of all cases worldwide. To
reach the global elimination goal, specific challenges in DRC need to be
understood and addressed.
Aim: Provide overview on HAT and its control in DRC from colonial times
to the present.
Methods: Review of literature and historic program records.
Results: In the 1960s, the disease was almost eliminated, but in the
early years of independence of the former Belgian colony, HAT cases
increased steadily leading to a major peak with more than 25,000 cases
reported in 1998 alone. This evolution led to renewed Belgian support to
the Programme National de Lutte contre la Trypanosomiasis Humaine
Africaine (PNLTHA) of DRC, first through an emergency programme
implemented by three NGOs, then for about 15 years via the Belgian
Technical Cooperation (BTC) and recently through the Institute of Tropical
Medicine Antwerp (ITM). Other agencies joined forces to introduce
diagnostic and therapeutic innovation, and recently an investment in
innovative vector control was made. The result was a sharp decline in the
annual number of diagnosed cases.
Conclusion: Though the numbers of HAT cases detected in DRC has
substantially declined, and the elimination threshold seems within
reach, there are major challenges ahead. Adaptive management,
improved surveillance and continued innovation seems to be the way
forward.
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OUTCOMES OF THE HAT ELIMINATION EFFORTS IN DRC
Verlé P.1, Mpanya A.2, Hasker E.1, Snijders R.1, Inocencio da Luz
R.1, Boelaert M.1, Miaka E.M.2
1Dept. of Public Health, ITM, Antwerp, Belgium;
2PNLTHA, Kinshasa, DRC
Introduction: Since 2016 a consortium of scientific institutes supports
the national HAT control program of DRC in its elimination efforts. This
consortium benefits of the generous support of the B&M Gates founda-
tion and the Belgian government. A number of innovations have been
introduced at scale in three endemic provinces, formerly known as Ban-
dundu Province. A door-to-door screening approach, a digitized data
capture, use of rapid diagnostic tests in health facilities, mapping and
microplanning of activities and quality assurance system are part of
the package. In addition, the potential of a sero-surveillance model is
currently being assessed to timely detect a new outbreak and ensure
sustained elimination of HAT.
Aim: To analyse the outputs and outcome of recent innovative HAT
control efforts.
Methods: Compare results of improved active screening through mobile
teams and Results of enhanced passive detection of HAT in health facili-
ties over the last 3 years in the previous Bandundu Province.
Results: The combination of improved active detection and enhanced
detection in health facilities resulted in increased decline of the number
of HAT cases detected. However, the active screening approach through
mobile teams, has its limitations and becomes harder to justify. On
the other hand, with available tools, also the enhanced integration in
the primary health care system is insufficient to reach elimination of
transmission because of accessibility problems and low attendance rates.
Sero-surveillance could provide a solution for continuous surveillance
by screening a large amount of people in their village with minimal
discomfort.
Conclusion: Available strategies proved to be effective but with dwindling
case numbers, new challenges emerge and new strategies are required.
Further integration in the primary health care system is essential, while
the HAT control programme could serve as leverage to improve the
system itself.
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DESCRIPTION OF A PUBLIC HEALTH PROJECT AIMED TO
IMMIGRANT POPULATION: SALUD ENTRE CULTURAS (SEC)
PROJECT
Chamorro S.
National Referral Unit for Tropical Diseases, Infectious Diseases
Dept., Ramón y Cajal University Hospital, Madrid
Introduction: The growing flow of migration into Europe persists. Just
in 2017, 171,635 immigrants and refugees arrived in Europe from
North Africa via Mediterranean routes. Immigrants face many obstacles
to access essential health-care services due to a number of factors,
including their irregular status, language barriers and lack of health
policies.
Aim: Description and evaluation of a public health project specifically
aimed at and adapted to the immigrant population: the Salud Entre
Culturas (SEC) project, linked to the Tropical Medicine Centre at Ramón y
Cajal University Hospital in Madrid, Spain.
Methods: SEC is implemented through three main programs:
(1) New Citizens New Patients (since 2006) - Health education workshops
on communicable diseases (HIV, STIs, TB, Chagas Disease (CD), Scabies),
Spanish Health System and maternal and child health.
(2) Silent Disease Screening Campaigns (since 2014) - Screening test for
CD and HIV.
(3) Building Bridges: Managing cultural diversity in health services (since
2006)- Accompaniment, interpretation and intercultural mediation in
medical practice and training programs as professional mediators aimed
at people of immigrant background.
Results: A total of N=20307 immigrants have been beneficiaries up to
2018:
(1) N=11285 immigrants attended NCNP workshops
(2) N=2119 were screened for CD with a prevalence of T cruzi infection of
19.15%. N=504 were tested for HIV (2017 campaign) with a prevalence
of 0.8%.
(3) N=6841 immigrants have benefited from the interpretation and
mediation service and N=22 have been trained as professional
mediators.
Conclusion: SEC project represents an initiative and a driving force
for health access, training and health education. Thus, the growing
number of users participating in its three programmes support the fact
that projects of this nature are more necessary than ever in a reality
where social inequalities and access barriers to the health system have
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BARRIERS TO FACILITY-BASED DELIVERY IN POST-EBOLA
SIERRA LEONE
Theuring S.1, Koroma A.P.2, Harms G.1
1Institute of Tropical Medicine and International Health, Charité-
Universitätsmedizin, Berlin, Germany
2Dept. of Obstetrics and Gynecology, Princess Christian Maternity
Hospital, Freetown, Sierra Leone
Introduction: Sierra Leone has one of the highest maternal mortal-
ity rates in the world. Encouraging the use of skilled birth attendance
in health facilities is an important step in the endeavor to increase
the number of safe deliveries. However, public trust in health facili-
ties has greatly been damaged during the Ebola epidemic outbreak
in Sierra Leone in 2014/2015, and little is known about specific barri-
ers to facility-based delivery (FBD) in the country after recovering from
Ebola.
Aim: Our aim was to analyze intrinsic and extrinsic barriers to FBD among
women in Freetown, Sierra Leone, in order to develop strategies increasing
the use of skilled birth attendance.
Methods: We conducted a qualitative study on FBD in Princess Christian
Maternity Hospital, Freetown, which is the national referral maternity
hospital in Sierra Leone. We performed six focus group discussions with
a total of 35 providers, pregnant women and recent mothers, pertaining
to experiences, attitudes and behaviors regarding FBD and potential bar-
riers. Discussions were tape recorded, transcribed and evaluated through
content analysis.
Results: Women in our study were overall technically aware of the higher
safety linked with FBD, especially in medical emergencies during delivery.
However, this awareness largely diverged from their individual desire to
deliver in a supportive and trusted social and traditional environment,
involving close family members. Relatives and community members
seemed to be highly influential regarding birth practices. Many women
associated FBD with negative staff attitudes and a fear of being left
alone. Logistic issues regarding transportation problems or late referral
from smaller health centers were identified as frequent structural barriers
to FBD.
Conclusions: Improving general staff attitudes, and allowing a deliv-
ering woman to bring a trusted accompanying person to support her
during labor could be promising approaches to increase women ´s con-
fidence in FBD. However, these approaches also imply revising health
systems structures, like working conditions of overloaded hospital staff
that are conducive for a friendly atmosphere, sufficient space in delivery
wards allowing the women to bring a birth companionship, or like the
establishment of a reliable peripheral ambulance system to ensure trans-
portation and fast referral.
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EFFECT OF PREOPERATIVE BICARBONATE INFUSION ON
MATERNAL AND PERINATAL OUTCOMES OF OBSTRUCTED
LABOUR IN MBALE REGIONAL REFERRAL HOSPITAL - A STUDY
PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL
Musaba W.M.1, Barageine J.K.2, Ndeezi G.3, Wamono F.4,
Wandabwa J.N.5, Weeks A.D.6
1Dept. of Obstetrics &Gynaecology, Busitema University/Mbale
Regional Referral Hospital, Mbale;
2Dept. of Obstetrics & Gynaecology, School of Medicine Makerere
University College of Health Sciences, Kampala;
3Dept. of Paediatrics and Child Health, School of Medicine Makerere
University College of Health Sciences, Kampala;
4School of Statistics & Planning Makerere University College of
Business & Management Sciences, Kampala;
5Dept. of Obstetrics &Gynaecology, Busitema University Faculty of
Health Sciences, Mbale, Uganda;
6Sanyu Research Unit, University of Liverpool/Liverpool Women’s
Hospital, Liverpool, UK
Background: To improve maternal and fetal outcomes among patients
with obstructed labour (OL) in low resource settings, the associated
electrolyte and metabolic derangements must be adequately corrected.
Oral fluid intake during labour and preoperative intravenous fluid replace-
ment following OL corrects the associated dehydration and electrolyte
changes, but it does not completely reverse the metabolic acidosis that
is a cause of intrapartum birth asphyxia and a risk factor for primary
postpartum haemorrhage due to uterine atony.
Sodium bicarbonate is a safe, effective, cheap and readily available acid
buffer that is widely used by sportspeople to improve performance. It
also appears to improve fetal and maternal outcomes in abnormally
progressing labour. However, its effects on maternal and fetal outcomes
among patients with OL is unknown.
Aim: To establish the effect of a single dose preoperative infusion of
sodium bicarbonate on maternal and fetal lactate levels and clinical
outcomes among patients with OL.
Methods: This will be a double blind, randomised controlled clinical phase
IIb trial. We will randomize 478 patients with OL to receive either 50
mls of placebo with standard preoperative infusion of Normal Saline
(1.5 L) or 4.2 g of sodium bicarbonate solution (50 mls of 50 mmol/L)
with the preoperative infusion of Normal Saline (1.5 L). The primary
outcome will be mean lactate levels in maternal capillary blood at one
hour after study drug administration and in the arterial cord blood at
birth. We will use the intention to treat analysis approach. Secondary
outcomes will include safety, maternal and fetal morbidity and mortal-
ity up to 14 days postpartum. Makerere University School of Medicine
Research and Ethics Committee and Uganda National Council for Sci-
ence and Technology have approved the protocol. Each participant will
give informed consent at enrolment. The trial registration number is
PACTR201805003364421.
Discussion: If it is safe and effective in reducing maternal and fetal
lactatemia (acidosis) among patients with OL, then the data from this
trial will inform the design of future trials that will facilitate the inclusion
of sodium bicarbonate infusion in the standard preoperative care for
patients with OL in low resource settings.
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“IT ´S AN OBSOLETE PRACTICE”: PERCEPTIONS OF SYMPHYS-
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1Research Group for Global Health Anthropology, Center for
International Health, Dept. of Global Public Health and Primary
Care;
2Dept. of Clinical Science, University of Bergen, Norway;
3Dept. of Gynecology and Obstetrics, Jimma University Hospital,
Ethiopia
Introduction: Eight percent of all maternal deaths are caused by
obstructed labor. Cesarean section is the standard procedure for
obstructed labor globally, but it is not widely accessible in low-income
settings leaving mother and child at risk. Symphysiotomy is an alternative
emergency obstetric intervention, but the procedure is not well known
and is surrounded by negative connotations. There is insufficient evidence
on how symphysiotomy may function as a lifesaving procedure in
contexts where cesarean section is not accessible.
Aim: The aim of this study was to explore health workers perceptions
on symphysiotomy, and the feasibility of carrying out further studies
assessing symphysiotomy as an alternative emergency obstetric
intervention in areas where cesarean section is inaccessible.
Methods: A formative qualitative study based on semi-structured in-
depth interviews with 35 urban and rural health workers was carried out
in the North Gondar Zone, Amhara region, northwest Ethiopia. University
of Gondar Hospital was the main site of the study.
Results: Symphysiotomy was an unfamiliar medical procedure to most
of the informants, and none of the informants had practical experience
carrying out the procedure. Symphysiotomy was perceived as outdated
by hospital health workers and had been presented as an obsolete and
harmful practice during their medical training. Rural health workers
were less skeptical, and also a few of the hospital staff commented
on symphysiotomy as a potential alternative lifesaving procedure that
could reduce unacceptable referral complications and maternal deaths.
There was a general call for more research-based knowledge on the
procedure.
Conclusion: The study revealed substantial ambivalence towards
symphysiotomy, hospital staff being most skeptical. Although there was
a stated interest in more evidence on the procedure, the substantial
reluctance encountered among hospital staff makes it difficult to
conduct further studies at the research site. The study brings to
the forefront of attention ethical dilemmas related to a potential
introduction of a medical procedure that may save mother and child
but is presently viewed as a second-best option in global maternity
care.
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ONCHOCERCIASIS-ASSOCIATED EPILEPSY: THE EPIDEMIOLOG-
ICAL EVIDENCE
Siewe Fodjo J.N.1, Menon S.1, Hotterbeekx A.1, Basanez M.G.2,
Colebunders R.1
1Global Health Institute, University of Antwerp, Antwerp, Belgium;
2London Centre for Neglected Tropical Disease Research, Imperial
College London, London, UK
Introduction: The relationship between onchocerciasis and epilepsy has
been subject to debate by the scientific community. There is a need to
investigate a possible association between both conditions in the light of
recent findings.
Aim: To provide up-to-date scientific evidence regarding onchocerciasis-
associated epilepsy (OAE).
Methods: We analysed peer-reviewed papers, abstracts presented at
international conferences, and grey literature including all study designs.
The available evidence was reviewed against the Bradford Hill criteria.
Results: Cross-sectional studies as well as case-control studies and
a meta-analysis demonstrated the strength of association between
epilepsy status and the presence of Onchocerca volvulus microfilariae
(mf) or antibodies. Furthermore, a biological gradient and temporality
between mf load and the risk of developing epilepsy were demonstrated
in a cohort study in Cameroon, with risk ratios of up 28.5 for children
having >200 mf per skin snip to develop OAE later in life. There is
additional evidence supporting the specificity, consistency, coherence
and plausibility of this association; indeed, OAE was observed to be
highly prevalent in onchocerciasis-endemic areas with sub-optimal
control measures in Cameroon and South Sudan, starting between
the ages of 3 and 18 years, with typical clinical aspects including
nodding syndrome, and in the absence of other epileptogenic tropical
diseases like neurocysticercosis. Conversely, epilepsy incidence drastically
reduced after strengthening onchocerciasis elimination programs in
Northern Uganda (Kitgum and Pader), and Nigeria (Imo river basin).
Notwithstanding, a few case-control studies did not report such an
association most likely due to the methodological approach used and
increased ivermectin coverage which had probably depleted the mf load
in most participants. A common mechanism of molecular mimicry was
suggested for both onchocercal retinopathy and seizure-causing cerebral
lesions in OAE, thus fulfilling the criteria for analogy. Experimental
evidence was weakest; mf had been detected in human cerebrospinal
fluid decades before the worldwide institution of mass treatment with
ivermectin, but not in recent studies.
Conclusion: Overall, applying the Bradford Hill criteria suggests strong
epidemiological evidence that infection with O. volvulus may cause
epilepsy, including nodding syndrome. However, the pathophysiological
mechanisms remain elusive.
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CARING FOR PATIENTS SUFFERING FROM FILARIAL INFEC-
TIONS: LESSONS FROM LYMPHATIC FILARIASIS PROGRAMMES
D Mackenzie C.D.1, Mandara W.L.2, Kristnastry S. 3, Malecela
M.N.4
1NTDSC, Task Force for Global Health, Atlanta, USA;
2NIMR, Dar es Salaam, Tanzania;
3Govt. T D Medical College, Alappuzha, Kerala, India;
4NTD, WHO, Geneva, Switzerland
Introduction: Patient care is a major component for defining success in
the lymphatic filariasis (LF) elimination programme - this is not the case
any of the other major filarial disease programme, the onchocerciasis
elimination programme, despite the fact that there is still considerable
morbidity associated with the latter infection.
Aim: To use the lessons learnt from the LF Programme to develop
approaches for caring for those suffering from onchocerciasis.
Methods: Compare the underlying aetiologies, the different medical
needs and treatments, as well as the differences and commonalities,
and develop a field approach to providing care for those suffering from
onchocerciasis and other filarial conditions.
Results: The different pathogeneses of filarial infections underscore the
need for focused treatment protocols in many instances, nevertheless
there are also many commonalties, and the experiences from the LF
Programme can inform onchocerciasis and other programmes and create
and improve the provision of care to the affected individuals. To do this
it is important to consider the range of areas associated with providing
patient care i.e. clinical presentations and needs, quality of life, supportive
care, and rehabilitation.
Conclusion: Although each filarial infection has its own individual
characteristics many commonalities exist and this can allows for the
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approaches taken by the LF Programme to ensure that care is provided
for lymphoedema and hydrocele patients can provide lessons for other
filariasis disease programmes, including the global onchocerciasis pro-
gramme. Understanding the pathogenesis of the different presentations
is fundamental to providing the best care for these patients.
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SAFE MOTHERHOOD REVOLVING FUNDS - ARE THEY REALLY
LIFE-SAVERS FOR THE POOR? PRACTICES AND IMPACT IN
NEPAL
Baral K.1, Kshetri R.2, Gautam A.2, Paudel G.2, Khadka R.2,
Gautam P.2, Rana S.2
1Swiss Red Cross, Country Coordination Office, Kathmandu;
2Nepal Red Cross Society, Community Empowerment for Health
Promotion Program, Nepalgunj, Nepal
Introduction: The Swiss Red Cross in collaboration with the Nepal Red
Cross Society implemented Safe Motherhood Revolving Funds (SMRF)
within the MNCH project. The funds are raised and operated by local
Health Mothers groups (HMGs).
Aim: This study enhances the understanding of the functionality of these
community based revolving funds for safe motherhood and its potential
for scale-up and integration in Government programme/policy.
Methods: A mixed method approach with quantitative and qualitative
Methods was applied, using a semi-structured questionnaire survey and
physical observation in health mothers groups (n=66), 14 Focus Group
Discussions (n≈200) and key informant interviews (n=32). The research
took place between November 2017 and March 2018 in five districts of
rural Nepal.
Results: 94% of all Health Mothers Groups (HMGs) under study do
monthly revenue collection and maintain separate register for record
keeping. However, only 32% of the groups maintain a bank account
and only 32% of groups receive financial contributions outside their own
members. While the majority of groups disseminate the safe motherhood
fund regularly in their community, only 44% of the HMGs support
women who are non-members. All groups reported that members solely
decide among themselves about the interest rates, administration and
distribution of the fund to eligible women. All respondents from the
interviews unanimously stated that the funds are distributed to the poor
and vulnerable. However, more than half of the HMG (57.6%) are also
utilizing the fund for issues other than safe motherhood. In all groups
the fund utilization has increased from 17 women in the first year to 456
in the second year. District health authorities reported their appreciation
and interest towards scaling up and integrating SMRFs in the government
health programme.
Conclusion: The SMRF has been successfully continued and self-managed
by the HMGs. There remains scope to increase access to the funds by
including non-HMG members and by enhancing local fundraising from
sources outside the group. This encourages increased participation from
women, who cannot contribute financially to the fund. The funds are an
important vehicle for improved health care seeking. Their scale up and
development of national policy or guidelines is encouraged.
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PALESTINE: A QUALITATIVE STUDY
Abu Khader K.1, Bungudo B.B.2,3, Baniode M.1, Frost K.4, Frost
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Introduction: Performance feedback (PFB) is used to enable health
professionals to assess and improve the quality of health care, and works
better in enhancing adherence to clinical guidelines. Automating PFB
to care providers through a nationwide electronic registry would bring
benefits to the health system. PFB is more effective when it is theory-
driven and combined with quality improvement training.
Aim: Is to describe the development and implementation of a theory-
driven PFB dashboard to care providers as a digital health intervention
automated from the electronic maternal and child health registry (MCH
eRegistry) at primary healthcare in Palestine.
Methods: We carried out interviews and focus group discussions with
healthcare providers, supervisors and Ministry of Health employees
to map and understand the current feedback procedures, and care
providers’ perceptions of feedback. Guided by the Model of Actionable
Feedback and systematic reviews, we iteratively co-designed the PFB
dashboard with the users. We trained healthcare providers in using
the dashboard to identify quality gaps, set and monitor targets and
use recommended “actions” from the dashboard for improvement. The
“actions” was developed in dialog with nursing and medical directors.
Results: The feedback to healthcare providers were mainly restricted
to irregular supervision visits from supervisors. The feedback was done
based on predefined items, and not individualized. Some healthcare
providers described the visits as a punitive evaluation. Overall healthcare
providers were not satisfied with the frequency and content of the
feedback. The co-designing with the users made possible to develop
a PFB dashboard they recommended to have. The PFB dashboard is
continuously available, private and not disclosed with supervisors. It
prompts the healthcare provider with “actions” written in a friendly
language. The data and “actions” are made easy to understand and
individualized based on the healthcare providers’ performance.
Conclusion: The theory-driven PFB dashboard; which is considered as
one of the strategies used to improve clinical practice among health care
providers; co-designed with users, is automated from the MCH e Registry
to care providers. Its effectiveness is being put to randomized control trial
in 140 clinics in the West Bank and Gaza.
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ASSESSING THE TRANSLATION OF NATIONAL LEVEL POLICIES
AND STRATEGIES TO ADDRESS STILLBIRTH AT SUBNATIONAL
LEVEL IN UGANDA
Ssegujja E.1,3, Ddumba I.2, Andipartin M.3
1Makerere University School of Public Health, Kampala;
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3University of Western Cape, South Africa
Introduction: Decentralization of health services has placed subnational
implementers as key players in translation of policies into practice. With
Global campaigns towards addressing stillbirth gaining momentum at
the close of the MDG era, subsequent translation have seen concerted
efforts at multi-level governance strata from national by formulating
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translation of these policies. However due to implementation complexes,
translation often times differ from the policy intent with health systems
capacity playing a vital role. No study has analyzed the extent to which
policies intended to address stillbirths have been translated into service
provision. By analyzing the subnational level implementation processes,
this study sought to document the translation of national policies to
address stillbirths.
Methods: This was a cross sectional descriptive study conducted in
a single case district with relatively high stillbirth rates in Uganda.
Qualitative interviews were conducted on a purposively selected sample
of 15 key informants comprising of the health workers, facility and
district managers. Data was collected using digital audio recorders
and transcribed verbatim with content analysis done using Atlas ti a
qualitative data management software.
Results: Overall although stillbirth was a felt problem, policy implemen-
tation was selective at subnational level where aspects easily adopted
being characterized by support and embedded within existing service
delivery such as perinatal death reviews within the MPDR activities and
fused in existing facility CQI activities. Facility specific initiatives like
group ANC counseling/peer support, agreeing on MPDR recommendations
before notification to DHO and MoH implemented for self-improvement
also supported policy translation. Enforcement was constrained by
inadequate human resources, focus on maternal mortality and less
on stillbirths, a lack of a Behavioral Change Communication strategy
for meaningful engagement with the community, deferral of hard to
implement recommendations to higher authority. Implementing partner
support was identified as key in policy translation which ranged from
commodities and equipment supply to human resource capacity building
and support to data transmission. Window of opportunity took advantage
of the World Bank’s Results Based Financing program to integrate MPDR
as one of the output indicators of focus.
Conclusion: Beyond formulation of the policies, there is need to
match it by strengthening the existing health system to deliver policy
recommendations. Opportunities remain with engagement of health
partners who in this case bridged the implementation gaps that couldn’t
be addressed by government calling for more coordinated efforts at the
subnational level if policy objectives are to be realized.
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A HISTORIC COHORT OF OLD CASES OF MALNUTRITION IN
CHILDHOOD IN THE CONTEXT OF EASTERN DR CONGO: A GREAT
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1Regional School of Public Health (ERSP), Université Catholique de
Bukavu, Bukavu, DRC;
2Research Center ‘Politique et Systèmes de Santé-Santé Interna-
tionale’, Université Libre de Bruxelles, Brussels, Belgium;
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4Institute of Health and Society (IRSS), Université Catholique de
Louvain, Brussels, Belgium
Introduction: Malnutrition has been endemic in South Kivu since the
1960s. The Lwiro Hospital was among the first structures that were
involved in the management of malnutrition. This Hospital has a database
of children who were previously treated for severe acute malnutrition
from 1988 to 2007. Unfortunately, there is no data based on long-term
outcomes following discharge from severe acute malnutrition (SAM)
treatment in DRC.
Aim: Our aim was to follow up patients over 15 years after their treatment
for SAM and to describe the longer-term mortality.
Methods: A total of 1981 medical files were extracted from the
data management unit of Lwiro Hospital and set up as the baseline
sample size. The median age at admission was 41 months. Children’s
anthropometry at admission was adapt to the current WHO curves. From
December 2017 to June 2018, we proceed to the tracing of the former
malnourished. For deceased subjects, community health workers asked
for the cause and year of death.
Results: On this day, 693 are alive in the area with a mean age of 23 years
old, 201 dead, 441 displaced and 646 not found. For all-cause deaths,
association stunting and acute malnutrition was responsible of 85,6 %,
with men accounting for about two-thirds of deceased. About 3/4 of the
deceased had an outdated immunization Schedule. About two-thirds of
deaths occurred before subjects celebrated their tenth birthday and that
more than half of deaths occurred within 5 years after admission, with
a crude mortality rate of 8.36 deaths per 1000 person-years. Infectious
diseases were the common cause of death followed by malnutrition.
Diabetes accounted for 5% of deaths.
Conclusion: A follow-up study of this size and length in a setting where
malnutrition is prevalent is rare. This cohort is a great opportunity to
evaluate whether treatment programmes are effective or not. Few
points of interest can be raised at this level: Do they have higher
rates of Non-Communicable Diseases after discharge? Different body
composition? Have their immune systems genuinely recovered optimally?
These are research priorities required in a context of nutritional
vulnerability.
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ONCHOCERCIASIS-ASSOCIATED EPILEPSY: THE EPIDEMIOLOG-
ICAL EVIDENCE
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Introduction: The relationship between onchocerciasis and epilepsy has
been subject to debate by the scientific community. There is a need to
investigate a possible association between both conditions in the light of
recent findings.
Aim: To provide up-to-date scientific evidence regarding onchocerciasis-
associated epilepsy (OAE).
Methods: We analysed peer-reviewed papers, abstracts presented at
international conferences, and grey literature including all study designs.
The available evidence was reviewed against the Bradford Hill criteria.
Results: Cross-sectional studies as well as case-control studies and
a meta-analysis demonstrated the strength of association between
epilepsy status and the presence of Onchocerca volvulus microfilariae
(mf) or antibodies. Furthermore, a biological gradient and temporality
between mf load and the risk of developing epilepsy were demonstrated
in a cohort study in Cameroon, with risk ratios of up 28.5 for children
having >200 mf per skin snip to develop OAE later in life. There is
additional evidence supporting the specificity, consistency, coherence
and plausibility of this association; indeed, OAE was observed to be
highly prevalent in onchocerciasis-endemic areas with sub-optimal
control measures in Cameroon and South Sudan, starting between
the ages of 3 and 18 years, with typical clinical aspects including
nodding syndrome, and in the absence of other epileptogenic tropical
diseases like neurocysticercosis. Conversely, epilepsy incidence drastically
reduced after strengthening onchocerciasis elimination programs in
Northern Uganda (Kitgum and Pader), and Nigeria (Imo river basin).
Notwithstanding, a few case-control studies did not report such an
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increased ivermectin coverage which had probably depleted the mf load
in most participants. A common mechanism of molecular mimicry was
suggested for both onchocercal retinopathy and seizure-causing cerebral
lesions in OAE, thus fulfilling the criteria for analogy. Experimental
evidence was weakest; mf had been detected in human cerebrospinal
fluid decades before the worldwide institution of mass treatment with
ivermectin, but not in recent studies.
Conclusion: Overall, applying the Bradford Hill criteria suggests strong
epidemiological evidence that infection with O. volvulus may cause
epilepsy, including nodding syndrome. However, the pathophysiological
mechanisms remain elusive.
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COMMUNITY-BASED PREVALENCE OF TYPHOID FEVER, TYPHUS,
BRUCELLOSIS AND MALARIA AMONG SYMPTOMATIC INDIVID-
UALS IN AFAR REGION, ETHIOPIA
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Background: In sub-Saharan Africa, where there is the scarcity of proper
diagnostic tools, febrile illness related symptoms are often misdiagnosed
as malaria. Information on causative agents of febrile illness related
symptoms among pastoral communities in Ethiopia have rarely been
described.
Method: With a community based cross-sectional survey, we assessed
prevalence of typhoid, typhus, brucellosis and malaria among individuals
with a set of given symptoms in Amibara district, Afar Region, Ethiopia.
Blood samples were collected from 650 participants and examined by
Widal and Weilflex of direct card agglutination test (DCAT) and tube
based titration tests for Salmonella enterica serotype Typhi (S. Typhi) and
Rickettsial infections. Rose Bengal Plate Test (RBPT) and Complement
Fixation Test (CFT) were used to screen Brucella infection. Thin and thick
blood smears were used to diagnose malaria.
Results: Out of 630 sera screened by DCAT, 83 (13.2 %) were reactive to
H and/or O antigens for S. Typhi infection. Among these, 46 (55.4%) were
reactive by the titration test at the cut off value ≥ 1:80. The combined
sero-prevalence for S. Typhi by the two tests was 7.3% (46/630). The
sero-prevalence for Rickettsia infection was 26.2% (165/630) by DCAT
and 53.3% (88/165) by the titration test at the cut off value ≥ 1:80.
The combined sero-prevalence for Rickettsia infection by the two tests
was 14.0 % (88/630). The sero-prevalence for Brucella infection was
12.7% (80/630) by RBPT, of which 28/80 (35%) were positive by CFT.
The combined sero-prevalence for Brucella infection by the two tests was
4.4% (28/630). Out 650 suspected individuals for malaria, 16 (2.5%) were
found positive for P. falciparum infection.
Conclusion: Typhoid, typhus, brucellosis and malaria were observed
among symptomatic individuals. The study also highlighted that
brucellosis cases can be misdiagnosed as malaria or other disease based
solely on clinical diagnosis. Therefore, efforts are needed to improve
disease awareness and laboratory services for the diagnosis of brucellosis
and other zoonotic diseases to identify other causes of febrile illness in
this pastoral setting.
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MOBILE SUITCASE LABORATORY FOR MULTIPLE TESTING OF
PATHOGENS TO SUPPORT THE ELIMINATION OF MALARIA IN
NIGERIA
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Introduction: The detection of cases with very low parasitemia is very
crucial to achieve the goal towards malaria eradication. On top of that
the identification of other pathogens causing similar clinical picture is
important to avoid misdiagnosis and the unnecessary use of antimalarial
drugs. The polymerase chain reaction is the gold standard of molecular
diagnostics, but it is not suitable for point of need diagnostics.
Aim: The aim was to deploy a point of need diagnostic test to screen
for Plasmodium, Rickettsia, Leptospira, Salmonella, Strep. pneumonia,
Dengue, yellow fever and chikungunya.
Methods: A solar powered mobile suitcase laboratory was constructed
and deployed in rural community in Ibadan, Nigeria. It contains all
reagents and equipment for the detection of nucleic acid of the
pathogens using SpeedXtract and recombinase polymerase amplification
(RPA) assay. All reagents are cold-chain independent in order to ease the
use at poor resource settings. The mobile suitcase laboratory was used
to identify malaria cases as well as screening for other causes of non-
malaria febrile illness in Nigeria.
Results: In total 88 blood samples were tested from patient (age 1-
63 years). Interestingly, about 47% of the samples were positive in the
Plasmodium RPA assay, despite that the screening was done during the
dry season in Nigeria. Only one patient was positive for Salmonella. None
of the other pathogens were detected.
Conclusion: The mobile suitcase has proven to be efficacious as a point
of need diagnostic for the detection of Plasmodium and other pathogens
that could cause fever in Nigeria and other tropical regions. Further study
using sequencing (metagenomic diagnostics) is needed to identify the
cause of non-malaria febrile illnesses.
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CONCEPT STUDY OF A NOVEL MICROBIOPSY DEVICE
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Introduction: In 2005 the governments of India, Nepal and Bangladesh
have committed to eliminating visceral leishmaniasis (VL) as a public
health problem by 2020, and recent review shows they are close to
reaching this target. However, unresolved questions remain about the
role of asymptomatically infected individuals in sustaining transmis-
sion. Infectiousness is usually assessed by direct xenodiagnosis in which
sand flies are allowed to feed on study subjects and later analysed
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large scale population studies on asymptomatic people. Many authors
therefore use parasite load in the blood as a proxy for infectiousness, but
animal studies suggest that parasite load in the skin might be a better
marker. As standard skin biopsies are too painful to be used on a large
scale on asymptomatic individuals, we set out to pilot the potential of a
prototype microbiopsy device.
Aim: To examine to what extent parasite load in the skin as collected with
the novel microbiopsy device correlates with a) parasite load in the blood,
and b) disease status.
Methods: We collected skin samples from 175 individuals; 30 VL patients,
21 Post-Kala azar leishmaniasis (PKDL) patients, 64 asymptomatically
infected individuals, 30 endemic controls and 30 non-endemic controls.
Each individual was sampled on the lower arm and in the neck, PKDL
patients were sampled in addition on one of the skin lesions. A blood
sample was collected to assess parasitaemia. Agreement between par-
asite load in skin and blood was assessed on a quantitative scale with
correlation coefficients using regression analysis and on a binary scale
using Cohen’s kappa coefficient. Correlation between skin parasite load
and disease status was assessed using a receiving operating characteris-
tics (ROC) curve.
Results: Results are preliminary as data were not complete at the time
of abstract submission. In the first available data we found no clear
correlation between blood and skin parasite load, both on a quantitative
scale (correlation coefficient 0.4198) and on a qualitative scale (kappa
0.1309). A strong correlation was present between skin parasite load
and disease status (VL or PKDL), but not between skin parasite load and
infection status.
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Introduction: Vector-borne diseases (such as malaria, dengue, chikun-
gunya and Zika virus infections) cause thousands of deaths every
year. Prevention of these diseases is best achieved by vector control
which relies on the use of insecticides. Monitoring mosquito vector
populations is an integral component for effective vector control
programs.
Methods: An essential part of vector research is the characterization
of field vector populations, such as species/subspecies, insecticide
resistance traits and pathogen and symbiote infection status. Several
diagnostic Methods have been used for this task, but all have important
limitations including protocol complexity, technical training requirements
and high per-assay and platform cost.
Results: To address these limitations, diagnostic platforms (MalVec-
LabDisk / ArboVec-LabDisk) for monitoring Anopheles and Aedes mosquito
populations will be established. We have already developed novel
multiplex assays, which are applicable to pooled specimens and
integrable to such automated platforms. These assays can reliably
calculate the frequency of target site resistance mutations in pooled
specimens (Mavridis et al, 2018, Genes, 9 (10), pii: E479), monitor the
levels of major detoxification genes and metabolic resistance (Mavridis
et al, 2019, Parasit Vectors, 12(1):9) and detect pathogens (such as
P. falciparum) at the infective stage without the need of head/thorax
dissection and post-PCR processing (Kefi et al, 2018, Sci Rep ;8(1):1462).
We are currently in the phase of integrating these multiplex assays to
the automated systems that will be evaluated as a whole in malaria and
arbovirus endemic countries.
Discussion: We aim to deliver novel and improved tools to support
informed decision-making in vector control and disease management
to ultimately increase the efficacy of vector control programs.
Acknowledgements: This work has received funding from the Euro-
pean Union’s Horizon 2020 research and innovation programme
under the DMC-MALVEC (GA: 688207) and INFRAVEC2 (GA: 731060)
projects.
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HOOD VACCINATION THROUGH COLOR-CODED BRACELETS: A
PILOT STUDY AMONGST FULANI TRIBE IN NIGERIA
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Introduction: Routine childhood immunization is considered one of the
most cost-effective public health interventions for prevention of morbid-
ity and mortality due to vaccine preventable diseases (VPD). However,
the coverage of childhood immunization is still unacceptably low in a
number of sub-Saharan African countries including Nigeria. Moreover,
vaccine effectiveness depends largely on the timing of its administration.
To achieve maximum protection against VPD, a child should receive all
immunizations within the recommend intervals.
Aim: The primary objective of this study was to test the effects of a pilot
intervention on vaccination parameters in infants born to Fulani parents.
Infants received color-coded bracelets symbolising different levels of
vulnerability to specific VPD as reminders of due dates for vaccination to
enhance timeliness and completeness of immunization schedules. The
provision of bracelets was supported by a peer education schedule, to
further promote uptake and increase coverage.
Methods: In 2018, a total of 435 children (0-14 days old) were recruited
across six study sites (three intervention and three comparison health
facilities) in two districts of Bauchi State in north-eastern Nigeria and
followed up for 11 months. During follow-up, the dates of their visits
to the study sites were recorded for each of the five foreseen vaccina-
tion dates according to Nigeria immunization policy. All children in the
three intervention sites (n=256) were provided with the 5-color coded
bracelets and caregivers informed about the meaning of the colours
with regard to vaccine type and timing of these vaccinations. The care
takers of children at the three control sites (n=179) did not receive
bracelets and were simply informed about the vaccination timing. At
the intervention sites, mothers were voluntarily enrolled as peer-to-
peer mobilizers to motivate other women to bring their children for
vaccination.
Results: Preliminary findings point to an improvement of the timelines
and coverage of vaccination associated with this pilot intervention. Full
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Introduction: The quality of care is essential to save life. Many invest-
ments are done in terms of human resources, commodities, drugs, equip-
ment. However, the clinical laboratory is one of the neglected compo-
nents in the aim to have an acceptable quality of care. Indeed, bad
diagnosis cannot end up with good management of patients. We con-
ducted a descriptive cross-sectional in three general hospital in the
Democratic Republic of Congo to assess the performance of clinical
laboratory.
Methods: Observations, visit and structured interviews were performed
using questionnaires. A team with national experts in laboratory visits
the three laboratories. We used also recommendations from guidelines
on laboratory platform at hospital level.
Results: Clinical laboratories had a lot of gaps especially regarding infras-
tructures, training of the personnel, equipment, supervision and the
quality control. The platform is not adapted to the need of quality of care.
For example, there is no one dedicated for laboratory supervision at te
level of the hospital even at the level of health zone.
Conclusion: In Conclusion, there is a need of investments in laboratory to
ensure the quality of care. Within the system, there is a need to dedicate
more attention to the laboratory in term of budget but also in term of
training, supervision etc. . .
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Introduction: Ethiopia is one among the five countries hosting half of
the global maternal mortality. There is robust evidence that Ethiopian
women do not show up for facility-based delivery due to experienced and
perceived mistreatment in health facilities (only 28% deliveries happen in
health facilities).
Aim: This study aimed to identify and address the mistreatment of
women during facility-based child birth.
Methods: Pre and post-intervention surveys were conducted in three
hospitals in south Ethiopia. Initially, 25 previously tested indicators were
administered to 198 women to benchmark the magnitude of mistreat-
ment of women during childbirth. The indicators range from those inquir-
ing on using simple languages to those with serious offenses like slapping
and gagging. Based on the gaps identified, a training manual, job aids
and action plan were developed and contextualized by stakeholders.
Training was offered to 64 service providers from the study hospitals;
three rounds of post-training supportive supervisions that were guided by
the continuous quality improvement cycle approach were also conducted
after the training. Finally, post-intervention surveys were administered to
190 women. An adjusted Poisson regression analysis was used to identify
the association between the interventions and the level of mistreatment
during childbirth.
Results: The majority of participants were 15-44 years of age both
in the pre and post-intervention groups (p=0.93). 87.9% of the pre-
intervention and 77.4% of the post-intervention survey participants had
vaginal birth (p=0.01). Almost all (99.2%) of women reported expe-
riencing at least one of 25 mistreatment indicators during childbirth.
After controlling for effects of potential confounders, the number of
mistreatment items experienced by post-intervention survey participants
was 18% lower (adjusted coefficient=0.82 [0.74-0.91]). Having vaginal
delivery was also associated with higher number of mistreatment items
experienced (adjusted coefficient=1.54 [1.07-2.22]). Similarly, the num-
ber of mistreatment items experienced was higher among women who
had complications during pregnancy (adjusted coefficient=1.21 [1.06-
1.41]) and delivery (adjusted coefficient=1.21 [1.07-1.38]).
Conclusion: This study has demonstrated that patient reported outcome
measures can be used in maternity settings for monitoring and evalu-
ation of service quality. The training manuals and job aids are currently
being reviewed for national scaleup study by the ministry of health and
stakeholders.
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Introduction: An estimated 289,000 maternal deaths and 2.4 million
newborn deaths occur globally each year. Most of these deaths occur
in resource limited settings. Improving access to family planning,
Emergency Obstetric and Newborn Care (EmONC) and skilled attendance
at birth, are key strategies for improving maternal health. Although the
proportion of births attended by skilled health workers has doubled over
the last 15 years, studies have shown that health workers lack the knowl-
edge and skills to provide good quality care. There is evidence that the
pre-service training curriculum may be deficient in low resource countries.
Aim: To measure the effectiveness of pre-service EmONC training
interventions on the knowledge and skills of final year midwifery students
in Kenya.
Methods: Kenya PETI study (Pre-service Emergency obstetric care
Training Interventions Study) ISRCTN74563398 https://doi.org/10.1186/
ISRCTN74563398 was a quasi-experimental controlled trial with 2
intervention and 1 control arm, involving 12 Kenya Medical Training
Colleges and 240 final year midwifery students. Midwifery colleges in the
intervention arm, received EmONC skills laboratory equipment, training of
teaching staff on teaching Methods, EmONC and clinical supervision skills.
The teaching staff were also mentored for a period of 12 months. The
colleges in the control arm had no intervention. Scores for the knowledge
test, written skills test, and practical skills test were analysed using mixed
effects linear models, with random effect for cluster (midwifery colleges).
Fixed effects considered were the interaction of study arm. Likelihood
ratio tests were used to compare models, in order to test the significance
of the fixed effects. Fitted estimates of the significant fixed effects are
reported with 95% confidence intervals.
Results: The effect of the study arm was significant (chi sq=9.49,
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the knowledge test was significantly higher in the intervention group
compared to the control group OR 3.17 (1.1 – 9.83) p<0.05. The scores
in the skills tests were significantly higher in the intervention group
compared to the control group 19.85 (7.8-31.9) p<0.01
Conclusion: The EmONC interventions were effective in improving the
knowledge and skills of final year midwifery students.
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USING MACHINE LEARNING PREDICTIONS OF MALARIA
PREVALENCE TO IMPROVE GEOSTATISTICAL DISAGGREGATION
MODELS OF INCIDENCE
Lucas T.C.D., Nandi A., Nguyen M., Rumisha S., Battle K.E.,
Howes R.E., Cameron E., Gething P.W., Weiss D.J.
Malaria Atlas Project, Big Data Institute, University of Oxford,
Oxford, UK
Introduction: As more countries move towards malaria elimination,
global risk maps with accurate estimates of transmission in low
prevalence areas are increasingly vital. However, traditional mapping
using prevalence point-surveys is ineffective in low prevalence areas
due to low statistical power and geographic biases in data availability.
Therefore, models must be developed that can estimate risk at
high spatial resolution from surveillance data that reports incidence
aggregated to a geographic polygon. Current models developed for
polygon incidence data suffer from lower statistical power for learning
relationships between malaria risk and environmental covariates.
Aim: We aimed to develop a model that combines prevalence survey
data and aggregate incidence data.
Methods: The model uses prevalence survey data to train machine
learning models and then uses geospatial, disaggregation regression
to combine these machine learning models with incidence data.
Using Colombia and Madagascar as case examples we examined the
performance of the new model using six fold random cross-validation
and three fold spatial cross-validation. We compared the predictive
performance of baseline dissaggregation regression models using
environmental covariates with our new model that combines machine
learning models trained on prevalence data with the disaggregation
model.
Results: When considering random cross-validation, predictions from
the new model were more correlated with observed data than the
baseline model in both Madagascar (baseline: 0.70, new: 0.76) and
Colombia (b: 0.45, n: 0.55). Under spatial cross-validation, the new model
outperformed the baseline model in Madagascar (b: 0.22, n: 0.63) but
both models performed poorly in Colombia.
Conclusions: Our new method provides a way to combine information
from prevalence surveys and aggregated incidence data, leveraging the
strengths of both.
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AGROCHEMICAL POLLUTION INCREASES ABUNDANCE OF
SCHISTOSOMA HOST SNAILS IN WESTERN KENYA
Ganatra A.A.1, Becker J.2, Kandie F.1, Muehlbauer L.2, McOdimba
F.1, Torto B.1, Lelo E.3, Brack W.2, Fillinger U.1, Liess M.2
1Human Health Dept., icipe, Nairobi, Kenya;
2System-Ecotoxicology, UFZ, Leipzig, Germany;
3CBRD, KEMRI, Nairobi, Kenya
Introduction: Schistosomiasis is a neglected tropical disease that occurs
widely across Africa. The disease is caused by Schistosoma trematodes
which are hosted by Planorbid snails of the genus Biomphalaria or Buli-
nus. Kenya’s Lake Victoria shore, where both snail genera reside natu-
rally, is surrounded by fertile lands used for commercial and subsistence
farming of various crops (maize, sugarcane, tea and rice). Agrochemi-
cals used on these farms wash into the waters and potentially affect
the community composition of aquatic organisms. Because snails are
generally highly tolerant to agrochemicals, we hypothesized that the
community in a polluted environment may shift towards an increased
abundance of host snails, resulting in an increased risk of infection with
schistosomiasis.
Aim: The study aimed at investigating the effects of agrochemicals on
the habitats of the host-snails present in the inland waters surrounding
the Kenyan Lake Victoria.
Methods: Concentrations of agrochemicals were analysed in water sam-
ples from 48 sites ranging from streams to ponds Agrochemical pollution
was quantified relating the concentrations to the sensitivity of the refer-
ence organism Daphnia magna (toxic unit). To confirm the comparably
high tolerance of host snails, they were collected together with another
19 macroinvertebrate taxa and acute-toxicity tests were conducted using
a neo-nicotinoid and an organophosphate insecticide.
Results: The sensitivity of Kenyan taxa to agrochemicals was comparable
to European taxa. Snails (and particularly the Planorbid host snails) were
highly tolerant to both insecticides. The incidence and the density of
snails increased with agrochemical pollution. Additionally, with increasing
agrochemical pollution snail communities became more dominated by
the Planorbid host snails.
Conclusion: The results show that agrochemical pollution in East African
inland waters have significant effects on the macroinvertebrate commu-
nity structure that favour the highly tolerant host snails of Schistosoma.
Because people are living in close contact with the investigated water
bodies, we conclude that agrochemical pollution is a relevant driving
factor for the risk of infection with schistosomiasis.
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A CRITICAL EVALUATION OF THE APPETITE TEST FOR CHILDREN
WITH SEVERE ACUTE MALNUTRITION
Zangenberg M.1,2, Abdissa A.3, Johansen Ø.H.4,5, Tesfaw G.3,
Friis H.6, Briend A.6,7, Kurtzhals J.A.L.1,2, Girma T.8
1Centre for Medical Parasitology, Dept. of Immunology and Micro-
biology, University of Copenhagen;
2Dept. of Clinical Microbiology, Copenhagen University Hospital
(Rigshospitalet), Copenhagen, Denmark;
3Dept. of Medical Laboratory Sciences and Pathology, Jimma Uni-
versity, Ethiopia;
4Dept. of Clinical Science, University of Bergen;
5Dept. of Microbiology, Vestfold Hospital Trust, Tønsberg, Norway;
6Dept. of Nutrition, Exercise and Sports, University of Copenhagen,
Denmark;
7University of Tampere School of Medicine and Tampere University
Hospital, Center for Child Health Research, Tampere, Finland;
8Dept. of Pediatrics and Child Health, Faculty of Medical Sciences,
Jimma University, Ethiopia
Introduction: In children with severe acute malnutrition (SAM) the
appetite test is used to risk-stratify for in-patient or outpatient care. The
appetite test is recommended in national and international guidelines
despite lack of evidence.
Aim: To evaluate the ability of the appetite test to identify children at risk
of a poor treatment outcome.
Methods: We conducted a prospective observational study of children
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standardised examination for medical complications, performed blood
cultures and analysed blood samples. The appetite test was done by
research nurses independent of the routine staff, and the result did not
affect decisions for hospitalisation, clinical care and treatment duration.
Data were analysed using a mixed linear model for continuous outcomes
and a mixed model logistic regression for binary outcomes.
Results: Appetite was tested in 298 (89%) of 343 enrolled children and
only 56 (19%) passed. In most cases (94%) where the test was not
performed this was due to a clinical condition that precluded testing.
Counterintuitively, we found a trend towards a higher increase in weight
during follow-up among children failing the test than children passing
the test, adjusted for type and duration of treatment, oedema, duration
of follow-up, and age (p=0.08). Furthermore, using a similar model
but using weight gain from the first oedema-free weight, we found
that children failing the appetite test had a higher weight gain than
children passing the test (p=0.002). We found one or more medical
complications in 179 (54%) of the patients. There was a trend towards
those with complications having a lower weight gain than those
without complications (p=0·07). Medical complications but not the
appetite test result was associated with blood markers of metabolic
disturbances. Neither the appetite test nor medical complications
were associated with bacteraemia (n=11), treatment failure (n=57) or
mortality (n=17).
Conclusion: Our findings question the rationale for using the appetite test
and challenge its use to identify children who need in-patient care. While
this should be confirmed in other settings, we suggest that assessment
of medical complications alone could suffice for this purpose.
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ENDEMIC LEPTOSPIROSIS IN SRI LANKA: VALUE OF CLINI-
CAL PRESENTATION, LABORATORY DATA AND SUSPECTED CASE
DEFINITION FOR EARLY DIAGNOSIS
Nisansala G.G.T.1, Bandara A.W.M.K.2, Weerasekera M.M.1,
Gunasekara T.D.C.P.1, Gamage C.D.3, Marasinghe M.G.C.P.4,
Fernando S.S.N.1, Ranasinghe K.N.P.5
1Dept. of Microbiology, Faculty of Medical Sciences, University of Sri
Jayewardenepura;
2Dept. of Basic Sciences, Faculty of Allied Health Sciences, General
Sir John Kotelawala Defence University;
3Dept. of Microbiology, Faculty of Medicine, University of Per-
adeniya;
4Dept. of Medicine, Faculty of Medical Sciences, University of Sri
Jayewardenepura;
5Base hospital, Panadura, Sri Lanka
Introduction: Leptospirosis is a neglected tropical zoonosis endemic to
Sri Lanka. Diagnosis and treatment of leptospirosis in high-burden low-
resource settings is a challenge due to limited access to diagnostics.
Thus treatment is initiated based on clinical diagnosis. In resource poor
settings evaluation of clinical diagnostic criteria supported by basic lab-
oratory investigations can be useful in early diagnosis in absence of
availability of specific diagnostics.
Aim: We analyzed patterns of disease of suspected and confirmed cases
of leptospirosis during leptospirosis outbreaks in three high endemic dis-
tricts of Sri Lanka to determine clinical background of endemic leptospiro-
sis in tropical setting. Further, existing clinical leptospirosis case definitions
for suspected case of leptospirosis were accessed by recommendations
of World Health Organization (WHO), Centers for Disease Control and
Prevention and from national guidelines on management of leptospirosis,
Epidemiology unit, Ministry of Health, Sri Lanka to recruit patients for
better management.
Methods: This was a retrospective multicenter study carried out dur-
ing 2013-2017 in 5 selected hospitals representing three high endemic
districts in Sri Lanka. Clinically suspected leptospirosis patients were
recruited according to Communicable Disease Epidemiology Profile Sri
Lanka, WHO. Leptospirosis was confirmed by either single microscopic
agglutination test(MAT) titre ≥1:400 or by positive polymerase chain
reaction(PCR).
Results: Out of 372 clinically suspected patients, 29% were found to
be confirmed as leptospirosis by either MAT (50%) or PCR (52.7%) while
13% were presumptively identified as leptospirosis. Among confirmed
group mean age was 44.8±15.7 years, with 87.6 % males. Clinical symp-
toms (headache, vomiting, jaundice and dyspnoea) and haematological
(haemoglobin, platelet count) and biochemical (serum creatinine, serum
urea, serum bilirubin and C-reactive protein(CRP)) alterations were asso-
ciated (p<0.05) with confirmed cases. When case definition of Ministry
of Health, Sri Lanka was evaluated, sensitivity, specificity, positive predic-
tive value and negative predictive value were 96%, 9%, 31% and 92%
respectively.
Conclusions: Haemoglobin, platelet count, serum creatinine, serum urea,
serum bilirubin and CRP were useful diagnostic findings in leptospirosis
which may be helpful in clinical care. The case definition of Ministry of
Health, Sri Lanka was found to have higher sensitivity and enabled screen-
ing of all probable cases of leptospirosis in terms of initiate treatment
strategies.
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MASS CAMPAIGN ON NON-COMMUNICABLE DISEASES - CITY
OF KIGALI 2017: ASSESSING UTILITY AND EFFECTIVENESS
Mukantagara M.1, Zinnen V.2, Kangabire M.T.3, Mbarushimana
A.4, Tihon V2., Ndayisaba G.1, Condo J.1
1Biomedical Center;
2Enabel (Belgian Development Agency;
3Public Health Directorate, City of Kigali;
4Rwanda NCD Alliance, Kigali, Rwanda
Introduction: The City of Kigali organizes a mass campaign on Non-
Communicable Diseases (NCDs) every year in order to raise awareness,
for better prevention and for early detection. Thousands of people are
screened for free (Body Mass Index, blood pressure and glycemia),
education messages are provided, and people with abnormal values
receive counselling.
Aim: This study aimed to evaluate utility and effectiveness of the
campaigns.
Methods: Close follow-up of people screened during the 2017 mass
campaign: all cases with abnormal values compared to the standard
definition of hypertension and hyperglycaemia were extracted. A struc-
tured questionnaire was prepared to interview the selected people by
phone.
Results: Of 2147 people enrolled, 674 had abnormal values (31%) and
439 could be reached and gave their consent. The main reason for
people to attend the screening (94%) was to know their status. 73% of
respondents didn’t know their status beforehand. 90% of those screened
received counselling primarily on more physical activity and a healthy
diet, and less on alcohol (23%) and smoking (12%). 35% were advised to
go to health facility to confirm diagnosis and/or for further management.
Concerning knowledge, the majority knows about hypertension (62%),
diabetes (61%), cancer (28%), and mentioned unhealthy diet (46%) as
main risk factor. After the campaign, 39% of respondents changed their
life habits through more regular physical activities, eating more fruits and
vegetables, reducing use of salt and sugar. The majority found this mass
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Conclusion: The mass campaign contributed to detect NCDs as 73%
of respondents didn’t know their status. People received information
and counselling, however, it did not cover all risk factors (especially
tobacco and alcohol. While all had abnormal values, only 35% were
advised to go to the health facility, and only 39% changed their life
habits. In Conclusion, mass campaigns seem to be useful with room for
improvement, especially on education and case management. This kind
of evaluation should be repeated by including all screened people to get
more information and continuously improving the impact of such mass
campaigns.
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CHARACTERISTICS OF PATIENTS AT RISK OF, OR WITH NEWLY
DIAGNOSED DIABETES IN A SUB-URBAN TOWNSHIP, SOUTH
AFRICA: SMART2D BASELINE SURVEY RESULTS
Delobelle P.A.1,2, Onagbiye S.O.1, De Man J.3, Manuga T.1, Has-
sen M.1, Puoane T.1
1School of Public Health, University of Western Cape,
Bellville;
2Chronic Disease Initiative for Africa, University of Cape Town, Cape
Town, South Africa;
3Dept. of Primary Care, University of Antwerp, Antwerp, Belgium
Introduction: Type-2 diabetes is increasing rapidly in low- and middle-
income countries, especially among populations with a low socio-
economic status. SMART2D is an adaptive cluster randomised imple-
mentation trial aimed at testing innovative community-based self-
management support for type-2 diabetes prevention and management
in high-, middle- and low-income countries.1 This study is part of the
baseline assessment of SMART2D.
Aim: Assess the socio-demographic, anthropometric and glycaemic
profile of patients with newly diagnosed type 2 diabetes, or at risk of
type-2 diabetes.
Methods: Cross-sectional study using a structured contextually validated
survey questionnaire among 294 newly diagnosed (<1 year) type-2
diabetes patients (n=197 women; 97 men) and 292 patients at high risk of
type-2 diabetes (n=227 women; 65 men) recruited from two community
health centres in a peri-urban township in Cape Town. Anthropometric
(height, weight, waist circumference) and biomedical measurements
(blood pressure, HbA1c, FPG) were conducted and Results analysed using
descriptive statistics.
Results: The mean age of participants was 52+10 years (range 30-
77), with 72% women, 70% having some secondary education, and
45% unemployed. Mean BMI and waist circumference were significantly
higher among women and positively correlated with HbA1c in the at-risk
group (p<0.01), whereas mean FPG was significantly higher among at-
risk men (p<.05). Waist circumference, FPG and HbA1c were significantly
correlated (p<.01) and higher in the diabetes group (p<.001). Higher
education and income were significantly positively associated with FPG
and HbA1c among diabetics (p<.01). A high proportion of the diabetic
and at-risk group was obese and treated for hypertension with limited
glycaemic control among diabetics.
Conclusion: Results of this study highlight the need to strengthen type-2
diabetes prevention and treatment efforts among socio-economically
disadvantaged population groups in South Africa, with attention to
gender differences and the impact of obesity.
Reference:
1. Guwatudde D., Absetz P., Delobelle P., Östenson C.-G., Olmen van J.,
Alvesson H.M., et al. Study protocol for the SMART2D adaptive imple-
mentation trial: a cluster randomised trial comparing facility-only care
with integrated facility and community care to improve type 2 diabetes
outcomes in Uganda, South Africa and Sweden. BMJ Open 2018; 8(3). Doi:
10.1136/bmjopen-2017-019981.
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SALMONELLA TYPHI IN AN ONGOING OUTBREAK FROM
HARARE, ZIMBABWE
Olaru I.D.1,2, Feasey N.3,4, Ferrand R.1,2, Mabey D.2, Hopkins H.2,
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Introduction: Salmonella enterica serovar Typhi (S. Typhi) is a major
cause of blood stream infections throughout Asia and Africa. In sub-
Sarahan Africa the multi-drug resistant H58-haplotype (genotype 4.3.1)
has recently emerged, making ceftriaxone and ciprofloxacin essential
agents in the management of typhoid fever.
Aim: We present blood culture data from outpatients recruited in Harare,
Zimbabwe as part of a multi-centre study investigating the causes of
febrile illness.
Methods: We recruited febrile adults and children presenting to an
outpatient clinic in an area of Harare experiencing a typhoid fever
outbreak since 2017. Blood was taken for automated culture using
aseptic technique, filling one blood culture bottle per patient (BacT/ALERT,
Biomerieux). Isolates were identified using biochemical tests (API 20E,
Biomerieux) and confirmed by serotyping at the National Microbiology
Reference Laboratory. Drug susceptibility testing (DST) was performed by
disc-diffusion for ampicillin, chloramphenicol, co-trimoxazole, ceftriaxone
using EUCAST breakpoints. Pefloxacin discs were used to screen for
fluoroquinolone resistance. E-Test were used to determine minimum
inhibitory concentrations (MICs) for azithromycin and ciprofloxacin.
Multidrug resistance (MDR) was defined as resistance to ampicillin,
chloramphenicol and co-trimoxazole.
Results: 43/229 (19%) blood cultures were positive for S. Typhi, 25/111
[23%] from children aged <15 years and 18/118 [15%] from individuals
≥15 years. 38/43 (88%) isolates were MDR and 36 were pefloxacin
resistant. Ciprofloxacin MICs were available for 38 isolates, of which 6
were susceptible and 33 had MICs between 0.06 and 0.75 μg/mL and
were thus of intermediate susceptibility and reported resistant in line with
EUCAST guidelines. There was complete concordance between resistance
determined using pefloxacin discs and ciprofloxacin MICs. All isolates
were susceptible to ceftriaxone and azithromycin, which were used to
treat these patients.
Conclusion: A very high culture positivity rate for S. Typhi was recorded
in these patients, especially in children. Additionally, most of the isolates
were both MDR and ciprofloxacin-resistant, which is typically the case for
S. Typhi in Asia, but is an emerging problem in Africa. Increased availability
of azithromycin, investment in infrastructure to ensure safe water and
better diagnostic capacity are paramount to control the current and
prevent future outbreaks.
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NOVEL POINT-OF-CARE RAPID DIAGNOSTIC TESTS FOR INDI-
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Introduction: Visceral leishmaniasis (VL) and Chagas disease are
neglected tropical diseases (NTDs) that are responsible for major public
health problems. Point-of-care (POC) rapid diagnostic tests (RDTs) are
lacking for assessing cure versus relapse in VL, and for determining
Trypanosoma cruzi infecting lineage in Chagas disease.
Aims: To develop an RDT for monitoring VL treatment outcome, and an
RDT for T. cruzi TcII/V/VI lineage-specific serology.
Methods: We applied a novel combination of serology, using rK39 antigen
and IgG1 detection by ELISA and RDTs, to paired pre-and post-treatment
sera from Indian VL patients. We produced an RDT (Chagas Sero K-SeT)
incorporating a synthetic peptide representing the T. cruzi TcII/V/VI–
shared specific epitope (TSSApep-II/V/VI) to detect T. cruzi lineage-
specific infections in humans and mammalian reservoir hosts.
Results: VL: in combination with rK39 antigen IgG1 provided greater
discrimination than IgG between pre-treatment and paired cured 6-
month samples, and between cured and relapsed samples (p <0.0001
for either comparison). The Chagas Sero K-SeT was at least as sensitive
as ELISA; severity of chagasic cardiomyopathy among Bolivian chagasic
patient groups was significantly associated with TcII/V/VI seropositivity
(p = 0.007).
Conclusion: This is the first demonstration of an association between
reaction to a specific T. cruzi antigen and severity of chagasic symptoms,
and encourages development of a full range of lineage-specific serology
to investigate clinical associations and ecological distributions. We have
provided further evidence of the use of IgG1 as a potential biomarker for
monitoring VL treatment outcome, now being validated in eastern Africa.
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R.T.2
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Introduction: Schistosomiasis control through mass treatment with Praz-
iquantel is progressing rapidly, and elimination has recently been included
on the agenda by the WHO in certain areas. For design of effective control
programs, it is important to determine an accurate estimate of infection
in a program area. Current diagnostic Methods (detection of eggs in stool
by Kato-Katz) are limited and may be particularly unreliable at low infec-
tion intensities, as would be expected after several rounds of treatment
or where transmission is low. Point-of-Care Circulating Cathodic Antigen
(POC-CCA) detection in urine has been documented to be a sensitive and
specific alternative to Kato-Katz through direct comparisons, however,
data comparing multiple days of microscopy and antigen detection tests
in low prevalence settings is currently lacking.
Aim: To compare the performance of POC-CCA with Kato-Katz in a low
endemic area and in a moderate endemic area in Brazil. The study also
enhances knowledge of the spatial distribution of schistosomiasis in Brazil
that will assist planning of the preventive chemotherapy strategy for the
national schistosomiasis control programme.
Methods: Samples were obtained from school-aged children in two dif-
ferent populations in Brazil: Januária, located in Minas Gerais, considered
to be a region of low endemicity; and Malhador, in the state of Sergipe,
considered to be moderately endemic. Samples were obtained from
individuals who were diagnosed as having schistosomiasis by three days
of duplicate Kato-Katz test and one urine POC-CCA diagnosis.
Conclusion: Overall, the present data support previous work showing that
the rapid urine dipstick POC-CCA test is sensitive for the diagnosis of
intestinal schistosomiasis and offers a practical alternative to microscopic
assessment of multiple faecal samples. However, we also discovered sig-
nificant variation in the sensitivity of the POC-CCA tests between batches,
leading to an erroneous interpretation of the rapid test. There is an urgent
need to quality control different batches. Furthermore, three days of
duplicate Kato-Katz is highly sensitive even in low prevalence settings.
The Results of this study will contribute to the literature as increasingly
POC-CCA is being recognised as a mapping tool and therefore WHO
guidelines need to be developed, particularly as many countries can
realistically transition to achieving elimination.
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Introduction: Current rotavirus vaccines are less immunogenic in low-
and middle-income countries compared with high-income countries, lim-
iting their potential benefits. The development of the infant microbiome
has been hypothesised to contribute to this phenomenon. However,
previous studies have failed to identify reproducible signatures of vaccine
failure.
Aim: We performed a multi-centre prospective cohort study to examine
the association between bacterial microbiota development and rotavirus
vaccine response.
Methods: We enrolled 318 infants in India, 112 in Malawi and 82 in the
UK. Rotarix was administered according to the routine immunisation
schedule in each country. Microbiota development was assessed by
sequencing the V3–V4 region of the 16S rRNA gene in samples collected
at 1 and 4 weeks of age, and before each vaccine dose (4 samples per
infant). Rotarix immunogenicity was determined by measuring rotavirus-
specific IgA pre- and post-vaccination, and rotavirus shedding was
measured 1 week after each dose. At each site, we compared microbiota
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Results: Based on preliminary analyses, we observed seroconversion
rates of 28%, 23% and 53% in India, Malawi and the UK, respectively.
Microbiota composition did not differ significantly according to rotavirus
vaccine response based on taxon abundances. However, non-responders
in India had significantly higher microbiota richness in early life (p = 0.010
in linear mixed-effects models).
Conclusion: Specific bacterial taxa do not appear to drive within-
population differences in rotavirus vaccine response. However, overall
microbial exposure may be higher in infants who fail to respond to
vaccination.
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Introduction: The use of vaccines against various vaccine-preventable
diseases is beneficial and an effective measure for protecting different
age groups. Evidence-based approaches were used in making recom-
mendations for vaccination against vaccine-preventable diseases for
immunocompromised individuals but with limited substantiation.
Aim: This study investigated the efficacy and effectiveness of vaccines in
HIV-infected and HIV-exposed children in comparison to HIV unexposed
children.
Methods: We included randomised-controlled trials (RCT), cohort and
case-control studies that included efficacy or effectiveness of vaccines
in HIV-infected in comparison with HIV-exposed or HIV-uninfected
children aged ≤ 18 years. The intervention group included those with
standard vaccines or dosages while the comparison groups comprised
of placebo, non-vaccinated groups, groups that were vaccinated
with other control vaccines or other dosages among HIV-infected
and HIV-exposed children. For case-control studies, cases were HIV-
infected while controls were HIV-exposed uninfected and HIV-uninfected
children.
Results: Vaccine efficacy of 9-valent pneumococcal conjugate vaccine
(PCV9) in preventing first episodes of invasive pneumococcal disease
was 53% among HIV-infected children and 42% among HIV-uninfected
children. Efficacy of PCV9 against total vaccine serotype invasive
pneumococcal disease was 32% in HIV-infected children and 78%
among HIV-uninfected children. Vaccine effectiveness of Bacillus
Calmette–Guérin vaccine in preventing tuberculosis in HIV-infected
children was zero compared to 59% protection in HIV-unexposed
children. Likewise, HIV-uninfected children have better protection against
invasive Haemophilis influenzae type b (Hib) disease than the HIV-
infected children. Effectiveness studies of rotavirus vaccines show that
HIV-exposed uninfected children have similar protection against rotavirus
gastroenteritis compared to the non-exposed children. Children who
are severely immunosuppressed are poorly protected against invasive
pneumococcal diseases.
Conclusion: Efficacy and effectiveness studies on vaccination exhibit
possibilities for direct and indirect protection against various vaccine-
preventable diseases among HIV-infected and HIV-exposed children.
HIV-infected children tend to have less protection against vaccine-
preventable diseases when compared to unexposed children. HIV-
infected children who are immunocompetent are more likely to have
better vaccine protection against vaccine-preventable diseases than the
immunosuppressed ones. This study reveals that only a few vaccine-
efficacy and effectiveness studies have been done in HIV-infected and
exposed children previously.
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FACTORS ASSOCIATED WITH THE NON-COMPLETENESS OF
THE IMMUNIZATION SCHEDULE IN CHILDREN AGED 12 TO 23
MONTHS IN THE HEALTH ZONE OF BINZA OZONE, 2016
Bile F., Mvumbi G., Okitolonda V., Babakazo P.
Kinshasa School of Public Health, Kinshasa, Congo
Introduction: Vaccination has been shown to be the most effective way
to fight the disease of all times. Non-compliance with the child immuniza-
tion schedule is a serious problem in the city of Kinshasa in general, and
in the health zone of Binza Ozone in particular. Several factors could be at
the origin of this phenomenon. The objective of this study was to identify
factors related to the non-completeness of the immunization schedule
in the health zone.
Methodology of the Study: An analytical cross-sectional study was con-
ducted in the health zone of Binza Ozone from January to December
2016. We interviewed 370 mothers / caregivers of children aged 12 to
23 months to obtain information on children’s immunization status and
reasons for non-compliance. -completeness of their vaccination sched-
ule. The collected data were entered on the EPI Data 3.1 software and
then analyzed on the SPSS version 21 software. The association between
the state of non-completeness of the vaccination calendar on the one
hand and the qualitative explanatory variables on the other hand was
established by the Chi-square test of independence; the strength of the
association was estimated by the calculation of the odds ratio and its
confidence interval.
Results: Out of 370 children included in the study, 240 completed their
immunization schedule, or 64.9%. Vaccine coverage was low for all
antigens. The analyzes found that mothers’ lack of knowledge of the vac-
cination schedule (p = 0.021), long waiting times (p = 0.012), low maternal
education (p = 0.046) and low socio-economic level of the household
(p = 0.010) are significantly associated with the non-completeness of
children’s immunization schedule.
Conclusion: In 2016, vaccine coverage in Binza Ozone Health Zone was
below targets for all antigens. Communication with parents on immuniza-
tion of children, reorganization of immunization services and staff training
are ways to improve the completeness of the immunization schedule.
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Introduction: Snakebite envenoming is the deadliest neglected tropi-
cal disease globally, with 5 million cases and 81,000-138,000 yearly
deaths. Agok Hospital, South Sudan, where Médecins Sans Frontières
(MSF) supports the Ministry of Health, reported 341 snakebites in 2018.
A new treatment algorithm was introduced in 2017, using two antiven-
oms: Echitab-Plus for cytotoxic and haemotoxic envenoming (vipers, spit-
ting cobras), and SAIMR-Polyvalent for neurotoxic envenoming (cobras,
mambas).
Aim: To describe clinical symptoms, outcomes, and adverse reactions due
to the antivenoms.
Methods: We performed a prospective observational study of snakebite
patients, with clinical evaluations at admission, 6h, 24h, hospital dis-
charge, and 28d. Patients identified snakes using a photo album and
bite wounds were swabbed for snake DNA. Ethical approval was given by
South Sudan and MSF ERBs.
Results: We describe 151 patients admitted 14 March-August 2018, of
whom 46 (31.3%) were <15 years and 84 (55.9%) were male; most were
students or farmers. Median travel time and distance to hospital was 2h
(IQR 1-3), and 5 km (IQR 1-50); 100 (86.2%) arrived <6h of being bitten.
Most bites (82; 55.8%) occurred between 18h00-23h59, occurring most
commonly at home (69; 47.3%). Patients identified puff adders (Bitis
arietans, 56.4%), spitting cobras (Naja nigricollis, 12.8%) and carpet vipers
(Echis pyramidum, 7.7%); PCR analysis is pending. Thirty-three (22.3%)
received traditional treatments. Patients requiring antivenom (56/146,
38.4%) presented with cytotoxic or cytotoxic-haemotoxic syndromes
(including 25 bleeding, 15 with necrosis). Median extent of swelling was 9
cm (IQR 5-35). Two patients had continued bleeding at 6h that resolved
at 24h. 20 minute-clotting test was abnormal in 5.2% (5/95). Patients
received 1-4 “treatments” of 3 vials; among the 84 Echitab-Plus treat-
ments, no anaphylaxis or respiratory symptoms were described; 6.1%
had itching/urticaria. 3 patients had probable/definite serum sickness at
28d. No adverse events occurred after a single treatment of SAIMR. No
patient died.
Conclusion: This group of patients is younger than others described in
sub-Saharan Africa. Mortality was zero, likely due improved access to care
and antivenoms. Unfortunately, pan-African polyvalent antivenoms are
not yet available nor affordable in most places in Africa, contributing to
snakebite’s high burden. MSF welcomes WHO’s Snakebite Roadmap.
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SNAKE-BYTE: FIRST NATIONAL EPIDEMIOLOGICAL STUDY ON
SNAKEBITE SHOWS HIGH ANNUAL INCIDENCES IN NEPAL AND
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Introduction: Snakebite envenoming affects 4.5-5.4 million people and
kills 81,000-138,000 victims yearly according to the World Health Orga-
nization (WHO), but estimates are extrapolations, and community-based
country-wide studies are very scarce.
Aim: To measure the impact of snakebite on human and animal health
(incidence, mortality, disability) and livelihoods in Cameroon and Nepal.
Methods: This epidemiological study is part of the SNAKE-BYTE project
that aims at understanding the impact of snakebite in Cameroon and
Nepal through one-health, health economy, and epidemiology using
digital epidemiology and geo-health tools (Kobo-collect®, Stata® qGIS®,
Guru-Maps®, AccesMod®). Based on minimal expected snakebite inci-
dence of 100/100,000/year, 0.05% confidence limit, design effect of 2.0,
99% confidence level, 15% non-response margin, sample size was 61,000
people per country, i.e. 11,700 households in Cameroon and 13,800 in
Nepal (respectively 5.2 and 4.4 persons per household). Households were
preselected from satellite images, among 500 (2x250) randomly prese-
lected administrative areas, where six mobile survey teams conducted
the e-questionnaires. After ethical approval by Cameroonian, Nepalese,
and Swiss authorities, surveys started in November 2018.
Results: Interim data analysis on 5045 households in Cameroon and
10,163 in Nepal, showed respectively 120 victims per 29,537 persons-
year and 141 victims per 46,888 persons-year. National snakebite inci-
dence rates per 100,000 persons-year translate to 406.3 (95%CI: 338.3,
484.0) or 65,008 victims in rural Cameroon (population 16 million), and
300.7 (95%CI: 254.1, 353.5) or 39,993 victims in Nepal’s Terai lowlands
(population 13.3 million). Victims were young adults (median 30/31y),
often farmers, predominantly males in Cameroon (54.5%) and females
in Nepal (66.4%), and 22.5% were children <15y. Snakes were seen by
victims in 66%-71.2% cases, indoors or outdoors. Snakebite case-fatality
ratios were high: 5.8% (n=7/120) in Cameroon, and 6.6% (n=9/141) in
Nepal. About 10% received some injections, likely antivenom. Only 46.0%
and 50.4% were taken to medical facilities. Multivariate analysis will
model “hotspots” including demographic, clinical, ecological and socio-
economic variables, and animals lost.
Conclusion: This first country-wide community-based study shows very
high annual snakebite incidence and mortality in rural Cameroon and
Nepal. It should help health authorities to estimate antivenom needs by
geographical area.
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Introduction: In French Guiana most of the snakebites are caused
by Crotalinae, leading to local necrosis, bleeding and acute kidney
injury. Since December 2014 the Western Guiana Hospital (WGH) uses
Antivipmyn TriTM, a Mexican polyvalent antivenom developed against
Bothrops, Lachesis and Crotalus venoms.
Aim: The aim of the study was to assess the benefit of Antivipmyn
TriTM on the correction of hemostasis parameters and the frequency
of envenoming complications.
Methods: This retrospective study recruited patients hospitalized at
the WGH during 2013-2017 with a snakebite and: a prothrombin rate
(PR) lower than 45%, an activated partial thromboplastin time (aPTT)
ratio upper than 2 or a fibrinogenemia lower than 1 g/L. Patients who
received Antivipmyn TriTM from December 2014 to September 2017
were defined as the antivenom group. Patients who were admitted
between January 2013 and November 2014 when no antivenom was
ever available or between December 2014 and September 2017 during
periods of antivenom shortage were defined as the control group.
Graphical charts describing the time courses of PR, aPTT ratio and
fibrinogenemia were constructed for each group and compared. Other
endpoints were the length of hospital stay and the need for surgery or
dialysis.
Results: 84 patients were included: 42 in the antivenom group, 42
in the control group. Both groups were similar in terms of age, sex-
ratio, proportion of bleedings, necrosis and severity. All patients in
antivenom group received three vials at least. Hemostasis dynamics
didn’t differ significantly between antivenom and control groups: PR
and aPTT time courses were superimposable. Fibrinogenemia recovery
was faster beyond the 30th hour after bite in antivenom group but
the time needed to reach an efficient level of 1 g/L was not different
between both groups. There were no significant differences in the other
endpoints.
Conclusion: Antivipmyn TriTM – as currently used – didn’t show any benefit
on recovery for the studied criteria. Immunotherapy is certainly part of
the solution but further studies are needed in French Guiana, either with
a higher dosage or with another product.
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Samara F.V.M.1, Henry M.P.1,2, Jacqueline S.3,4, Sâmella S.O.3,4,
Alves E.C.3,5, Ibiapina H.N.S.3,4, Wuelton M.M.3,4, Maria R.F.O.1,2
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Introduction: Snakebite envenomation in the Brazilian Amazon is a
recognized public health problem that receives no appropriate attention
from stakeholders. The morbidity rate is relevant, but it is until underesti-
mated. A study of cost analysis that will enable better understanding of
its economic impact and contribute to the management and prevention
of snakebites.
Aim: This study aimed to estimate the cost of snakebite envenomation
a nd economic impact of snakebites on population in the Brazilian
Amazon, for year of 2015.
Methods: We conducted a cost of illness study of snakebites in the
Brazilian Amazon, in 2015, based on official surveillance data to
estimate burden, from a societal, patient and public health system
perspective. Direct medical costs were estimated through the top-down
approach.
Results: The study included 11,503 cases and 56 deaths. The estimated
costs from Health System perspective were US$ 1.199.013,11. The
estimated costs of premature death due to snakebites were US$
3.031.300,38. The costs related to the loss of productivity related in
absence from work were US$ 1.539.518,62. Thus, the total cost of
envenomation by snakebites in Brazilian Amazon was estimated to be
more of US$ 6 million in 2015.
Conclusion: The economic burden of snakebites in Brazilian amazon
is notably high, also arise for individual victims, their families and
communities. Snakebites cause loss of productivity by inpatient treat-
ment or deaths. This study provide a useful basis for developing
improvements to snakebite management in Brazil and others countries
by stakeholders for reduce number of cases and sequelae must be a
priority especially for vulnerable populations, like rural workers that have
most at risk.
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Introduction: Noma (Cancrum Oris), a rapidly progressing oral cavity
infection, associated with a reported 90% mortality rate, mainly affecting
children, is frequently reported in northern Nigeria but the true disease
burden is unknown.
Aim: We aimed to estimate the prevalence of all stages of noma in Sokoto
and Kebbi states, Nigeria.
Methods: From Sept-Nov 2018, we conducted a prevalence survey
using two stage cluster random sampling proportional to population
size; using village geosampling through satellite imagery. We included
177 clusters and 3499 households, and sampled all persons <15
years (with household head consent and assent from children aged
7-15 years). We conducted mid-upper-arm-circumference (MUAC) in
children <5 years and oral screening for all children. Caretakers answered
survey questions. World Health Organisation classification of noma was
used:S0:simple gingivitis;S1:necrotizing gingivitis;S2:oedema;S3:necrosis;
S4:healing;S5:sequela. We conducted an unweighted analysis of noma
prevalence in the study sample and severe and moderate acute
malnutrition (SAM-MUAC <115mm; MAM-MUAC 115-125mm) in children
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this survey dataset, we aim to estimate risk factors using univariate and
multivariate logistic regression.
Results: Most caretakers were female (n=3423;97.8%), median age
was 30 years(IQR 25,35). Of the 7120 children included, 4268(59.9%)
were 0-5 years. We identified S0 noma in 181 children(2.5%;CI
2.1%,3.1%); S1 in 10 children(0.1%;CI0.1%,0.3%) and S2 in 3 chil-
dren(0.04%;CI0.01%,0.1%). No stage 3-5 was detected. Prevalence was
higher in children aged 6-15 years (4.5%; CI 3.7,5.5%),compared to 0-
5 year olds(1.5%;CI1.1, 1.9%;p<0.001). Households with a noma case
had older caretakers (median 31.5 years;IQR 28,38) than those with no
noma case(median 30 years;IQR 25, 35;p=0.006). Prevalence of SAM
was 3.5%(CI 2.9, 4.1%) and MAM 7.3% (CI 6.4, 8.3%). There were no
differences in prevalence, SAM or MAM between Sokoto and Kebbi states.
Conclusion: Many cases of precursor stages of noma (S0-1) were
identified, particularly in children >5 years. The absence of stages 3-5 in
the survey requires further investigation as it may be due to high mortality
or low prevalence. These findings need to be taken into consideration for
program planning. Additional prevalence surveys for noma are required
to better map the burden of this disease.
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Introduction: Despite historically been associated with poor tolerability,
the safety of antileishmanial chemotherapies has not been well
characterised and reported.
Aim: To estimate the incidence risk of mortality and serious adverse
events in patients treated with antileishmanial therapies within 30 days
of commencing therapy.
Methods: We conducted a systematic review to identify clinical trials of
therapies for visceral leishmaniasis from 1980 to 2018 by searching four
databases: clinicaltrials.gov, WHO International Clinical Trials Registry
Platform (ICTRP), the Cochrane Library, and PubMed. We estimated
the incidence rate of death occurring in the first 30 days from starting
treatment for each of the study arms with confidence interval estimated
using exact Poisson counts. Estimates were combined using a random
effects meta-analysis of single incidence rates after applying continuity
corrections to handle structural zeros. The pooled incidence rate was
expressed per 1,000 person-days.
Results: We identified 152 published studies (1980 to 2018) which
enrolled 28,593 patients in 339 treatment arms. Amphotericin B
formulations were administered in 147 (43.4%) arms (10,544 patients),
pentavalent antimonial in 73 (21.5%, 7,054 patients), and combination
therapies in 35 (10.3%, 2,609 patients). A total of 382 deaths were
reported in publications during treatment and follow-up, of which 212
(55.5%) were clearly described as occurring during the first 30 day
of starting treatment. The overall expected incidence rate of death
regardless of antileishmanial drug administered was estimated as 0.685
[95% CI: 0.577 - 0.813] per 1,000 person days. This was 2-fold higher in
study arms which enrolled HIV patients: 1.308 [95% CI: 0.678- 2.523]
from 14 arms compared to 0.659 [95% CI: 0.552 - 0.787] from 290 arms
which excluded (or did not describe) HIV patients. The incidence rates
stratified by drugs were comparable between treatment arms.
Conclusion: This comprehensive systematic review allows to estimate
the incidence risk of mortality in VL patients treated with a range of
therapies, and can serve as baseline against which mortality data from
prospective studies can be compared.
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Introduction: An estimated 185 million people are infected with hep-
atitis C virus (HCV) worldwide and most of them are unaware of it [1].
In Myanmar, the prevalence of HCV infection is estimated at 2.7% [2]
(approximately 1.4 million people) and accounts for 25% of hepato-
cellular carcinoma. As with HIV, the prevalence is concentrated among
people who inject drugs and to a lesser extend among men who have
sex with men and female sex workers. The high stigma for these key
affected populations and the lack of adequate treatment for hepatitis C
result in high transmission, late presentation and high mortality. Medical
Action Myanmar (MAM) is a non-profit, medical organization, supporting
10 primary health care clinics with integrated HIV treatment targeting
key affected populations who are reluctant to access the public health
HIV services. Given the high degree of HIV/HCV co-infection, and the
challenge to reach “hidden” at risk populations in Myanmar, MAM decided
to offer HCV treatment at its clinics with the adoption of the Extension
of Community Healthcare Outcomes (ECHO) project model [3]. ECHO is
an educational intervention to transfer subspecialty knowledge about
hepatitis C to primary care providers.
Aim: To improve access to hepatitis C treatment for HIV/HCV co-infected
people at primary care settings.
Methods: Five general practitioners who routinely manage treatment of
HIV patients were trained by a team of hepatitis experts (2 face to face
trainings and regular discussions by email and skype conference calls).
The doctors assessed 85 co-infected patients and proposed 72 patients
for treatment with sofosbuvir and daclatasvir to the expert team. All
patients were agreed to get treatment by the expert team.
Results: A total of 72 HIV-HCV co-infected patients were started on
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patients got virologically cured (87.5%) 4 patients failed treatment,1
patient died and 1 patient lost to follow. 24 patients are still under
care.
Conclusion: This pilot project highlighted that the ECHO model is feasible
and successful in Myanmar using community based primary health care
doctors with the high cure rate to improve the access to hepatitis C
treatment.
References:
1. Gower, E., et al., Global epidemiology and genotype distribution of the
hepatitis C virus infectaion. J Hepatol, 2014. 61(1 Suppl): p. S45-57.
2. Aung, K., Viral Hepatitis in Myanmar: Current situation and response
2016, National Hepatitis Control Program, Khin Sanda AungDepartment
of Public Healtha
3. Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis
C virus infection by primary care providers. N Engl J Med 2011;364:
2199–207.
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Introduction: Strongyloidiasis is a helminthiasis potentially severe in
immunosuppressed patients. It is unclear which is the best strategy to
deal with imported strongyloidiasis in migrants.
Aim: We aimed to evaluate the cost-effectiveness of six different
screening and treatment strategies compared to the present base case
scenario with no specific program in place.
Methods: We developed a stochastic compartmental Markov chain
model. The target population were adult migrants from strongyloidiasis
endemic countries to the European Union. The time horizon was a
lifetime and the perspective of the health system was used. The outcome
measures were incremental cost-effectiveness ratios(ICER) measured as
2016e per life-year gained(LYG).
Results: base case scenario results: produced a total of 2,488,428
life-years with a cost of 847154.3 2016e. Hospital based empiric
treatment: 2,488,440 life-years (an increase of 12.2 life-years); cost:
14,118,932 2016e; ICER: 1,087,803.75 2016e/LYG. Hospital based
serology and treatment: 2,488,442 life-years (13.82 life-years increase);
cost: 207,843,924.3e; ICER: 14,967,596.25 2016e/LYG. Hospital based
empiric treatment of immunosuppressed: 2,488,440 life-years, cost:
748,996.2 2016e; ICER: -8,027 2016e/LYG (strategy cost-saving).
Hospital based serology and treatment of immunosuppressed: 2,488,442
life-years (14.05 life-years increase), cost: 7,422,424.72016e; ICER:
467,882.22 2016e/LYG. Primary care empiric treatment: 2,488,441 life-
years, cost: 7,768,318 2016e; ICER: 540,096.5 2016e/LYG. Primary
care serology and treatment: 2,488,442 life-years (14.62 life-years
gained), cost: 207,729,670.2 2016e; ICER: 14,150,266.5 2016e/LYG.
Sensitivity analyses: a one-way sensitivity analysis was carried out for
each one of the strategies evaluated, varying key parameters. The
parameters with the highest impact were the prevalence of infection
and the probability of seeking care as an outpatient. Nevertheless,
the Hospital based presumptive treatment of immunosuppressed
patients’ strategy, remained below the CE threshold for all the range
of the parameters. A probabilistic sensitivity analysis was carried out
to evaluate overall uncertainty. The strategy showing the highest
probability of being cost-effective was the hospital based empiric
treatment of immunosuppressed patients’ strategy, with a probability
of 0.85.
Conclusion: Our data suggest that it would be cost-saving to treat
empirically migrants from strongyloidiasis endemic countries that are
immunosuppressed.
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Introduction: The search for new rapid diagnostic tests (RDT) for
malaria is a priority to fight this endemic disease, according to WHO
recommendations1. In fact, available RDT based on the detection of
antigens, suffer from several limitations (i.e., are not quantitative, remain
positive for up to 1 month, exibit prozone effect at high parasitaemas,
may be falsely negative).
Aim: We present an easy to operate lab-on-chip diagnostic test (TMek)
for the quantification of the plasmodium parasitaemia and hemozoin
concentration in a blood smear. The method is based on the absolute
paramagnetic susceptibility of hemozoin crystals2 found within the
infected red blood cells (RBC) and free in the blood of patients affected
by malaria. A silicon microchip with an array of Nickel posts and some
suitable electrodes is put in contact with a smear of blood (5 microL)
diluted (1:10) with EDTA and PBS, in the field produced by external
magnets. Due to the competition between the magnetic and the gravity
forces, only infected RBC and hemozoin crystals are attracted towards
the Nickel concentrators and electrodes. The entity of the electrodes
impedance variation is thus proportional to the parasitemia and/or the
hemozoin concentration.
Methods: The microchip, fabricated via optical lithography, is placed in a
cartridge where the diluted blood smear is also loaded. After insertion of
the cartridge in a portable reading unit, the quantification is automatically
performed.
Results: TMek was tested at Sacco Hospital on control blood samples
from healthy donors as well from patients affected by malaria, diagnosed
by haemoscopy and LAMP ( Malaria Illumigene – Meridian EU). Preliminary
Results show that the test has a limit of detection around 0.003%,
comparable with that of currently used RDT. In just 10 minutes, a distinct
quantification of both parasitemia and hemozoin crystals concentration
is carried out, thus providing complementary information on the illness
status.
Conclusion: TMek has shown to hold a great potential for implementing
a rapid, quantitative and pan-plasmodic test for malaria suitable for









ent_1/S1/5569919 by guest on 24 M
arch 2020
Transactions of the Royal Societyof Tropical Medicine and Hygiene
next April, in Cameroon, and related Results will be presented at the
conference.
References:
1. World Health Organization, World Malaria Report 2017 (2017).
2. M. Giacometti, C. Rinaldi, M. Monticelli, L. Callegari, A. Collovini, D. Petti,
G. Ferrari, and R. Bertacco, Electrical and magnetic properties of hemozoin
nanocrystals, Appl. Phys. Lett., 113, 203703 (2018)
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FEASIBILITY AND IMPACT OF LEPROSY POST-EXPOSURE PRO-
PHYLAXIS: EVIDENCE FROM LPEP, A MULTI-COUNTRY, 5-YEAR
IMPLEMENTATION RESEARCH PROGRAM
Richardus J.H.1, Cavaliero A.2, Steinmann P.3;4, LPEP Study
Group
1Erasmus MC, University Medical Center Rotterdam, Rotterdam,
The Netherlands;
2Novartis Foundation, Basel, Switzerland;
3Swiss Centre for International Health, Swiss Tropical and Public
Health Institute;
4University of Basel, Basel, Switzerland
Introduction: The number of newly diagnosed leprosy patients remains
stable at over 200,000 per year since more than a decade. Post-exposure
prophylaxis (PEP) with single dose rifampicin (SDR) for close contacts of
leprosy patients is among the most promising new tools to control leprosy
since the introduction of standardized multidrug therapy in the 1980s.
Aim: The Leprosy Post-Exposure Prophylaxis (LPEP) program was designed
to evaluate the feasibility, effectiveness and impact of PEP with SDR
in selected pilot areas representing different health systems, epidemio-
logical conditions and socio-cultural settings across 3 continents and 8
countries: Brazil, Cambodia, India, Indonesia, Myanmar, Nepal, Sri Lanka,
and Tanzania.
Methods: A standard protocol was developed1 and then adapted to
the specific context of each country. Household, and in some settings
neighbour and social contacts of recently diagnosed leprosy patients
were traced, screened for signs of leprosy, and assessed for a num-
ber of exclusion criteria. Eligible contacts were offered an age/weight-
adjusted rifampicin dose. The intervention was maintained for 3 years.
Leprosy programme staff implemented the intervention while interna-
tional NGOs and academic partners provided technical support, quality
control, and outcome evaluation. The funder also acted as program
coordinator.
Results: Over 150,000 contacts of recently diagnosed leprosy patients
were identified, of whom 1% could not be screened and 10% were
excluded from SDR for medical reasons. Less than 1% of eligible contacts
refused SDR administration. While representing a considerable added
workload for front-line health workers and health volunteers, particularly
in settings that had not yet routinely implemented contact screening,
the program was appreciated by health workers as the inclusion of a
preventive treatment made screening for signs of leprosy much more
attractive to the population2. The program also resulted in the early diag-
noses of several hundred leprosy patients. Impact modelling suggests the
intervention will result in considerably reduced numbers of new leprosy
patients if it is maintained.
Conclusion: The intervention was well accepted among health workers,
patients and contacts. It is now recommended in the latest relevant
guidelines of the World Health Organization3.
References:
1. Barth-Jaeggi T, et al. Leprosy Post-Exposure Prophylaxis (LPEP) pro-
gramme: study protocol for evaluating the feasibility and impact on case
detection rates of contact tracing and single dose rifampicin. BMJ Open
2016; 6; e013633.
2. Steinmann P, et al. The Leprosy Post-Exposure Prophylaxis (LPEP) pro-
gramme: update and interim analysis. Leprosy Review 2018; 89; 102-116.
3. World Health Organization. Guidelines for the diagnosis, treatment and
prevention of leprosy. 2018; 1-106
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KALA-AZAR VECTOR (PHLEBOTOMUS ARGENTIPES; DIPTERA:
PSYCHODIDAE) CONTROL IN BANGLADESH: A CLUSTER RAN-
DOMIZED CONTROLLED TRIAL
Chowdhury R.1,2, Faria S.2, Huda M.M.1, Chowdhury V.3, Mondal
D.1, Akhter S.2, Akter S.2, Nabi S.G.4, Dash A.P.5, Banu Q.6
1International Centre for Diarrhoea Disease Research (icddr,b);
2Dept. of Medical Entomology, National Institute of Preventive and
Social Medicine (NIPSOM), Mohakhali;
3Dept. of Statistics, Dhaka College;
4Dept. of Parasitology, Mugda Medical College, Dhaka, Bangladesh;
5Central University of Tamil Nadu, Thiruvarur, India;
6Dept. of Biology, Asian University for Women, Chittatong,
Bangladesh
Background: A number of studies on visceral leishmaniasis (VL) vector
control tools have been conducted during the past decade with
sometimes confirmative and sometimes contradictory Results.
Aim: We aimed to investigate a large sample different options which have
not yet been fully explored including: (1) indoor residual spraying (IRS)
with alpha cypermethrin 5WP; (2) long lasting insecticide impregnated
bed-net (LLIN); (3) impregnation of local bed-nets using insecticide
KOTAB-123 (KOTAB); (4) possible breeding places sprayed with chlor-
pyrifos 20EC (OUT) and five different combinations.
Methods: The study is a controlled cluster randomized trial where 3089
houses from 11 villages were divided into 10 sections, each section having
six clusters and each cluster having about 50 houses. Vector density was
measured before and up to 22 months after intervention using CDC light
traps.
Results: Total 17,434 sandflies were collected during baseline and 9
follow-up surveys. At baseline, the average Phlebotomus argentipes
density per household was 10.6 (SD=11.5) in the control arm and 7.3
(SD=8.46) to 11.5 (SD=20.2) in intervention arms. Among single type
interventions, the effect of IRS with 2 rounds of spraying ranged from
13% to 75% reduction of P. argentipes density compared to control
arm (rate-ratio [RR] ranged from 0.25 to 0.87). LLINs caused a vector
reduction of 9% to 78% (RR, 0.22 to 0.91). KOTAB reduced vectors by
4% to 73% (RR, 0.27 to 0.96). The combination of LLIN and OUT reduced
26% to 86% (RR, 0.14 to 0.74) vector. The reduction for IRS and OUT
together was 8% to 88% (RR, 0.12 to 0.92). IRS and LLIN combined
resulted in a vector reduction of 13% to 85% (RR, 0.15 to 0.77). IRS
plus KOTAB reduced vector densities by 16% to 86% (RR, 0.14 to 0.84).
Some intermediate measurements for KOTAB alone and for IRS plus LLIN;
and IRS plus KOTAB were not statistically significant. The bioassays on
sprayed surfaces or netting materials showed favourable Results (>80%
mortality) for 22 months (IRS was 12 months). In the KOTAB a gradual
decline was observed after 6 months.
Conclusions: LLIN and outdoor spraying was the best combination to
reduce VL vector densities for 22 months or longer.
The intervention Results presented as the range of percent reductions of
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CAN BUILDING A COMMUNITY OF PRACTICE IMPROVE PHAR-
MACOVIGILANCE IN AFRICA?
Walker R.J.1, Lang T.2, Allen E.3
1The Global Health Network;
2The Global Health Network, University of Oxford, Oxford, UK;
3Division of Clinical Pharmacology, Dept. of Medicine, University of
Cape Town, Cape Town, South Africa
Introduction: Undertaking effective drug safety monitoring can be
particularly challenging in low-resource settings due to a lack of
infrastructure, weak regulatory systems and limited access to training
and education opportunities. Having identified that more could be done
to provide new, or link to existing, free or low-cost resources, Global
Pharmacovigilance (GPV) was launched as a new online member site
on The Global Health Network (TGHN) in mid-2016. GPV hosts a broad
range of information, including notices of events, training and education
opportunities, news items, links to a pharmacovigilance organisations,
institutions and societies, and a growing number of articles on related
topics. The platform is consistently in the top 5 most-accessed sites
forming TGHN, and, following on from this successful start, we will look
to harness its membership to work together in a ‘community of practice’
on specific challenges facing pharmacovigilance in Africa.
Aim: To assess whether a dedicated online pharmacovigilance platform
would be taken up and used within Africa, and to measure the
impact of these resources and increased engagement on drug safety
reporting.
Methods: This project will take an action research mixed Methods
approach. The GPV platform will be used to identify volunteers with an
interest in working in a community of practice to address areas of interest
and perceived needs in African pharmacovigilance. Online surveys, and
qualitative Methods will be used to identify and understand gaps in
pharmacovigilance resources. The parties will then work together to
develop identified training, guidance, tools, using the online environment
as the workspace for discussions, networking and dissemination of
outputs. A final survey will gather impressions of whether the project
has impacted pharmacovigilance practice.
Results: Results will be presented in the form of a knowledge/resource
gap analysis for pharmacovigilance in Africa, qualitative data on safety
reporting in case study regions, and qualitative/quantitative data on the
uptake and use of the platform and resources.
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EVALUATION OF THE IMPACT OF AN INTERVENTION TO REDUCE
MALARIA MORBIDITY AND MORTALITY IN BURKINA: 2006-
2015 RETROSPECTIVE STUDY
Akotionga E.1, Ouedraogo T.2, Nassa S.1, Nitiema A.P.1, Bakiono
F.3, Bicaba A.4, Bazira L.5, Nakoulma R.J.F.6, Laokri S.7, Com-
paoré C.S.I.8
1Directorate General of Studies and Sectoral Statistics (DGESS) in
Ouagadougou;
2JPHIEGO;
3Health Service of the Armed Forces of Burkina Faso;
4Public Health Research and Study Society (SERSAP), Oua-
gadougou, Burkina Faso;
5Faculty of Medicine, University of Burundi, Bujumbura, Burundi;
6Marie Stopes International Burkina Faso, Ouagadougou, Burkina
Faso;
7Free University of Brussels (ULB), Brussels, Belgium;
8National Malaria Control Program, Ouagadougou, Burkina Faso
Introduction: Malaria remains a public health problem in the world and
in Africa. In Burkina Faso, 45.7% of consultations and hospitalizations, as
well as 25.2% of deaths are related to malaria. Each year, considerable
resources are committed to combat this scourge.
Aim: The aim of this study was to evaluate the impact of health expendi-
ture on malaria control monitoring indicators in Burkina Faso over a period
of 10 years.
Methodology: This is a cost-effectiveness medico-economic study on the
financing committed in the fight against malaria in Burkina Faso from
2006 to 2015. Through the analysis of the data of the health accounts
and epidemiological data, the aim was to study the impact of funding on
the reduction of morbidity and mortality related to malaria.
Results: In Burkina Faso, health expenditures were set at 4.990.040.000
$US from 2006 to 2015. 14.4% of these expenditures, with an average of
71.814.800 $US per year, were used to combat malaria. The contribution
of households in this funding accounted for 42.2%. This has reduced the
distances of access to care from 7.8 to 6.8 km, improved attendance of
populations with a number of new contacts per capita and per year from
0.37 to 0.87 for the general population and from 1.4 to 1.7 for children
under 5 years of age.
Among the observed effects, there is a reduction in malaria lethality from
2.3% to 1.2% in the general population, from 4.0% to 1.5%, in children
under 5 and 1.5% to 0.2% in pregnant women (P = 0.0001). Malaria
incidence has also been observed to increase from 181  to 449  in the
general population and from 468  to 947  in children under 5, justified
by the reduction in access distances to health care, the implementation
of subsidy and free healthcare policies.
Conclusion: Direct payments challenge policymakers to maintain advo-
cacy to mobilize more resources and direct action towards universal
health insurance to help reduce malaria mortality by 40% by 2020.
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ELECTRONIC DATA CAPTURING FOR THE WHO VERBAL AUTOPSY
INSTRUMENT TO FACILITATE ROUTINE CAUSE OF DEATH
MONITORING
Di Pasquale A.1,2, Leitao J.3, Nichols E.4
1Dept. of Epidemiology and Public Health, Swiss Tropical and Public
Health Institute, Basel;
2University of Basel, Basel;
3Health Information and Statistics, WHO, Geneva, Switzerland;
4International Statistics Division, Centers for Disease Control and
Prevention, Hyattsville, USA
Introduction: Verbal autopsy (VA) is a systematic approach for determin-
ing individuals’ causes of death (CoD) in populations without a complete
vital registration system. It consists of relatively lengthy interviews to
collect information about the signs, symptoms, and other characteristics
of a deceased person.
Aim: Our objective here is to describe the process used to implement, and
standardise the WHO VA instrument using an electronic data collection
system to make it feasible for application on a larger scale such as in
routine civil registration and vital statistics (CRVS) systems.
Methods: Recent technological advances, specifically mobile devices
used for electronic data collection (EDC), and adoption of data
management best practices using Open Data Kit (ODK 1) survey software
have the potential to resolve many of the major shortcomings of running
a paper data collection (PDC) surveys. The WHO 2016 Verbal autopsy
instrument (fully compatible with publicly available analytical software
for assigning the cause of death) was translated in EDC format and used
in different countries and settings to collect the data requested using
Android devices through the ODK software. The conversion to EDC allowed
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to ensure the robustness of the instrument and the easy use of it from
fieldworkers without specific IT skills. ODK allows the possibility to localize
the instrument (e.g. language, country specific variables), maintaining
the core questions and functionality of the master VA instrument. After
data collection, we assessed the time required for data collection and
the completeness of the data feeding the analytical software for analysis
available.
Results: Time to availability of a record is reduced with ODK (data flows to
the database in near real time). Fieldworkers take on average 20 minutes
less for a questionnaire than with paper forms. Costs are reduced by the
absence of paper and data clerks also reducing the possibility of manual
introduced errors.
Conclusion: EDC addresses some problems posed by PDC through
validation at data collection time, near real time data to the central
database, mostly automated review protocols, reports of data issues for
managers allowing near real time review and processes. Electronic data
capture can improve quality, timeliness, and costs (1).
Reference:
1. Di Pasquale A. Improving quality, timeliness and efficacy of data
collection and management in population-based surveillance of vital
events [Internet] [Thesis]. University_of_Basel; 2018 [cited 2019 Mar 13].
Available from: http://edoc.unibas.ch/diss/DissB_12701
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BURDEN OF DISEASE IN NEONATAL UNITS IN NIGERIA AND
KENYA
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Introduction: Sub-Saharan Africa bears the greatest burden of the 2.6
million neonates that die every year and progress in improving survival
has been slow. A key challenge for quality improvement is a lack of good
quality routine clinical data to quantify common neonatal morbidities
and describe current treatment strategies.
Aim: To establish a central clinical database of all admissions to 7
neonatal units (NNUs; 5 in Nigeria and 2 in Kenya), to estimate the burden
of newborn morbidity and mortality, describe care practices and identify
key targets for interventions.
Methods: From August 2018-February 2019, participating NNUs com-
pleted standardised case report forms. Data was entered into a REDCap
database and analysed using Stata v15.0.
Results: 1,617 newborns were included. Mean maternal age was 29
years (SD 6.2) and the majority (1455, 89%) were married. 176/1598
(11%) mothers had not attended antenatal clinic, 75/1595 (4.7%)
were HIV positive and 18/841 (2%) Hep B positive. 239/1485 (16%)
had pregnancy induced hypertension,108/789 (14%) an antepartum
haemorrhage and 20/1242 (2%) gestational diabetes. Most infants were
singleton: 1315/1598 (82%).
Most births were facility-based (1472/1604; 92%) and 923/1602 (58%)
were vaginal deliveries. Mean birth weight was 2.44 kg (SD 0.95) and
median gestation was 37 weeks (IQR 33, 39). 824/1617 (51%) infants
were low birth weight (<2.5kg) of whom 351/824 (43%) were very low
birth weight (vLBW; <1.5 kg). 88/239 (37%) of vLBW infants died before
their first feed and only 5/150 (3%) received a feed within 1 hour of birth.
141/259, 54% received breastmilk as the first feed. Use of breastmilk
fortifier was uncommon (2, <1%).
Common neonatal morbidities were jaundice (725/1617, 45%), sepsis
(629/1617, 39%), respiratory conditions (471/1617, 29%), birth asphyxia
(307/1617, 19%) and congenital anomalies (93/1533, 6%). Only 46/1617
(3%) had an abdominal condition including necrotising enterocolitis.
264/1617 (16%) newborns died prior to discharge.
Conclusion: Electronic linkage of clinical databases identifies a high bur-
den of maternal and neonatal illness and identifies areas for quality
improvement and research. Feeding practices in vLBW infants were sub-
optimal. The very low frequency of abdominal signs suggests feeds could
be introduced earlier which may improve outcomes.
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LITERATURE REVIEW: THE IMPACT OF HOUSEHOLD AIR POLLU-
TION AND EFFECTIVENESS OF CLEAN-BURNING COOKSTOVES
ON MATERNAL AND NEONATAL HEALTH
McIntosh A.
Norwich Medical School, University of East Anglia, Norwich, UK
Introduction: Household air pollution poses a threat to the health of
women worldwide, increasing the risk of cancer, cardiovascular and
respiratory disease. Ambient air pollution is linked to adverse pregnancy
outcomes, yet the impact of household air pollution on pregnant women
who spend a large amount of time cooking is underreported, as is
the effectiveness of clean-burning cookstoves in improving pregnancy
outcomes.
Aim: To explore the impact of pollution exposure within the home from
cooking during pregnancy in low to middle income countries, and if clean-
burning cookstoves are effective in improving maternal and neonatal
health.
Methods: Comprehensive search on multiple databases was conducted
for relevant literature, using key terms related to maternal and neonatal
health combined with Boolean operators, subject headings and the terms
“household air pollution”, “indoor air pollution” and “cook∗”. 47 studies
met inclusion criteria.
Results: This review exploring the role of household air pollution
on pregnancy shows that cooking with polluting fuels significantly
increases the risk of stillbirth, low birth weight and neonatal mortality,
which may be mediated by preterm birth or growth restriction. Early
evidence suggests that it may also increase the risk of hyperten-
sion and birth defects. This risk varies amongst different fuels and
may be higher for kerosene and coal users. Evidence that clean-
burning cookstoves are effective in improving pregnancy outcomes is
limited.
Conclusion: Despite evidence for an increased risk of stillbirth, low birth
weight and neonatal mortality from household air pollution, it is unclear
which pollutants cause adverse birth outcomes. Further research is
required to establish if clean-burning cookstoves are effective and to
better establish the role of household air pollution on outcomes such as
preterm birth. A stronger evidence base is required to speed up the slow
uptake of cookstoves across the globe to minimise the burden of disease
and improve maternal and neonatal health.
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A MIXED METHODS EVALUATION OF THE FEASIBILITY AND
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CHILDHOOD ILLNESSES THROUGH USE OF MOBILE TECHNOL-
OGY IN A DEVELOPING COUNTRY SETTING
Munir M.1, Siddique D.A.1, Hussain O.2, Habib A.2, Khan A.J.3,
Chandir S.3,4
1Maternal and Child Health, Interactive Research and Develop-
ment;
2Interactive Health Solutions, Karachi, Pakistan;
3Interactive Research and Development, Singapore;
4Center for Global Health Delivery, Harvard Medical School, Dubai,
UAE
Introduction: Launched by the World Health Organization (WHO) in 1995,
the Integrated Management of Childhood Illnesses (IMCI) strategy was
designed to reduce childhood mortality across the globe through better
management of common childhood illnesses by frontline health workers
(FHWs). However, due to persistent barriers to implementation, its impact
has been limited and transient, especially in resource-constrained set-
tings. We developed an electronic version of IMCI (eIMCI) using Android
technology to overcome implementation problems, including poor proto-
col compliance, lengthy trainings, and paper-based data collection.
Aim: Our aim was to test the feasibility of eIMCI in low-resource settings.
Methods: We conducted a mixed Methods pilot study in Muzzafargarh,
a rural district of Pakistan’s Punjab province. The pilot consisted of 8-
weeks of field-testing of eIMCI phone-application by 10 Frontline Health
Workers (FHWs) in 5 public health facilities. Baseline and end line surveys
were conducted to capture basic health data for pre-post evaluation. 5
in-depth interviews (IDIs) were conducted with FHWs and 3 IDIs were
conducted with medical officers (MOs) at participating health facilities
to elicit opinions and perceptions, and 3 Focus Group Discussions (FGDs)
were held with mothers of enrolled children. The data analysed included
health indicators from the eIMCI application, demographic and health
information from the baseline and end line survey as well as the quali-
tative data from interviews and discussions.
Results: A total of 1,979 children were enrolled in the eIMCI appli-
cation during the 8-weeks of implementation; average screening time
per child was 15 minutes. FHWs appreciated the application’s ease of
use, and mothers reported enhanced FHW productivity. Medical Offi-
cers reported increased utilization of facility services following eIMCI
deployment, revealing strengthened referral linkages between various
cadres of the health system. Diarrhea incidence decreased from 84.2%
to 69.0% and referrals to the community vaccinator by FHWs increased
from 0 to 33.0%.
Conclusion: Evidence from eIMCI pilot indicates the feasibility of eIMCI,
and delineates the benefits associated with digitizing the IMCI proto-
col. Further studies should be undertaken with larger sample sizes and
randomized design to estimate impact of eIMCI on child morbidity and
mortality.
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IS CLIMATE THE GREAT DRIVING FORCE BEHIND DENGUE
INFECTIONS IN URBANS AREAS? A STUDY IN DENGUE-
ENDEMIC SANTO DOMINGO, DOMINICAN REPUBLIC
Tapia L.1,2, Arredondo-Abreu C.2, Ruiz-Matuk C.B.2, Paulino-
Ramirez R.1,2
1Institute for Tropical Medicine & Global Health, Universidad
Iberoamericana;
2Research Dept., Universidad Iberoamericana, Santo Domingo,
Dominican Republic
Introduction: The Caribbean Region is home to Dengue viruses and its
vectors due its tropical climate. With new evidence of climate change,
monitoring of climatologic factors has emerged as a prevention strategy
for tropical infections. Understanding tropical disease dynamics based
on climatologic variables is the key to achieve eradication of arthropod-
borne diseases, especially in heavily populated urban areas.
Aim: The aim of this study is to describe the relationship between clima-
tologic factors and dengue cases in Santo Domingo.
Methods: Weekly dengue reports from January 2012 to December 2017
were extracted from the Ministry of Health database. Meanwhile, Maxi-
mum, Minimum and Mean Temperature, Rainfall and Relative Humidity
were obtained from to the National Meteorological Office. Correlations of
individual factors were calculated using 1 weeks and 12 weeks. Regres-
sions for these lags were conducted to explain the individuality of the
climatologic factors.
Results: The 1-week lag shows a correlation between Dengue Cases and
Average Temperature (rho=0.22, p < .01), Dengue Cases and Rain (rho =
-.14, p < .05), and Dengue Cases and Humidity (rho = -.16, p < .05.). The
regression model performed at 1 week lag explains 4% of the variance
and was a significant predictor F(3,308), p < 0.01; Average temperature
(B = 11.26, p < 0.01) and Humidity (B = -4.08, p < 0.01) contributed
significantly to the model. The12 weeks lag shows a negative correlation
between Dengue Cases and Mean Temperature (rho= -0.20, p<0.01),
Dengue Cases and Rain (rho= -0.15, p<0.01), and Dengue Cases and
Humidity (rho= -0.20, p<0.001), the regression model explains 21% of
the variance and was a significant predictor F(3,297), p < 0.001; Average
Temperature (B = -28.67, p <0.001) Humidity (B = -6.60, p <0.001)
contributed significantly to the model.
Conclusion: The relation between climate and infectious diseases in
urban areas is complex. Temperature, rainfall and humidity has demon-
strated to individually correlate with Dengue infections in the city of
Santo Domingo. Strategies must be developed to take into consideration
the changing climate experienced in the Dominican territory as well to
compare the climatologic drive for dengue infections in other parts of the
nation.
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IDENTIFICATION OF HIGH-RISK AREAS OF LEPROSY IN NORTH-
WEST BANGLADESH – A GEOSPATIAL MODELLING AND ECO-
LOGICAL STUDY
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J.C.4, Nicholls P., Le Rutte E.1,6, de Vlas S.1, Richardus J.H.1
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6Swiss Tropical and Public Health Institute, Basel, Switzerland
Objectives: Countries often have difficulty to localise focal high-risk areas
or ‘hotspots’ of leprosy. Geospatial tools seem promising to support the
“final push” towards zero leprosy, to strengthen capacities in surveillance
and to monitor new cases.
Aim: We aim to geospatially visualize leprosy incidence trends and iden-
tify the potential presence of leprosy hotspots in Bangladesh over the
past two decades, and explore possible environmental predictors of
leprosy.
Methods: Data come from four districts in northwest Bangladesh, where
a total of ∼10,000 cases were included between 2000-2018. GPS coordi-
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A Poisson model was used to detect spatiotemporal hotspots of high
incidence among the population. Hotspots among children <15 years
and early stage MB cases (characterized by grade 0 disability and positive
skin smear) were identified, indicating active foci of leprosy transmission.
For the ecological analysis we utilize open-source environmental and
location data (UN, NASA, Google) to explore possible predictors of leprosy
hotspots: population density, landcover, and proximity to water bodies,
clinics or towns.
Results: Preliminary results show that annual incidence levels dropped
from ∼3.3 to ∼1.2 cases/10,000 capita during the study period; the
number of MB cases (a quarter of all cases) remained relatively sta-
ble. Over 10% of the cases <15 years at time of diagnosis, which is
above the reported mean global estimate (7.5%). Of all MB cases, 30%
were detected during the early stage of disease. Statistically significant
hotspots of both incidence and transmission were identified. Hotspots
largely varied in size (2-40km radius), and captured 150-10,000 people.
The relative risk of having leprosy was always ∼2 times higher for inhabi-
tants of hotspots, compared to those living outside hotspots. Hotspots of
active transmission – characterized by large numbers of patients under
the age of 15 years and early MB patients – appear to be located in areas
with high population densities.
Conclusion: Comparable to other endemic pockets across the world, lep-
rosy shows a heterogenous distribution with clear hotspots in northwest
Bangladesh. Identifying such hotspots helps to geographically target
active case-finding strategies towards achieving the WHO global leprosy
goals.
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SPATIAL DISTRIBUTION AND POLYMORPHISM OF THE
PFKELCH13 GENE IN AFRICA IN THE ERA OF EMERGING
PLASMODIUM FALCIPARUM RESISTANCE TO ARTEMISININ AND
DERIVATIVE DRUGS: A COMPREHENSIVE SYSTEMATIC REVIEW
Kayiba N.1,3, Yobi D.4, Rosas-Anguirre A.1, Devleesschauwer D.1,
Mvumbi D.4, Okitolonda E.3, DeMol P.2, Mvumbi G.4, Hayette
M.P.2, Speybroeck N.1
1Faculté de Santé Publique, Université Catholique de Louvain, Brux-
elles;
2Centre Hospitalier Universitaire de Liège, Université de Liège,
Liège, Belgique;
3Ecole de Santé Publique, Université de Kinshasa, Kinshasa;
4Université de Kinshasa, Faculté de Médecine, DR Congo
Introduction: The emergence of Plasmodium falciparum (Pf ) resistance
to artemisinin (PfART-R) in Africa is a worrisome situation that would
annihilate the progress made in reducing the global burden of malaria.
The discovery of mutations occurring in portions of the Pf gene sequence
encoding kelch 13 (PfK13) – propeller domain and inducing PfART-R, has
provided unprecedented opportunities for monitoring such resistance at
large scale.
Aim: This study aimed to review the PfK13 allelic polymorphism and
its spatial distribution in Africa for drawing a baseline for subsequent
epidemiological surveillance and containment efforts of PfART-R.
Methods: A systematic review was performed according to PRISMA guide-
lines through six electronic databases consulted up to December 2018.
Studies assessing the PfK13 gene in any of the 54 African countries were
explored and data related to individual single nucleotide polymorphisms
from each report and sampling location were geo-referenced and locus-
referenced to be uploaded on maps displaying spatial and molecular
patterns.
Results: From 8,678 screened records, 50 reports were identified as
eligible providing 22,739 Pf isolates successfully sequenced for the PfK13
and originating from 109 sites surveyed in 41 African countries. Overall
619 nonsynonymous (NS) mutants (2.7% of sequenced isolates) were
reported at varied relative frequencies (0.5 to 50%) most often being
K189T and A578S.Intermediate proportions (30 to 50%) of NS mutants
were found in Western and Eastern Africa, moderate proportions (10 to
20%) in Middle Africa and low to very low proportions (<5%), elsewhere.
NS mutations were not detected in 11 of 41 sampling countries. A total of
8 PfK13 NS mutations (F446I, C469Y, R515K, S522C, P553L, V568G, P574L,
and A675V) out of 24 known as “associated molecular markers” for
PfART-R were noticed at relative frequencies from 0.08 to 10.2%. One NS
mutation (M476I) out of 6 established as “validated molecular markers”
for PfART-R was reported at a relative frequency of 0.42%. Possible foci of
NS mutations were noticed in Eastern, Western, and Middle Africa.
Conclusion: Africa has noticed rare but alarming signals of possible
emergence of Pf -ART-R. Proactive surveillance strategies are needed
to be established in different African regions to refrain from massive
development of resistance.
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THE PSYCHOSOCIAL BURDEN OF LOCALISED CUTANEOUS
LEISHMANIASIS - A POINT OF VIEW
Bennis I.1,2, Boelaert M.2
1National School of Public Health, Ministry of Health, Rabat,
Morocco;
2Dept. of Public Health, Institute of Tropical Medicine, Antwerp,
Belgium
Introduction: Localised cutaneous leishmaniasis (LCL) is considered to
be a self-healing parasitic dermatological disease. However, depending
on the severity, type of lesions or scars, and context, CL can lead to self-
and social stigma influencing quality of life (QoL) and psychological well-
being, with potential association with co-morbid depressive disorders.
These dimensions have been spotlighted in recent reviews and are now
the subject of research in additional sites around the world.
Aim: To highlight the substantial psychosocial burden and stigma linked
to LCL as hidden problems that the scientific community and health
professionals should be aware of.
Methods: This is a point of view based on the authors’ previous work and
on their review of the most relevant recently accepted articles (up to the
end of 2018).
Results: LCL patients suffer from various psychological and social
problems. Besides the skin lesion itself, there are other major problems
associated with a loss of self-confidence, self-esteem, and self-
awareness; the presence of stigma, segregation, social contempt,
avoidance by others, marriage difficulties and self-harm due to feelings
of embarrassment, shame, anxiety, sadness, depression, and/or suicidal
thoughts which are not directly checked for or treated by health
professionals, who only consider the dermatological condition. Moreover,
the psychosocial burden on LCL patients is multi-dimensional, including
self-acceptance, expectation of stigma, adaptation to anxiety and
depression, fear of scars being of spiritual origin, and changes in
perception of body image. However, this multi-dimensional interaction
is dynamic and time dependant, decreasing or increasing the overall
suffering of the individual and family. The perception of LCL scars as
being due to a curse or a fatality destroys the life of young unmarried
people and remains the most difficult mental health issue that needs
addressing.
Conclusion: Considering LCL as a self-healing disease hides a consistent
psychosocial burden; the scientific evidence is being reinforced by
qualitative studies and pragmatic clinical trials. The latest studies














PSYCHOLOGICAL AND PSYCHOSOCIAL CONSEQUENCES OF
ZOONOTIC CUTANEOUS LEISHMANIASIS AMONG WOMEN IN
TUNISIA
Bellali H.1,2, Ben Jemaa S.3, Bellaj T.3, Chahed M.K.1,2
1Dept. of Epidemiology and Public Health, Faculty of Medicine of
Tunis, Tunis-El Manar University, Tunis;
2Research Unit ‘Analysis of the Effects of Environmental and Cli-
mate Changes on Health’, Dept. of Epidemiology and Statistics, A.
Mami Hospital, Ariana, Tunisia;
3Psychology Dept., University of Human Sciences of Tunis, Tunis,
Tunisia
Introduction: Zoonotic cutaneous leishmaniasis (ZCL) is the most
common form of leishmaniasis in Tunisia. The disease is not severe; it
heals spontaneously but leaves a definite scar, which has a psychosocial
impact, mainly when the lesion occurs on the face.
Aim: To assess the psychosocial impact of ZCL scars among Tunisian
women.
Methods: We conducted an exploratory study among a volunteer group
of girls and women selected randomly in primary health care facilities
during medical visits for any pathology or for routine vaccination of
children. A psychologist and/or a ZCL health educator administered the
Revised Illness Perception.
Questionnaire (IPQ-R), Psoriasis Life Stress Inventory (PLSI), and World
Health Organization Quality Of Life-26 (WHOQOL-26) questionnaires to
this group in their homes or at the local clinic.
Results: The distributions of the scores collected from the three
scales are heterogeneous: IPQ-R (M = 63.6, SD = 15.6), PSLI (M = 9.5,
SD = 6.7), WHOQOL Physical (M = 63, SD = 12.9), WHOQOL-Psychological
(M = 52.6, SD = 11.1), WHOQOL Social (M = 61.8, SD = 17.5), and WHOQOL-
Environmental (M = 47.8, SD = 13.3). We demonstrated a wide range
of psychological effects (anxiety, psychological distress, lack of self-
confidence and self-esteem, frustration, etc.) and psychosocial impacts
(stigma, rejection, discrimination in social and professional settings, etc.)
of permanent ZCL scars, mainly when located on the face. Emotional
representations associated with ZCL were correlated with a loss of
self-esteem and feelings of inferiority (r = 0.77, p<0.05). High levels
of education and knowledge about ZCL are positively correlated with
cognitive and emotional representation in the IPQ-R (r = 0.33, p<0.05).
"Rejection experiences" and the "anticipation and avoidance of stress"
were negatively correlated with age (r = -0.33, p<0.05 and r = -0.31,
p<0.05).
Conclusion: This study suggests the need for social and psychological
support and professional integration for women and girls in rural
remote areas. Combating real and/or perceived stigmatization is another
decisive step in the delivery of care, because stigma has negative
impacts on quality of life, mental health and participation in social and
professional life.
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THE FUTURE OF GLOBAL TREATMENT OF CUTANEOUS LEISHMA-
NIASIS
Arana B.
Drugs for Neglected Diseases initiative, Geneva, Switzerland
Introduction: Ideally, treatment for cutaneous leishmaniasis (CL) would
be based on the clinical presentation: local therapies for subjects with
small/ few lesions, systemic oral drugs for subjects with numerous
or large lesions, and an anti-leishmania drug in combination with an
immunomodulator to enhance a Th-1 type immune response in subjects
with complicated forms of CL.
Aim: To describe the current research landscape of programs aiming to
develop new treatments for CL.
Methods: A literature review and landscape analysis of research groups
working on different types of treatment for CL were conducted.
Results: Treatment of CL has long depended on antiquated drugs
that would be considered far too toxic for introduction under modern
registration systems. There are no examples of a pre-clinical testing
strategy that has led to the formal clinical development of an anti-CL
agent. Most efforts on discovering new chemical entities (NCEs) focus on
visceral leishmaniasis (VL). Luckily, compounds that have been shown
to be effective against VL have also shown activity against CL strains.
DNDi, in collaboration with other groups, is working to discover and
develop NCEs, some of which are already in initial clinical development.
Developing an NCE is, however, expensive and time consuming, hence it
is not surprising that most efforts to find new treatments for CL focus on
repurposing drugs that are already on the market for other conditions,
or using existing CL treatments in combination. Immuno-chemotherapy
and therapeutic vaccines represent an alternative modality of treatment.
Conventional CL chemotherapy aims to kill most of the parasites and it
is hypothesized that fostering an effective immune response in the host
will improve the control of any remaining parasites. DNDi is working on an
immunomodulator which activates the innate and adaptive immune sys-
tem by triggering Toll-like receptor 9 expressed on plasmacytoid dendritic
cells. This very specific stimulation favors Th1 type responses that are
known to be effective in clearing parasites and promoting lesion healing.
Conclusion: Although progress has been made for the treatment of VL,
it is likely that currently available treatments represent almost the entire
therapeutic arsenal for CL for the coming years.
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SENTINEL SURVEILLANCE THROUGH TRAVELLERS: EVALUA-
TION OF AN FTA CARD BASED MOSQUITO SALIVA TRAP FOR
ARBOVIRUS MONITORING
Hedrich N.1,2, Vavassori L.1,2, Guedes R.D.3, Paiva M.H.S.3, Beuret
C.4, Neumayr A.1,2, Müller P.1,2
1Vector Control Group, Dept. of Epidemiology and Public Health,
Swiss Tropical and Public Health Institute;
2University of Basel, Basel, Switzerland;
3Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife,
Brazil;
4Spiez Laboratory, Spiez, Switzerland
Introduction: Arboviruses (arthropod-borne viruses) represent a large
and increasing burden of disease threatening both human and animal
health. Many of these viruses are transmitted by mosquitoes, including
dengue, chikungunya, and Zika virus, and are a particular hazard to
travellers. The increase in international travel Results in a worldwide virus
circulation, and favors the transmission in non-endemic areas. As such,
arbovirus surveillance is fundamental to detect outbreaks before they
expand, to inform vector control strategies, and to evaluate the risks for
travellers. A new promising method of arbovirus surveillance is the use
of nucleic acid preserving Flinders Technology Associates (FTA) cards to
collect mosquito saliva.
Aim: To evaluate the use of FTA cards included into specialized kits for
arbovirus surveillance and the use of travellers as sentinels as part of the
global Zikaplan initiative.
Methods: We have developed mosquito saliva kits containing sugar-
baited FTA cards, which are given to travellers who are going to Brazil,
recruited through the travel clinic at the Swiss Tropical and Public Health
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the presence of arbovirus RNA using RT-qPCR and sequencing. Initial
experiments with laboratory infected mosquitoes will be conducted to
examine the usability of the cards to detect viruses from mosquito saliva,
and the ability to detect multiple infections on one card.
Results: More than 50 travellers have been recruited to the study carrying
250 FTA card kits to various destinations across Brazil.
Conclusion: In our presentation we will give the latest results and discuss
how this promising new tool could be expanded across the globe and
possibly replace other Methods of surveillance.
190
MUTUAL FUNDS IN BURUNDI: AN OPPORTUNITY FOR UNIVER-
SAL HEALTH COVERAGE OR ONLY A VESTIGE OF COLONIALITY
IN HEALTH SYSTEMS?
Sere F.1, Nkurunziza E.2, Durnez D.3, Van Belle E.1
1Management & Funding, Memisa, Brussels, Belgium;
2Burundi’s Office, Memisa, Bujumbura, Burundi;
3Projects & Operations, Memisa, Brussels, Belgium
Introduction: By the end of the 20th and beginning of the 21st century,
international – mostly Belgian - organizations filled the gap of health
coverage by promoting and supporting local non-for-profit mutual funds.
A few years later, while the Ministry of Health ignores this initiative, the
mutual funds were acknowledged and authorized by the Ministry of
National Solidarity. Both public and private systems coexist, competing
with each other and therefore increasing the financial risk for the
population.
Aim: Burundi’s health system faces important challenges regarding
fragmentation within the sector. Our research put the question of
relevance of this mutual funds based on a series of parameters, and builds
bridges between public and not-for-profit health sectors, recognizing
their strengths and difficulties and emphasizing the opportunity of
learning.
Methods: As a framework, we assessed the mutual funds based on
UHC models as well as development cooperation guiding principles.
Qualitative Methods were used to assess the financial sustainability,
efficacy and effectiveness of the mutual funds while participatory
observation and semi-structured interviews were conducted to assess
harmonisation, technical and social sustainability, ownership and
alignment.
Findings: The mutual funds, organized within a national platform, are
currently working towards harmonizing their efforts in the country. How-
ever, in some provinces, mutual funds supported by different interna-
tional donors still compete with each other. In 2017, 91.782 inhabitants
of Burundi were covered by the Mutual Funds, which represents 0,8% of
Burundi’s population and 3% of the direct target group.
The affiliation cost can cover the entire expenses for the year. However, all
mutual funds are still supported by international cooperation in some way
(logistics, administration, etc.). The mutual funds don’t have resources to
mobilize in case of outbreak or emergency.
Conclusion: After 20 years of experience, Mutual Funds are not sustain-
able and not well rooted in the country. The implementation of the
national Medical Assistance Card experience difficulties as a UHC policy
at this stage. It is thus not irrelevant for the community to look for alter-
natives. They play however an important role in community development,
by organizing trainings and being presents in the entire country, and as
advocacy organizations.
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SPREADING INTERNATIONAL HEALTH IN PRIMARY CARE
Sequeira-Aymar E., Carcasó-Díaz A., Jiménez-Lozano A.I.,
De Gispert-Uriach B., Saperas-Pérez C., García-Gozalbes J.,
González-Martínez M.A., Mallart-Raventós M., Gispert-sauch-
Puigdevall N.
Commission for Cooperation and International Health (COCOOPSI),
Catalan Society of Family Medicine (CAMFIC), Barcelona, Spain
Introduction: Primary Care (PC) professionals are used to deal with
different situations and scenarios regarding disease, prevention and
health promotion. International Health is a flexible discipline that needs
to be updated very often. In PC context, to introduce this discipline
represents a big challenge. Travelers and migrants have their first access
to the Health system in Catalonia through PC. If the professionals working
in PC are sensitive to this matter a lot of work can be done at this level.
For that a working group about Cooperation and International Health
(COCOOPSI) was created twenty years ago inside the Catalan Society for
Primary Care (CAMFIC).
Aim: Spread International Health matters in PC and improve the skills
of the professionals in the Catalonian region through the activity of a
working group from a scientific society. Give better care to travelers and
migrants in PC.
Methods: Working group members come from different areas of the
whole Catalan region. Meetings are conducted every two months and
between that the contact is through a whats-app group and an e-
mail group address. There are regular links with other organizations
that work in these subjects as Public Health and Tropical Medicine
Hospitals departments. There is also interaction with other groups
inside the Scientific Society as Vaccines, Gynecology or Mental Health.
There are connections with similar groups from other regions of the
country.
Results: Protocols and guides about International Health adapted to PC
are created, reviewed and presented. Same of them are discussed with
other groups from different places or distinct disciplines. On-line course
and different trainings for PC professionals are held. Also provides medical
education for residents at least once a year. Scientific and opinion articles
have been published. Yearly the group implements a funding cooperation
between CAMFIC and health institutions or NGOs working in developing
countries.
Conclusion: PC becomes a great scenario to train and develop abilities
in International Health subjects weaving a network with other actors
through the activity of the working group. Prevention, diagnosis and
treatment for migrants and travelers have improved in the Catalonian
region.
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THE EFFICACY OF THE VILLAGE HEALTH CLUB IN CON-
TRIBUTING TO SUSTAINABLE MANAGEMENT OF CHILDHOOD
MALARIA
Ochieng D.1, Gudoi S.S.1, Bwanika J.B.1, Tushabe B.2, Ssegawa






5Ministry of Health, Kampala, Uganda
Introduction: The village health club (VHC) concept has the power/po-
tential ensuring sustainability of health interventions at community level
and averting childhood illness with great outcomes. The VHC concept is a
community led participatory approach that engages all members of the
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cause of morbidity and mortality in Uganda, contributing to 30-50% of
outpatient visits and half of inpatient pediatric deaths. USAID’s Malaria
Action Program for Districts (MAPD) Projects have designed a Behavior
Change and communication plan to Chase Malaria out of Uganda. One
of the initiatives in changing behavior is the concept of the village health
club that serve as a sustainability approach to the community health
initiatives in improving malaria indicators.
Aim: To assess the efficacy of Village Health Clubs in contributing to
sustainable management of childhood malaria.
Methods: The Project closely worked with VHCs and Health facilities,
providing coaching, mentorship and support supervision. There have also
been behavioral Change campaigns in place to aid in health promotion.
Employing a quasi-experimental study methodology, Results looked at
the implementation areas with VHCs and control areas without VHT in
order to counteract the outcomes of the interventions.
Results: Uncomplicated malaria at the Outpatient department for chil-
dren below 5 years reduced from 10.9% in 2016 to 10.8% and to 8.2% in
2017 and 2018 respectively in the intervention arm while in the control
arm, it was at 13% in 2018. On the other hand, severe malaria reduced
from 24.6% in 2017 to 15.9% in 2018. And In-patient deaths due to
malaria for children under 5 reduced from 13.4% in 2016 to 5.4% in 2017
to 2.8% in 2018 on intervention arm.
Conclusion: To realize positive outcomes in the long run, there’s need for
a holistic approach at the community level to completely fight malaria in
the region, since it greatly impacts on the country’s economy and reverses
the Gross domestic Product (GDP) since a lot of money is spent in treating
malaria.
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SCHISTOSOMA MANSONI INFECTION AMONGST SCHOOL-AGE
CHILDREN IN MAROLAMBO, MADAGASCAR: RESULTS FROM A
THREE YEAR ANNUAL FOLLOW-UP STUDY
Spencer S.A.1, Penney J.2, Linder C.2, Russel H.2, Hyde K.2,
Henstridge-Blows J.2, Young I.1, Stothard J.R.3, Bustinduy A.L.4,
Rahetilahy A.5
1North Bristol NHS Trust, Bristol;
2University of Manchester, Manchester;
3Liverpool School of Tropical Medicine, Liverpool;
4London School of Hygiene & Tropical Medicine, London, UK;
5Ministère de la Santé Publique, Antananarivo, Madagascar
Introduction: Schistosoma mansoni causes substantial disease burden
in eastern Madagascar, where prevalence of egg-patent infections can
be greater than 94%. Madagascar Medical Expeditions (MADEX) is a
voluntary research organisation set up by students from the University
of Manchester to tackle this issue, integrating activities alongside actions
of the national control programme.
Aim: To investigate and monitor schistosomiasis prevalence and morbid-
ity in school-age children in response to annual mass drug administration
(MDA).
Methods: Repeated cross-sectional surveys across six villages in the
Marolambo district, every June from 2015 to 2017. Prevalence of S.
mansoni was determined by Kato-Katz stool microscopy and urine cir-
culating cathodic antigen (CCA) tests. Eggs of S. mansoni were visualised
by microscopy with eggs per gram of stool (epg) calculated.
Results: Prevalence of S. mansoni by urine-CCA decreased from 94%
(2015) to 88% (2017) (p=0.005) although prevalence of egg-patent infec-
tion did not change significantly (74% to 77%; p=0.27). However, the
mean epg dropped from 482 to 277 (p <0.001) from 2015 to 2017. More
importantly, heavy infections (>400 epg) declined from 32.1% (69/215)
in 2015 to 17.1% (39/228) in 2017 (p<0.0001) while moderate infections
did not change significantly (31.2% (67/215) to 36.4% (83/228); p=0.24)
light infections increased (36.7% (79/215) to 46.5% (106/228; p=0.04).
Similar changes were observed in grading urine-CCA Results: reduction of
3+ grades from 32.9% (125/379) in 2015 to 3.1% (9/295) in 2017 and
decrease of 2+ grades from 32.5% to 10.8% while increase in trace/1+
CCA grades from 28.4% (108/379) to 73.9% (218/295).
Conclusion: Despite annual MDA of praziquantel in this region, the preva-
lence of egg-patent infections remains a significant public health chal-
lenge. Although we have seen a general shift in the intensity of infection
with S. mansoni from heavy to light, the overall prevalence remained
unchanged (according to stool microscopy) thus we recommend bian-
nual MDA is required in this high transmission zone.
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CHILDHOOD CUTANEOUS TUBERCULOSIS: CLINICO-
EPIDEMIOLOGICAL PROFILE FROM NEPAL
Bhattarai S.1, Shrestha S.B.1, Pradhan S.2
1Dept. of Dermatology and Venereology, Kathmandu Medical Col-
lege;
2Dept. of Clinical Pathology, Kathmandu Medical College, Kath-
mandu, Nepal
Background: Although cutaneous tuberculosis constitutes a small
percentage of extra pulmonary tuberculosis, it has not been fully
documented in Nepal and more so in the pediatric population. Early
detection and intervention could result in fewer morbidities and
mortalities.
Aims: The aim of the study was to assess the epidemiology and clinical
profile of childhood cutaneous tuberculosis at Kathmandu Medical
College and Teaching Hospital, Nepal.
Material and Methods: Children (below 15 years of age) with cutaneous
tuberculosis who attended the teaching hospital between April 2008 and
Dec 2018 were studied.
Results: A total of 18 children with skin tuberculosis were identified
during the study period, which constituted 34% of all patients with skin
tuberculosis. There were 11 boys and 7 girls with a mean age of 8.8
years. The duration of the lesions ranged from 1 month to 4 years and
13 (76.5%) were brought for medical help after six months of onset of
the disease. Lower limb was the most common site of involvement. Of
the various patterns of cutaneous tuberculosis; scrofuloderma and lupus
vulgaris were wthe most common in 7 (33.3%) followed by, erythema
nodosum 2 (11.2%) and gumma 1 (0.05%). Combination of lupus vulgaris
and scrofuloderma was noted in one patient. Three patients (16.6%) had
internal organ involvement as pulmonary tuberculosis.
Conclusion: The pattern of skin tuberculosis had a wide variation with
a few of them having systemic involvement. Therefore, these patients
need a thorough evaluation or a uniform standard therapeutic regimen
to cover both internal organ and cutaneous tuberculosis. Active surveil-
lance and BCG vaccination could help reduce the burden of childhood
cutaneous TB and its further dissemination which till now has reduced
the incidence in children.
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THE IMPACT OF INSULIN DONATIONS FOR CHILDREN IN 43
LOW- AND MIDDLE-INCOME COUNTRIES
Hogerzeil H.V., Recourt S.
Dept. of Health Sciences Global Health, University Medical Centre
Groningen, The Netherlands
Introduction: Diabetes mellitus is rapidly becoming one of the major
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diabetes patients who need insulin to survive, especially in low and
middle-income countries (LMIC), are not able to get this life-saving
medicine. Since 2000 the three major insulin-producing companies
have started support programmes, some with a component of insulin
donations, to children and youth with type 1 diabetes in 43 LMIC. The
impact of these programmes has rarely been studied.
Aim: Study the impact of support programmes with a component of
insulin donation in 43 Low- and Middle Income countries, over the period
2009-2016. This study is part of Health Action International’s ACCISS
study (Addressing the Challenge and Constraints of Insulin Sources and
Supply).
Methods: Literature review of company and foundation websites, annual
reports, peer-reviewed and grey literature, and conference presentations;
discussions with key stakeholders from national diabetes programmes in
LMIC and international experts.
Results: Public reporting is scattered, incomplete and sometimes
inconsistent. Most programmes report large increases in the number
of diabetes treatment centres. The estimated number of children and
young adults benefitting from insulin donations rose from 8’193 in
2009 to 35’382 in 2015. The average body weight and/or body mass
index increased from 4-23% over three years. The median reported
HbA1c value after 1-3 years of treatment was 8,4% (range 7,9-
9,8%), and 9,5% (range 8,2-10,43%) after 6-8 years. In several pro-
grammes the frequency of serious and fatal complications was reduced.
Insulin donation programmes can lead to changes in national health
systems.
Conclusion: We conclude, contrary to common belief, that the diagnosis,
treatment and prevention of fatal complications in children with type 1
diabetes in LMIC is very well possible in practice. Medicine donations
can never offer a sustainable solution and we now propose a ten-
step transition process towards a fully sustainable national diabetes
care and prevention programme for children and youth with diabetes
type 1.
Reference:
1. Hogerzeil HV, Recourt S. Company and company-supported pro-
grammes with a component of donated insulin in low- and middle-
income countries. Amsterdam: Health Action International, 2017. ACCISS
report.
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ORAL FEXINIDAZOLE FOR GAMBIENSE HUMAN AFRICAN TRY-
PANOSOMIASIS: THE WHO TREATMENT GUIDELINES
Franco J.R., Priotto G., Barrett M., Chappuis F., Diarra A., Ebeja
A.K., Kazumba L., Lejon V., Lindner A., Mwamba Miaka E., Olema
E., Seixas J., Simarro P.P.
WHO Guidelines Development Group for Human African Try-
panosomiasis (HAT) Treatment
Human African trypanosomiasis due to Trypanosoma brucei gambiense
(g-HAT) is one of the neglected tropical diseases. Despite tremendous
improvements, g-HAT treatment is disease stage dependent and remains
complex, with intravenous therapy and hospitalization for second stage.
Fexinidazole, developed by the Drugs for Neglected Diseases initiative
(DNDi) and partners, is the first oral monotherapy against g-HAT. Effec-
tive in both disease stages, fexinidazole also simplifies the diagnostic
approach by not necessarily requiring a lumbar puncture and CSF exam-
ination for disease staging. In November 2018, the European Medicines
Agency (EMA) adopted a positive opinion for fexinidazole treatment of
g-HAT under article 58, a mechanism designed for drugs intended for
use outside the EU. The approval of fexinidazole is a breakthrough in
management of the disease. However, as pointed out in the EMA’s
scientific opinion, this new drug also has limitations: Patients with severe
central nervous system involvement are at higher risk of failing treatment
with fexinidazole.
In December 2018, the WHO Guideline Development Group on the treat-
ment of HAT met in Geneva. Backed-up by an independent evidence
review using the GRADE approach (Grading of Recommendations Assess-
ment, Development and Evaluation), an international panel of experts
formulated new recommendations. Available evidence, the benefits and
limitations of fexinidazole, resource implications, patient values and the
aim of disease elimination were considered. The new WHO guidelines
for the treatment of g-HAT, implicating fundamental changes for clinical
practice, will be presented.
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THE CHALLENGE OF THE LABORATORY DIAGNOSIS IN A CON-
FIRMED CONGENITAL ZIKA VIRUS SYNDROME IN UTERO: A
CASE REPORT
Soriano-Arandes A.1, Sulleiro E.2, Rodó C.3, Frick MA.1, Rando
A.2, Suy A.3, Espiau M.1, Martín-Nalda A.1, Pumarola T.2, Soler-
Palacín P.1
1Paediatric Infectious Diseases and Immunodeficiencies Unit,
Hospital Universitari Vall d’Hebron;
2Dept. of Microbiology, Hospital Universitari Vall d’Hebron;
3Dept. of Obstetrics, Hospital Universitari Vall d’Hebron, Barcelona,
Spain
Introduction: Congenital Zika virus (ZIKV) infection has been associated
to microcephaly and other malformations. Laboratory diagnosis should
rely on the detection of ZIKV-RNA, ZIKV-IgM response, or the persistence
of the ZIKV-IgG serological response beyond the first months of age.
However, there are important challenges for ZIKV laboratory diagnosis,
partly due to the narrow ZIKV viremia time-frame.
Aim: To describe the clinical and laboratory outcomes at age 24 months
of the first European alive case of Congenital ZIKV Syndrome (CZS).
Methods: To assess the risk of foetal involvement any pregnant woman
was screened for ZIKV infection following the US-CDC protocol since
February 2016 (1). Confirmed maternal ZIKV infection was defined when
ZIKV RT-PCR tested positive during pregnancy. At birth, ZIKV RT-PCR
assays of the maternal and neonatal samples were also performed.
Infant serological ZIKV IgM/IgG responses were tested during the first 24
months of age. Any child born to ZIKV-infected mother was followed-up
as per protocol at approximately 1, 4, 9, 12, 18-21, and 24 months of
age, by a multidisciplinary team.
Results: We describe a two-year-old girl born in Barcelona to a confirmed
ZIKV-infected mother. Maternal ZIKV RT-PCR tested positive for serum
in the first term of pregnancy, and later in amniotic fluid. Foetal MRI
revealed bilateral ventriculomegaly, a shortened corpus callosum, brain
calcifications, and severe cerebral atrophy. Amniotic genetic and TORCH
testing were respectively normal and negative. She was delivered at
37 weeks’ gestation showing microcephaly and features of foetal brain
disruption sequence. All neonatal ZIKV RT-PCR assays were negative,
ZIKV-IgM was negative in serum and CSF, and congenital TORCH
infections were ruled out. Postnatal neuroimaging studies confirmed
the foetal findings. At 24 months of age her head circumference
was 40.5cm (-4.8 z-score). The patient never tested positive for ZIKV
RT-PCR or specific ZIKV-IgM. Her ZIKV-IgG response was monitored,
seroreversion was first observed at 21-m-old, and confirmed at
24-m-old.
Conclusion: We presume that prenatal ZIKV infection ends during
intrauterine life causing direct injury to foetal brain and other organs,
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INCREASING UNCERTAINTY ON THE DENGUE VACCINE: A THE-
MATIC ANALYSIS OF THE ACUTE MEDIA COVERAGE OF THE
PHILIPPINE DENGUE VACCINATION
Valido E., Jumalon N.J., Roberto G.
Alliance for Improvement of Health Outcomes
Introduction: The Philippines introduced the only mass dengue vaccina-
tion to school children in 2016 and has halted the vaccination after a
dengue vaccine controversy in late 2017. Media coverage of the event
played a role in shaping public opinion and has affected the acceptability
of the dengue vaccine and other vaccines.
Aim: The study aims to explore the themes that emerge acutely after the
start of the dengue controversy that could have affected dengue vaccine
perception.
Methods: Online news clips were collected main news outlets in the
country daily from Nov 31-Dec 31, 2017. The coding instrument captured
how the headline was depicted, how the vaccine and vaccination was
labelled, how the program was initiated, the pharmaceutical industry
response, political motivations and societal issues surrounding the vac-
cine and vaccination and information on dengue. All three authors coded
and codes were managed using Open Code 4.03.
Results: There were 308 articles recorded from 7 news websites. Analysis
showed that media focused on the political motivations in running the
mass dengue vaccination and to the unconfirmed child deaths that were
associated to the vaccine.
Conclusion: The media focus on the possible corruption in the vaccine
program and unverified cause of deaths of children vaccinated may have
generated negative sentiment towards the dengue vaccine and general
public vaccines.
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IMPACT OF CONCOMITANT ADMINISTRATION OF ORAL OR
INJECTABLE POLIOVIRUS VACCINE ON ROTARIX IMMUNO-
GENICITY IN SOUTH INDIA
Parker E.P.K.1,2, Babji S.3, Sindhu K.N.3, Immanuel S.3, Kumar
V.3, John A.J.3, Ganesan S.K.3, Praharaj I.3, Kang G.3, Iturriza-
Gómara M.4, on behalf of the RoVI Consortium
1London School of Hygiene and Tropical Medicine, London, UK;
2Imperial College London, London, UK;
3Division of Gastrointestinal Sciences, Christian Medical College,
Vellore, India;
4Global Vaccine Research Centre, Institute of Infection and Global
Health, University of Liverpool, Liverpool, UK
Introduction: The World Health Organization currently advocates the use
of inactivated poliovirus vaccine (IPV) in combination with oral poliovirus
vaccine (OPV) across much of the globe, although OPV will eventu-
ally be withdrawn to achieve a polio-free world. In India, oral rotavirus
vaccination has recently been introduced into the infant immunisation
programme with the aim of reducing the substantial burden of rotavirus-
related mortality and morbidity. However, it is well known that in India,
as in other low- and middle-income countries, rotavirus vaccine efficacy
and effectiveness are lower than in high-income countries. One potential
contributor to the impaired performance of oral rotavirus vaccine is the
concomitant administration of OPV, which may interfere with vaccine
immunogenicity.
Aim: We conducted a study in Vellore, India, to assess the immunogenic-
ity of rotavirus vaccine administered concomitantly with either OPV or
IPV.
Methods: Starting at 6 weeks of age, 305 infants were given either OPV (n
= 206) or IPV (n = 99) with two doses of Rotarix®, 4 weeks apart. The OPV
and IPV arms were sequentially recruited. Blood samples were collected
pre-vaccination and 4 weeks post-vaccination to assess rotavirus-specific
IgA levels. In addition, stool samples were collected 1 week after each
rotavirus vaccine dose to measure vaccine virus shedding.
Results: Rotavirus-specific IgA levels post-vaccination were similar in the
OPV and IPV arms (geometric mean concentrations and 95% confidence
intervals of 23.3 [17.6, 30.7] and 18.3 [12.5, 26.7], respectively; p =
0.31) and the proportion of infants seroconverting to Rotarix® was also
comparable (119/206 [57.8%] and 62/99 [62.8%], respectively; p = 0.42).
Although fewer infants in the OPV arm shed rotavirus vaccine after
the first dose compared with those receiving IPV, this was overcome
during the second dose, in which shedding was more common in the
OPV arm.
Conclusion: Our Results show that OPV is unlikely to be responsible for
the lower immunogenicity and protection conferred by rotavirus vaccines,
and that the planned switch to IPV should not alter rotavirus vaccine
effectiveness in India.
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EX VIVO EVALUATION OF CELLULAR IMMUNE RESPONSES
ELICITED IN HUMAN PBMC BY LIVE ATTENUATED LEISHMANIA
PARASITE VACCINE CANDIDATE
Salotra P.1, Avishek K.1, Selvapandiyan A.2, Gannavaram S.3,
Ramesh V.4, Nakhasi H.L.3
1ICMR-National Institute of Pathology, New Delhi, India;
2JH- Institute of Molecular Medicine, New Delhi, India;
3Division of Emerging and Transfusion Transmitted Diseases, CBER,
FDA, Bethesda, USA;
4Dept. of Dermatology, Safdarjung Hospital, New Delhi, India
Introduction: Visceral leishmaniasis (VL) is a potentially fatal disease
with an annual incidence of 50,000 to 90,000 worldwide and over 600
million people at risk. In the absence of a suitable and cost-effective
anti-leishmanial drug, a viable alternative choice for the control of this
disease is immuno-prophylaxis. We have developed a live attenuated L.
donovani parasite as a vaccine candidate by deletion of growth regulating
centrin1 gene (LdCen1-/-) and demonstrated it to be safe, immunogenic
and protective in various animal models including mice, hamsters and
dogs.
Aim: Evaluation of the vaccine potential of LdCen1-/- for human VL by
identifying correlates of protection induced in human PBMCs obtained
from healthy individuals and those pre-exposed to Leishmania.
Methods: Infectivity of LdCen1-/- to human PBMC derived macrophages
was evaluated microscopically following Diff-Quik staining. Cytokine
levels in supernatants of PBMCs infected with wild type (Ld1S) or
LdCen1-/-parasites was estimated using multiplex cytokine ELISA in
healed VL (HVL, n=15), post kala-azar dermal leishmaniasis (PKDL, n=15),
healthy (n=15) and VL (n=7) groups. A total of 8 human cytokines
representative of Th1/Th2/Th17 response were analyzed. Cellular source
of cytokines was determined using flow cytometry.
Results: Infectivity of macrophages with LdCen1-/- was similar to that of
Ld1S parasite. PBMCs from HVL and PKDL patients showed predominant
Th1 response with significant induction of IFN-γ , TNF-α and IL-2 in
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uninfected cells. IL-4 and IL-10 levels remained unaltered in all the
groups. Significant increase was found in IFN-γ secreting CD4+ and
CD8+ T cells in PBMCs of HVL group, with no increase in IL-10 secreting
cells.
Conclusions: LdCen1-/- have great potential as live vaccine candidates
against VL since they elicit strong protective immune response in human
PBMCs from HVL, similar to the wild type parasite infection, mimicking
a naturally acquired protection following cure. As a prerequisite for
clinical trials, cGLP grade LdCen1−/−parasites have been prepared in
collaboration with partners from industry. Toxicological studies in animals
and evaluation of the immune responses elicited in human PBMCs ex
vivo after exposure to the cGLP grade LdCen1−/− vaccine candidate are
under way.
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PARTICIPATORY RESEARCH METHODS TO IMPROVE COMMU-
NITY ENGAGEMENT AND PROGRAMME COVERAGE FOR MASS
DRUG ADMINISTRATION
Lar L.A.1, Adekeye T.1, Oluwole A.1, Yashiyi J.N.1, Isiyaku S.1,




3Liverpool School of Tropical Medicine, Liverpool, UK;
4COUNTDOWN, Liverpool, UK
Introduction: Nigeria has the largest burden of neglected tropical dis-
eases (NTD) in sub-Saharan Africa. Recent changes in context, workforce
and partnerships have led to decreased community engagement in the
programme and coverage. In response, participatory action research
(PAR) was conducted with stakeholders from the federal, state and local
level and with non- governmental organizations.
Aim: To utilize a PAR approach to generate practical and sustainable
modifications to NTD programme delivery to improve community
engagement and equity by addressing barriers to availability, accessibility
and acceptability of medicines in rural and urban settings.
Methods: Four phases: Phase one used participatory research (e.g.
transect walks and ranking exercises) methods with community
members and influential leaders to identify bottlenecks and solutions
to improve engagement. Phase Two involved the adoption of innovative
solutions. An enhanced package of programme delivery was co-created
with programme implementers with innovative intervention ideas
selected and monitored using observations, ethnography of the mass
drug administration (MDA) process in communities. Phase Three will be
the implementation of the developed community engagement strategy
including a process and quality evaluation. Phase Four will involve a
reflection workshop with stakeholders to assess the challenges and
successes and develop recommendations for the next cycle of MDA.
Results: Preliminary findings from the ongoing PAR cycle showed
engagement at different levels of the health system and between
sectors and a more innovative and holistic approach to solution-
based problem-solving. For example, stakeholders identified relevant
community structures that could optimize community engagement
and reviewed information, education and communication materials for
more effective health education. Using innovative participatory research
processes which considered intersectional data collection of gender,
age and education ensured an equitable approach to solution finding
and ownership of the programme. Engaging health systems actors as
co-researchers presents opportunities for capacity strengthening and
sustainability of the PAR process.
Conclusion: Using a PAR approach to foster multisectoral collaboration
and partnerships results in the instant application of research findings in
an ongoing solution-focused manner. It promotes mechanisms of health
systems design and development that can allow for shared governance
between sectors that enhance progress toward collaborative goals for
social development.
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THE PARASAHARA PROJECT: SCHISTOSOMIASIS EPIDEMIOL-
OGY AND CONTROL AT THE LAKES OF OUNIANGA IN THE
SAHARA DESERT IN CHAD
Moser W.1,2, Ott R.1,2, Batil A.A.3, Greter H.1,2
1Swiss Centre for International Health, Swiss Tropical and Public
Health Institute, Basel, Switzerland;
2University of Basel, Basel, Switzerland;
3Institut de Recherche en Elevage pour le Developpement,
N’djamena, Chad
Introduction: Schistosomiasis is a water borne parasitic infection pre-
dominantly occurring in Sub-Saharan Africa. In Chad, single case reports
pointed at the disease being present in the Sahara desert, specifically
at the lakes of Ounianga. The PARASAHARA project was initiated to
investigate whether schistosomiasis is prevalent and if transmission is
taking place in the Sahara.
Aim: This research aims at elucidating the schistosomiasis epidemiology
at the lakes of Ounianga, with the goal to identify, test and validate
a context adapted intervention in a setting where no schistosomiasis
control programme is in place, as is the current situation in Chad.
Methods: An epidemiological, sociological and malacological assessment
was taking place in January 2019. In order to establish the schistoso-
miasis prevalence, a population survey was carried out. Urine samples
were collected from randomly selected people, tested for haematuria,
and subjected to urine filtration followed by microscopy. Focus group
discussions (FGDs) addressed knowledge, awareness and perception of
schistosomiasis as well as access to treatment. Fresh water sources and
water contact sites at different lakes of Ounianga Kebir and Ounianga
Serir where systematically searched for the presence or absence of Schis-
tosoma spp. intermediate host snail species following a standard protocol
(15 min./site).
Results: The schistosomiasis prevalence among all age groups was 39%
(CI 37.3 – 40.7), with the highest prevalence among school children (50%
(CI 48.8 – 51.2)). Typical symptoms such as blood in urine and abdominal
pain were mentioned as one of the major health concerns during the
FGDs, its cause was also related to water contact. Yet, the population
was not aware that these symptoms are caused by a parasite infection,
and treatment was mainly traditional. Five snail species were detected at
fresh water sources, among these the schistosomiasis intermediate host
snail species Bulinus truncatus and Biomphalaria pfeifferi.
Conclusion: We show that schistosomiasis occurs at the Lakes of Ouni-
anga at an elevated prevalence, and that transmission is taking place
in the Sahara desert. Due to the remoteness and shear isolation of the
population, the setting fits for an intervention trial to control and finally
eliminate schistosomiasis locally.
203
THE CATASTROPHIC ECONOMIC BURDEN OF VISCERAL LEISH-
MANIASIS IN BANGLADESH, INDIA, ETHIOPIA AND SUDAN:
FINANCIAL RISK PROTECTION IS NOT ENOUGH
Paintain L.1, Boudarene L.1, Pearson M.2, Edwards T.1, Alatiaby
A.A.3, Mondal D.4, Adera C.5, Prakash M.6, Ruiz Postigo J.7,
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Introduction: Visceral Leishmaniasis (VL) is a fatal NTDs with character-
istics making VL patients and their households particularly vulnerable
to catastrophic costs. Financial protection strategies consisting of the
provision of free VL diagnosis and treatment are policy in Bangladesh,
Ethiopia and Sudan, while an additional treatment completion incentive
is used in India.
Methods: Cross sectional surveys with a total of 909 VL patients treated at
46 VL treatment facilities in endemic areas of Bangladesh, India, Ethiopia
and Sudan were conducted between February and September 2016 and
repeated in all sites aside from Bangladesh between March and October
2018 with a total of 777 VL patients. A structured questionnaire was used
to collect data on patient and household characteristics, the treatment
pathway and the financial and economic cost to the household of the
recent VL illness episode, including financial coping strategies.
Results: For most VL patients, the pathway from onset of symptoms to
VL diagnosis and treatment was long and involved multiple providers;
this was particularly the case in South Asia. In all countries, once
patients reached a provider with the capacity to manage their VL
illness, diagnosis and treatment costs were minimal/zero supporting that
VL-specific financial protection strategies were adhered to. However,
diagnostic procedures and treatments received before a correct VL
diagnosis incurred substantial financial loss for the patient’s household.
In addition, economic costs of illness, including reported loss of earnings
for the patient and caretakers, were approximately double the financial
costs. Full economic costs were catastrophic to around 40-50% of VL
patients and their households (in relation to average annual household
expenditure). The social protection strategy of a fixed-sum cash transfer
payment of USD 100 for VL patients in India reduced the proportion of
households facing catastrophic costs to approximately 20%.
Conclusion: VL illness resulted in substantial economic burden for
patients and their households, largely due to medical and non-medical
out-of-pocket costs incurred before diagnosis and loss of income
to patients and/or caretakers. VL-specific financial risk protection is
insufficient to prevent catastrophic health costs for VL patients; broader
comprehensive social protection strategies are needed.
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A HOLISTIC APPROACH TO MYCETOMA MANAGEMENT
Bakhiet S.
The Mycetoma Research Centre (MRC), Khartoum, Sudan
Aim: A study was conducted to assess the effectiveness of a holistic
approach to mycetoma case detection and treatment at the village level,
to improve patient outcomes by diagnosing earlier in disease progression
and treating patients early on and close to home.
Introduction: Mycetoma, one of the most badly neglected tropical dis-
eases, is a localised chronic granulomatous inflammatory disease char-
acterised by painless subcutaneous masses and formation of multiple
sinuses that produce purulent discharge and grains. In the absence of
early and appropriate treatment, it usually spreads to affect deep tissue
and bone, resulting in massive damage, deformities and disability. It can
also spread via the lymphatics and blood leading to distant secondary
satellites associated with high morbidity and mortality.
To date and despite progress in mycetoma research, a huge knowledge
gap remains in mycetoma pathogenesis and epidemiology, resulting
in the lack of objective and effective control programmes. Currently,
the best available disease control method is early case detection and
proper management. However, the majority of patients present late
with advanced disease, and for many of them, major deforming surgical
excisions or amputation are the only treatment options.
Methods: The MRC in collaboration with Sennar State Ministry of Health,
Sudan established a regional mycetoma centre in an endemic village to
pilot a holistic approach to increasing early case detection and treatment.
Patients were treated locally at the centre, and local health personnel
were trained on early case detection and case management, while
the local community was educated on mycetoma and improvement of
environmental conditions. This comprehensive approach also addressed
patients’ socioeconomic constraints that hinder early presentation and
treatment, and also included the active engagement of local health
authorities, and community and civil society participation, to deliver the
best possible case management.
Results: This holistic approach for mycetoma patients’ management
proved to be effective for early case detection and management, optimal
treatment and improved treatment outcomes, with more favourable
disease prognosis. During the study period, the number of patients with
massive lesions and the amputation rate dropped, reducing the disease
and socioeconomic burdens on patients and their families.
Conclusion: In the absence of more effective therapeutic tools, a holistic
and community-based approach, including local availability of treatment,
can increase early case detection and treatment, and improve disease
outcomes for mycetoma patients.
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MYCETOMA AND INTEGRATED SKIN NTD MANAGEMENT
Hay R.1, Estrada-Castañón R.2, Estrada-Chávez G.2, Chávez-
López M.G.2, Bonifaz A.3
1Kings College London, London, UK;
2Dermatologia Comunitaria, Acapulco, Mexico;
3Hopital General de Mexico, Mexico
The skin is the first and most readily available source of clues to diag-
nosis of many conditions including NTDs; helping disease recognition
through skin signs has important implications for diagnosis, mapping,
disease control and minimization of stigma. In this talk we will discuss
the approach to identifying mycetoma cases adopted in an endemic
area of Mexico using a community-based surveillance system, backed
by training of community workers using direct contact, teledermatology
and a manual adapted for local needs. But this work has highlighted
other areas that would benefit from a skin NTD approach. These include
the importance of making available simple diagnostic techniques such
as direct microscopy in identification of cases; this was identified as an
urgent need by an international consensus forum on simple diagnostic
support for mycetoma and other fungal NTDs. It provides a focus for a
new laboratory training initiative. A second area in development is the use
of long range back up support, using a locally established referral network
or teledermatology, via either real time or store and forward technology,
where advice on the management of complex cases such as mycetoma
can be accessed by front line staff. A third area of development lies in
using an integrated strategy, together with other skin NTDs, to assess
and combat disability and stigma through foot protection, local commu-
nity groups and care packages. In some endemic areas sporotrichosis
and mycetoma co-exist but there are other regions where approaches
designed for other non-fungal foot disabilities such a podoconiosis or
neuropathic foot injury have been combined in a package of community
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OPPORTUNITIES AND CHALLENGES OF NON-ACADEMIC COL-
LABORATIONS DURING PHD TRAINING
Pissarra J.
1UMR 177 INTERTRYP, Institut de Recherche pour le Développe-
ment (IRD), Montpellier, France
Introduction: Translation in the context of NTDs goes beyond innovation
and R&D. It also means to contribute to capacity building through the
continued improvement of research centres and future researchers, to
prepare local health facilities and workers, as well as to advocate for the
interests of the communities directly affected by NTDs.
Aim: Young researchers must be aware of the social, political and eco-
nomic issues associated with NTDs and have an active role in the trans-
lation process. Also, individual communication and organisational skills
must be developed to potentiate collaborations. For technology trans-
fer to effectively translate to the field, it is pivotal to bring academic,
local stakeholders and industrial partners together. Such partners have
great expertise in product development and distribution, and have an
important role to play in the deployment of diagnostic or therapeutic
technologies.
Results: The inclusion of industrial partners in the Innovative Training
Network EUROLEISH.net was extremely fruitful from both perspectives.
There are 15 projects within this multidisciplinary network, including
basic and translational sciences, and implementation projects. All stu-
dents and projects benefitted from interactions with industrial or non-
academic partners, important for leishmaniasis control worldwide, such
as the Foundation for New Diagnostics (FIND), Médecins sans Frontières
or Glaxo-Smith Kline. The international and innovative character of the
collaborations integrated in EUROLEISH.net projects is noteworthy, and
students were often a key element in the connection between the aca-
demic and private institutions.
Conclusion: Such symbiotic collaborations contribute to both the stu-
dents’ professional development and the company’s own product port-
folios and objectives. Successful collaborations rely on shared purpose
and commitment, and imply high trust, interdependent resources, as well
as shared leadership and management teams. Indeed, some obstacles
are common, such as different goals and expectations among partners,
or administrative and intellectual property issues. The main factors that
will contribute to the success of industrial and non-academic collabora-
tions, in the context of PhD training networks, are: i) a clear agreement
about the common goals and expectations regarding the outcomes
(objectives, workloads, methodology); ii) the establishment of data pro-
tection and confidentiality documentation; and, finally, iii) the investment
in the relationships with periodic meetings and updates.
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BRIDGING ACADEMIA AND THE PRIVATE SECTOR: THE WAY
FORWARD IN DOCTORAL PROGRAMMES TARGETING REAL-
WORLD SOLUTIONS
Bremer Hinckel B.1,2
1Dept. of Biomedical Sciences, University of Antwerp, Antwerp;
2Coris BioConcept, Gembloux, Belgium
Introduction: Over qualification, a late start in the career, frustration and
lack of available positions in academia are unfortunately a reality in the
life of recently graduated students. Still a great number of traditional
doctoral programmes are mostly focused on fuelling controversial and
debatable aspects of academia rather than targeting real-world prob-
lems. Bridging academia and the private sector can be beneficial for all
parts involved.
Aim: To present the experience of a recently graduated PhD student who
carried out his doctoral programme in close collaboration with the private
sector.
Methods: The personal experience of a recently graduated PhD student,
who carried out most of his doctoral programme in a private organi-
zation, will be presented orally. The scientific aims and achievements
of the project will be briefly outlined. Points that shall be addressed/
discussed include (I) the synergistic effect between the private sector and
academia, (II) the importance of straightening this collaboration early
on in the career of the graduate student and (III) the overall personal
assessment of such a collaborative doctoral programme.
Results: Such a collaborative programme is of great advantage for the
graduate student as well as for the corporation involved. While the gradu-
ate student has the chance of becoming acquainted with the corporative
world early on in his career, he serves also as a bridge between the cor-
poration and academia, which has its crucial role in fundamental aspects
of research. Having participated in such a modern doctoral programme
was of utmost importance for quickly finding a suitable position in a
competitive corporate world for the involved graduate student.
Conclusion: Given the scarce availability of professorship positions in
academia and the reality that a growing portion of graduate students
become frustrate along their doctoral programmes, it is important to
provide them with a solid training programme that is also a good fit for the
private sector. Such a doctoral programme strengthens the collaboration
between the private sector and academia, benefiting not only the grad-
uate student involved, but also the private sector and academia. Finally,
bridging the private sector and academia increases the chance of bringing
real-world solutions for society.
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ADDRESSING THE SOCIAL DETERMINANTS AND CONSE-
QUENCES OF TUBERCULOSIS
Dixit K.1, Winfield T.2
1Birat Nepal Medical Trust, Kathmandu, Nepal;
2Dept. of Clinical Sciences and International Public Health, Liver-
pool School of Tropical Medicine, Liverpool, UK
Introduction: Reducing poverty and health inequality remain a global
imperative, enshrined in the United Nation’s Sustainable Development
Goals. Poorer people have a higher likelihood of ill-health, malnutrition,
and limited healthcare access. This talk will highlight that there are few
infectious diseases that better illustrate this health-wealth association
than TB, the archetypal disease of poverty, and elaborate on socioeco-
nomic support interventions for TB-affected households.
Objectives:
• To understand the social determinants of TB infection, disease, and
adverse TB treatment outcomes.
• To explore the socioeconomic consequences at an individual- and
household-level of being ill with TB disease.
• To review the available evidence on the health and non-health impacts
of socioeconomic support for TB-affected households.
Presentation summary: This presentation will give a brief overview of
the intimate relationship of TB and poverty throughout history. It will
then describe recent research addressing the social determinants of TB,
including the development of an innovative WHO-endorsed threshold
for measuring catastrophic costs of TB-affected households and results
from the world’s first trial of an integrated socioeconomic intervention to
improve TB prevention and cure in TB-affected households (the “HRESIPT”
and “CRESIPT” trials in Peru).
Finally, the talk will disseminate preliminary results of an ongoing study
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Conclusions: Expansion of this multi-disciplinary research addressing the
social determinants of TB, which involves strong community participation,
will lead to policy and practice changes that reduce poverty and improve
health and wellbeing of TB-affected households in diverse country
settings.
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ABOUT 125 PATIENTS ONE YEAR AFTER TRICHIASIS SURGERY
IN MALI
Touré A.1,3, Keita M.1, Dembélé B.1, Traoré L.2, Thonneau P.3,
Rapp C.4
1Maladies tropicales négligées, Helen Keller International, Bamako,
Mali;
2Santé Oculaire, Institut d’Ophtalmologie Tropicale d’Afrique,
Bamako, Mali;
3Dépt. de Santé, Université Senghor, Alexandria, Egypt;
4Maladies tropicales infectieuses, Hôpital militaire Bégin, Saint-
Mandé, France
Introduction: The World Health Organization’s first preventable cause
of infectious blindness in the world, trachomatous trichiasis (TT), is the
ultimate stage of trachoma evolution before blindness. Poorly operated
on, it can recur and continue its evolution towards irreversible blindness,
thus aggravating the precariousness of families.
Aim: Our study aimed to assess the quality of TT surgery and patient
satisfaction in Kayes, Mali.
Methods: A cross-sectional study conducted from June 22 to July 1, 2018,
on 125 individuals randomly selected from among the 492 individuals
operated on for trichiasis in 2017 in the health districts of Kita and Diema,
one year after surgery. An experienced ophthalmologist examines the
eyes with a magnifying glass at 2.5 mm magnification and a lamp, to look
for possible recurrences and complications recorded in a standardized
questionnaire. Eye care was provided where appropriate based on the
informed consent of the participant.
Results: Women represented (62%), the over-60s were the most numer-
ous (66%), with a median age (31 - 101 years). Recurrence (15%) at one
year after surgery with a high frequency in women (72%). Minor compli-
cations (granuloma types) were 3 or (2%), with (88%) of the operations
performed in the beneficiaries’ homes. Azithromicin was administered
immediately after surgery in 66.4% of cases. Of these, 95% were satisfied
with the outcome of their operation.
Conclusion: Our study shows that TT surgery is of an acceptable quality.
Indeed, TT surgery is a priority in the elimination of trachoma by 2020.
In Mali, the National Eye Health Program with its partners, including
Helen Keller International, has been working since 2007 to achieve this
objective. Since studies have shown that there can be no recurrence,
preventing and/or reducing the occurrence of complications would be a
key to the success of any program. It is in this sense that the NGO HKI
financed this study in order to get an overview of the well-being and
satisfaction of the beneficiaries, a highly beneficial and encouraging act.
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CO-DISPERSAL OF THE BLOOD FLUCK SCHISTOSOMA JAPON-
ICUM AND HOMO SAPIENS IN THE NEOLITHIC AGE
Yin M.1, Zheng H.X.1, Su J.1, Feng Z.2, McManus D.P.3, Zhou X.N.2,
Jin L.1,4, Hu W.1,2
1State Key Laboratory of Genetic Engineering and Ministry of Edu-
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4Chinese Academy of Sciences, Key Laboratory of Computational
Biology, CAS-MPG Partner Institute for Computational Biology,
SIBS, CAS, Shanghai, China
Introduction: The global spread of human infectious diseases is of con-
siderable public health and biomedical interest. Little is known about
the relationship between the distribution of ancient parasites and that
of their human hosts. Schistosoma japonicum is one of the three major
species of schistosome blood flukes causing the disease of schistoso-
miasis in humans. The parasite is prevalent in East and Southeast Asia,
including the People’s Republic of China, the Philippines and Indonesia.
We studied the co-expansion of S. japonicum and its human definitive
host.
Aim: To investigate the expansion and migration of S. japonicum in
South-east Asia.
Methods: A total of 119 S. japonicum samples were collected from 13
locations endemic for Asiatic schistosomiasis, including Japan, Indonesia,
Philippines, Taiwan and mainland China. These 119 complete S. japon-
icum mitochondrial DNA (mtDNA) genomes were sequenced using Next-
Generation Sequencing (NGS) technology. The phylogeny of the 119
complete mtDNA sequences was inferred by the Bayesian method via
Mrbayes v3.2.1, which was further confirmed by both the maximum
likelihood (ML) method via PhyML v3.0 and median-joining network via
Network v4.6. The ages of S. japonicum haplogroups were estimated by
two strategies of the ML method via PAML package v4.7 and the Bayesian
method via BEAST v1.8. The 435 complete human mtDNA sequences of
Haplogroups B5, M7 and F were used to construct the BSPs for the human
population. The co-expansion of S. japonicum and its human definitive
host were calculated from the BSP.
Results: It was shown that S. japonicum radiated from the middle and
lower reaches of the Yangtze River to the mountainous areas of China,
Japan and Southeast Asia. In addition, the parasite experienced two
population expansions during the Neolithic agriculture era, coinciding
with human migration and population growth. The data indicate that
the advent of rice planting likely played a key role in the spread of
schistosomiasis in Asia.
Conclusion: S. japonicum radiated from the lake region of China to the
other endemic areas with the co-expansion of its human host driven by
the rice planting agriculture spreading during the recent 10,000 years.
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SYNDEMIC OF OPISTHORCHIASIS AND LEPTOSPIROSIS IN
THAILAND: A NATIONALWIDE ANALYSIS
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Sripa B.1
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3Dept. of Disease Control, Ministry of Public Health, Thailand
Introduction: Opisthorchiasis caused by Opisthorchis viverrini is an
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Interestingly, the opisthorchiasis endemic region overlaps with an area
of leptospirosis emergence. Syndemic of opisthorchiasis and leptospirosis
needs to be explored.
Aim: To investigate the syndemic interaction between O. viverrini
and Leptospira sp, its association with socio-economic determinants,
occupation factors and reservoir hosts in Thailand.
Methods: Incidence data of opisthorchiasis and leptospirosis for years
2009 and 2014 were obtained from Ministry of Public Health of Thailand.
Epidemiological data of opisthorchiasis was aggregated to provincial
level and categorized by year so do for leptospirosis and related risk
factors. Relationship between O. viverrini prevalence and leptospirosis
morbidity rate were analyzed using linear regression. Correlation among
socio-economic status, occupation risk and reservoir hosts factor was
analyzed by Pearson’s product moment correlation. To account for
over-dispersion of Poisson data distribution, generalized linear negative
binomial regression models were used to adjust the trend among regions
and 2 different time setting across all risk factors.
Results: We found compelling evidence O. viverrini infection act as
synergistic syndemic enhancing leptospirosis incidence (P<0.001). Inter-
estingly, it also performs as counter syndemic reducing the number of
case fatality rate particularly in north-eastern region. The level of poverty
significantly showed high positive correlation for opisthorchiasis and
leptospirosis incidence (P<0.001, r=0.6 and 0.4, respectively), followed
with significant negative correlation for provincial GDP, income per-
capita and individual income (P <0.001, r=-0.3, -0.6, -0.6, respectively).
Northeast region significantly has the highest poverty level and the
lowest economic saving in both year (based on subset regional analysis).
Moreover, north-eastern region has the highest proportion for high risk
workers for both diseases. Working in agriculture sector and animal
husbandry correlate positively high (all P<0.001 and all r-value >0.4).
Similarly, the role of animal reservoirs (particularly, dogs, buffalo and
cows) showed high positive correlation to the syndemic between O.
viverrini and Leptospira sp (r= 0.2, 0.5, and 0.3, P<0.001, respectively).
Conclusion: This study provides the syndemic evidence of opisthorchiasis
and leptospirosis, particularly in Northeast Thailand and is highly
associated with determinants tailing to the characteristics of neglected
tropical diseases.
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IMPORTED MALARIA IN WESTERN ROMANIA: A 9 YEAR RETRO-
SPECTIVE STUDY
Lupu M.A.1,2, Lazureanu V.E.1,3, Pasat A.A.1, Olariu T.R.1,4
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3”Victor Babes” Infectious Diseases Hospital, Timisoara;
4Municipal Clinical Emergency Hospital, Timisoara, Romania
Introduction: Malaria was eradicated from Romania in 1963. Since then,
it has been imported into the country by international travellers and
immigrants from endemic regions.
Aim: The aim of the study was to evaluate the epidemiological, clinical,
laboratory and therapeutic data of patients diagnosed with malaria in
Western Romania over a period of 9 years.
Methods: A retrospective study was conducted on patients admitted
to „Victor Babes” Infectious Diseases Hospital in Timisoara, Romania,
between 01.01.2010-31.12.2018. Seventeen patients with malaria were
diagnosed and included in this study. Clinical and epidemiological data
were collected from patients’ medical records.
Results: The 17 patients aged 19 to 60 years (mean=35.9), 15(88.2%)
were males. Two patients were refugees from Eritrea (Africa), 2 were
travelers returning from Asia and 13 from Africa. The journey time for
travelers ranged from 2 weeks to 2 years. Eleven patients did not follow
any chemoprophylaxis and 6 followed an incomplete chemoprophylaxis
prior or during their stay in malaria endemic regions. Symptomatology at
admission included fever and shiver (100%), headache (47.1%), myalgia
(23.5%) and diarrhea (23.5%). Time between arriving in Romania from
a malaria endemic country and the onset of symptoms for malaria
ranged between 2 days and 7 months. Malaria was confirmed by par-
asite detection in thin and/or thick blood smear. Thirteen patients were
diagnosed with Plasmodium falciparum, two with P.vivax and one with
P.malariae; a mixed infection of P.falciparum and P.malariae was reported
in one patient. Hepatosplenomegaly was described in 3(17.6%) patients,
splenomegaly in 4(23.5%), thrombocytopenia in 14(82.4%), anemia in
5(29.4%) and jaundice in 2(11.8%). The hospitalization period ranged
between 1 and 19 days, with a mean length of hospital stay of 7.6 days.
All patients received antimalarial drugs and had a favorable outcome,
except one female patient, infected with P.falciparum, who died.
Conclusion: The number of malaria cases can increase in Romania in
the near future due to increasing number of refugees, tourists and work-
travelers to tropical regions and because prevention measures are not
applied/known or are ignored by the travellers.
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COMMUNITY-BASED SCREENING FOR CHAGAS DISEASE AND
STRONGYLOIDIASIS AMONG LATIN AMERICAN MIGRANTS IN
ALICANTE, SPAIN
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5Dept. of Microbiology, Hospital General Universitario de Alicante-
ISABIAL, Alicante;
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Introduction: Chagas disease (CD) and strongyloidiasis are parasitic
infections endemic in Latin America. Asymptomatic cases may host the
parasites for years unaware of the infection.
Aim: To describe the prevalence of CD and strongyloidiasis in Latin
American migrants attending a community-based screening campaign.
Methods: A community-based screening campaign of CD and strongy-
loidiasis was simultaneously carried out in three municipalities of the
province of Alicante (Spain), on 28th October 2018. After an informative
talk, a blood sample of each participant was obtained to perform the
serological tests. Two different ELISAs were performed against T. cruzi;
a third test (IFAT) was used in discordant cases. Two positive serological
test results were required to consider a person infected with T. cruzi.
Strongyloides spp. serology was performed using Strongyloides IgG IVD-
ELISA (DRG Instruments GmbH, Marburg, Germany).
Results: 369 people were screened, of whom 70 were children (19.0%). Of
the 299 adults, 223 were women (60.4%). Main countries of origin were
Bolivia (n = 133), Ecuador (n = 108) and Colombia (n = 28). Thirty-three
participants (8.9%) had a positive T. cruzi serology, all of them adults of
Bolivian origin. Seroprevalence in Bolivians was 25% (33/132) (p <0.001).
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were positive (p = 0.004). Seroprevalence was 9.5% in women and 13.3%
in men (p = 0.3) and was higher in the age group >40 years old (14.7%
vs 7%; p = 0.04).
Strongyloides spp. seroprevalence was 10% (37/369), 5.7% in participants
under 18 and 11.0% in adults (p = 0.2). Seroprevalence was of 12.9% in
Bolivians, 11.1% in Ecuadorians and 10.7% in Colombians. More men were
infected (16.7% vs 7.3%; p <0.01), with no significant difference by age.
Six participants (1.6%) were co-infected with T. cruzi and Strongyloides,
all of them adults >40 years old (p = 0.03) and from Bolivia.
Conclusions: Seroprevalence of CD in Latin American asymptomatic
migrants was 9%. All the positive cases were adults from Bolivia. One in
four Bolivian adults screened had CD. The seroprevalence of Strongyloides
spp infection was 10%; children under 18 were also infected (5.7%).
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CHAGAS DISEASE IN THE UNITED KINGDOM: A REVIEW OF
CASES MANAGED AT THE HOSPITAL FOR TROPICAL DISEASES,
LONDON 1995 – 2018
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De Sario V.2, Alvarez M.3, Lowe P.2, Yacoub S.4, Moore D.1,2,
Chiodini P.L.1,2
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Aim: Chagas disease (CD) in non-endemic areas is an increasing concern.
The Hospital for Tropical Diseases (HTD) provides tertiary care for man-
agement of T. cruzi infection in the UK. All cases of CD diagnosed at HTD
between 1995 and 2018 were reviewed.
Methods: Patients were identified based upon positive CD serology from
samples tested at The National Parasitology Reference Laboratory. Elec-
tronic records and paper notes were reviewed to analyse demographics,
presentation, symptoms and case management.
Results: A total of 60 patients with serologically-confirmed CD were
identified. 42 were female (70%). Median age was 37 years (1-58 years).
All were born in Latin America, most in Bolivia (n=45, 75%). 67% were
aware of their CD diagnosis on arrival in the UK (n=40). 46.7% were
asymptomatic at presentation (n=28). Symptomatic patients reported
cardiac, gastrointestinal or a combination of both (26.7%; 18.3%; 8.3%
respectively). ELISA was positive in all; median IFAT titre 1:160 (1:20 to
1>2650). PCR was positive in 8 (13%) and equivocal in 2 (3.3%). Amongst
patients with cardiac complaints, 62% had at least one abnormal cardiac
test. Only 7% of patients with gastrointestinal symptoms had abnormal
gastrointestinal studies. 25% of asymptomatic cases had abnormal car-
diac and/or gastrointestinal investigations.
Seven patients (11.7%) had already been treated when presenting to
HTD; eight (13.3%) were not eligible for treatment; six (10%) declined
therapy; three (5%) are considering treatment and five (8.3%) were lost
to follow up before treatment was discussed. 31 patients (51.7%) were
treated at HTD. 29 received Benznidazole as first line, 20 reported side
effects and five of those were switched to Nifurtimox. Seven cases were
treated with Nifurtimox, two as first line, 5/7 reported side effects, and 3
discontinued treatment.
Conclusion: It is important to recognize cases of imported CD. Urgent
action is required to raise awareness of this disease among health care
workers and Latin American migrants in the UK. Special efforts should be
made to include pregnant women, babies born to mothers infected by
CD, patients immunocompromised or due to receive immunosuppression,
and relatives of CD patients. Cases identified should be referred to a
specialist centre for management.
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EMPOWERING MALARIA RESEARCH IN AFRICA: CONTROLLED
HUMAN MALARIA INFECTION IN TANZANIA, KENYA, GABON,
MALI, EQUATORIAL GUINEA AND THE GAMBIA TO TEST THE
EFFICACY OF MALARIA VACCINES AND DRUGS AND TO INVES-
TIGATE INNATE RESISTANCE AND ACQUIRED IMMUNITY TO
MALARIA
Richie T.L., for the International PfSPZ Consortium
Clinical Dept., Sanaria Inc., Rockville, USA
Introduction: Controlled human malaria infection (CHMI) by mosquito
bite has been used for decades to test new malaria vaccines and drugs.
However, African research institutions have not used this key research
tool due to costs and safety concerns regarding the importation of the
Anopheles stephensi vector.
Aim: Sanaria Inc. has developed methods to manufacture, purify and
cryopreserve aseptic Plasmodium falciparum sporozoites (PfSPZ) that
meet all regulatory requirements. With support from the International
PfSPZ Consortium, PfSPZ Challenge, composed of non-attenuated, fully
infectious PfSPZ, has been developed as a standardized “challenge in a
bottle” for conducting CHMI without the requirement for mosquitoes.
Sanaria’s aim is to support African research institutions in using PfSPZ
Challenge to test malaria vaccines and drugs in endemic populations.
Methods: PfSPZ Challenge is stored in liquid nitrogen vapor phase and
shipped to African countries from Sanaria’s clinical manufacturing facility
(CMF) in Rockville Maryland. 3200 PfSPZ are injected by direct venous
inoculation (DVI), a nearly painless procedure that reliably induces par-
asitemia in malaria-naïve recipients. Six days later, research subjects
begin daily follow-up by thick blood smear (TBS), PCR assay and clinical
assessment. Parasitemia is treated with a standard course of antimalar-
ial drugs, and subjects remaining parasite free are treated empirically
on day 28.
Results: CHMI by PfSPZ Challenge has now been conducted 25 times
in 6 African countries: 2 CHMIs to optimize methodology, 17 to study
vaccine efficacy, 5 to study malaria biology and host immunology, and 1
to study antimalarial drugs. The procedure has proven extremely safe and
well tolerated, with no serious adverse events. Consistent with findings in
malaria-naïve adults, 100% of minimally malaria-exposed Africans have
developed parasitemia, while up to 50% of those with life-long exposure
remain PCR and TBS negative. This spectrum of response is being used to
identify innate resistance and acquired immune factors associated with
protection. Vaccine-induced protection against CHMI is being evaluated
as a surrogate for field efficacy.
Conclusion: PfSPZ Challenge has strongly promoted translational malaria
research at several African institutions including the development of new
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Introduction: Soil-transmitted-helminthiases (STH) and schistosomiasis
(SCH) control are major control programs of WHO agenda for neglected
tropical diseases (NTDs). Periodic mass drug administration for at-risk
population is the main public health strategy for reducing the burden.
Despite all the efforts made, so far the burden of STH-SCH still is far from
its control in endemic areas in Africa. Since 2017, WHO demands for
integrating NTDs into global health programs, as an essential new step
to ensure a universal health coverage (UHC) that “leaves no one behind".
In developing countries, health centers are the main entrance door to the
health system.
Aim: To improve the diagnosis protocol in a primary health center in a
rural area of Ethiopia integrating, in an effective and efficient manner,
STH-SCH control program in the primary health system.
Methods: According to the Ethiopian national guidelines, the wet mount
technique is used for the diagnosis of STH-SCH infection in the health cen-
ters. We compared the results of that technique with the ones obtained
by our protocol that includes three easy to perform techniques: formol-
ether concentration, Kato-Katz and Baermann methods.
Results: From October to December 2018, 186 patients from the out-
patient department were included in the study. Infections by hook-
worm, Ascaris lumbricoides, Trichuris trichiura, Strongyloides stercoralis
and Schistosoma mansoni were recorded. 24 (13%) patients were diag-
nosed by the wet mount technique in the routine laboratory, while with
the new protocol the number of diagnosis increased until 131 (70.4%)
(p=0.0008).
Conclusion: The vast majority of patients carrying intestinal helminths
are not diagnosed in this health center. This pattern could be similar for
the rest of health centers in endemic areas, working in similar conditions,
as they all do the diagnosis by wet mount. Integrating a comprehensive
management of intestinal helminth infection in primary health facilities,
including an accurate diagnosis, will be a step forward to reach UHC. It will
also be a turning point for the control of NTDs as this under-diagnosis (and
therefore the lack of treatment) perpetuates these infections in endemic
areas. More studies are necessary and make new and more promising
steps to achieve UHC.
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FOLLOWING UP COMMUNITY WIDE TREATMENT FOR SCHISTO-
SOMIASIS IN THREE COMMUNITIES FROM THE GREATER ACCRA
REGION, GHANA
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Background: Where a helminth control program has the goal of inter-
ruption of transmission, expanded access to anthelminthic treatments
to additional demographic groups at-risk of schistosomiasis and soil-
transmitted helminthiasis (STH) is recommended. This study reports on
the findings of a pilot, community-wide, treatment intervention in the
Greater Accra region of Ghana.
Method: From three communities 658 individuals were enrolled into the
study; participants provided both urine and faecal samples to screen
for the relevant helminth ova and answered an epidemiological ques-
tionnaire to identify risk factors associated with schistosomiasis and STH
infections. Separately, logistic GEE models were used to investigate risk
factor associations with infection prevalence.
Results: In all three communities both Schistosoma species were found
with the prevalence of S. haematobium ranging from 3.3% (95% CI=1.9-
4.7) to 19% (95% CI=15.8-22.2) and S. mansoni ranging from 30% (95%
CI=26.5-33.5) to 78.3% (95% CI=74.7-81.9) at baseline. A six month
follow-up survey revealed that the prevalence had been significantly
reduced across all three sampling sites for S. mansoni now ranging from
19% (95% CI=14.7-23.4) up to 48% (95% CI=41.7-53.5). The effects of
treatment on S. haematobium prevalence was a significant reduction in
two sites. of the sites for S. haematobium. The total prevalence of STH
across all three sites was negligible at 1.3% (24/1847; 95% CI=0.8-1.9)
comprising mainly hookworm (10/1847).
Our statistical analysis also revealed that males were 2.3 times (95%
CI=1.7-3.3) more likely to have a high intensity S. mansoni infection and
1.5 (95% CI=1.1-2) times more likely to have a S. haematobium infection
than females. There was no significant difference in the likelihood of
infection with S. mansoni between adults and school age children (SAC),
however S. haematobium infections were 2.3 times (95% CI=1.7-3.3)
more likely to occur in SAC than in adults.
Conclusion: Our study shows the effects of community wide treatment
has on the prevalence and intensity of schistosomiasis. At baseline we
detail the current prevalence of disease and highlight significant risk
factors. Our six month follow up data also reveals the impact treatment
has on prevalence but also intensity, with the latter being of greater
significance regarding morbidity.
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THE PREVALENCE OF COMMON MENTAL HEALTH DISORDERS
AMONG MIDDLE-AGED WOMEN IN SRI LANKA
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Cader M.4, Fonseka P.5
1Ministry of Health;
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Introduction: Common mental health disorders such as depression, anx-
iety, stress are increasingly identified as significant public health prob-
lems among middle-aged women due to various reasons, hence this
study.
Aim: The aim of this study is to estimate the prevalence of depression,
anxiety and stress in women aged 40 to 55 years, in the District of
Colombo.
Methods: A cross-sectional descriptive study was carried out for a cal-
culated sample of 1605 women aged 40-55 years using the multi-stage
stratified probability proportionate to size cluster-sampling technique. A
validated DASS-21 Sinhala version (to estimate the prevalence of depres-
sion, anxiety and stress) and pretested interviewer-administered ques-
tionnaire (to collect information on demographic and socio-economic
factors and menopausal status) were administered by trained interview-
ers amongst middle-aged women in 40 to 55 years.
Results: One thousand five hundred and fifty-three (1553) women par-
ticipated in the study with a response rate of 96.8%. The mean age of the
study population was 47.7 years (SD±4.36). The study population was
comparable to that of women in the district of Colombo.
The adjusted prevalence of depression, anxiety and stress among
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statistically significant association between sector of residence and the
prevalence of depression, anxiety or stress among women aged 40 to 55
years (p>0.05).
A stepwise increase in the prevalence of depression was observed accord-
ing to the menopausal status: premenopausal, perimenopausal and
postmenopausal (11.5%, 19.9%, and 25.5% respectively). The prevalence
of anxiety was highest among perimenopausal women (17.4%) com-
pared to premenopausal (14.5%) and postmenopausal women (14.9%).
Further, the prevalence of stress was observed to be increasing from
premenopausal to postmenopausal state: 15.4%, 18.9%, and 23.7%
respectively.
Conclusions: As prevalence of depression, anxiety and stress are high
among middle-aged women, policies have to be developed and imple-
mented to establish proper mental health screening programmes at
existing primary health care settings (clinics at community level) to
address the problem, after assessing the cost and acceptability of the
programme to suit the low resource settings in Sri Lanka.
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‘UNLESS I CAN WORK, I AM WORTHLESS’ THE EMOTIONAL
IMPACT OF ACUTE ADENOLYMPHANGITIS IN THOSE WITH
PODOCONIOSIS: A CASE STUDY IN WAYU TUKA WOREDA,
OROMIA, WESTERN ETHIOPIA
Phillips C.1, Samuel A.1,2, Tiruneh G.2, Deribe K.1,3, Davey G.1,3
1Dept. of Global Heath and Infection, Brighton and Sussex Medical
School, Falmer, Sussex, UK;
2Dept. of Medical Laboratory Sciences, Wollega University,
Nekemte, Ethiopia;
3School of Public Health, College of Health Sciences, Addis Ababa
University, Addis Ababa, Ethiopia
Introduction: Podoconiosis, also known as mossy foot or endemic non-
filarial elephantiasis, is a preventable form of lower-leg lymphoedema
caused by prolonged (typically barefoot) exposure to soil derived from
volcanic rocks. Acute adenolymphangitis (also called ‘acute attacks’) is
a serious complication of podoconiosis resulting in significant symptoms
and worsening disability. Furthermore, NTDs, including podoconiosis,
are known to have a strong association with mental illness and those
who have recently experienced an acute attack are more likely to be
depressed(1,2).
Aim: This study explored the experiences and impact of acute attacks on
those with podoconiosis in one endemic district of Ethiopia.
Methods: This qualitative study was based in Wayu Tuka woreda (district),
Oromia, Western Ethiopia. 27 semi-structured interviews of those with
podoconiosis and their caregivers were conducted in June 2018. Here
we report on one aspect of the interviews with those affected by
podoconiosis, the emotional impact. Data were analyzed using NVivo
12. Directed content analysis, a qualitative approach related to thematic
analysis, was used to analyze the results.
Results: Interviews revealed the broad impact of acute attacks on
individual’s family life and community relationships, specifically, affecting
access to education and the ability of individuals to earn a living.
Notable was the emotional impact acute attacks had on individuals.
A sense of resignation, or fatalism, along with feelings of regret, guilt,
worthlessness, helplessness and desperation were all reported. Stigma
was also discussed by some participants. Four key themes emerged:
regret and reflection, guilt, stigma and helplessness and desperation.
Conclusion: Acute attacks have a significant and complex emotional
impact on those with podoconiosis. This underscores the importance
of prevention and early treatment of podoconiosis to reduce this
complication and of including psychosocial care in the management
of people with podoconiosis.
References:
1. Litt E, Baker MC, Molyneux D. Neglected tropical diseases and men-
tal health: a perspective on comorbidity. Trends Parasitol. 2012;28(5):
195-201.
2. Bartlett J, Deribe K, Tamiru A, Amberbir T, Medhin G, Malik M,
et al. Depression and disability in people with podoconiosis: a com-
parative cross-sectional study in rural Northern Ethiopia. Int Health.
2016;8(2):124-31.
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Introduction: The global burden of cardiovascular diseases (CVD) in
people living with HIV (PLHIV) is well known but less documented in
Rwanda, where the expanded access to antiretroviral therapy (ART)
has changed the natural history and outcomes of the disease into a
manageable chronic condition. At the end of June 2018, the ART services
coverage accounted for 189,362 people (83% of all PLHIV). Although this
has improved patient prognosis and increased life expectancy, there is
evidence that CVD are emerging.
Aim: To investigate the determinants of CVD risk in PLHIV receiving ART.
Methods: We will conduct a prospective longitudinal cohort study (36
months) and assess various predictors and outcomes among a cohort
of PLHIV on ART, compared to a cohort of HIV uninfected individuals. All
facilities with HIV and NCD clinics that have adequate infrastructure,
electronic medical records and the ability to undertake monitored
patient follow up will be selected for inclusion into the study. PLHIV
receiving ART will be recruited randomly from those facilities’ database;
HIV uninfected individuals will be recruited randomly from multiple
outpatient departments and the surrounding area of selected health
facilities.
We will select a sample of 449 PLHIV and 1794 HIV uninfected individuals
considering gender and age, and using a proportion of 1:5 to mitigate the
potential high rate of lost to follow up. The analysis will be done using
regression models to identify the significant determinants. CVD cases
detected will be directly linked to the NCD clinics for the provision of
treatment and care.
Results: This is a study protocol review. The study outcome is any
cardiovascular event defined by cardiovascular morbidity (elevated blood
pressure, abnormal lipid profiles, cardiomyopathy, ischemic heart disease
and stroke) and mortality occurring within the study cohorts. The health
determinants of interests include individual medical, biochemical and
immunological characteristics, demographic factors like social economic
status, gender, and cardiovascular risk factors such as metabolic
syndrome, diet and lifestyles.
Conclusion: Knowing the determinants of CVD in PLHIV receiving ART is
key for several reasons. This will inform preventive measures, develop
innovative strategies for management, help set up comprehensive
care, improve the quality of life for this specific population and provide
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THE EKOS PROJECT - DEVELOPMENT OF A NOVEL CONCEPT TO
ENSURE INFECTIOLOGICAL-MEDICAL CARE IN GERMAN TER-
TIARY CARE HOSPITALS OF PATIENTS SUFFERING FROM HIGH
CONSEQUENCE INFECTIOUS DISEASES
Stitterich N.1, Heim K.2, Grünewald T.3, Rößler S.4, Schöpke T.5,
Koeppen M.6, Lichtner E.7, Rösler U.8, Gröschke D.9, Kratz T.10
1Institute of Tropical Medicine and International Health, Charité-
Universitätsmedizin, Berlin;
2Dept. of Infectious Diseases and Respiratory Medicine, Charité-
Universitätsmedizin, Berlin;
3Dept. of Infectious Diseases and Tropical Medicine, Nephrology
and Rheumatology, St. Georg Hospital, Leipzig;
4Dept. of Hygiene, Chemnitz Hospital, Chemnitz;
5Emergency Dept. of Werner Forssmann Hospital, Eberswalde;
6Institute of Industrial Building and Construction Design, Technical
University Braunschweig, Braunschweig;
7Hermann Rietschel Institute, Technical University Berlin, Berlin;
8Institute for Veterinary Hygiene and Environmental Health, Freie
Universitaet Berlin, Berlin;
9Dept. of Intercultural Studies, Friedrich Schiller University Jena,
Jena;
10Federal Information Centre for Biological Threats and Special
Pathogens, Robert Koch Institute, Berlin, Germany
Introduction: Germany has got seven high level isolation units (HLIU) in
order to care for patients who are suspected or confirmed to be suffering
from high consequence infectious diseases (HCID). Provision of health-
care in tertiary care hospitals (TC) in Germany could be compromised
by suspected or confirmed HCID patients due to contamination and
loss of reputation. HCID patients are at risk to become neglected and
to stay untreated for other diseases due to fear of contagion. The EKOS
project was established in 2016 as a consequence of imported Ebola
Virus Disease (EVD) suspect cases during the EVD West Africa outbreak.
Aim: We aim to close the gap in health care provision through
strengthening tertiary care facilities with enabling them to manage a
HCID patient for a maximum of 24 hours until transfer to a HLIU.
Methods: EKOS focusses on process-related and constructional-functional
hygiene management as well as resilience strengthening. Process-related
hygiene management includes a training concept targeting improvement
of knowledge, attitude and skills towards HCID management. We
assessed knowledge of hospital staff on HCID clinical management,
infection prevention and control as well as public health (PH). Trainings
took place in two German TCs (Chemnitz, Eberswalde) and were
evaluated. Data analysis is ongoing. Upcoming results will be presented.
Results: From June 2018 to February 2019 seven trainings were carried
out with 78 participants (63 (80.8 %) medical staff and 15 (19.2 %)
non-medical staff).Evaluations on the question if they feel more safe in
context with HCID after participation show a mean approval rate of 2.65
(n = 45) in Chemnitz and 3.11 (n = 20) in Eberswalde on a zero to five
approval rating scale. Pretests show that concerning medical staff only
10 (32.3 % n = 31) in Chemnitz and 6 (37.5 % n = 16) in Eberswalde knew
how to contact PH authorities outside regular working hours.
Conclusion: Further steps need to be taken to close the HCID clinical
management supply gap in German TC.
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MORTALITY AMONG CONFIRMED LASSA FEVER CASES DURING
THE 2017–2019 OUTBREAK IN ONDO STATE, NIGERIA
Ilesanmi O.1, Ayodeji O.2, Abejegah C.2
1Dept. of Community Medicine, College of Medicine, University of
Ibadan, Ibadan;
2Dept. of Community Health, Federal Medical Centre, Owo, Nigeria
Background: Lassa fever (LF) is an acute viral hemorrhagic disease
endemic in Nigeria. In 2017 a new treatment center was started
at Federal Medical Centre, Owo in Ondo State – a LF endemic state
contributing 35-50% of total number of cases in Nigeria since 2017.
This study aimed to determine factors associated with mortality among
confirmed Lassa fever cases in Ondo State.
Methods: We analyzed surveillance, epidemiological, clinical and
laboratory data during the 2017 to 2018 outbreak and the peak period
(January to March) of 2019. The LF Emergency Operation Centre (EOC)
was activated in 2018. Support from partners are received in the peak
period of the first 12 weeks (January-March) yearly. We used descriptive
statistics and logistic regression to identify factors associated with
mortality.
Results: We reviewed 276 positive cases, 30 died (case fatality rate [CFR]
= 10.9%; median age 34 years; Inter Quartile Range= 24-48 years). Male
who died were 24 (15.5%). Fatality rates went from 1.6% in 2017 to
10.5% in 2018 and 16.7% in 2019, Chi square for linear trend: p=0.025. In
peak period mortality recorded was 15 (8.5%) and another period (April
to December) 14 (14.9%) was recorded (p=0.104). Fatality was 12.5%
(1 out of 8) among pregnant women with 100% fatal death. Patients
who were more likely to die were, those commenced on Ribavirin after 7
days of symptoms onset (Adjusted odds ratio [AOR] = 4; 95% confidence
interval [CI] = 1.1, 15.4), those with elevated urea level (AOR 7.5; CI = 2.5,
23.1). Patients aged 18-45 years had 75% lesser odds of dying (AOR =
0.25; CI= 0.08, 0.76).
Conclusions: Coordinated response should be put in place during
both peak period and other period. Attention to pregnant women,
management of renal complications, strategy to ensure prompt patient
presentation and laboratory confirmation and commencement of
treatment should be intensified.
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ELDER ABUSE IN A SELECTED MEDICAL OFFICER OF HEALTH
AREA IN THE DISTRICT OF COLOMBO: PREVALENCE AND
CORRELATES OF PHYSICAL, EMOTIONAL, FINANCIAL ABUSE
AND NEGLECT FROM FIRST COMMUNITY BASED STUDY IN SRI
LANKA
Samaraweera P.C.1, Sivayogan S.2, Kathriarachchi S.3
1National Dengue Control Unit, Ministry of Health, Colombo;
2Dept. of Community Medicine, University of Sri-Jayewardenepura,
Sri-Jayewardenepura;
3Dept. of Psychiatry, University of Sri-Jayewardenepura, Sri-
Jayewardenepura, Sri Lanka
Introduction: Elder abuse has been identified as a global phenomenon
which demonstrated a considerable cultural diversity. Elder abuse is
defined as physical, emotional, sexual and financial maltreatment and
neglect of a person made vulnerable by advanced age.
Aims: The aim was to determine prevalence and correlates of physical,
emotional, financial abuse and neglect among elderly aged 60 years and
above in a selected Medical Officer of Health area in Colombo district.
Methods: This study was conducted in three components. First Compo-
nent, developed and validated an interviewer administered questionnaire
– Elder Abuse Assessment questionnaire (EAAQ), to assess the prevalence
of elder abuse in a community setting. Subtypes and methods of abuse
common to the Sri Lankan situation were generated by reviewing existing
instruments, literature review and focus group discussions. Item reduc-
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Judgmental validity was assessed by experts and the criterion validity by
Consultant Psychiatrist as the gold standard. Second Component was a
cross sectional survey conducted among a community sample of 1500
elders aged 60 and above to assess the prevalence of abuse by cluster
sampling. Third Component was a comparative cross sectional study
which assessed the correlates in abuse.
Results: The sensitivity for overall abuse in the EAAQ was 83.7% (95%
CI 70.9-91.4) and specificity for overall abuse was 92.7% (95% CI 87.4-
92.7). The overall response rate was 96.5%. The prevalence of any type
of abuse was 19.2% while physical abuse was 2.7% (95% CI 1.9-3.7) and
financial abuse was 3.7% (95% CI 2.8-4.6). Emotional abuse was 14.4%
(95% CI 12.7-16.6) and neglect was 15.1 (95% CI 13.3-17.0). Children
were the main perpetrators of abuse. The correlates of abuse were lower
educational level of elder (AOR 2.2; 95%CI 1.2-3.4); problems of grand
children(AOR 4.0: 95%CI 1.2-13.9); poor practical support from the family
members (AOR 4.6: 95% CI 2.8-7.7); and having depression (AOR 11.1;
95% CI 6.5-18.5).
Conclusions: As elder abuse exists to a considerable extent in Sri Lanka. it
is recommended that availability of valid instrument for its measurement
should be made known to the relevant authority.
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DRUG DISCOVERY EFFORTS AND DEVELOPMENT OF KINETO-
PLASTID ASSAYS AT NOVARTIS INSTITUTES FOR TROPICAL DIS-
EASES
Pei L., Saldivia Concepcion M., Cheung H., Chen Y.L., Rao S.,
Williams S., Gable J., Song J.G., Patra D., Jiricek J.
Novartis Institute for Tropical Diseases, Emeryville, USA
Collectively, kinetoplastid diseases caused 30,000 deaths annually with
up to a billion people at risk of contracting the diseases. We have devel-
oped various assays in all three kinetoplastid disease areas and have car-
ried out high-throughput phenotypic screenings. Several classes of com-
pounds were prioritized with disease relevant secondary in vitro assays.
Triazolopyrimidine (TP) inhibitors were among one of the classes iden-
tified that are active against all kinetoplastids. Resistant Trypanosoma
cruzi parasites were generated and were mapped to F24L and I29M
mutations in β4 subunit of 20S proteasome. We are also pursuing other
classes of compounds with entirely different mode of action. Various
biochemical assays and omics based approaches were also employed for
target identification and validation. The most recent data on the assay
development and compound prioritization will be discussed here.
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CHAGAS DISEASE, AN EPIDEMIOLOGICAL CHALLENGE IN
EUROPE
Albajar Viñas P.
Dept. of Neglected Tropical Diseases, World Health Organization,
Geneva, Switzerland
Introduction: Chagas disease cases have been progressively detected in
17 European countries since the 70s, when the first patient was reported
in Europe. This phenomenon has been mainly due to the increased pop-
ulation mobility between Latin America and Europe, but in the past three
decades non-vector-borne transmission routes have been also detected
in some European countries, what has significantly contributed to this
public health problem.
Aim and methods: At the end of 2018 the World Health Organization
(WHO) organized the fourth meeting of the nonendemic countries ini-
tiative (NECI). In the meeting the epidemiological profile of the disease
outside Latin America was updated, together with the implemented
measures to interrupt the transmission from transfusion of contaminated
blood/blood products, mother to child (congenital transmission) and
during organ transplantation.
Results: In the NECI meeting new strategies and innovative tools were
also presented and endorsed, including the switch from the control to
the elimination strategy of congenital Chagas disease, the necessity to
combine and balance the biomedical and psychosocial approaches in
a new intersectoral approach or the possibility to monitor and verify
the interruption of transmission with the help of the WHO Information
System to Control/Eliminate neglected tropical diseases.
Conclusion: At the very moment of the definition of the post 2020
agenda, in the framework of the United Nations Sustainable Development
Goals to be reached in 2030, many European territories could be ready to
initiate the process of verification of interruption of transmission in 2020.
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STRATEGIES AND TOOLS FOR THE SCREENING OF STRONGY-
LOIDIASIS IN MIGRANTS
Buonfrate D.1, Bisoffi Z.1,2
1Dept. of Infectious – Tropical Diseases and Microbiology, IRCCS
Sacro Cuore Don Calabria Hospital, Negrar, Verona;
2Dept. of Diagnostics and Public Health, University of Verona,
Verona, Italy
Introduction: The burden of Strongyloides stercoralis infection has
long been underestimated globally, consequently the infection has not
received attention in relation to migrants’ health in European countries.
In recent years, new evidence based on more sensitive diagnostic tools
has shed new light on the real prevalence of strongyloidiasis.
Aim: To discuss the possible approach for screening and individual
diagnosis of strongyloidiasis in migrants, also in light of new estimates of
prevalence of strongyloidiasis at global level and in migrants.
Methods: Elaboration of a model to obtain new estimates of the global
prevalence of strongyloidiasis, and comparison with the results obtained
by a systematic review of literature collecting data on prevalence in mi-
grants. Review of diagnostic methods available for S. stercoralis infection.
Results: A global map showing the estimated prevalence of strongyloidi-
asis at country level is going to be presented. A proposal for the screening
of populations at higher risk of the infections will be made. Serological
tests are the methods with the highest sensitivity for strongyloidiasis, and
are useful for screening. Molecular tests have better accuracy compared
to conventional parasitological methods, and do not require fresh stools.
Conclusion: Screening for strongyloidiasis is recommended for migrants
coming from highly endemic countries. Serology is the best tool for
screening. In the European context, PCR can have a relevant role for
individual diagnosis and as confirmatory test.
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AUTOCHTHONOUS ARBOVIROSES OUTBREAKS IN THE MEDITER-
RANIAN REGION. INNOVATIVE PREDICTIVE DATA ANALYSIS
PLATFORM
Molina I.
Tropical Medicine and International Health Unit, Vall d’Hebron
Hospital, Barcelona, PROSICS Barcelona, Spain
Introduction: Diseases transmitted by mosquitoes pose a threat to the
European Region. Emerging arboviroses (such as Dengue, Chikungunya,
Zika, West Nile virus) have acquired significant relevance in recent years.
The favourable climatologically conditions, the presence of the transmit-
ting vectors and the numerous international trips, make the Mediter-
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Such theoretical framework has been overcome for the recent arboviroses
outbreaks in the southern countries of Europe.
Centralized surveillance systems and public health agencies with limited
resources may not be sufficiently operational to provide an adequate
response to a new threat of such type.
Aim: We pretend to give an overview of the current epidemiological
scenario in our region and to present at premiere an innovative initia-
tive based on an integrated management platform for epidemiological
surveillance with advanced applications of predictive models and citizen
participation which will help to control these epidemics.
The “PICAT” platform aims to integrate all the relevant information that
can determine the emergence of autochthonous cases in our territory
and create a network with the main agents involved (primary care,
specialized centres, advanced research centres, public health agencies
and civil society). By developing an innovative geo-localized data man-
agement system, they will help predict the potential risk of epidemics and
the dynamics of infections, helping to optimize epidemiological control
interventions.
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ANTI-PEPTIDE ANTIBODIES AGAINST PLASMODIAL GAPDH,
LDH AND PHOSPHOETHANOLAMINE-N-METHYLTRANSFERASE
TO DIAGNOSE PLASMODIUM FALCIPARUM, VIVAX AND
KNOWLESI MALARIA
Goldring J.P.D.
Biochemistry, University of KwaZulu-Natal, Pietermaritzburg,
South Africa
Introduction: Rapid and accurate diagnosis of malaria is essential for
patient survival and the administration of correct treatment. Point of
care Rapid Diagnostic Tests employ antibodies to both capture and
detect Plasmodial proteins on an immunochromatographic test strip.
Histidine Rich Protein 2 expressed by Plasmodium falciparum parasites
is the protein target in the most popular and widely used commercial
RDT test kits. There are increasing reports of deletions of the gene for
PfHRP-2 in isolates from South America, Asia and Africa and thus failure
of the PfHRP-2 test to detect parasites. The reagents in RDTs are subject
to high ambient temperatures leading to reagent degradation and false
positives. Mouse IgG monoclonal antibodies, employed in some tests,
cross-react with human rheumatoid factor.
Aim: There is therefore a need to develop new diagnostic biomarkers to
replace PfHRP-2 and to identify antibodies that are heat stable and do
not interact with human rheumatoid factor.
Methods: An ideal biomarker: is present in high concentrations and has a
short (few days) half-life in patient blood; is not expressed in the host or
has parasite specific antigenic motifs; is essential for parasite survival; has
minimal genetic variation; can be recombinantly expressed and the x-ray
crystallographic structure is available. Ideal antibodies are heat stable,
readily obtainable and do not cross-react with human proteins. Ideally
the host does not produce high titres of antibodies against targeted
antigenic structures.
Results: This rationale has identified two potential diagnostic biomarkers,
Plasmodial glyceraldehyde-3-phosphate dehydrogenase and phosphoet-
hanolamine-N-methyltransferase. The proteins from different Plasmodial
species have been recombinantly expressed. Anti-peptide antibodies
have been generated in chickens against antibody accessible “diagnostic”
linear peptide domains on these proteins and on Plasmodial lactate
dehydrogenase and the antibodies have been affinity purified. The
peptide antibodies can identify the recombinant and native proteins and
can differentiate between species of malaria. Chicken antibodies do not
cross-react with rheumatoid factor and are stable for prolonged periods
judged by from differential scanning fluorimetry measurements.
Conclusion: Reagents detecting and differentiating between Plasmodium
falciparum, vivax and knowlesi parasites have been developed.
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MINING THE SALIVA PROTEOME – DISCOVERY, VALIDA-
TION, AND PROTOTYPE DESIGN FOR A NON-INVASIVE RAPID
MALARIA DIAGNOSTIC
Hamerly T.1,2,3, Tao D.1,2, McGill B.1,2, Kobayashi T.2,4, Khare P.3,
Dziedzic A.1, Leski T.5, Holtz A.6, Shull B.7, Jedlicka A.E.1, Walzer
A.7, Slowey P.D.8, Slowey C.C.8, Nsango S.E.9,10, Stenger D.A.5,
Chaponda M.11, Mulenga M.11, Jacobsen K.H.12, Sullivan D.J.1,
Ryan S.J.13, Ansumana R.14, Moss W.J.2,4, Morlais I.9, Dinglasan
R.R.1,2,3
1W. Harry Feinstone, Dept. of Molecular Microbiology and Immunol-
ogy, Johns Hopkins Bloomberg School of Public Health, Baltimore,
USA;
2Johns Hopkins Malaria Research Institute, Baltimore, USA;
3Emerging Pathogens Institute and Dept. of Infectious Diseases &
Immunology, College of Veterinary Medicine, University of Florida,
Gainesville, USA;
4Dept. of Epidemiology, Johns Hopkins Bloomberg School of Public
Health, Baltimore, USA;
5United States Naval Research Laboratory (NRL), Center for
Biomolecular Science and Engineering, Washington, USA;
6College of Science, George Mason University, Fairfax, USA;
7Thermo Fisher Scientific, Fremont, USA;
8Oasis Diagnostics, Vancouver, USA;
9Laboratoire de Recherche sur le Paludisme, Institut de Recherche
pour le Développement–Organisation de Coordination et de
Coopération pour la Lutte Contre les Grandes Endémies en Afrique
Centrale (IRD-OCEAC), Yaoundé, Cameroon;
10Faculty of Medicine and Pharmaceutical Sciences, University of
Douala, Douala, Cameroon;
11Tropical Disease Research Centre, Ndola, Zambia;
12College of Health and Human Services, George Mason University,
Fairfax, USA;
13Emerging Pathogens Institute and Dept. of Geography, College
of Liberal Arts and Sciences, University of Florida, Gainesville, USA;
14Mercy Hospital Research Laboratory, Kulanda Town, Bo, Sierra
Leone
Introduction: A large proportion of ongoing malaria parasite transmis-
sion is attributed to low-density subclinical infections not readily detected
by available rapid diagnostic tests (RDTs) or microscopy. Plasmodium falci-
parum gametocyte carriage is subclinical, but gametocytemic individuals
comprise the parasite reservoir that leads to infection of mosquitoes
and local transmission. Effective detection and quantification of these
carriers can help advance malaria elimination strategies. However, no
point-of-need RDTs for gametocyte detection exists, much less one that
can perform non-invasive sampling of saliva outside a clinical setting.
Aim: We sought to develop a saliva-based rapid test to quantify subclini-
cal gametocyte carriers that make up the malaria parasite reservoir.
Methods: Using liquid chromatography-mass spectrometry (LC-MS), we
profiled the saliva proteome from children with subclinical infections and
selected a candidate marker. We then performed a competitive profiling
study using a liquid chromatography–multiple reaction monitoring (LC-
MRM) mass spectrometry (MS) workflow to estimate the prevalence of our
candidate marker in the saliva of children with subclinical infections. Last,









ent_1/S1/5569919 by guest on 24 M
arch 2020
Oral Presentations
further validated the presence of the marker in saliva from children with
subclinical infection.
Results: Our initial analysis of saliva revealed 35 malaria proteins, of
which PF3D7_1218800 or Plasmodium sexual stage protein 17 (PSSP17),
was the most abundant in gametocyte positive individuals. Using PSSP17
as a candidate gametocyte marker, we analysed saliva from 364 chil-
dren and found a high prevalence (over 85%) of PSSP17 in saliva of
gametocytemic individuals. We developed a prototype LFIA rapid test
to detect PSSP17 and found our saliva-based diagnostic to have good
correlation with our LC-MRM assay, validating these results. Furthermore,
we found our RDT to be highly sensitive in the detection of PSSP17 from
saliva, outperforming microscopy and achieving detection levels of <1
gametocyte/μL based on qPCR of matched blood samples.
Conclusion: We show here the discovery, validation, and development of
a prototype, non-invasive saliva-based rapid test capable of identifying
sub-microscopic parasite carriage in both clinical and nonclinical settings.
The process that we demonstrate forms a template for the validation of
other potential parasite biomarkers in saliva and other biofluids.
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GOING VIRAL: INSIDER TIPS ON GETTING YOUR STORY ON THE
FRONT PAGE FOR THE RIGHT REASONS
Bigham B.1,2,3,4
1Dept. of Medicine, McMaster University, Hamilton, Canada;
2School of Medicine, University of Namibia, Windhoek, Namibia;
3Munk School of Global Affairs and Public Policy, University of
Toronto, Toronto, Canada;
4Canadian Broadcasting Corporation, Toronto, Canada
Introduction: In a world of fake news and pseudoscience, it’s more
important than ever that health experts engage with the public - but
our traditional models of public engagement are flawed. Human beings
are hard-wired to emotionally respond to stories about each other, an
expertise held by the popular press.
Aim: This session introduces global health leaders to journalistic tech-
niques so that they can generate strong stories that compel behaviour
change and lead to action - action that can save a life, alter an epidemic,
change public policy, or overcome social barriers to change.
Methods: In this interactive session, a doctor-scientist turned journalist
will outline an algorithm which introduces the key criteria that make for
compelling stories that will pique the interest of a newspaper editor or
TV news producer. In a workshop, participants will put the criteria to
practice by developing a “pitch” for an editor. The lessons shared offer an
alternative approach to traditional “public communications” or “media
relations” methods.
Results: In a presentation that defies common beliefs and challenges the
scientific approach to storytelling, Blair will present a "BLS algorithm" -
Basic Lifesaving Storytelling - to help participants frame their message
in a way that promotes public attention and leads to personal action or
policy change when it matters most by applying journalistic trade craft to
global health prerogatives.
Conclusion: Either proactively or reactively, physicians and scientists can
have a substantial impact when they engage effectively with the popular
press. The algorithm and journalistic lessons gleaned from this workshop
also apply to conversations with grant agencies, funding partners, public
and private institutions, and governments.
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A GROUNDED THEORY APPROACH IN THE DEVELOPMENT OF
CULTURALLY APPROPRIATE PSYCHOSOCIAL SUPPORT FOR VIC-
TIMS OF SEXUAL VIOLENCE IN THE DEMOCRATIC REPUBLIC OF
THE CONGO
Konan E.1, Schmitz O.2, Verelst A.3, Bosmans M.4, Bossyns P.5
1Prevention of Sexual Violence Programme, Enabel–Belgian Devel-
opment Agency, Kisangani, DRC;
2School of Public Health, Université Catholique de Louvain-la-
Neuve, Louvain-La-Neuve, Belgium;
3Faculty of Psychology and Pedagogical Sciences, Ghent University,
Ghent, Belgium;
4Health Unit, Enabel-Belgian Development Agency, Brussels,
Belgium;
5Health Unit, Enabel-Belgian Development Agency, Brussels,
Belgium
Introduction: In the DR Congo the Ministry of actively contributed
to the development of the four national protocols for aid to victims
of sexual violence (medical aid, psychosocial support and mental
health, socioeconomic reintegration and legal aid). The sexual violence
prevention programme supported by Enabel is aimed at strengthening
the role of the health sector in improving access of victims to quality
services. A one-stop centre model is developed focusing on the victim’s
right to health but within a multi-stakeholder and multidisciplinary
approach. In view of improving the quality of the services, the programme
builds on the hypothesis that evidence based approaches to victim
support that are adapted to prevailing social and cultural norms and
values are key for the effectiveness and the quality of the services. The
programme has a duration of three years.
Aim: The aim of this presentation is to explain the process that has
been followed in developing the grounded theory approach and to share
preliminary results and lessons learned.
Methods: An action research model has been developed using the
grounded theory methodology involving a multidisciplinary group of
different stakeholders (health professionals, local authorities, academics,
opinion leaders, victims).
Results: The action research model is comprised of two phases. The
first phase consists of 1) literature review (scientific and grey literature);
2) a socio-anthropological survey among different stakeholders and
institutions involved in aid to victims; 3) focus group discussions and
interviews with victims, health professionals and community members;
4) analysis of the patient files. The data analysis is done in a participatory
way. Based on the results of the data analysis the protocols and
therapeutic models for aid to victims are adapted and piloted in the
Alwaleed Health Centre in Kisangani. The implementation of the adapted
protocols and therapeutic models is monitored and evaluated before
finalisation.
Conclusion: The use of the grounded theory approach sheds a new light
on how best to provide aid to victims of sexual violence in a sensitive
social environment affected by strongly embedded taboos and cultural
practices that enhance the vulnerability of women, girls and boys to
sexual and other forms of gender-based violence, whilst at the same
time fostering cultural sources of support. Three years is too short to
ensure a scaling up of the initiative and embed it into national policies.
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RISK AND PROTECTIVE FACTORS FOR THE PSYCHOSOCIAL
WELL-BEING OF ADOLESCENT VICTIMS OF SEXUAL VIOLENCE
IN EASTERN DRC. IMPLICATIONS FOR SUPPORT
Verelst A.
Dept. of Social work and Social pedagogy, Ghent University, Ghent,
Belgium
Introduction: Eastern Congo has set the scene for large-scale use of
sexual violence in the context of war. In this (post) conflict setting also
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in as outside the context of armed conflict. Practice-oriented research
by Centre for Children in Vulnerable Situations aims to unveil the risk
and protective factors playing a role in determining the psychosocial
impact of sexual violence in adolescent girls and determine how they
could be addressed in psychosocial services offered to victims and their
communities.
Aim: This presentation will address the psychological and social
consequences that adolescent survivors of sexual violence in Eastern
Congo face and the implications they have for psychological treatment
and social acceptance for trauma survivors.
Methods: Based on a large scale triangulatory study this paper discusses
the protective and risk factors associated with psychosocial well-being
in girls that have experienced sexual violence in (post-)conflict Eastern
Congo. Firstly, in a school-based study, (n=1300) self-report question-
naires on post-traumatic stress symptoms, externalising and internalising
psychological problems, war-related traumatic events, daily stressors,
coping and social support, rape myth acceptance were completed.
Furthermore, this multi-method study included a qualitative exploration
(n=27) of these psychological and social consequences of sexual
violence.
Results: Findings of the intertwined studies combined show that
adolescent victims of sexual violence face a myriad of psychological
and social consequences of sexual violence. Stigmatisation, social
support and daily stressors seem to be associated with the psychological
problems adolescent survivors of sexual violence face. Important
protective factors that are important for young victims of sexual violence
are unveiled as well.
Conclusion: Implications for psychological treatment of adolescent
survivors of sexual violence and individual context-specific needs for
dealing with sexual violence in Eastern Congo are formulated.
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RISK FACTORS FOR POSITIVE APPRAISAL OF MISTREATMENT
DURING CHILDBIRTH AMONG ETHIOPIAN MIDWIFERY STU-
DENTS
Bakker R.1, Sheferaw E.1,2, Yigzaw T.2, Stekelenburg J.1, de
Kroon M.1
1University of Groningen, Groningen, The Netherlands;
2Jhpiego Ethiopia, Addis Ababa, Ethiopia
Introduction: Only 28% of births in Ethiopia were attended by a skilled
health worker in 2016, while maternal and neonatal mortality rates
remain high. Care providers’ mistreatment of women during childbirth
can partially account for these findings due to creating a culture of fear
that reduces pregnant women’s healthcare utilization.
Aim: This study was carried out in order to identify risk factors for positive
appraisal of mistreatment during childbirth among Ethiopian midwifery
students. Insights may be of particular interest to the Ethiopian gov-
ernment that aims to promote respectful maternity care with its Health
Sector Transformation Plan.
Methods: This study employed a cross-sectional design. We collected
data among 391 Ethiopian final year midwifery students from six edu-
cation institutions. Students were invited to complete a paper-and-pen
questionnaire, which included questions on background characteristics,
prior observation of mistreatment during education, self-esteem (using
the Rosenberg Self Esteem scale), stress (using the Perceived Stress Scale)
and mistreatment appraisal (using the MISAP Scale, work in progress).
A multivariable linear regression analysis was applied to answer the
research question.
Results: Age (p=.005), stress (p=.019) and previous observation of mis-
treatment during education (p<.001) were significant predictors of mis-
treatment appraisal. More positive mistreatment appraisal was observed
among younger students, stressed students and students that observed
more mistreatment during their education. Origin (p=.373) and self-
esteem (p=.445) were not significantly associated with mistreatment
appraisal.
Conclusion: Data collection among students allowed us to identify risk
factors for positive mistreatment appraisal before employment. Findings
can be used to develop educational interventions that increase pro-
fessionalism and promote respectful maternity care among Ethiopian
midwifery students.
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EXPERIENCE WITH COMMERCIAL MOLECULAR DIAGNOSTICS
FOR PARASITE DETECTION IN A ROUTINE DIAGNOSTIC
LABORATORY
Polley S.D.1, Watson J.1, Kinson R.1, Chiodini P.L.2
1Dept. of Clinical Parasitology, Health Services Laboratories Analyt-
ics LLP, London;
2University College London Hospitals Trust, London, UK
Introduction: Traditionally the world of parasite diagnostics has evaded
molecular detection except where they could be detected by microscopic
or macroscopic observation. With the advent of nucleic acid amplification
techniques and lateral flow immunochromatographic techniques (also
known as RDTs), parasite molecules been now been targeted for diagnos-
tics. Whereas RDTs were quickly picked up and developed by commercial
ventures, the world of NAATs has been mostly pioneered by scientists
developing in-house assays. The decade has seen an increasing number
of commercial molecular diagnostics released that claim to allow for
sensitive and specific parasite diagnosis.
Aim: To review the different commercial molecular technologies tested
and employed by Health Services Laboratories for the detection of para-
sitic infections in routine clinical samples. This will involve the opportuni-
ties, benefits and threat analyses of such technologies with discussion on
mitigation of any associated risks.
Methods: Retrospective analysis of data generated from the verification
and routine deployment of commercial diagnostic systems against in
house assays acting as the “Gold Standard”.
Results: Data will be presented for the Enteric Bio system and commer-
cial multiplex PCR for enteric parasites compared to in house multiplex
PCR for Giardia intestinalis, Cryptosporidium and Entamoeba histolytica,
commercial Leishmania diagnostic real time PCR reagent against in house
Noyes et al PCR, commercial LAMP reagents against in house Snounou
PCR as well and experience of the use of the XTAG system and other
commercial systems for the detection of parasites.
Conclusion: Commercial systems offer laboratories the ability to quickly
and reliably initiate molecular testing for parasites and CE marked prod-
ucts are externally quality controlled allowing adherence to ISO 15189
guidelines. The rapid increase in the market does, however, bring its own
challenges in that not all companies may be equal in the quality of their
pre-release testing and not all kits may be tested for a given patient
population meaning it is essential to locally verify any technology prior
to its implementation.
Reference:
1. Polley S.D. Parasite Genomes and Diagnostics. Genomic and Clinical
Diagnostics Ed David Whitehouse and Ralph Rapley, Pub Royal Society of
Chemistry 2019.
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LABORATORY DEVELOPED MOLECULAR TESTS COMPLIANT














Laboratory for Medical Microbiology and Immunology, Elisabeth-
Tweesteden Hospital, Tilburg, The Netherlands
Introduction: In the last decades, molecular diagnosis of parasitic infec-
tions has evolved from confirmatory PCR in reference laboratories into
first line diagnostics replacing microscopy. Clinical medical laboratories
are inclined to comply with the requirements for quality and competence
as set in the ISO15189 guidelines.
Aim: The validation and maintenance compliant with the ISO 15189
guidelines of in-house PCRs for the diagnosis of intestinal parasitic infec-
tions.
Methods: Relevant criteria were set for the validation of in-house PCRs
including in silico sensitivity and specificity, multiplex efficiency, sensitiv-
ity and specificity, reproducibility and clinical applicability. These criteria
were accessed on assays already in use as well as on modified and new
assays for the detection of intestinal protozoa and helminths.
Results: The results of the validations provided new insights and were
used to further improve, adjust and modify the existing assays to make
them even more suitable for use in our setting.
Conclusion: Tailor-made interpretation and application of the ISO15189
guidelines provides a continuous improvement of the diagnostic perfor-
mance of a clinical medical laboratory.
References:
1. Verweij J.J. Application of PCR-based methods for diagnosis of
intestinal parasitic infections in the clinical laboratory. Parasitology
2014,141(14),1863-1872.
2. Verweij J.J., Stensvold C.R. Molecular testing for clinical diagnosis and
epidemiological investigations of intestinal parasitic infections. Clinical
Microbiology Reviews. 2014, 27(2),371-418.
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HOW ACCURATE IS THE DIAGNOSTIC PERFORMANCE OF
YOUR STOOL PCR? EXPERIENCES FROM AN INTERNATIONAL
EXTERNAL QUALITY ASSESSMENT SCHEME FOR PCR-BASED
DETECTION OF PARASITES IN CLINICAL STOOL SAMPLES
Van Lieshout L.∗
Dept. of Parasitology, Leiden University Medical Center, Leiden, The
Netherlands
∗Representing the board of the Parasitology section of the Dutch
Foundation for Quality Assessment in Medical Laboratories (SKML)
and the international Helminth External Molecular Quality Assess-
ment Scheme (HEMQAS) workgroup
Introduction: In response to growing demand for proficiency panels for
PCR-based diagnosis of stool parasites, the Dutch non-profit organisation
for quality assessment in medical laboratories (SKML) initiated in 2012 an
international External Quality Assessment Scheme (EQAS) for the detec-
tion of gastrointestinal protozoa. In an EQAS laboratories are regularly
tested on their diagnostic performance by providing them with blinded
samples. This SKML scheme makes use of well validated clinical stool
samples and not of an artificial matrix spiked with purified DNA target,
which allows control of the entire diagnostic workflow, including DNA
extraction procedures.
Aim: Here we report about the PCR outcome of the SKML schemes of stool
samples over the period 2012-2018.
Methods: Approximately 35 laboratories participate each year in the
scheme for the detection of protozoa, i.e. Giardia, Cryptosporidium, Enta-
moeba histolytica, Entamoeba dispar and Dientamoeba. Based on the
successes of this protozoa scheme, a pilot was introduced early 2018 to
evaluate the feasibility of a similar scheme for the detection of helminths,
i.e. Ascaris, Trichuris, Ancylostoma, Necator, Schistosoma and Strongy-
loides. This EQAS pilot was conducted by the international Helminth
External Molecular Quality Assessment Scheme (HEMQAS) workgroup
initiated by the STARWORM project and was driven by the need to improve
laboratory diagnostic procedures for monitoring the efficacy of mass drug
treatment programs for helminths.
Results: Reports of false-positive and false-negative PCR results occurred
in every scheme. Misdiagnosis was more often seen for the helminths
than the protozoa. In particular Trichuris was often missed, while false-
positive results were mostly noted for Strongyloides. The reported semi-
quantitative parasite loads (Cq-values) differed substantially between
laboratories, while the intra-laboratory variation was low. Clusters of
poor-performers and good-performers were noticed. Preliminary analysis
suggests a relation between the performance within the scheme and the
applied DNA extraction procedure.
Conclusion: Overall, our findings confirm that periodic participation in a
quality assessment scheme is essential for any laboratory when estab-
lishing PCR-based detection as a routine procedure for the diagnosis
of parasites in stool. In addition, inter-laboratory comparison is most
informative when results are derived from well validated clinical samples
and not by artificially prepared materials.
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PAST, PRESENT AND FUTURE: A REVIEW OF THE UK NEQAS EQA
SCHEMES FOR LABS PERFORMING PARASITE DIAGNOSTICS
Shrivastava J., Saez A.C., Chiodini P.L.
UK NEQAS Parasitology, Public Health England, The Halo Building,
London, UK
Introduction: Parasitic diseases are continually on the rise with many
parasitic diseases currently appearing or reappearing in non-endemic
regions. Thus, there is increasing trend of using both commercial as well
as in-house developed novel diagnostic tools to adress the need for
simple, quick and accurate parasite diagnoses. These novel diagnostic
tools are mostly molecular assays and rapid diagnostics tests (RDTs).
However, these diagnostic technologies are not without their challenges
and there has been recent evidence of lack of consensus amongst pro-
tocols and results which have been observed via the External Quality
Assurance (EQA) schemes run by UK NEQAS Parasitology.
Aim: External Quality Assurance (EQA) is an educational tool that allows
participants to monitor, evaluate and improve their own performance. UK
NEQAS is celebrating its 50th year this year as leaders in EQA provision. UK
NEQAS Parasitology targets diagnostics in the field of blood and faecal
parasitology and I will present the findings/recommendations from our
existing EQA schemes. I will also discuss the need for new EQA schemes
to address the advent of new technologies in the field- especially with
respect to molecular assays and Rapid diagnostics (RDTs).
Methods: Participants’ learnings and trend analyses were gathered. Two
EQA schemes will be discussed in particular- Malaria Rapid and Malaria
molecular.
Results: Consistent theme across all schemes were identified: lack of
harmonisation of practices and protocols leading to missed or wrong
diagnoses. Impact of human factors (e.g. lack of suitable training) was
observed. Current lack of international standards for most blood and
faecal parasites leads to use of in-house controls leading to erroneous
results.
Conclusion: In parallel with technological advances there is an urgent
need for EQA of these novel diagnostic methodologies as they become
routine diagnostic procedures to ensure that such tests are accurate,
precise and consistent.
References:
1. Shrivastava J. Assessors Assemble: need for harmonised External Qual-
ity Assessment schemes for emerging diagnostic methodologies in the
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DELAYED DIAGNOSIS AND ONGOING TRANSMISSION OF LEP-
ROSY IN THE POST-ELIMINATION ERA IN BORU MEDA HOSPI-
TAL, ETHIOPIA: WE NEED TO DO MORE
Getahun S.1, Diro E.2, Tilahun F.3, Tadese F.1, Enbiale W.4, Sisay
K.2, Tweya H.5, Timire C.5, van Griensven J.6
1Wollo University, Dessie, Ethiopia;
2University of Gondar, Gondar, Ethiopia;
3Boru Meda Hospital, Dessie, Ethiopia;
4Bahir Dar University, Bahirdar, Ethiopia; 5International Union
Against Tuberculosis and Lung Disease (The Union), Paris, France;
6Institute of Tropical Medicine, Antwerp, Belgium
Introduction: Following the recommendation of the Global Leprosy
Strategy, Ethiopia targeted to reduce the incidence of new leprosy cases
and the proportion with severe disability (grade 2) from 13.6% in 2016 to
<1% in 2020.
Aim: To assess the clinical profile of new leprosy cases and the sequelae
of previously treated ones, 20 years after leprosy was eliminated as a
public health problem in the country.
Methods: Medical records of all leprosy patients seen at the dermatology
clinic of Boru Meda Hospital from August to December 2018 were
reviewed and data captured using a standard data collection form.
Results: Over the study period, 57 (27.4%) new cases and 151 (72.6%)
previously treated cases were seen. The median age was 44 years
(interquartile range 32-57). Among the newly diagnosed two were
children, 51 (89.5%) were multibacillary and 34 (59.6%) had grade 2
disability. This included visual loss or impairment in 10 (17.5%) and
neurological complications in 44 (77.2%). Of the 151previously treated
cases, 104 presented with disabilities, including 97 (64.2%) with grade
2. Amongest previously treated cases, 130 (82.8%) had neurological
complications. In addition, 53 (35.1%) had vision loss or impairment.
Conclusion: This study showed evidence of ongoing leprosy transmission
and delayed diagnosis in the country. This calls for operational research
to determine the underlying reasons and provide ways forward. At the
same time, the high burden of disabilities in previously treated cases
should be addressed.
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CYSTS AND PARASITES IN AN ABATTOIR IN NORTHWEST
ETHIOPIA: AN URGENT CALL FOR ACTION ON “ONE HEALTH”
Gebree D.1, van Henten S.2, Abera A.1, Senkoro M.3, Owiti P.4,
Lombamo F.5, Girma B.1, Ashenefe B.6, Deressa A.1, Diro E. 7
1Ethiopian Public Health Institute, Addis Ababa, Ethiopia;
2Institute of Tropical Medicine, Antwerp, Belgium;
3National Institute for Medical Research, Muhimbili Centre, Dar es
Salaam, Tanzania;
4The Union, Paris, France;
5Saint Paul’s Hospital Millennium Medical College, Ethiopia;
6Gondar Elfora Abattoir, Gondar, Ethiopia;
7Dept. of Internal Medicine, University of Gondar, Gondar, Ethiopia
Introduction: Zoonotic parasitic infections such as echinococcosis affect
cattle, sheep and goats in terms of the quality of meat and hides as well
as milk production. The burden among humans is usually underestimated
as they are difficult to diagnose.
Aim: To investigate the trend and prevalence of echinococcosis and other
zoonotic parasites among animals in an abattoir in North Gondar zone of
Ethiopia during the period 2005 to 2018.
Methods: Data from 2005-2018 was used from the registry of an abattoir
in Northwest Ethiopia. Frequencies, proportions and trends over time were
analyzed. Meat inspection is conducted by visualization, palpation and
incision.
Results: A total of 58,787 animals were slaughtered in the abattoir during
the period. These included 51,956 (88.4 %) cattle 5,890 (10.0 %) sheep
and 941 (1.6%) goats. The detected parasites include Echinococcus in
12,334/58,787 (21.0%) and Fasciola in 10,551/58,787 (17.9%) animals.
Echinococcus infection was highest among goats, 267/941(28.4%),
followed by cattle, 11,591/51,956(22.3%) and sheep 476/5,890 (8.1%).
Fasciolosis was detected in 9877/51,956 (19.0%) of cattle and 178/941
(18.9%) of goats. The number of animals slaughtered was strongly
decreasing over time from 8,405 (14.2%) in 2006 to 1,605 (2.7%) in
2018. However, the prevalence of the parasitic infection remained high
with some fluctuations over the study period.
Conclusion: Echinococcosis and fasciolosis was very common with one
out of five animals slaughtered being infected. This is of public health
concern and needs urgent multi-sectorial efforts from stakeholders at
the national and regional level and others for control of the diseases. One
health programs approaches may warrant the control of transmission to
humans.
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TOWARDS THE 2020 TARGET OF TRACHOMA ELIMINATION IN
SOUTHERN REGION OF ETHIOPIA: HOW WELL IS THE SAFE
STRATEGY IMPLEMENTED?
Asnakew M.1, Zolfo M.2, Nigussu N.3, Tadesse F.3, Tadele T.4,
Sisay A.5, Seyum D.5, Gezmu T.1, Senkoro M.6, Owiti P.7,8,
Adriaensen W.2
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2Institute of Tropical Medicine, Clinical Sciences Dept., Antwerp,
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3Federal Ministry of Health, Neglected Tropical Diseases, Addis
Ababa, Ethiopia;
4Southern Nation Nationalities and Peoples Regional Government
Health Bureau, Neglected Tropical Diseases, Hawassa, Ethiopia;
5Orbis International, Ethiopia, Country office, Addis Ababa,
Ethiopia;
6National Institute for Medical Research, Muhimbili Centre, Dar es
Salaam, Tanzania;
7International Union Against Tuberculosis and Lung Disease (The
Union), Paris, France;
8National Tuberculosis, Leprosy and Lung Disease Programme,
Nairobi, Kenya
Introduction: Trachoma is one of the 20 neglected tropical diseases
and a serious public health problem in Ethiopia. To reach WHO elim-
ination target by 2020, SAFE (Surgery, Antibiotics, Facial cleanliness,
Environmental improvement) strategy has been implemented in many
districts of Southern Nations, Nationalities, and Peoples’ Region (SNNPRs),
Ethiopia. Scarce evidence exists in the region regarding recent progress in
achieving elimination of active trachoma (TF) (<5% in children aged 1-9
years) and on implementation results.
Aim: To assess how districts did progress in terms of achieving trachoma
elimination and how well is the SAFE strategy implemented.
Methods: A retrospective analysis of programmatic data for the period
2013-2018 was used. All 134 trachoma endemic districts in SNNPR were
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prevalence and SAFE strategy were analysed. To evaluate the most recent
progress per district, we analysed the differences of prevalence between
two most recent surveys. Implementation of SAFE strategy was assessed
based on the reporting of the individual components of the SAFE strategy,
using recent data, in 2017.
Results: Out of 134 endemic districts, only 35 had their planned impact
survey, of which only 11 districts achieved elimination target (TF<5%).
Six districts reverted back from eliminated status to low or moderate
prevalence level. The median prevalence of active trachoma was 10%
in 2017/18. In 2017, the mean antibiotic treatment coverage was 90%,
and 56% and 68% of districts implemented and reported on “F” and
“E” component of SAFE strategy, respectively. In the high prevalence
districts, only 10% delivered the planned 5 rounds of Zithromax® mass
distribution.
Conclusion: Only a limited number of districts reached the WHO elimi-
nation target by 2018 and in recent years some districts even reverted
back to low or moderate prevalence levels. An urgent call for accelerated
SAFE strategy implementation and in particular for the high endemic
districts, as potential transmission drivers, is required in order to achieve
the elimination target.
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THE CLINICAL SENSITIVITY OF STANDARD DIRECT WET MOUNT
MICROSCOPY FOR SOIL-TRANSMITTED HELMINTH INFECTIONS
IN SCHOOL CHILDREN IN JIMMA, SOUTH-WEST ETHIOPIA
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Verdonck K.3, Tweya H.4, Timire C.4, Geldof P.2, Levecke B.2
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Institute of Health, Jimma University, Jimma, Ethiopia;
2Dept. of Virology, Parasitology and Immunology, Faculty of Vet-
erinary Medicine, Ghent University, Merelbeke, Belgium;
3Dept. of Public Health, Institute of Tropical Medicine, Antwerp,
Belgium;
4The International Union against Tuberculosis and Lung Disease,
Paris, France
Introduction: Soil-transmitted helminthiasis is a disease caused
by Ascaris lumbricoides, Trichuris trichiura and the two hookworms
(Ancylostoma duodenale and Necator americanus) and remains a major
public health problem in school children in Ethiopia. Although direct wet
mount microscopy is the standard means to diagnose intestinal parasitic
diseases in health care facilities in Ethiopia, it remains unclear what its
diagnostic performance is for soil-transmitted helminths.
Aim: To determine the clinical sensitivity of standard direct wet mount
microscopy for soil-transmitted helminth infections compared to the
composite reference standard in school children in Jimma, South-West
Ethiopia.
Methods: A school based cross-sectional study was performed in Jimma
Town and included 600 children from 10 primary schools. The clinical
sensitivity of direct wet mount microscopy was compared to a composite
reference standard consisting of Kato-Katz thick smear, McMaster and
Mini-FLOTAC.
Results: The composite reference standard about 210 Ascaris (35.0%),
312 Trichuris (52.0%) and 102 hookworm cases (17.0%). The median
intensity of infections [expressed as eggs per gram of stool (EPG)]
equalled 2,057 EPG for Ascaris, 200 EPG for Trichuris and 110 EPG for
hookworms. The sensitivity of direct wet mount microscopy was 73.8%
for Ascaris, but was only around 17% for both Trichuris and hookworms.
For each of the three soil transmitted helminths there was an increase in
sensitivity as a function of increasing intensity of infections. For Ascaris,
the sensitivity ranged from 30.2% for the lowest infection intensities to
94.3% for the highest levels of infection intensity. For both Trichuris and
hookworms, the sensitivity ranged from nearly 0% to 42.9% across the
different levels of infection intensity.
Conclusion: Using direct wet mount microscopy severely underestimated
the prevalence of soil transmitted helminths. The sensitivity of direct wet
mount microscopy is low for STH, particularly for infections with Trichuris
and hookworm when the infection intensities are low.
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A PRELIMINARY REPORT ON THE SPILL OVER EFFECT OF MASS
DRUG ADMINISTRATION FOR ONCHOCERCIASIS ON SCABIES
CONTROL IN NORTHERN ETHIOPIA
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Introduction: Scabies is a skin infestation caused by the mite Sarcoptes
Scabiei var. hominis. WHO included the disease among the Neglected
Tropical Diseases in the year 2017. Ethiopia bears a very high scabies
burden and a series of scabies outbreaks have been recorded in the past
few years. To respond to growing public health concern, the Ethiopian
Federal Ministry of Health is looking for approaches to control the disease.
In Ethiopia, Mass Drug Administration (MDA) with ivermectin has been
taking place for the control of onchocerciasis since 2003 but its secondary
effects on the transmission of scabies have not been evaluated.
Aim: The aim of this study was to evaluate the effect of MDA for onchocer-
ciasis on the transmission of scabies.
Methods: A comparative cross-sectional study design with multi-stage
sampling was used. Districts in Ethiopia, with varying time of onset of
MDA were selected. Data were collected using a pretested structured
interview questionnaire on the prevalence of scabies infestation, socioe-
conomic and socio-demographic variables, and health service utilization.
The recently developed Consensus Criteria were used by the trained field
data collectors (clinical nurses) and an experienced dermatologist to
screen and identify clinical cases of scabies during a house-to-house
survey. In one district, pre- and post- MDA data are being collected to
measure the effectiveness of MDA.
Results: To date, data from one district have been analyzed. This com-
prises household and individual level data from 402 households and 1400
individuals. The prevalence of scabies was estimated to be 15% (210
cases/1400 individuals). Half (105) of the cases have been re-evaluated
by the dermatologist.
Conclusion: Our preliminary findings suggest that prevalence of scabies in
the district in which ivermectin MDA has been carried out since 2015 is still
high. The agreement between clinical nurses and the dermatologist on
scabies case identification was good. By finding out the impact of varying
time of onset of ivermectin MDA on scabies, we anticipate formulating an
improved control strategy for scabies, thereby reducing the burden of the
disease.
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INTEGRATING A HOLISTIC CARE PACKAGE FOR PODOCONIOSIS,
LYMPHATIC FILARIASIS AND LEPROSY INTO ROUTINE HEALTH
SERVICES IN ETHIOPIA – THE ENDPOINT PROJECT
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Introduction: Lower-limb lymphoedema resulting from podoconiosis,
lymphatic filariasis (LF) or leprosy are common in Ethiopia and pose
a significant burden on patients, in terms of disability, mental distress,
depression, stigma and loss of economic productivity. However, morbidity
management and disability prevention (MMDP) for these diseases is
currently largely delivered by NGOs, which cannot reach the huge number
of people affected. There have also been increasing calls to include
mental health care within MMDP.
Aim: The EnDPoINT implementation research project aims to integrate
and scale up a holistic package of physical, psychosocial and mental
health care for patients with podoconiosis, LF and leprosy into the
government-run health services in selected districts in Ethiopia.
Methods: EnDPoINT is being carried out over three phases: 1) formative
work to inform the development of the care package, which has included
a situational analysis, systematic review, three ‘Theory of Change’
workshops, and key informant interviews and focus group discussions
with key stakeholders; 2) piloting of the care package in one district; and
3) scaling up of the care package in three districts. This presentation
focuses on Phase 1.
Results: The care package was successfully developed based on
the formative activities, and includes limb care, mental health and
anti-stigma interventions at the healthcare administration, health facility
and community level. Based on the care plan, an integrated guideline
addressing podoconiosis, LF, leprosy and common mental illnesses has
been prepared and peer-evaluated, and training has been piloted in one
health centre. The focus group discussions of community representatives,
health care workers and decision makers revealed the feasibility and
acceptability of integrated care of the three diseases and co-morbid
mental illnesses.
Conclusion: The EnDPoINT project takes a holistic approach, by
integrating physical, psychosocial and mental health care for patients
with lymphoedema caused by podoconiosis, LF and leprosy within all
levels of the routine health system. By finding out what works best in
the integration of care – integration both within the government-run
health care system, and across the three diseases and co-morbid mental
illnesses –, we hope that the care for people living with these diseases
improves, thereby reducing their burden.
244
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Introduction: Podoconiosis is a type of tropical lymphoedema that
causes massive swelling of the lower limbs. The disease is associated
with both economic insecurity, due to long-term morbidity-related loss
of productivity, and intense social stigma. Reliable and detailed data on
the prevalence and distribution of podoconiosis are scarce.
Aim: To determine the prevalence and geographical distribution of
podoconiosis within all districts of Rwanda among the adult population
(≥15 years) and to estimate the number of podoconiosis cases by district
across the country.
Methods: A population-based cross-sectional survey was conducted to
determine the national prevalence of podoconiosis. A podoconiosis case
was defined as a person residing in the study district for at least ten years
with bilateral, asymmetrical lymphoedema of the lower limb present for
more than one year, who tested negative for Wuchereria bancrofti antigen
and specific IgG4 using the FTS and Wb123 test respectively and had a
history of any of the associated clinical signs and symptoms. All adults
(≥15 years) who resided in all 30 districts of Rwanda for ten or more
years were invited at the household level to participate. We then fitted a
binomial mixed model combining the site-level podoconiosis prevalence
with continuous environmental covariates to estimate prevalence at
unsampled locations. Finally, we produced estimates of cases by district
combining our mean predicted prevalence and a contemporary gridded
map of estimated population density.
Results: In July 2017, a total of 1,360,612 individuals; 719,730 (52.9%)
women and 640,882 (47.1%) men were screened from 80 clusters in 30
districts across Rwanda. In total, 1,143 individuals with lymphoedema
were identified, of whom 914 (79.9%) confirmed podoconiosis cases were
based on the standardized diagnostic algorithm. The overall prevalence of
podoconiosis was 68.5 per 100,000 people (95% confidence interval [CI];
41.0-109.7). Podoconiosis was found to be widespread in Rwanda. District
level prevalence ranged from 28.3 (95% CI; 16.8-45.5, Nyarugenge, Kigali
province) to 119.2 (95%CI; 59.9-216.2, Nyamasheke, Western province)
per 100,000 people. We estimate that 6,429 (95%CI; 3,938- 10,088)
people live with podoconiosis across Rwanda.
Conclusions: Despite relatively low prevalence, podoconiosis is widely
distributed geographically throughout Rwanda. Many patients are likely
to be undiagnosed and morbidity management is limited. The findings
presented here are intended to inform national level planning, monitoring
and implementation of interventions.
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Introduction: Scabies, impetigo, dermatophytosis, and tungiasis are very
common and treatable diseases globally, which left untreated, may lead
to morbidity and important sequelae in children. Prevalence of these
diseases remains inadequately investigated in Guinea-Bissau.
Aim: To obtain prevalence data on common infectious skin diseases
including scabies, impetigo, tinea capitis and tinea corporis amongst
children in the Bijagos Archipelago, Guinea-Bissau.
Methods: Two population based cross-sectional prevalence surveys were
conducted in the wet and dry seasons of 2018. Data from the dry season
were collected from randomly selected villages across 6 islands in the
archipelago. For logistical reasons, the wet season data were collected
from all villages on the most populous island Bubaque. Trained investiga-
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Results: Wet season: 486 participants aged 1-15 years were recruited.
Prevalences were: tinea capitis 20.6%, impetigo: 8.6%, tinea corporis:
8.4%, scabies: 1.7%, tungiasis: 0%. 94% had 1 diagnosis, 6% had 2
diagnoses, 1% had 3 diagnoses. 47% of participants were female, 53%
were male.
Dry season: 1062 participants aged 0-9 years were recruited. Prevalences
were: tinea capitis 14.5%, impetigo: 7.7%, tinea corporis: 7.9%, scabies:
5.3%, tungiasis: 0.8%. 83% had 1 diagnosis, 14% had 2 diagnoses, and
3% had 3 diagnoses. 52% of the participants were female, 48% were
male.
Tinea capitis was associated with: the wet season (OR 1.9, 95% CI: 1.38-
2.6, p <0.001), and with male gender (OR 3.1, 95% CI: 2.3-4.2, p <0.001).
Conclusion: This study is the first of its kind to demonstrate the high
burden of treatable skin disease in Guinea-Bissau and we use a robust
sampling method. The integrated approach for diagnosing and managing
skin disease used in this study improves efficiency, use of resources and
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